angiotensin ii, des-phe(8)- has been researched along with angiotensin i in 1469 studies
| Studies (angiotensin ii, des-phe(8)-) | Trials (angiotensin ii, des-phe(8)-) | Recent Studies (post-2010) (angiotensin ii, des-phe(8)-) | Studies (angiotensin i) | Trials (angiotensin i) | Recent Studies (post-2010) (angiotensin i) |
|---|---|---|---|---|---|
| 1,533 | 21 | 995 | 30 | 0 | 22 |
| 1,533 | 21 | 995 | 4,218 | 125 | 1,253 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (0.27) | 18.7374 |
| 1990's | 105 (7.15) | 18.2507 |
| 2000's | 340 (23.14) | 29.6817 |
| 2010's | 804 (54.73) | 24.3611 |
| 2020's | 216 (14.70) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Deddish, PA; Erdös, EG; Tan, F | 1 |
| Coffman, TM; Cunha, TS; Elased, KM; Gurley, SB; Morris, M | 1 |
| Averill, DB; Chappell, MC; Diz, DI; Ferrario, CM; Figueroa, JP; Rose, JC; Shaltout, HA; Westwood, BM | 1 |
| Castro, P; Collantes, P; Copaja, M; Diaz-Araya, G; Godoy, I; Jalil, JE; Lavandero, S; Ocaranza, MP; Pinto, M; Ramirez, C; Roman, M; Varas, M | 1 |
| Arthur, JM; Bland, AM; Janech, MG; Raymond, JR; Velez, JC | 1 |
| Oliveira, EB; Pereira, HJ; Salgado, MC; Souza, LL | 1 |
| Batlle, D; Evora, K; Garcia-Halpin, L; Gonzalez-Pacheco, FR; Poglitsch, M; Salem, M; Schuster, M; Wysocki, J; Ye, M | 1 |
| Almalik, A; Flores-Muñoz, M; Godinho, BM; Nicklin, SA | 1 |
| Bujak-Gizycka, B; Gebska, A; Jawien, J; Korbut, R; Kus, K; Madej, J; Olszanecki, R; Suski, M; Toton-Zuranska, J | 1 |
| Fattah, C; Loughrey, CM; McKinney, CA; Milligan, G; Nicklin, SA | 1 |
| Bustamante, M; Chiong, M; García, L; Lavandero, S; Ocaranza, MP; Pavez, M; Westermeier, F | 1 |
| Akashi, AP; Amaral, SL; Becari, C; Colombini-Ishikiriama, BL; Didier, DN; Dionísio, TJ; Faria, FA; Figueiredo, CM; Garlet, GP; Greene, AS; Lima, MC; Maciel, RP; Matus, I; Morandini, AC; Oliveira, EB; Rodini, CO; Salgado, MC; Santos, CF; Sipert, CR; Souza, GP | 1 |
| Azocar, A; Castro, PF; Chiong, M; Jalil, JE; Lavandero, S; Mendoza-Torres, E; Mondaca-Ruff, D; Ocaranza, MP; Oyarzún, A | 1 |
| Simões E Silva, AC; Teixeira, MM | 1 |
| Kittana, N | 1 |
| Awan, FR; Hussain, M | 1 |
| Barocci, S; Benedetti, S; Canonico, B; Carlotti, E; Montanari, M; Nordi, E; Vandini, D; Zamai, L | 1 |
| Brosnihan, KB; DiCorleto, PE; Ferrario, CM; Jacobsen, DW; Santos, RA | 1 |
| Brosnihan, KB; Chappell, MC; Ferrario, CM; Yamamoto, K | 1 |
| Baracho, NC; Santos, RA | 1 |
| Diz, DI; Pirro, NT | 1 |
| Braszko, J; Hoły, Z; Kupryszewski, G; Wiśniewski, K; Witczuk, B | 1 |
| Campbell, DJ; Clark, IJ; Lawrence, AC | 1 |
| Jarrott, B; Krstew, E; Widdop, RE | 1 |
| Batista, EN; Campagnole-Santos, MJ; Heringer, SB; Khosla, MC; Santos, RA | 1 |
| Brosnihan, KB; Chappell, MC; Ferrario, CM; Greene, LJ; Santos, RA; Welches, WR | 1 |
| Brosnihan, KB; Chappell, MC; Ferrario, CM; Khosla, MC; Kohara, K | 1 |
| Diz, DI; Ferrario, CM; Jaiswal, N; Tallant, EA | 1 |
| Brosnihan, KB; Diz, DI; Ferrario, CM; Jaiswal, N; Khosla, MC; Milsted, A; Tallant, EA | 1 |
| Diz, DI; Ferrario, CM; Jaiswal, N; Khosla, MC; Tallant, EA | 1 |
| Barnes, KL; Felix, D; Ferrario, CM; Imboden, H; Khosla, MC; Montani, B | 1 |
| Ferrario, C; Fouad-Tarazi, FM; Khosla, M; Kumagai, H | 1 |
| Campagnole-Santos, MJ; Diz, DI; Ferrario, CM | 1 |
| Barnes, KL; Ferrario, CM; Knowles, WD | 1 |
| Ferrario, CM; Khosla, MC; Meixner, K; Trachte, GJ | 1 |
| Barnes, KL; Block, CH; Brosnihan, KB; Diz, DI; Ferrario, CM; Khosla, MC; Santos, RA | 1 |
| Brosnihan, KB; Campagnole-Santos, MJ; Diz, DI; Ferrario, CM; Khosla, MC; Santos, RA | 1 |
| Brosnihan, KB; Chappell, MC; Diz, DI; Ferrario, CM | 1 |
| Brosnihan, KB; Ferrario, CM; Khosla, MC; Santos, RA; Schiavone, MT | 1 |
| Imura, H; Khosla, MC; Kono, T; Oseko, F; Taniguchi, A | 1 |
| Benter, IF; Diz, DI; Ferrario, CM | 1 |
| Khosla, MC; Lima, CV; Paula, RD; Santos, RA | 1 |
| Dean, RH; Ferrario, CM; Fuller, SB; Nakamoto, H; Robaczewski, DL; Winicov, E | 1 |
| Smith, RD | 1 |
| Hintze, TH; Nasjletti, A; Seyedi, N; Xu, X | 1 |
| Benter, IF; Diz, DI; Ferrario, CM; Morris, M | 1 |
| Absher, DR; Rowe, BP; Saylor, DL; Speth, RC | 1 |
| Block, CH; Calka, J | 1 |
| Ahima, RS; Kadowitz, PJ; Khosla, MC; Minkes, RK; Osei, SY; Weaver, JP | 1 |
| Brosnihan, B; Bunnemann, B; Cintra, A; Ganten, D; Hasselrot, U; Hilgenfeldt, U; Lippoldt, A; Metzger, R; Rosén, L; Ueki, A | 1 |
| Carr, RD; Henderson, IW; Mahon, JM; Nicol, AK | 1 |
| Bell-Quilley, CP; Hilchey, SD | 1 |
| Ferrario, CM; Ganten, D; Matsumura, K; Moriguchi, A; Reilly, TM; Tallant, EA; Walton, H | 1 |
| Garcia, NH; Garvin, JL | 1 |
| Ambühl, P; Felix, D; Khosla, MC | 1 |
| Baracho, NC; Caligiorne, SM; Campagnole-Santos, MJ; Fontes, MA; Gropen Júnior, C; Neves, LA; Oliveira, DR; Rodrigues, AR; Santos, RA; Silva, LC | 1 |
| Busse, R; Hecker, M | 1 |
| Campagnole-Santos, MJ; Fontes, MA; Guertzenstein, PG; Khosla, MC; Santos, RA; Silva, LC | 1 |
| Block, CH; Botelho, LM; Khosla, MC; Santos, RA | 1 |
| Brosnihan, KB; Ferrario, CM; Ganten, D; Kumagai, H; Moriguchi, A; Senanayake, PD | 1 |
| Cheng, DY; Dent, EL; DeWitt, BJ; Kadowitz, PJ; Nossaman, BD | 1 |
| Bell-Quilley, CP; DelliPizzi, AM; Hilchey, SD | 1 |
| Bara, AT; Busse, R; Hecker, M; Pörsti, I | 1 |
| Campagnole-Santos, MJ; Santos, RA | 1 |
| Adler-Graschinsky, E; Enero, MA; Gironacci, MM; Peña, C | 1 |
| Campagnole-Santos, MJ; Campos, RR; Fontes, MA; Guertzenstein, PG; Khosla, MC; Santos, RA; Silva, LC | 1 |
| Busija, DW; Meng, W | 1 |
| Andreatta-van Leyen, S; Douglas, JG; Khosla, MC; Romero, MF | 1 |
| Cooney, AS; Fitzsimons, JT | 1 |
| Diz, DI; Ferrario, CM; Jaiswal, N; Jaiswal, RK; Tallant, EA | 1 |
| Campbell, DJ; Duncan, AM; Harrap, SB; Kladis, A | 1 |
| Batlle, D; Flores, G; Ye, M | 1 |
| Brosnihan, KB; Ferrario, CM; Li, P | 1 |
| Baracho, NC; Cesar, KR; Khosla, MC; Magaldi, AJ; Passaglio, KT; Santos, RA; Simões e Silva, AC | 1 |
| Allen, M; Fitzsimons, JT; Herbert, J; Mahon, JM | 1 |
| Chisolm, GM; Ferrario, CM; Freeman, EJ; Tallant, EA | 1 |
| Diz, DI; Ferrario, CM | 1 |
| Ferrario, CM; Handa, RK; Strandhoy, JW | 1 |
| Brosnihan, KB; Fernandez, C; Ferrario, CM; Luque, M; Martell, N; Martin, P | 1 |
| Botelho, LM; Carvalho, AC; Greene, LJ; Santos, RA | 1 |
| Campagnole-Santos, MJ; Fontes, MA; Khosla, MC; Lima, DX; Oliveira, RC; Santos, RA | 1 |
| Berglund, L; Reneland, R | 1 |
| Chappell, MC; Ferrario, CM; Lu, X; Tallant, EA; Weiss, RB | 1 |
| Brosnihan, KB; Chappell, MC; Ferrario, CM; Li, P | 1 |
| Bosch, SM; Diz, DI; Falgui, B; Ferrario, CM; Ganten, D; Kent, J; Westwood, BM | 1 |
| Higson, JT; Tallant, EA | 1 |
| Campagnole-Santos, MJ; Fontes, MA; Khosla, MC; Lopes, OU; Martins Pinge, MC; Naves, V; Santos, RA | 1 |
| Adler-Graschinsky, E; Gironacci, MM; Lorenzo, PS | 1 |
| Abbas, A; Carbini, LA; Gorelik, G; Scicli, AG | 1 |
| Brosnihan, KB; Chappell, MC; Diz, DI; Ferrario, CM; Tallant, EA | 1 |
| Khosla, MC; Lima, CV; Paula, RD; Resende, FL; Santos, RA | 1 |
| Britto, RR; Campagnole-Santos, MJ; Fagundes-Moura, CR; Khosla, MC; Santos, RA | 1 |
| Forster, C; le Tran, Y | 1 |
| Heyne, N; Osswald, H; Richter, K; Vallon, V | 1 |
| Benter, IF; Harper, JL; Malik, KU; Muthalif, MM; Uddin, MR | 1 |
| Brosnihan, KB; Ferrario, CM; Ganten, D; Li, P | 1 |
| Chappell, MC; Ferrario, CM; Iyer, SN | 1 |
| Chappell, MC; Ferrario, CM; Pirro, NT; Sykes, A | 1 |
| Averill, DB; Chappell, MC; Diz, DI; Ferrario, CM; Iyer, SN | 1 |
| Brosnihan, KB; Chappell, MC; Dean, RH; Fernandez, A; Ferrario, CM; Flack, JM; Luque, M; Martell, N; Novikov, SV; Pinillas, C; Yunis, C | 1 |
| Deddish, PA; Erdös, EG; Jackman, HL; Marcic, B; Skidgel, RA; Wang, HZ | 1 |
| Carbini, LA; Gorelik, G; Scicli, AG | 1 |
| Ferrario, CM; Friedman, DP; Krob, HA; Vinsant, SL | 1 |
| Fechter, K; Heyne, N; Khosla, MC; Richter, K; Vallon, V | 1 |
| Baracho, NC; Bello, AP; Khosla, MC; Santos, RA; Simões e Silva, AC | 1 |
| Chappell, MC; Ferrario, CM; Ganten, D; Iyer, SN; Yamada, K | 1 |
| Gironacci, M; López Ordieres, MG; Peña, C; Rodríguez de Lores Arnaiz, G | 1 |
| Brosnihan, KB; Ferrario, CM; Li, P; Tallant, EA | 1 |
| Chappell, MC; Diz, DI; Ferrario, CM; Yunis, C | 1 |
| Brosnihan, KB | 1 |
| Bomtempo, CA; Campagnole-Santos, MJ; Santos, GF; Santos, RA | 1 |
| Chappell, MC; Diz, DI; Ferrario, CM; Iyer, SN | 1 |
| Baracho, NC; Khosla, MC; Santos, RA; Simões-e-Silva, AC | 1 |
| Ferrario, CM; Iyer, SN | 1 |
| Ferrario, CM; Strawn, WB; Tallant, EA | 1 |
| Brosnihan, KB; Chappell, MC; Ferrario, CM; Fukuhara, M; Iyer, SN; Yamada, K | 1 |
| Handa, RK | 2 |
| Buikema, H; de Zeeuw, D; Henning, RH; Pinto, YM; Roks, AJ; van Geel, PP; van Gilst, WH | 1 |
| Britto, RR; Campagnole-Santos, MJ; Khosla, MC; Lima, CV; Paula, RD; Santos, RA | 1 |
| Campagnole-Santos, MJ; Fontes, MA; Khosla, MC; Lima, DX; Santos, RA | 1 |
| Davie, AP; McMurray, JJ | 1 |
| Diz, DI; Ferrario, CM; Tallant, EA | 1 |
| Jarrott, B; Sampey, DB; Widdop, RE | 1 |
| Coba, MP; Gironacci, MM; Peña, C | 1 |
| De Carvalho, MH; Fortes, ZB; Kosla, MC; Oliveira, MA; Santos, RA | 1 |
| Dixon, B; Rowe, BP | 1 |
| Chappell, MC; Ferrario, CM; Gomez, MN; Pirro, NT | 1 |
| Andrade, SP; Machado, RD; Santos, RA | 2 |
| Linz, W; Malinski, T; Schölkens, BA; Wiemer, G; Wohlfart, P | 1 |
| Cervenka, L; Heller, J; Horácek, V; Kramer, HJ; Malý, J | 1 |
| Ashino, K; Gotoh, E; Ishii, M; Masumori-Maemoto, S; Nagahara, T; Ueda, S; Umemura, S | 1 |
| Almeida, AP; Campagnole-Santos, MJ; Frábregas, BC; Madureira, MM; Santos, RA; Santos, RJ | 1 |
| Fernández, BE; Gironacci, MM; Peña, C; Rodriguez-Fermepín, M; Vatta, M | 1 |
| Chappell, MC; Diz, DI; Ferrario, CM; Iyer, SN; Yamada, K | 1 |
| Feterik, K; Katusic, ZS; Smith, L | 1 |
| Caruso-Neves, C; Grossi, AL; Lara, LS; Lopes, AG; Rangel, LB | 1 |
| Andrade, SP; Campagnole-Santos, MJ; Santos, RA | 1 |
| Coviello, A; Jerez, S; Peral de Bruno, M; Santos, JC | 1 |
| Coleman, MJ; Dampney, RA; Horiuchi, J; Potts, PD | 1 |
| Allred, AJ; Averill, DB; Chappell, MC; Ferrario, CM; Iyer, SN; Yamada, K | 1 |
| Bader, M; Baltatu, O; Caligiorne, SM; Campagnole-Santos, MJ; Fontes, MA; Ganten, D; Santos, RA | 1 |
| Allred, AJ; Chappell, MC; Diz, DI; Ferrario, CM | 1 |
| Min, L; Sim, MK; Xu, XG | 1 |
| Khosla, MC; Milsted, A; Neves, LA; Santos, RA | 1 |
| Fernandez, BE; Gironacci, MM; Peña, C; Rodríguez-Fermepín, M; Rubio, M; Vatta, M | 1 |
| Caligiorne, SM; Campagnole-Santos, MJ; Chaves, GZ; Khosla, MC; Santos, RA | 1 |
| Campbell, DJ; Moritz, KM; Wintour, EM | 1 |
| Catelli De Carvalho, MH; Fernandes, L; Fortes, ZB; Nigro, D; Santos, RA; Tostes, RC | 1 |
| Ardaillou, R; Chansel, D; Curat, C; Oko, A; Vandermeersch, S | 1 |
| Brunner, DB; Brunner, HR; Linder, L; Nussberger, J; Nyfeler, JA | 1 |
| Clark, MA; Diz, DI; Tallant, EA | 2 |
| DiBona, GF; Jones, SY | 1 |
| Brown, NJ; Gainer, JV; Murphey, LJ; Vaughan, DE; Wilsdorf, T | 1 |
| Cao, YX; Shen, LL; Sun, ZJ; Wang, J; Wang, Q; Zhu, DN | 1 |
| Campagnole-Santos, MJ; Heringer-Walther, S; Khosla, MC; Santos, RA; Walther, T | 1 |
| Allred, AJ; Chappell, MC; Ferrario, CM | 1 |
| Ihara, H; Nagai, N; Napiorkowska-Pawlak, D; Pawlak, R; Takada, A; Takada, Y; Urano, T | 1 |
| Higashi, Y; Kajiyama, G; Matsuura, H; Nakagawa, K; Oshima, T; Sasaki, S | 1 |
| Danser, AH; de Vries, R; Saxena, PR; Tom, B | 1 |
| Bader, M; Passaglio, KT; Pesquero, JB; Simões E Silva, AC; Souza Dos Santos, RA | 1 |
| Almeida, AP; Ferreira, AJ; Santos, RA | 2 |
| Elgemark, MK; Handa, RK; Handa, SE | 1 |
| Brosnihan, KB; Ishii, M; Masumori-Maemoto, S; Ueda, S; Umemura, S; Wada, A | 1 |
| Arima, S; Ito, S | 1 |
| Bica, RB; Caruso-Neves, C; Correa, JS; Lara, LS; Lopes, AG; Marques-Fernandes, MF; Sena, SL | 1 |
| Caligiorne, S; Frézard, F; Santos, RA; Silva-Barcellos, NM | 1 |
| Bradley, WE; Brosnihan, KB; Dell'Italia, LJ; Farrell, DM; Ferrario, CM; Jaffa, AA; Wei, CC | 1 |
| Borges, EL; Braga, AA; Cabral, BM; Neves, MJ; Rogana, E; Santos, RA | 1 |
| Bayorh, MA; Eatman, D; Emmett, N; Socci, RR; Thierry-Palmer, M; Walton, M | 1 |
| Beirão, PS; Bevilaqua, ER; Kushmerick, C; Naves, LA | 1 |
| Yang, YJ; Zhong, J; Zhu, ZM | 1 |
| Fernández-Tomé, Mdel C; Gironacci, MM; Peña, C; Speziale, E; Sterin-Speziale, N | 1 |
| Buczko, W; Chabielska, E; Kucharewicz, I; Matys, T; Pawlak, D; Rólkowski, R | 1 |
| Berrios, C; Brosnihan, KB; Corthorn, J; Ferrario, CM; Foradori, AC; Germain, AM; Valdés, G | 1 |
| Baggerman, G; Broeck, JV; Le, MT; Vanderheyden, PM; Vauquelin, G | 1 |
| Carretero, OA; Garvin, JL; Ren, Y | 1 |
| Ferrario, CM | 4 |
| Boomsma, F; Henning, RH; Loot, AE; Roks, AJ; Suurmeijer, AJ; Tio, RA; van Gilst, WH | 1 |
| Campagnole-Santos, MJ; Côrtes, SF; Lemos, VS; Santos, RA; Silva, DM | 1 |
| diZerega, GS; Rodgers, KE; Xiong, S | 1 |
| Braga, AN; da Silva Lemos, M; da Silva, JR; dos Santos, RA; Fontes, WR | 1 |
| Bader, M; Baltatu, O; Campagnole-Santos, MJ; Couto, AS; Ganten, D; Santos, RA | 1 |
| Tangelder, GJ; Ter Wee, PM; van Lambalgen, TA; van Rodijnen, WF; van Wijhe, MH | 1 |
| Naito, Y; Takada, A; Takada, Y; Urano, T; Yoshida, M | 1 |
| Igić, R; Jackman, HL; Mahmood, A; Teplitz, L | 1 |
| Andrade, SP; Belo, AV; Ferreira, MA; Machado, RD; Santos, RA | 1 |
| Carvalho, MH; Fortes, ZB; Nigro, D; Oliveira, MA; Passaglia, Rde C | 1 |
| Averill, DB; Brosnihan, KB; Chappell, MC; Dean, RH; Diz, DI; Ferrario, CM; Iskandar, SS | 1 |
| Alzamora, AC; Campagnole-Santos, MJ; Santos, RA | 2 |
| Liu, D; Tepel, M; Van Der Giet, M; Zhong, J; Zhu, S; Zhu, Z | 1 |
| Buczko, W; Kucharewicz, I; Matys, T; Pawlak, D; Pawlak, R | 1 |
| Bürgelová, M; Cervenka, L; Heller, J; Kramer, HJ; Malý, J; Teplan, V; Velicková, G; Vítko, S | 1 |
| Davie, AP; McMurray, J | 1 |
| Brosnihan, KB; Chen, K; Ferrario, CM; Karoly, M; Merrill, DC | 1 |
| Dobrucki, LW; Heitsch, H; Louka, FR; Malinski, T; Wiemer, G | 1 |
| Buczko, W; Chabielska, E; Kucharewicz, I; Matys, T; Pawlak, R | 1 |
| Bosch, S; Clark, MA; Diz, DI; Tallant, EA; Tommasi, E | 1 |
| Caruso-Neves, C; Fernandes, MS; Leão-Ferreira, LR; Lopes, AG; Luz, FF; Provenzano, K; Santos, FM | 1 |
| Nascimento, AA; Sampaio, WO; Santos, RA | 1 |
| Dupont, A; Ebinger, G; Michotte, Y; Sarre, S; Smolders, I; Vanderheyden, P; Vauquelin, G | 1 |
| diZerega, G; Espinoza, T; Felix, J; Maldonado, S; Roda, N; Rodgers, KE | 1 |
| Campagnole-Santos, MJ; Guerra, MT; Haibara, AS; Khosla, MC; Leite, MF; Lemos, VS; Paula, RD; Pinheiro, SV; Santos, RA; Silva, DM; Simões e Silva, AC | 1 |
| DiZerega, GS; Rodgers, K; Xiong, S | 1 |
| Danser, AH; Dendorfer, A; Tom, B | 1 |
| Costa, AP; Dos Reis, AM; Fagundes-Moura, CR; Pereira, VM; Santos, RA; Silva, LF; Vieira, MA | 1 |
| Aschner, JL; Averill, DB; Brosnihan, KB; Chappell, MC; Ferrario, CM; Neves, LA; Walkup, MP | 1 |
| Alhenc-Gelas, F; Campbell, WB; Skidgel, RA | 1 |
| Carey, RM; Siragy, HM | 1 |
| Bild, W; Boisteanu, CP; Haulica, I; Ionita, T; Mihaila, CN; Neagu, B | 1 |
| Derdau, V; Oekonomopulos, R; Schubert, G | 1 |
| Henning, RH; Roks, AJ | 1 |
| Oberhauser, V; Rump, LC; Stegbauer, J; Vonend, O | 2 |
| Bader, M; Campagnole-Santos, MJ; de Buhr, I; Heringer-Walther, S; Lemos, VS; Lopes, MT; Machado, RP; Maric, C; Mendes, EP; Pinheiro, SV; Santos, RA; Schultheiss, HP; Silva, DM; Simoes e Silva, AC; Speth, R; Walther, T | 1 |
| Averill, DB; Brosnihan, KB; Ferrario, CM; Neves, LA; Walkup, MP; Williams, AF | 1 |
| Bie, P; Plovsing, RR; Sandgaard, NC; Wamberg, C | 1 |
| Bie, P; Hoilund-Carlsen, PF; Holstein-Rathlou, NH; Plovsing, RR; Sandgaard, NC; Simonsen, JA; Wamberg, C | 1 |
| Averill, DB; Brosnihan, KB; Chappell, MC; Ferrario, CM; Joyner, J; Neves, LA; Penninger, J; Sarao, R | 1 |
| Cao, YX; Shen, LL; Wang, J; Zhu, DN | 1 |
| Clark, MA; Tallant, EA | 1 |
| Chiong, M; Godoy, I; Jalil, JE; Lavandero, S; Ocaranza, MP; Palomera, C; Román, M | 1 |
| Bristow, MR; Canver, CC; Meixell, GE; Zisman, LS | 1 |
| Bristow, MR; Canver, CC; Keller, RS; Lin, Q; Speth, R; Weaver, B; Zisman, LS | 1 |
| Averill, DB; Chappell, MC; Ferrario, CM; Ishiyama, Y | 1 |
| Cesar, KR; de Araújo, M; Magaldi, AJ; Santos, RA; Simões e Silva, AC | 1 |
| Dobruch, J; Khosla, MC; Paczwa, P; Szczepańska-Sadowska, E; Łoń, S | 1 |
| diZerega, GS; Ellefson, DD; Espinoza, T; Maldonado, S; Roda, N; Rodgers, KE | 1 |
| Collister, JP; Hendel, MD | 1 |
| Behnia, R; Garber, S; Igić, R; Sekosan, M; Urbanska, RA | 1 |
| Caruso-Neves, C; Fernandes, MS; Leão-Ferreira, LR; Lopes, AG; Quintana-Gomes, E; Santos, DP; Soares, AC | 1 |
| Correia, ML; de Carvalho, LC; Emiliano, AF; Mendes-Ribeiro, AC; Resende, AC; Soares de Moura, R; Tano, T | 1 |
| Gironacci, MM; Gorzalczany, S; Peña, C; Taira, C; Yujnovsky, I | 1 |
| Caligiorne, S; dos Santos, RA; Frézard, F; Silva-Barcellos, NM | 1 |
| Bernstein, KE; Brosnihan, KB; Chappell, MC; Gallagher, PE; Kramer, GL; Modrall, JG; Sadjadi, J; Yu, CH | 1 |
| Averill, DB; Brosnihan, KB; Ferrario, CM; Gallagher, PE; Ishiyama, Y; Tallant, EA | 1 |
| Carey, RM | 1 |
| Bader, M; Baltatu, O; Braga, AN; Campagnole-Santos, MJ; de Almeida, AP; Ferreira, AJ; Iliescu, R; Nadu, AP; Reudelhuber, TL; Santos, RA | 1 |
| Campagnole-Santos, MJ; de Carvalho, MH; Fernandes, L; Maia, LG; Ramos, MC; Souza dos Santos, RA | 1 |
| Burke-Wolin, T; Du, L; Li, X; Oeckler, R; Olson, S; Traganos, F; Zhao, X | 1 |
| Abi-Abib, R; Cardozo, FP; Caruso-Neves, C; De Souza, AM; Fernandes, MS; Fossari, RN; Lopes, AG; Miguel, NC; Pizzino, CP; Santos, DP | 1 |
| Diniz, JS; Regueira Filho, A; Santos, RA; Simões E Silva, AC | 1 |
| Chappell, MC; Diz, DI; Ferrario, CM; Modrall, JG | 1 |
| Anton, L; Brosnihan, KB; Joyner, J; Merrill, DC; Neves, LA; Valdes, G | 1 |
| Grant, PJ; Hooper, NM; Rice, GI; Thomas, DA; Turner, AJ | 1 |
| Gallagher, PE; Tallant, EA | 1 |
| Alenina, N; Bader, M; Bleich, M; Bontempo, ED; de Paula, RD; Mendes, EP; Pesquero, JB; Pinheiro, SV; Sampaio, WO; Santos, RA; Simões e Silva, AC; Walther, T | 1 |
| Aschner, JL; Averill, DB; Brosnihan, KB; Ferrario, CM; Neves, LA | 1 |
| Campbell, DJ; Esler, MD; Horowitz, JD; Zeitz, CJ | 1 |
| Gironacci, MM; Peña, C; Valera, MS; Yujnovsky, I | 1 |
| Burns, KD; Cheng, K; Li, N; Wilkins, JA; Zimpelmann, J | 1 |
| Langeveld, B; Roks, AJ; Tio, RA; van Gilst, WH; Zijlstra, F | 1 |
| Chappell, MC; Ferrario, CM | 1 |
| Ferreira, AJ; Mendes, AC; Pinheiro, SV; Santos, RA | 1 |
| de Zeeuw, D; Henning, RH; Nijholt, J; Roks, AJ; van Buiten, A; van Gilst, WH | 1 |
| Chen, RF; Jiao, XY; Wang, J; Zhao, RR; Zhi, JM | 1 |
| Nishio, I; Tsuda, K | 1 |
| Ecarnot-Laubriet, A; Oudot, A; Rochette, L; Vergely, C | 1 |
| Casarini, DE; de Carvalho, MH; Fernandes, L; Fortes, ZB; Nigro, D; Santos, RA; Tostes, RC | 1 |
| Reudelhuber, TL | 2 |
| Boomsma, F; de Jong, PE; Kocks, MJ; Lely, AT; Navis, G | 1 |
| Gaspari, TA; Walters, PE; Widdop, RE | 1 |
| Bürgelová, M; Cervenka, L; Kramer, HJ; Teplan, V; Thumová, M | 1 |
| De Mello, WC | 7 |
| Becker, LK; Campagnole-Santos, MJ; Santos, RA | 1 |
| Ferrario, CM; Gallagher, PE; Geary, RL; Igase, M; Strawn, WB | 1 |
| Chrisman, PA; McLuckey, SA; Pitteri, SJ | 1 |
| Cai, YM; He, JG; Liao, XX; Liu, J; Ma, H; Wang, LC; Wang, LJ; Zeng, WT | 2 |
| Averill, DB; Brosnihan, KB; Chappell, MC; Diz, DI; Ferrario, CM; Gallagher, PE; Jessup, J; Tallant, EA | 1 |
| Peng, YJ; Wang, J; Zhu, DN | 1 |
| Caruso-Neves, C; De Carvalho, T; Lara, LS; Leão-Ferreira, LR; Lopes, AG | 1 |
| Albrecht, D; Hellner, K; Schubert, M; Walther, T | 1 |
| Ferrario, CM; Gallagher, PE; Tallant, EA | 3 |
| Ferreira, AJ; Santos, RA | 2 |
| Averill, DB; Diz, DI; Ferrario, CM; Gallagher, PE; Kasper, SO; Sakima, A; Tommasi, EN | 1 |
| Cowling, RT; Greenberg, BH; Gurantz, D; Iwata, M; Moore, C; Yuan, JX; Zhang, S | 1 |
| Fontes, MA; Santos, RA; Silva, AQ | 1 |
| Campagnole-Santos, MJ; Ferreira, AJ; Pinheiro, SV; Sampaio, WO; Santos, RA; Touyz, R | 1 |
| Ferrario, CM; Jessup, JA; Trask, AJ | 1 |
| Duarte, FV; Faria-Silva, R; Santos, RA | 1 |
| diZerega, GS; Oliver, J; Rodgers, KE | 1 |
| Dantas, AP; Sandberg, K | 1 |
| Ebinger, G; Hristova, I; Michotte, Y; Sarre, S; Stragier, B | 1 |
| Alenina, N; Bader, M; Lemos, VS; Santos, RA; Silva, DM; Walther, T | 1 |
| Alenina, N; Almeida, AP; Bader, M; Castro, CH; Ferreira, AJ; Santos, RA | 2 |
| Campbell, DJ; Chirkov, YY; Horowitz, JD; Rajendran, S | 1 |
| Wilkinson-Berka, JL | 1 |
| Angus, PW; Burrell, LM; Cooper, ME; Lew, RA; Paizis, G; Schembri, JM; Shaw, T; Smith, AI; Tikellis, C; Warner, FJ; Zuilli, A | 1 |
| Chappell, MC; Ferrario, CM; Gallagher, PE; Tallant, EA | 1 |
| Grobe, JL; Katovich, MJ | 1 |
| Ann Tallant, E; Averill, DB; Brosnihan, KB; Chappell, MC; Ferrario, CM; Gallagher, PE; Jessup, J; Smith, RD | 1 |
| Bargetto, J; Jalil, JE; Lavandero, S; Ocaranza, MP; Palomera, C; Román, M | 1 |
| Ferreira, AJ; Frézard, F; Santos, RA | 1 |
| Akyurek, S; Altundag, K; Altundag, O; Silay, K; Turen, S | 1 |
| Allen, PL; Baker, CB; Gonzalez-Villalobos, R; Hammond, TG; Johanson, K; Klassen, RB; Kobori, H; Navar, LG | 1 |
| Axelband, F; Caruso-Neves, C; Cavalcante, F; De Souza, AM; Lara, Lda S; Lopes, AG | 1 |
| Anim, JT; Benter, IF; Cojocel, C; Diz, DI; Yousif, MH | 1 |
| Grobe, JL; Katovich, MJ; Mao, H; Mecca, AP | 1 |
| Ciobanu, A; Costuleanu, M; Gurzu, B; Petrescu, G; Slatineanu, SM | 1 |
| Boomsma, F; de Zeeuw, D; Deelman, LE; Henning, RH; Roks, AJ; van der Wouden, EA | 1 |
| Merino, M; Naftolin, F; Nemeth, G; Pepperell, JR; Yamada, Y | 1 |
| Alenina, N; Almeida, AP; Bader, M; Castro, CH; Cruz, JS; Ferreira, AJ; Gava, E; Irigoyen, MC; Kitten, GT; Paula, RD; Pinheiro, SV; Ramos, AS; Rosa, KT; Santos, RA | 1 |
| Burns, KD; Su, Z; Zimpelmann, J | 1 |
| Gironacci, MM; Höcht, C; Opezzo, JA; Peña, C; Taira, CA | 1 |
| Ferreira, AJ; Pereira, RM; Pinheiro, SV; Santos, RA; Simões e Silva, AC | 1 |
| Chappel, MC; Ferrario, CM | 1 |
| Almeida, AP; Bader, M; Castro, CH; Ferreira, AJ; Pinheiro, SV; Rentzsch, B; Reudelhuber, TL; Santos, RA; Silva, AC; Silva, GA | 1 |
| Brunner, HR; Gavras, H | 1 |
| de Zeeuw, D; Deelman, LE; Henning, RH; Ochodnický, P; Roks, AJ; van der Wouden, EA; van Dokkum, RP | 1 |
| Gamliel-Lazarovich, A; Kaplan, M; Keidar, S | 1 |
| Campbell, WB; Hanke, CJ; Holmes, BB; Nithipatikom, K; Xu, Y | 1 |
| Diniz, JS; Pereira, RM; Pinheiro, SV; Santos, RA; Simões e Silva, AC | 1 |
| Aranda, FJ; Aranda, P; Ferrario, CM; Gaitan, MJ; Mayor-Olea, A; Morcillo, L; Reyes-Engel, A; Ruiz, M | 1 |
| Bolton, TA; Grobe, JL; Katovich, MJ; Lingis, M; Machado, JM; Mecca, AP; Raizada, MK; Shenoy, V; Speth, RC | 1 |
| da Mata Machado, LT; Faria-Silva, R; Sampaio, WO; Schiffrin, EL; Souza dos Santos, RA; Touyz, RM | 1 |
| Campagnole-Santos, MJ; Cortes, SF; Lemos, VS; Santos, RA; Silva, DM; Vianna, HR | 1 |
| Dos Santos, RA; Frézard, F; Silva-Barcellos, NM | 1 |
| Barcelos, LS; Collares, GB; Costa, LP; da Costa Dias, FL; Dos Santos, RA; Leite, VH; Pereira, RM; Simões e Silva, AC; Teixeira, MM | 1 |
| Bramlage, P; Brosnihan, KB; Ferrario, CM; Kirch, W; Koch, R; Maywald, U; Oertel, R; Schindler, C | 1 |
| Bader, M; Botelho-Santos, GA; Campagnole-Santos, MJ; Reudelhuber, TL; Sampaio, WO; Souza dos Santos, RA | 1 |
| Al-Maghrebi, M; Benter, IF; Cojocel, C; Diz, DI; Yousif, MH | 1 |
| Peña, C; Pereyra-Alfonso, S; Rodríguez de Lores Arnaiz, G | 1 |
| Baber, SR; Fokin, A; Greco, AJ; Kadowitz, PJ; Master, RG | 1 |
| Cabral, AC; Drumond, TC; Freire, CM; Machado, LJ; Nogueira, AI; Ribeiro-Oliveira, A; Simões E Silva, AC; Souza Santos, RA; Vieira, RL | 1 |
| Averill, DB; Chappell, MC; Ferrario, CM; Ganten, D; Trask, AJ | 1 |
| Heringer-Walther, S; Malberg, H; Schultheiss, HP; Walther, T; Wessel, N | 1 |
| Achike, FI; Dharmani, M; Mustafa, MR; Sim, MK | 1 |
| Agata, J; Hyakkoku, M; Sasaki, H; Shimamoto, K; Shinshi, Y; Taniguchi, S; Ura, N; Yoshida, H | 1 |
| Campagnole-Santos, MJ; Ferreira, PM; Souza Dos Santos, RA | 1 |
| Albrecht, D | 1 |
| Bartoli, F; Brosnihan, KB; Cerinic, MM; Cinelli, M; Ferrario, CM; Fiori, G; Generini, S; Guiducci, S; Livi, R; Perfetto, F; Pignone, A; Rogai, V; Rosso, AD; Tempestini, A | 1 |
| Callahan, MF; Cline, JM; Ferrario, CM; Gallagher, PE; Menon, J; Soto-Pantoja, DR; Tallant, EA | 1 |
| Chirkov, YY; Horowitz, JD; Rajendran, S | 1 |
| Cabral, AC; Kalapothakis, E; Santos, RA; Velloso, EP; Vieira, R | 1 |
| de Carvalho, MH; de Cássia Tostes Passaglia, R; dos Santos, R; Fortes, ZB; Nigro, D; Oliveira, MA; Rastelli, VM | 1 |
| Alexander, BT; Brosnihan, KB; Chappell, MC; Davis, WP; Ferrario, CM; Granger, JP; Joyner, J; Merrill, DC; Neves, LA | 1 |
| Huang, Y; Liu, CQ; Lu, LM | 1 |
| Moeller, JF; Simoni, G; Simoni, J; Tsikouris, JP; Wesson, DE | 1 |
| Casarini, DE; Irigoyen, MC; Ronchi, FA | 1 |
| Dominici, FP; Giani, JF; Gironacci, MM; Muñoz, MC; Peña, C; Turyn, D | 1 |
| Becker, LK; Campagnole-Santos, MJ; Etelvino, GM; Santos, RA; Walther, T | 1 |
| Chlopicki, S; Fedorowicz, A; Kozlovski, VI; Lomnicka, M | 1 |
| Angus, PW; Burrell, LM; Dean, RG; Herath, CB; Jia, Z; Lew, RA; Lubel, JS; Smith, AI; Warner, FJ | 1 |
| Gironacci, MM; Peña, C; Polizio, AH; Tomaro, ML | 1 |
| Bramlage, P; Ferrario, CM; Kirch, W; Schindler, C | 1 |
| Drazba, J; Hollyfield, JG; Karnik, S; Milsted, A; Miura, S; Nishiyama, K; Rungger-Brandle, E; Sears, JE; Senanayake, Pd; Shadrach, K | 1 |
| Ferrario, CM; Trask, AJ | 1 |
| Alenina, N; Bader, M; da Costa Gonçalves, AC; Fraga-Silva, RA; Leite, R; Pinheiro, SV; Reis, AB; Reis, FM; Santos, RA; Touyz, RM; Webb, RC | 1 |
| Chappell, MC; Gallagher, PE; Groban, L; Pendergrass, KD; Pirro, NT; Yamaleyeva, LM | 1 |
| Brosnihan, KB; Ferrario, CM; Gironacci, MM; Gorzalczany, S; Pascual, M; Peña, C; Taira, C; Verrilli, MA | 1 |
| Benter, IF; Kehinde, EO; Yousif, MH | 1 |
| Campagnole-Santos, MJ; Carvalho, MB; da Mata Machado, LT; de Paula, RD; Duarte, FV; Faria-Silva, R; Fauler, B; Santos, RA | 1 |
| Ferreira, AJ; Raizada, MK | 1 |
| De Mello, WC; Ferrario, CM; Jessup, JA | 1 |
| Bertera, FM; Gironacci, MM; Höcht, C; Mayer, MA; Schuman, M; Taira, CA | 1 |
| Benter, IF; Chappell, MC; Dhaunsi, GS; Diz, DI; Kaur, J; Yousif, MH | 1 |
| de Lima, GF; de Sousa, FB; Denadai, AL; Duarte, HA; Heine, T; Lula, I; Pilo-Veloso, D; Resende, JM; Santos, RA; Sinisterra, RD | 1 |
| Brosnihan, KB; Ferrario, CM; Gallagher, PE; Joyner, J; Merrill, DC; Neves, LA; Stovall, K; Valdés, G | 1 |
| Henrique de Castro, C; Sampaio, WO; Santos, RA; Schiffrin, EL; Touyz, RM | 1 |
| Azcutia, V; Gembardt, F; Heringer-Walther, S; Peiró, C; Rodríguez-Mañas, L; Sánchez-Ferrer, CF; Schultheiss, HP; Vallejo, S; Walther, T | 1 |
| Anton, L; Brosnihan, KB; Merrill, DC; Neves, LA | 1 |
| Alenina, N; Bader, M; Patkin, EL; Rentzsch, B; Xu, P | 1 |
| Cui, LQ; Guo, YJ; Li, WH; Wu, R; Xie, Q | 1 |
| Brosnihan, KB; Ferrario, CM; Joyner, J; Neves, LA; Stovall, K | 1 |
| Corvol, P; Hamming, I; Michaud, AA; Navis, G; Rushworth, CA; Turner, AJ; van Goor, H | 1 |
| Gilbert, JS; Granger, JP; LaMarca, BB | 1 |
| Burrell, LM; Hanchapola, I; Lew, RA; Manohar, J; Ramchand, J; Smith, AI; Warner, FJ; Yarski, MA | 1 |
| Kautiainen, H; Oksala, O; Vaajanen, A; Vapaatalo, H | 1 |
| Caruso-Neves, C; Correa, JS; Lara, LS; Lavelle, AB; Lopes, AG | 1 |
| Alzamora, AC; Campagnole-Santos, MJ; Ferreira, PM; Santos, RA | 1 |
| Anton, L; Brosnihan, KB; Diz, DI; Ferrario, CM; Gallagher, PE; Gruver, C; Merrill, DC; Moorefield, C; Neves, LA; Stovall, K | 1 |
| Lin, CS; Pan, CH; Wen, CH | 1 |
| Ji, H; Menini, S; Pesce, C; Sandberg, K; Wu, X; Zheng, W | 1 |
| Ferreira, AJ; Santos, RA; Simões E Silva, AC | 1 |
| Lin, CS; Pan, CH | 1 |
| Arnold, AC; Diz, DI; Ferrario, CM; Ganten, D; Sakima, A | 1 |
| Chappell, MC; Ferrario, CM; Garabelli, PJ; Modrall, JG; Penninger, JM | 1 |
| Chappell, MC; Ferrario, CM; Jessup, JA; Trask, AJ | 1 |
| Coffman, TM; Gurley, SB | 1 |
| Deng, BP; Dong, B; Dong, QL; Feng, JB; Li, SY; Liu, B; Liu, CX; Pan, CM; Song, HD; Yang, YP; Yu, QT; Zhang, C; Zhang, MX; Zhang, Y; Zhao, YX; Zhu, L | 1 |
| Luft, FC | 1 |
| Henning, RH; Iusuf, D; Roks, AJ; van Gilst, WH | 1 |
| Paton, JF; Raizada, MK | 1 |
| Dominici, FP; Giani, JF; Gironacci, MM; Muñoz, MC; Turyn, D | 1 |
| Becker, LK; Belchior, HA; Dias-Peixoto, MF; Ferreira, AJ; Filho, AG; Neves, SR; Pinheiro, SV; Santos, RA; Santos, SH; Silva Camargos, ER | 1 |
| Brosnihan, KB; Chappell, MC; Ferrario, CM; Pendergrass, KD; Pirro, NT; Westwood, BM | 1 |
| Averill, DB; Diz, DI; Ferrario, CM; Gallagher, PE; Ganten, D; Garcia-Espinosa, MA | 1 |
| Campbell, WB; Cui, L; Gauthier, KM; Nithipatikom, K; Zhang, DX | 1 |
| Ferrario, CM; Igase, M; Kohara, K; Miki, T; Nagai, T | 1 |
| Lu, J; Shi, J; Zhang, Y | 1 |
| Angus, PW; Burrell, LM; Herath, CB; Lubel, JS | 1 |
| He, M; Huang, Y; Lu, LM; Shao, Y; Yao, T; Zhou, L | 1 |
| Mallela, J; Pedigo, S; Perkins, R; Rimoldi, JM; Shariat-Madar, Z; Yang, J | 1 |
| Alenina, N; Almeida, PW; Alves, MN; Bader, M; Dias-Peixoto, MF; Fauler, B; Gomes, ER; Greco, L; Guatimosim, S; Rosa, M; Santos, RA | 1 |
| Chen, ZH; Feng, JQ; Guo, RX; Liao, XX; Ma, H; Wang, LC; Yang, CT | 1 |
| Grobe, JL; Katovich, MJ; Raizada, MK | 1 |
| Fyhrquist, F; Saijonmaa, O | 1 |
| Bader, M; Baltatu, OC; Campos, LA; Iliescu, R; Oliveira, ML; Popova, E; Rentzsch, B; Santos, RA; Todiras, M | 1 |
| Aranha, AB; Bader, M; Callera, GE; Ferreira, AJ; Mercure, C; Reudelhuber, TL; Santos, RA; Touyz, RM; Walther, T; Yogi, A | 1 |
| Bindom, SM; Lazartigues, E | 1 |
| Lavrentyev, EN; Malik, KU | 1 |
| Dominici, FP; Giani, JF; Gironacci, MM; Höcht, C; Mayer, MA; Muñoz, MC; Silberman, EA; Taira, CA; Turyn, D | 1 |
| Lazartigues, E; Lucchesi, PA; Stewart, JA | 1 |
| Bi, J; Carey, LC; Chappell, MC; Deibel, P; Figueroa, JP; Perrott, J; Rose, JC; Sun, X; Tang, L; Valego, N | 1 |
| Fan, F; Li, S; Nie, W; Yan, H; Yu, F; Zhang, Y; Zhu, J; Zhu, W | 1 |
| Chappell, MC; Diz, DI; Figueroa, JP; Rose, JC; Shaltout, HA | 1 |
| Burns, KD; Zimpelmann, J | 1 |
| Almeida, J; Nadu, AP; Ribeiro, Rda C; Ribeiro-Oliveira, A; Santos, RA; Simões e Silva, AC; Vieira, RL; Vilas-Boas, WW | 1 |
| Boas, WW; Dos Santos, RA; Nogueira, AI; Pereira, RM; Ribeiro-Oliveira, A; Simões e Silva, AC | 1 |
| Bahramifarid, N; Burns, KD; Gava, E; Kitten, GT; Samad-Zadeh, A; Santos, RA; Touyz, RM; Zimpelmann, J | 1 |
| Carneiro, MM; Ferreira, MC; Pinheiro, SV; Reis, AM; Reis, FM; Santos, RA; Silva, DA; Silva-Filho, AL; Vaz-Silva, J; Witz, CA | 1 |
| Al-Maghrebi, M; Benter, IF; Diz, DI | 1 |
| Dominici, FP; Gironacci, MM; Lopez Verrilli, MA; Pascual, MM; Pirola, CJ; Turyn, D | 1 |
| Alfany-Fernandez, I; Bintanel-Morcillo, M; Brosnihan, KB; Casillas-Ramirez, A; Ferrario, CM; Peralta, C; Rimola, A; Rodés, J; Roselló-Catafau, J; Serafin, A | 1 |
| Andrzejczak, D | 1 |
| Arthur, JM; Bland, AM; Budisavljevic, MN; Fitzgibbon, WR; Harbeson, CE; Janech, MG; Raymond, JR; Ryan, KJ; Velez, JC | 1 |
| Clarke, D; Medow, MS; Ocon, AJ; Stewart, JM; Taneja, I | 1 |
| Chen, J; He, Q; Li, Y; Pen, W; Shou, Z; Wu, J; Zhang, P; Zhu, Y | 1 |
| Falcão-Pires, I; Gonçalves, N; Henriques-Coelho, T; Leite-Moreira, AF; Moreira-Gonçalves, D; Roncon-Albuquerque, R | 1 |
| Angus, PW; Burrell, LM; Casley, D; Crowley, P; Grace, J; Herath, CB; Jia, Z; Lubel, JS; Sievert, W; Spencer, K; Tchongue, J | 1 |
| Eckert, K; Fichtner, I; Gembardt, F; Heringer-Walther, S; Rodgers, K; Schultheiss, HP; Schumacher, SM; Uharek, L; Walther, T; Wulf-Goldenberg, A | 1 |
| Angus, PW; Brown, L; Burrell, LM; Casley, D; Herath, CB; Jia, Z; Lubel, JS; Tikellis, C; Velkoska, E | 1 |
| Huang, ML; Li, X; Meng, Y; Ying, SS; Zhang, ZS | 1 |
| de Bruin, R; Egido, J; Esteban, V; Heringer-Walther, S; Mezzano, S; Ruiz-Ortega, M; Schultheiss, HP; Sterner-Kock, A; van den Engel, S; Walther, T; Wang, Y | 1 |
| Alenina, N; Bader, M; Bordoni, LS; Ferreira, AJ; França, LR; Leal, MC; Pinheiro, SV; Santos, RA | 1 |
| Bujak-Gizycka, B; Gebska, A; Korbut, R; Madej, J; Olszanecki, R; Suski, M | 1 |
| Horiuchi, M; Iwai, M | 2 |
| Almeida, J; dos Santos, RA; Nadu, AP; Pereira, RM; Ribeiro, Rda C; Ribeiro-Oliveira, A; Simões e Silva, AC; Vilas-Boas, WW | 1 |
| Okamoto, H | 1 |
| Park, TS; Zambidis, ET | 1 |
| Gallagher, PE; Menon, J; Soto-Pantoja, DR; Tallant, EA | 1 |
| Gao, YJ; Lee, RM; Lu, C; Su, LY | 1 |
| Anton, L; Brosnihan, KB; Corthorn, J; Diz, DI; Gallagher, PE; Gruver, C; Merrill, DC; Moorefield, C; Neves, LA; Stovall, K; Valdes, G | 1 |
| Castro-Chaves, P; Cerqueira, R; Fontes-Carvalho, R; Leite-Moreira, AF; Pintalhao, M | 1 |
| Alzamora, AC; Campagnole-Santos, MJ; Cangussu, LM; de Castro, UG; do Pilar Machado, R; dos Santos, RA; Ferreira, PM; Silva, ME | 1 |
| Burns, KD; Dilauro, M | 1 |
| Bader, M; Bürgelová, M; Cervenka, L; Dvorák, P; Kramer, HJ; Malý, J; Opocenský, M; Thumová, M; Vanourková, Z; Zelízko, M | 1 |
| Brosnihan, KB; Corthorn, J; Erices, R; Joyner-Grantham, J; Kaufmann, P; Valdes, G | 1 |
| Brenner, DA; De Minicis, S; Kluwe, J; Kodama, Y; Osterreicher, CH; Oudit, GY; Penninger, JM; Penz-Osterreicher, M; Schuster, M; Seki, E; Taura, K | 1 |
| Cassali, GD; dos Reis, AM; Honorato-Sampaio, K; Pereira, VM; Reis, FM; Santos, RA; Santos, SH | 1 |
| Gao, L; Patel, KP; Schultz, HD; Wang, W; Zucker, IH | 1 |
| Basu, R; Guo, D; Kassiri, Z; Liu, PP; Oudit, GY; Penninger, JM; Scholey, JW; Wang, X; Zhong, J | 1 |
| Huang, YS; Lei, ZY; Xiao, R; Zhang, BQ; Zhang, Q | 1 |
| Gallagher, PE; McCoy, TP; Miller, AA; Petty, WJ; Tallant, EA; Torti, FM | 1 |
| Byku, M; Macarthur, H; Westfall, TC | 1 |
| Ahmad, S; Brosnihan, KB; Chappell, MC; Ferrario, CM; Gallagher, PE; Groban, L; Tallant, EA; Varagic, J | 1 |
| Chappell, MC; Diz, DI; Gwathmey, TM; Pendergrass, KD; Reid, SD; Rose, JC | 1 |
| Barrios, C; Batlle, D; Brosnihan, KB; Evora, K; Ferrario, CM; González-Pacheco, FR; Loibner, H; Penninger, JM; Rodriguez, E; Schuster, M; Wysocki, J; Ye, M | 1 |
| Almeida, PW; Bader, M; Campagnole-Santos, MJ; Gomes, ER; Guatimosim, S; Guimarães, D; Lara, AA; Resende, RR; Santos, RA | 1 |
| Border, WA; Huang, Y; Noble, NA; Zhang, J | 1 |
| Almeida, AP; Almeida, PW; Alves, MN; Bader, M; Castro, CH; Dias-Peixoto, MF; Fagundes-Moura, CR; Ferreira, AJ; Gava, E; Gomes, ER; Guatimosim, S; Guimarães, AM; Kitten, GT; Rentzsch, B; Reudelhuber, T; Santos, RA | 1 |
| Arranz, C; Dominici, FP; Giani, JF; Mayer, MA; Muñoz, MC; Taira, CA; Toblli, JE; Turyn, D; Veiras, LC | 1 |
| Li, G; Li, J; Liu, E; Xu, Z; Yang, S; Yang, W | 1 |
| Escher, F; Qian, C; Reudelhuber, TL; Roks, AJ; Schoemaker, RG; Schultheiss, HP; Schumacher, SM; Tschöpe, C; van Gilst, WH; Walther, T; Wang, Y; Westermann, D | 1 |
| Romet, M | 1 |
| del Valle-Mondragón, L; Pastelín-Hernández, G; Rosas-Peralta, M; Sánchez-Mendoza, A; Tenorio-López, FA; Zarco-Olvera, G | 1 |
| Gao, J; Gao, XY; Han, Y; Shi, Z; Yuan, N; Zhou, LM; Zhu, GQ | 1 |
| Dominici, FP; Giani, JF; Muñoz, MC | 1 |
| Gao, S; Gul, R; Kim, SH; Kim, UH; Oh, YB; Shah, A; Yuan, K | 1 |
| Chudakov, DM; Guo, F; Kasparov, S; Lane, S; Liu, B; Paton, JF; Souslova, EA; Tang, F | 1 |
| Alenina, N; Bader, M; Botion, LM; Braga, JF; Mario, EG; Murari, A; Pôrto, LC; Rodrigues-Machado, Mda G; Santos, RA; Santos, SH | 1 |
| Akanbi, MH; de Vries, L; Meter-Arkema, A; Moll, GN; Reitzema-Klein, CE; Rink, R; van Dam, A | 1 |
| Campagnole-Santos, MJ; Guimarães, PS; Irigoyen, MC; Oliveira, LA; Santiago, NM; Santos, RA; Sirvente, RA | 1 |
| Chappell, MC; Ferrario, CM; Gallagher, PE; Ganten, D; Groban, L; Trask, AJ; Varagic, J; Westwood, BM | 1 |
| Araújo, Mda S; Bergasmaschi, CT; Campos, RR; Carmona, AK; Casarini, DE; Coelho, MS; de Oliveira-Sales, EB; Dolnikoff, MS; Freitas, Rde A; Heimann, JC; Lopes, KL | 1 |
| Kuan, TC; Lin, CS; Pan, CH; Wen, CH; Yang, TH | 1 |
| Burns, KD; Dilauro, M; Genest, D; Robertson, SJ; Zimpelmann, J | 1 |
| Araújo, FC; Dos Reis, AM; Pereira, VM; Reis, AB; Reis, FM; Santos, RA | 1 |
| Ferrario, CM; Varagic, J | 1 |
| Akhtar, S; Benter, IF; Chappell, MC; Dhaunsi, GS; Diz, DI; Yousif, MH | 1 |
| Casley, D; Gaspari, TA; Tesanovic, S; Vinh, A; Widdop, RE | 1 |
| Dalzell, JR; Jackson, CE | 1 |
| Allahdadi, K; Bader, M; Beiman, M; Cohen, Y; Cojocaru, G; Costa-Fraga, FP; de Almeida, AP; de Paula-Carvalho, V; Fraga-Silva, RA; Lautner, RQ; Pessoa, DC; Rotman, G; Santos, RA; Savergnini, SQ | 1 |
| Bruna-Romero, O; Carmona, AK; Cassali, GD; da Silveira, KD; de Sousa, LP; Diniz, LR; Pompermayer Bosco, KS; Ribeiro Vieira, MA; Santos, RA; Simões e Silva, AC; Teixeira, MM | 1 |
| Burns, WC; Burrell, LM; Dean, R; Thomas, MC; Velkoska, E | 1 |
| Díez-Freire, C; Dooies, A; Ferreira, AJ; Fraga-Silva, RA; Francis, J; Jun, JY; Katovich, MJ; Mariappan, N; Patel, JM; Pourang, D; Qi, Y; Raizada, MK; Reudelhuber, T; Santos, RA; Shenoy, V; Sriramula, S; Venugopal, CS | 1 |
| Kim, SH; Oh, YB; Park, BH; Shah, A; Shan, G; Song, CH | 1 |
| Chappell, MC | 1 |
| Durand, MJ; Lombard, JH; Raffai, G; Weinberg, BD | 1 |
| Bouissou, DR; Camargos, AF; dos Reis, AM; Pereira, VM; Reis, FM; Santos, RA | 1 |
| Arranz, C; Costa, MA; Gironacci, MM; Gomez, KA; Lopez Verrilli, MA; Nakagawa, P; Peña, C | 1 |
| Hayashi, N; Iwamoto, Y; Oguro, R; Ohishi, M; Rakugi, H; Shiota, A; Takeda, M; Takeya, Y; Tatara, Y; Yamamoto, K | 1 |
| Bhatia, K; Elmarakby, AA; Sullivan, JC; Yamamoto, T | 1 |
| Hu, Y; Xu, Q; Ye, S; Zhang, F | 1 |
| Li, G; Meng, R; Pei, Z; Ren, J; Wu, Z; Xu, C; Yan, G; Zhuang, Z | 1 |
| Cook, KL; Gallagher, PE; Metheny-Barlow, LJ; Tallant, EA | 1 |
| Ahmad, S; Ferrario, CM; Joyner, J; Varagic, J | 1 |
| Cao, G; Dominici, FP; Giani, JF; Muñoz, MC; Pons, RA; Toblli, JE; Turyn, D | 1 |
| Li, YL; Schultz, HD; Yang, RF; Yin, JX; Zimmerman, MC | 1 |
| Chen, WY; He, JG; Leng, XY; Ma, H; Zeng, WT | 1 |
| Anton, L; Brosnihan, KB; Gruver, C; Merrill, DC; Moorefield, C; Neves, LA | 1 |
| Ehlers, PI; Korpela, R; Nurmi, L; Turpeinen, AM; Vapaatalo, H | 1 |
| Alenina, N; Bader, M; Bürgelová, M; Cervenka, L; Husková, Z; Kramer, HJ; Malý, J; Mrázová, I; Netuka, I; Opočenský, M; Rakušan, D; Santos, RA; Skaroupková, P; Vaněčková, I; Vaňourková, Z | 1 |
| Burchill, L; Burrell, LM; Dean, RG; Griggs, K; Velkoska, E | 1 |
| Alenina, N; Bader, M; Rabelo, LA | 1 |
| Cowling, RT; Greenberg, B; Iwata, M; Yeo, SJ | 1 |
| Ferreira, AJ; Fraga-Silva, RA; Katovich, MJ; Qi, Y; Raizada, MK; Santos, RA; Shenoy, V | 1 |
| Wang, MJ; Wang, XJ | 1 |
| Chen, GR; Chen, SP; Ni, LS; Zheng, JC; Zhou, L | 1 |
| Andersen, ML; Bergamaschi, CT; Campos, RR; Casarini, DE; Perry, JC; Tufik, S | 1 |
| Lazartigues, E; Sriramula, S; Xu, P | 1 |
| Bu, L; Gao, X; Liu, ZM; Qu, S; Sun, LL; Tang, W; Zou, JJ | 1 |
| Li, G; Li, Y; Liu, T | 1 |
| Botros, FT; Casarini, DE; Feng, Y; Fernandes, FB; González-Villalobos, RA; Kobori, H; Lara, LS; Martin, VL; Navar, LG; Pagán, J; Prieto, MC; Satou, R | 1 |
| Gao, YJ; Lee, RM; Lu, C; Zhao, AX | 1 |
| Cassis, LA; Daugherty, A; Gurley, SB; Howatt, DA; Lu, H; Thatcher, SE; Zhang, X | 1 |
| Zimmerman, MC | 1 |
| Almeida, AP; Caliari, MV; Ferreira, AJ; Irigoyen, MC; Jacoby, BA; Marques, FD; Melo, MB; Nadu, AP; Santos, RA; Silva, GA; Sinisterra, RD; Sousa, FB; Souza, LE | 1 |
| Basu, R; Bodiga, S; Guo, D; Holland, SM; Kassiri, Z; Liu, GC; Lo, J; Oudit, GY; Penninger, JM; Scholey, JW; Wang, W; Zhong, JC | 1 |
| Al-Saleh, FM; Benter, IF; Chappell, MC; Diz, DI; Raghupathy, R; Yousif, MH | 1 |
| Casarini, DE; Cunha, T; Flues, K; Irigoyen, MC; Moraes-Silva, I; Moreira, ED; Mostarda, C; Paulini, J; Piratello, AC; Salemi, V; Sirvente, R; Souza, PR | 1 |
| Caruso-Neves, C; da Silva-Filho, JL; de Sá Pinheiro, AA; de Souza Silva, L; Ferreira-DaSilva, CT; Henriques, Md; Perales, J; Saraiva, VB; Souza, MC; Teixeira-Ferreira, A | 1 |
| Arnold, AC; Diz, DI; Isa, K; Nautiyal, M; Shaltout, HA; Tallant, EA | 1 |
| Aoki, T; Gohda, T; Hagiwara, S; Ihm, CG; Ishikawa, Y; Jeong, KH; Lee, SH; Lee, TW; Lim, SJ; Moon, JY; Murakoshi, M; Ohara, I; Tanimoto, M; Tomino, Y; Yamazaki, T | 1 |
| Clasen, T; Friedrich, S; Königshausen, E; Mergia, E; Potthoff, SA; Quack, I; Rump, LC; Sellin, L; Stegbauer, J; Vonend, O; Woznowski, M | 1 |
| Chen, L; Li, Y; Ma, H; Xiao, J | 1 |
| Ma, H; Tan, Z; Wu, J | 1 |
| Andrade, MC; Aragão, DS; Arita, DY; Casarini, DE; Cunha, TS; Fernandes, AB; Mortara, RA; Watanabe, IK | 1 |
| Abul, HT; Akhtar, S; Al-Khaledi, G; Benter, IF; Canatan, H; Renno, WM | 1 |
| Baykan, H; Günay, GK; Ozyazgan, I; Soyuer, I | 1 |
| Sharma, PL; Singh, K; Singh, T | 1 |
| Almeida, AP; Andrade, AB; Ferreira, AJ; Foureaux, G; Moraes, PL; Santos, RA | 1 |
| Albrecht, D; Kulisch, C; Staschewski, J | 1 |
| Oudit, GY; Penninger, JM | 1 |
| Bodiga, S; Das, SK; Lo, J; Oudit, GY; Patel, V; Wang, W | 1 |
| Abdul-Hafez, A; Gao, X; Li, X; Uhal, BD; Xue, A | 1 |
| Honorato-Sampaio, K; Oliveira, CA; Pereira, VM; Reis, AM; Santos, RA; Viana, GE | 1 |
| Adamo, HP; Carretero, OA; Corradi, G; Gironacci, MM; Ortiz, P; Santos, RA | 1 |
| Joseph, JP; Katovich, MJ; Mecca, AP; O'Connor, TE; Raizada, MK; Regenhardt, RW; Sumners, C | 1 |
| Afzal, A; Katovich, MJ; Li, H; Mocco, J; Qi, Y; Raizada, MK; Shenoy, V; Sumners, C; Wong, F | 1 |
| Hirooka, Y; Hoka, S; Ito, K; Kishi, T; Nakagaki, T; Sunagawa, K | 1 |
| Ager, EI; Chan, J; Chong, WW; Christophi, C; Neo, JH; Wen, SW | 1 |
| Carmona, AK; Casarini, DE; Fernandes, FB; Fernandes, T; Hashimoto, NY; Krieger, JE; Magalhães, FC; Oliveira, EM; Phillips, MI | 1 |
| Budinger, GR | 1 |
| Costa-Neto, CM; Souza, LL | 1 |
| Alenina, N; Bader, M; Costa-Fraga, FP; De Sousa, FB; Fraga-Silva, RA; Santos, RA; Sinisterra, RD | 1 |
| Grant, MB; Hauswirth, WW; Lei, B; Lewin, AS; Li, Q; Liu, X; Nakagawa, T; Raizada, MK; Shan, Z; Verma, A; Yuan, L | 1 |
| Durand, MJ; Lombard, JH; Raffai, G | 1 |
| Akhtar, S; Al-Farsi, O; Benter, IF; Chandrasekhar, B; Dhaunsi, GS; Yousif, MH | 1 |
| Alenina, N; Bader, M; Gao, YJ; Lee, RM; Lu, C; Santos, RA | 1 |
| de Oliveira, JF; Ferreira, R; Gasperin, BG; Gonçalves, PB; Reis, AM; Santos, RA; Siqueira, LC; Tonellotto dos Santos, J | 1 |
| Belatti, DA; Curry, PL; Gao, L; Kar, S; Zucker, IH | 1 |
| Burke, AS; Dizerega, GS; Louie, SG; Mordwinkin, NM; Rodgers, KE; Russell, JR | 1 |
| Gellar, MA; Kline, JA; Marchick, MR; Obraztsova, M; Stuart, L; Watts, JA | 1 |
| Becker, LK; Gomes-Filho, A; Lemos, VS; Olivon, VC; Santos, RA; Santos, TM; Silva, DM | 1 |
| He, HY; Liu, J; Wang, MY; Yuan, B | 1 |
| Shahid, M | 1 |
| Gurusamy, N; Kodama, M; Lakshmanan, AP; Ma, M; Sukumaran, V; Suzuki, K; Veeraveedu, PT; Watanabe, K; Yamaguchi, K | 2 |
| Arnold, AC; Chappell, MC; Diz, DI; Isa, K; Westwood, BM | 1 |
| Baumann, M; Heemann, U; Hermans, JJ; Lutz, J; Rusai, K; Schmaderer, C | 1 |
| Cao, K; Chen, XM; Huang, HJ; Huang, J; Lu, XZ; Qin, XY; Yang, XH; Yong, YH; Zheng, HJ; Zong, WN | 1 |
| Bos, AP; Florquin, S; Kamilic, J; Lutter, R; Moll, GN; Specht, PA; van der Loos, CM; van Goor, H; van Woensel, JB; Wösten-van Asperen, RM | 1 |
| Gao, H; Yallampalli, C; Yallampalli, U | 1 |
| Gao, L; Lazartigues, E; Xiao, L; Zucker, IH | 1 |
| Cerrato, BD; Fernandez, BE; García, S; Gironacci, MM; Landa, S; Longo Carbajosa, N; Lopez Verrilli, MA; Rodriguez Fermepín, M | 1 |
| Denton, KM; Hilliard, LM; Moritz, KM; Sampson, AK; Thomas, MC; Tikellis, C; Widdop, RE | 1 |
| Cao, X; Li, HX; Liu, C; Lv, XH; Wang, L; Yang, JK; Yu, M; Zhang, F | 1 |
| Ferreira, R; Gasperin, B; Gonçalves, PB; Oliveira, JF | 1 |
| Bellini, G; Bernardi, S; Buri, L; Burrell, LM; De Manzini, N; Fabris, B; Giacomel, G; Palmisano, S; Sabato, N; Toffoli, B; Velkoska, E; Zanconati, F; Zennaro, C | 1 |
| Mou, YL; Xie, YY; Zhang, YC | 1 |
| Alenina, N; Bader, M; de Oliveira, ML; Dos Santos, RA; Fontes, WR; Lazaroni, TL; Moraes, MF; Pereira, GS; Raslan, AC | 1 |
| Fan, L; Feng, Y; Gao, B; Li, Q; Ma, Q; Ni, L; Qian, Y; Wan, H; Xiang, Y | 1 |
| Ferrario, CM; Igase, M; Yokoyama, H | 1 |
| Bharadwaj, MS; Brosnihan, KB; Neves, LA; Yamaleyeva, LM | 1 |
| Batlle, D; Ranganath, K; Soler, MJ; Wysocki, J | 1 |
| Arozal, W; Arumugam, S; Giridharan, VV; Harima, M; Kodama, M; Palaniyandi, SS; Sari, FR; Soetikno, V; Suzuki, K; Thandavarayan, RA; Watanabe, K | 1 |
| Ann Tallant, E; Gallagher, PE; McCollum, LT | 1 |
| Li, X; Molina-Molina, M; Piasecki, CC; Uhal, BD | 1 |
| Fang, F; Liu, GC; Oudit, GY; Scholey, JW; Zhou, J | 1 |
| Ge, J; Guo, L; Modgil, A; O'Rourke, ST; Pingili, A; Singh, N; Sun, C; Xuan, C; Yao, F; Zhang, Q | 1 |
| Gurusamy, N; Kodama, M; Lakshmanan, AP; Ma, M; Nagata, M; Sukumaran, V; Suzuki, K; Takagi, R; Veeraveedu, PT; Watanabe, K; Yamaguchi, K | 1 |
| Chappell, MC; Diz, DI; Rose, JC; Shaltout, HA | 1 |
| Honorato-Sampaio, K; Pereira, VM; Reis, AM; Santos, RA | 1 |
| Carvalho, LC; Castro Resende, A; Costa, CA; de Moura, RS; Ognibene, DT; Rocha, AP | 1 |
| Denton, KM; Moritz, KM; Sampson, AK | 1 |
| Coffman, TM; Danser, AH; Gembardt, F; Schultheiss, HP; van Veghel, R; Walther, T | 1 |
| Huang, Y; Lu, L; Ni, J; Wang, Z; Xue, H; Yao, T; Yu, C; Zhou, L | 1 |
| Bernardi, S; Burns, WC; Burrell, LM; Fabris, B; Grixti, E; Johnston, C; Pickering, R; Sakoda, M; Thomas, MC; Tikellis, C; Toffoli, B; Tsorotes, D; Velkoska, E | 1 |
| Gao, XR; Liu, ZJ; Ma, H; Ma, ZF; Tang, AL; Tang, H; Wu, JG; Zhang, XJ | 1 |
| Gallagher, PE; McCollum, LT; Tallant, EA | 1 |
| Abduo, HT; Akhtar, S; Benter, IF; El-Hashim, AZ; Raghupathy, R; Renno, WM | 1 |
| Almeida, I; Brosnihan, KB; Chappell, MC; Gilliam-Davis, S; Lindsey, SH; Yamaleyeva, LM | 1 |
| Dizerega, GS; Espinoza, T; Hill, C; Louie, SG; Meeks, CJ; Roda, N; Rodgers, KE | 1 |
| diZerega, GS; Espinoza, T; Jadhav, SS; Louie, SG; Meeks, CJ; Mordwinkin, NM; Roda, N; Rodgers, KE | 1 |
| Du, C; Hu, X; Tu, S; Wang, K; Xie, X; Zhang, F | 1 |
| Gajda, M; Gebska, A; Guzik, TJ; Jawien, J; Korbut, R; Kus, K; Marcinkiewicz, J; Niepsuj, A; Nowak, B; Olszanecki, R; Pyka-Fosciak, G; Suski, M; Toton-Zuranska, J | 1 |
| Boustany-Kari, CM; Cassis, LA; Gupte, M; Karounos, M; Shoemaker, R; Thatcher, SE; Yiannikouris, F; Zhang, X | 1 |
| Patel, KP; Schultz, HD | 1 |
| Kim, SH; Lee, SH; Lim, JM; Oh, YB; Shah, A | 1 |
| Cerrato, BD; Frasch, AP; Gironacci, MM; Höcht, C; Longo-Carbajosa, N; Nakagawa, P; Peña, C | 1 |
| Burghi, V; Cao, G; Dominici, FP; Giani, JF; Muñoz, MC; Toblli, JE; Tomat, A; Turyn, D; Veiras, LC | 1 |
| Etelvino, GM; Passos-Silva, DG; Peluso, AA; Roepstorff, P; Santos, RA; Schwämmle, V; Sylvester, M; Verano-Braga, T | 1 |
| Almeida, PW; Braga, VB; Campagnole-Santos, MJ; Coutinho, DC; Dias-Peixoto, MF; Ferreira, AJ; Gomes Filho, A; Greco, L; Guatimosim, S; Lima, RF; Melo, DS; Melo, MB; Santos, RA | 1 |
| Basu, R; Bodiga, S; Das, SK; Fan, D; Kassiri, Z; Oudit, GY; Patel, VB; Wang, W; Wang, Z; Zhong, J | 1 |
| Bader, M; Ferreira, AJ; Santos, RA | 1 |
| Li, L; Lu, W; Shang, D; Zhang, T; Zhou, T; Zhou, X | 1 |
| Chappell, MC; Diz, DI; Gallagher, PE; Garcia-Espinosa, MA; Shaltout, HA | 1 |
| Durik, M; Roks, AJ; Sevá Pessôa, B | 1 |
| Huang, Y; Lu, L; Ni, J; Wang, J; Wang, Z; Xue, H; Yao, T; Yu, C; Yuan, P; Zhou, L | 1 |
| Burghi, V; Carranza, A; Dominici, FP; Giani, JF; Mayer, MA; Muñoz, MC; Taira, CA | 1 |
| Akhtar, S; Benter, IF; Dhaunsi, GS; Makki, BM; Qabazard, BA; Yousif, MH | 1 |
| Ali, Q; Hussain, T; Sabuhi, R; Samuel, P; Wu, Y | 1 |
| Burns, KD; Zimmerman, D | 1 |
| Gallagher, PE; Krishnan, B; Tallant, EA; Torti, FM | 1 |
| Dubey, P; Gallagher, PE; Krishnan, B; Smith, TL; Tallant, EA; Torti, FM; Willingham, MC; Zapadka, ME | 1 |
| Chen, YX; Lumbers, ER; Pringle, KG; Wang, Y; Zakar, T | 1 |
| Campagnole-Santos, MJ; Fontes, MA; Guimaraes, PS; Santiago, NM; Santos, RA; Velloso, EP; Xavier, CH | 1 |
| Horiuchi, M; Iwai, M; Kanno, H; Moritani, T; Nakaoka, H; Senba, I | 1 |
| Cavallo, IK; dos Reis, AM; Ferreira, MC; Honorato-Sampaio, K; Reis, FM; Santos, RA; Tavares, RL; Vaz-Silva, J | 1 |
| Bell, JF; Carey, RM; Howell, NL; Kemp, BA; Navar, LG; Padia, SH; Rottkamp, DM; Shao, W | 1 |
| Arab, AA; Lancien, F; Le Mével, JC; Mimassi, N; Takei, Y; Wong, M | 1 |
| Abu-Ghefreh, AA; Akhtar, S; Al-Banaw, AG; Benter, IF; George, P; Renno, WM | 1 |
| Kong, J; Li, J; Lu, J; Xing, J | 1 |
| Kim, JH; Kim, SH; Oh, YB; Park, BH; Park, BM | 1 |
| Alvarez-Leite, JI; Bader, M; Campagnole-Santos, MJ; de Paula, AM; Fernandes, LR; Guimarães, AL; Pereira, CS; Santos, RA; Santos, SH | 1 |
| Lu, LM; Ni, J | 1 |
| Dai, GY; Fu, HX; Gao, CY; Li, MW; Liu, HZ; Liu, YH; Niu, ZM; Qi, DT; Wang, XP; Wang, XQ; Yang, HH; Zhang, Y | 1 |
| Ihm, CG; Jeong, KH; Kim, SM; Kim, YG; Lee, SH; Lee, TW; Moon, JY | 1 |
| Debnam, ES; Ho, KY; Leung, PS; Ng, EK; Wong, TP | 1 |
| Gao, L; Guo, J; Jiang, T; Lu, J; Wang, Y; Zhang, Y | 1 |
| Li, X; Luo, W; Ning, Z; Yu, C; Zhang, W | 1 |
| Cai, R; Cheng, Y; Li, N; Niu, Y; Shen, B; Xu, J | 1 |
| Chen, F; Fan, JM; He, HY; Liu, J; Ou, ST; Tan, J; Xia, JY | 1 |
| Cui, BP; Han, Y; Li, P; Zhang, F; Zhou, YB | 1 |
| Bild, W; Ciobica, A | 1 |
| Bader, M; Bilman, V; Campagnole-Santos, MJ; Mares-Guia, L; Nadu, AP; Santos, RA; Santos, SH | 1 |
| Busija, DW; Chappell, MC; Diz, DI; Gallagher, PE; Katakam, PV; Nautiyal, M; Tallant, EA | 1 |
| Alenina, N; Bader, M; Campagnole-Santos, MJ; Guimarães, GG; Martins, AS; Motta, DF; Oliveira, ML; Pimenta-Velloso, EP; Santos, RA; Santos, SH | 1 |
| Hanasaki-Yamamoto, H; Hongyo, K; Kamide, K; Kawai, T; Oguro, R; Ohishi, M; Rakugi, H; Sugimoto, K; Takami, Y; Takeda, M; Takemura, Y; Takeshita, H; Takeya, Y; Tatara, Y; Yamamoto, K | 1 |
| Bartke, A; Burghi, V; Dominici, FP; Giani, JF; Kopchick, JJ; Masternak, MM; Miquet, JG; Muñoz, MC; Toblli, JE; Turyn, D | 1 |
| Aklilu, M; Lovato, J; Miller, AA; Petty, WJ; Savage, PD; Varela, VA | 1 |
| Shen, FJ; Tang, J; Zhang, N; Zhao, CX | 1 |
| Castro-Moreno, P; Del Valle-Mondragón, L; Hernández-Muñoz, R; Ibarra-Barajas, M; López-Guerrero, JJ; Pardo, JP; Pastelín-Hernández, G; Villalobos-Molina, R | 1 |
| Itoh, H; Kanda, T | 1 |
| Bian, YF; Gao, F; Li, J; Liang, B; Xiao, CS; Yang, HY; Yang, ZM; Zhang, HP; Zhang, NN | 1 |
| Huang, ML; Huang, S; Li, X; Meng, Y; Ning, ZW; Zhang, WY | 1 |
| Chappell, MC; de Lima, DC; Diz, DI; do Nascimento, K; Nautiyal, M; Shaltout, HA | 1 |
| Angus, PW; Burrell, LM; Herath, CB; Mak, K | 1 |
| Bader, M; Ferreira, AJ; Santos, RA; Verano-Braga, T | 1 |
| Kotov, AV; Pevtsova, EI; Shoibonov, BB; Tolpygo, SM | 1 |
| Gao, L; Jiang, T; Lu, J; Shi, J; Wang, Y; Zhang, Y | 1 |
| Cheng, HH; Cheng, JS; Chi, CC; Chou, CT; Huang, IF; Jan, CR; Kuo, CC; Liang, WZ; Lin, KL; Liu, CP; Lu, YC | 1 |
| Gao, Q; Gao, XY; Han, Y; Li, P; Sun, HJ; Zhang, F; Zhou, YB; Zhu, GQ | 1 |
| An, Y; Li, YH; Liu, P; Man, YL; Ren, BB; Wang, QX | 1 |
| Chu, Y; Faraci, FM; Heistad, DD; Miller, JD; Mitchell, IJ; Peña Silva, RA; Penninger, JM | 1 |
| Bi, J; Carey, LC; Chappell, MC; Contag, SA; Rose, JC; Tang, L; Valego, NK | 1 |
| Hao, XQ; Kong, T; Li, J; Li, M; Niu, MF; Sun, TW; Yang, DL; Yang, Z; Zhang, SY | 1 |
| Bader, M; Santos, RA; Steckelings, UM; Unger, T | 1 |
| Chou, CH; Chuang, LY; Guh, JY; Lu, CY | 1 |
| Ohishi, M; Rakugi, H; Yamamoto, K | 1 |
| Dos Santos, RA; Ferreira, AJ; Fraga-Silva, RA | 1 |
| Chan, K; Chen, H; Ren, J; Zhang, F | 1 |
| Bhatwadekar, AD; Caballero, S; Finney, EM; Grant, MB; Hazra, S; Jarajapu, YP; Kent, D; Medina, R; Raizada, MK; Shenoy, V; Stitt, AW; Thut, C | 1 |
| Alenina, N; Alves, MN; Bader, M; de Almeida, PW; de Azevedo Nunes, SL; de Freitas Lima, R; de Morais Gomes, ER; dos Santos Cruz, J; Gavioli, M; Gondim, AN; Guatimosim, S; Lara, A; Parreira, A; Resende, RR; Rocha-Resende, C; Roman-Campos, D; Santos, SL; Souza dos Santos, RA | 1 |
| Hu, X; Tian, F; Wang, L; Zhang, W | 1 |
| Adler, GK; Underwood, PC | 1 |
| Lin, LJ; Lo, WY; Wang, HJ | 1 |
| Passos-Silva, DG; Santos, RA; Verano-Braga, T | 1 |
| Bach, M; Benayahu, D; Berkutzki, T; Biton, I; Fridkin, M; Kohen, F; Limor, R; Marcus, Y; Nevo, N; Pappo, O; Sasson, K; Shechter, Y; Shefer, G; Stern, N | 1 |
| Corbett, A; Johns, EJ; O'Neill, J | 1 |
| Clarke, C; Flores-Muñoz, M; McKinney, CA; Milligan, G; Nicklin, SA | 1 |
| Chen, WW; Han, Y; Li, P; Sun, HJ; Xiong, XQ | 1 |
| Chang, JR; Chen, WJ; Qi, YF; Sui, YB; Tang, CS; Yin, XH; Yu, YR; Zhang, BH; Zhao, L | 1 |
| Chen, XJ; Dong, HY; Hui, YP; Li, ZC; Ma, SR; Shi, Y; Sun, RH; Wang, YX; Xu, DQ; Zhang, B | 1 |
| Alzamora, AC; Campagnole-Santos, MJ; Cunha, TM; Lima, WG; Silva, ME; Souza Santos, RA | 1 |
| Bharadwaj, MS; Brosnihan, KB; Corthorn, J; Joyner, J; Schneider, D; Valdés, G | 1 |
| Cruickshank, S; Delmore, JE; diZerega, GS; Drummond, L; Peterson, KJ; Pham, H; Reed, E; Rodgers, KE; Schwartz, BM | 1 |
| Adams, GN; Bilodeau, ML; Chen, A; Fang, C; Grobe, N; LaRusch, G; Mahdi, F; Morris, M; Nieman, MT; Schmaier, AA; Schmaier, AH; Stavrou, E; Warnock, M; Zhou, Y | 1 |
| Bernstein, KE; Elased, KM; Grobe, N; Leiva, O; Morris, M; Ong, FS; Schmaier, AH; Weir, NM | 1 |
| Andrade, JM; Caldeira, AP; Campagnole-Santos, MJ; de Carvalho Botelho, AC; de Paula, AM; de Pinho, L; Feltenberger, JD; Filho, AB; Guimarães, AL; Paraíso, A; Sousa Santos, SH | 1 |
| Cui, BP; Han, Y; Li, P; Sun, HJ; Zhou, YB | 1 |
| Beyer, AM; Guo, DF; Rahmouni, K | 1 |
| Li, P; Miao, J; Wang, Y; Zhang, W; Zhang, Y | 1 |
| Dekker, GA; Lumbers, ER; Pringle, KG; Roberts, CT; Sykes, SD; Zhou, A | 2 |
| Alenina, N; Alves, F; Alzamora, A; Bader, M; Barbosa, C; Braga, J; Campagnole-Santos, MJ; Costa-Fraga, F; Ferreira, A; Fraga-Silva, RA; Jankowski, J; Jankowski, V; Kemplin, F; Kjeldsen, F; Klempin, F; Lautner, RQ; Maia, G; Martins, A; Motta-Santos, D; Oliveira, A; Passos-Silva, D; Paula, R; Peluso, AB; Pimenta, A; Raizada, M; Santos, RA; Savergnini, S; Silva, N; Sinisterra, R; Soares, E; Sousa, F; Verano-Braga, T; Villela, DC | 1 |
| Gómez-Foix, AM; Montori-Grau, M; Orozco, A; Osorio-Conles, O; Serrano-Marco, L; Tarrats, N; Vázquez-Carrera, M | 1 |
| Ahmad, S; Batlle, D; Brosnihan, KB; Ferrario, CM; Moniwa, N; Varagic, J; VonCannon, JL; Wysocki, J | 1 |
| Azcutia, V; Gembardt, F; Hermenegildo, C; Novella, S; Palacios, E; Peiró, C; Rodríguez-Mañas, L; Sánchez-Ferrer, CF; Vallejo, S; Walther, T | 1 |
| Bader, M | 1 |
| Chen, YG; Hao, PP; Hou, GH; Liu, YP; Zhang, C; Zhang, MX; Zhang, Y | 1 |
| Ferreira, AJ; Silveira, KD; Simões e Silva, AC; Teixeira, MM | 1 |
| Gao, L; Jiang, T; Lu, J; Shi, JQ; Tan, L; Tan, MS; Yu, JT; Zhang, YD; Zhu, XC | 1 |
| Castelo-Branco, RC; de Mello-Aires, M; Leite-Delova, DC | 1 |
| Botion, LM; Campagnole-Santos, MJ; Ferreira, AV; Santos, CF; Santos, RA; Santos, SH | 1 |
| Bai, S; Chen, L; Ding, BP; Huang, ZG; Wang, JT | 1 |
| Andreozzi, F; Carnevale, D; Casaburo, M; Hribal, ML; Perticone, F; Perticone, M; Presta, I; Sciacqua, A; Sesti, G; Tassone, EJ | 1 |
| Campagnole-Santos, MJ; Oliveira, RC; Santos, RA | 1 |
| Cerrato, BD; Gironacci, MM; Goldstein, J; Longo Carbajosa, NA | 1 |
| Akhtar, S; Benter, IF; El-Hashim, AZ; Kilarkaje, N; Makki, B; Yousif, MH | 1 |
| Bhatia, K; Sullivan, JC; Zimmerman, MA | 1 |
| Velez, JC | 1 |
| Chan, JS; Chenier, I; Filep, JG; Ingelfinger, JR; Lo, CS; Maachi, H; Shi, Y; Zhang, SL | 1 |
| Dell'Italia, LJ; Ferrario, CM | 1 |
| Afzal, A; Desland, F; Mecca, AP; Mocco, J; Pioquinto, DJ; Regenhardt, RW; Sumners, C | 1 |
| Brosnihan, KB; Coveleskie, K; Diz, DI; Gallagher, PE; Neves, LA; Yamaleyeva, LM | 1 |
| Dang, M; Dang, V; Gopallawa, I; Jiang, J; Morimoto, K; Nguyen, H; Ono, S; Uhal, BD | 1 |
| Chen, Y; Sun, Y; Zhao, T; Zhao, W | 1 |
| Gong, X; Li, G; Li, Y; Song, Y; Yuan, L | 1 |
| Li, G; Li, X; Li, Z; Liu, A; Liu, Y; Su, J; Sun, L; Xu, Y; Zhu, Y | 1 |
| Bader, M; Castro Perez, A; Duarte, ID; Lima, Mde P; Pacheco, CM; Pacheco, Dda F; Pesquero, JL; Souza, Ade L | 1 |
| Bruggisser, M; Haschke, M; Krähenbühl, S; Loibner, H; Penninger, J; Poglitsch, M; Salzberg, M; Schuster, M | 1 |
| Cheng, XC; Guo, W; Hao, XQ; Li, L; Li, M; Sun, TW; Zhang, JL; Zhang, SY | 1 |
| Chen, YG; Gao, F; Hao, PP; Liu, YP; Yang, JM; Zhang, C; Zhang, MX; Zhang, Y | 1 |
| Bian, W; Feng, D; Guo, R; He, J; Hu, J; Li, JF; Ma, Q; Shi, X; Song, R; Sun, L; Wang, S; Xiong, Y; Xu, J; Yang, L; Yang, X; Zheng, S | 1 |
| Alvarez-Leite, JI; Andrade, JM; Feltenberger, JD; Fernandes, LR; Santos, RA; Santos, SH; Sinisterra, RD; Sousa, FB | 1 |
| Almeida, JF; Alves, GM; Castro, CH; Colugnati, DB; Ferreira, AJ; Macedo, LM; Mendes, EP; Porto, JE; Santos, RA; Sobrinho, DB; Souza, ÁP; Vêncio, EF | 1 |
| Dong, M; Gao, F; Hao, PP; Li, JJ; Liu, XL; Meng, X; Wang, XP; Yang, JM; Yang, XY; Zhang, C; Zhang, K; Zhang, MX; Zhang, Y; Zhao, XQ; Zhao, YX | 1 |
| Bader, M; Barroso, LC; Coelho, FM; Costa, VV; Oliveira, ML; Queiroz-Junior, CM; Santos, RA; Silva, AC; Silva, TA; Silveira, KD; Sousa, LF; Teixeira, MM; Vieira, AT | 1 |
| Fan, J; He, H; Liu, J; Ren, T; Tan, J; Yu, X | 1 |
| Andrade, JM; Barros, LO; Campagnole-Santos, MJ; de Paula, AM; dos Santos, RA; Feltenberger, JD; Filho, AB; Guimarães, AL; Paraíso, A; Qureshi, M; Santos, SH; Sinisterra, RD; Sousa, FB | 1 |
| Arantes, RM; Bader, M; Barroso, LC; Cisalpino, D; Dos Santos, RA; Lima, CX; Silveira, KD; Simões-E-Silva, AC; Teixeira, MM; Vieira, AT | 1 |
| Barreta, MH; Bohrer, RC; de Oliveira, JF; Ferreira, R; Gasperin, BG; Gonçalves, PB; Pereira, GR; Rovani, M | 1 |
| Ager, EI; Christophi, C; Neo, J; Wen, SW | 1 |
| Angus, PW; Burrell, LM; Grace, JA; Granzow, M; Herath, CB; Klein, S; Masing, N; Sauerbruch, T; Schierwagen, R; Trebicka, J; Walther, T | 1 |
| Guo, F; Hay, M; Johnson, AK; Johnson, RF; Xue, B; Zhang, Z | 1 |
| Ahmad, S; Ferrario, CM; Moniwa, N; Nagata, S; Simington, SW; Varagic, J; Voncannon, JL | 1 |
| de Visser, YP; de Vries, L; Fidder, M; Folkerts, G; Laghmani, el H; Rink, R; Roks, AJ; Sengers, RM; Wagenaar, GT; Walther, FJ | 1 |
| Ali, Q; Hussain, T; Wu, Y | 1 |
| dos Santos, RA; Ferreira, AJ; Fontes, MA; Martins Lima, A; Raizada, MK; Velloso, EP; Wallukat, G; Xavier, CH | 1 |
| Caliari, MV; Campagnole-Santos, MJ; Cara, DC; Cardoso, JA; Kangussu, LM; Lautner, RQ; Magalhães, GS; Marques, FD; Murari, A; Noviello, ML; Oliveira, ML; Pereira, JM; Rodrigues-Machado, MG; Santos, RA | 1 |
| Costa-Fraga, FP; da Silva, D; da Silva, RF; De Sousa, FB; Fraga-Silva, RA; Mach, F; Montecucco, F; Santos, RA; Savergnini, SQ; Sinisterra, RD; Stergiopulos, N | 1 |
| Chen, Q; Huang, Y; Liu, L; Pan, C; Qiu, H; Yang, Y | 1 |
| Ding, W; Gu, Y; Xu, C; Zhang, M | 1 |
| Chen, LN; Chen, YY; Gao, JL; Nissen, DH; Wang, JH; Wang, LJ; Yang, XH; Zhang, LY | 1 |
| Fraga-Silva, RA; Mach, F; Montecucco, F; Santos, RA; Stergiopulos, N | 1 |
| de Haan, MW; de Leeuw, PW; Houben, AJ; Kroon, AA; Mostard, GJ; van Twist, DJ | 2 |
| Chappell, MC; Diz, DI; Marshall, AC; Pirro, NT; Rose, JC; Shaltout, HA | 2 |
| Erfinanda, L; Gembardt, F; Kaestle, SM; Klein, N; Kuebler, WM; Lei, X; Mertens, M; Nickles, H; Supé, S; Szaszi, K; Walther, T; Wang, L; Yin, J | 1 |
| Chen, J; Du, D; Fang, J; Jing, H; Liu, M; Shen, L; Wang, J; Yu, J; Zhu, D; Zhu, M | 1 |
| Molina, PE; Whitaker, AM | 1 |
| Gallagher, PE; Kooshki, M; Metheny-Barlow, LJ; Moore, ED; Robbins, ME | 1 |
| Aguiar, DC; Alenina, N; Almeida-Santos, AF; Bader, M; Campagnole-Santos, MJ; Fontes, MA; Kangussu, LM; Santos, RA | 1 |
| Cao, L; Jiang, X; Tan, R; Xun, J | 1 |
| Cai, SX; Li, X; Meng, Y; Yu, CH | 1 |
| Becari, C; Camacho, FR; Costa-Neto, CM; Duarte, DA; Garcia-Cairasco, N; Gomes, MD; Oliveira, EB; Oliveira, JA; Pereira, MG; Salgado, MC; Souza, LL | 1 |
| Brzozowski, T; Jasnos, K; Korbut, R; Krzysiek-Maczka, G; Kwiecien, S; Magierowski, M; Olszanecki, R; Pawlik, M; Ptak-Belowska, A | 1 |
| Byku, M; Macarthur, H; Murray, J; Westfall, TC; Yang, CL | 1 |
| Gao, PJ; Jin, HY; Lu, L; Oudit, GY; Penninger, JM; Shang, QH; Song, B; Xu, YL; Zhang, ZZ; Zhong, JC; Zhou, T; Zhu, DL | 1 |
| Gao, L; Jiang, T; Lu, J; Wang, Y; Wu, L; Zhang, S; Zhang, Y; Zhou, F | 1 |
| diZerega, GS; Espinoza, TB; Meeks, CJ; Roda, N; Rodgers, KE | 1 |
| Campbell, WB; Kopf, PG | 1 |
| Bennion, DM; Regenhardt, RW; Sumners, C | 1 |
| Banuelos, C; Bizon, JL; Desland, F; Greenstein, D; Ludin, JA; Mecca, AP; Regenhardt, RW; Reinhard, MK; Ritucci-Chinni, PF; Sumners, C | 1 |
| Alenina, N; Bader, M; Braga, JF; Burghi, V; Dominici, FP; Giani, JF; Kotnik, K; Miquet, JG; Qadri, F; Santos, RA; Santos, SH; Todiras, M | 1 |
| Acuña, MJ; Bader, M; Brandan, E; Cabello-Verrugio, C; Cabrera, D; Muñoz-Canoves, P; Olguin, H; Pessina, P; Santos, RA; Vio, CP | 1 |
| Cai, SX; Huang, S; Li, T; Li, W; Li, X; Luo, W; Meng, Y; Wu, PS; Yu, CH | 1 |
| Li, XD; Liu, Y; Qin, S; Shen, HM; Tang, HJ; Yan, X; Zhou, YJ | 1 |
| Fukamizu, A; Imai, Y; Ito, H; Kadowaki, A; Kimura, A; Kuba, K; Liu, PP; Penninger, JM; Sato, T; Suzuki, T; Watanabe, H | 1 |
| Del Valle-Mondragón, L; Echeverría-Rodríguez, O; Hong, E | 1 |
| Clasen, T; Fähling, M; Ishak, B; Kojda, G; Mende, S; Patzak, A; Potthoff, SA; Rump, LC; Sivritas, SH; Stamer, S; Stegbauer, J; Suvorava, T; Thieme, M | 1 |
| He, J; Liao, X; Liu, C; Luo, D; Ma, H; Wang, L; Yang, C | 1 |
| Ahmad, S; Chappell, MC; Da Silva, J; Ferrario, CM; Groban, L; Jessup, JA; Lin, M; MacNamara, LM; Wang, H; Zhao, Z | 1 |
| Ji, L; Liu, W; Shi, J; Tian, M; Tong, Q; Xie, W; Zhu, D | 1 |
| Becker, L; Bertagnolli, M; Casali, KR; Dartora, DR; De Sousa, FB; Dias, LD; Irigoyen, MC; Milan, RD; Pinto, G; Rigatto, K; Santos, RA; Santos, SH; Schaan, BD | 1 |
| Karpe, PA; Tikoo, K | 1 |
| Chamsi-Pasha, MA; Shao, Z; Tang, WH | 1 |
| Ishibashi, Y; Matsui, T; Yamagishi, S | 1 |
| Chapleau, MW; Sabharwal, R | 1 |
| Cortes, S; Costa, A; Duarte, I; Galdino, G; Romero, T; Santos, R; Silva, G | 1 |
| Bai, HY; Chisaka, T; Higaki, J; Horiuchi, M; Iwanami, J; Kanno, H; Min, LJ; Mogi, M; Nakaoka, H; Ogimoto, A; Ohshima, K; Tsukuda, K; Wang, XL | 1 |
| Abo Alrob, O; Altamimi, T; Basu, R; Desaulniers, J; Kassiri, Z; Lopaschuk, GD; Mori, J; Oudit, GY; Patel, VB; Wagg, CS | 1 |
| Passos-Silva, DG; Santos, RA; Villela, DC | 1 |
| Khang, G; Raffai, G; Vanhoutte, PM | 1 |
| Cui, L; Liu, R; Qi, H; Wang, J; Wang, Y; Wen, Y; Yin, C | 2 |
| Chen, Y; Liu, C; Liu, H; Meng, W; Sun, Y; Zhao, T; Zhao, W | 1 |
| Alenina, N; Azevedo, LC; Bader, M; Costa-Neto, CM; Duchene, J; Santos, RA; Souza, LL; Todiras, M | 1 |
| Batlle, D; Haber, PK; Haque, SK; Maier, C; Wysocki, J; Ye, M | 1 |
| Burghi, V; Dominici, FP; Giani, JF; Muñoz, MC | 1 |
| Alghamri, MS; Elased, KM; Grobe, N; Meszaros, JG; Morris, M | 1 |
| Abd-Alhaseeb, MM; Abou-El-Ela, SH; Moustafa, YM; Zaitone, SA | 1 |
| Casselbrant, A; Kostic, S; Lönroth, H | 1 |
| Li, J; Lu, J; Xing, J | 1 |
| Heistad, DD; Peña Silva, RA | 1 |
| Bertolotto, M; Caffa, I; Capettini, LA; Costa-Fraga, FP; da Silva, RF; Dallegri, F; De Sousa, FB; Fraga-Silva, RA; Galan, K; Lenglet, S; Mach, F; Montecucco, F; Nencioni, A; Palombo, D; Pane, B; Pelli, G; Pende, A; Santos, RA; Savergnini, SQ; Sinisterra, RD; Soncini, D; Spinella, G; Stergiopulos, N | 1 |
| Chapleau, MW; Cicha, MZ; De Sousa, FB; Sabharwal, R; Santos, RA; Sinisterra, RD | 1 |
| Angus, PW; Burrell, LM; Garg, M; Gibson, PR; Griggs, K; Lubel, JS; Velkoska, E | 1 |
| Ahmad, S; Ferrario, CM; Nagata, S; Varagic, J | 1 |
| Braga, JF; Campagnole-Santos, MJ; Guimaraes, PS; Nadu, AP; Oliveira, MF; Santos, RA; Schreihofer, A | 1 |
| Arter, AL; Deng, G; Gallagher, PE; Tallant, EA | 1 |
| Alrob, OA; DesAulniers, J; Lopaschuk, GD; Mori, J; Oudit, GY; Patel, VB; Ramprasath, T; Scholey, JW | 1 |
| diZerega, GS; Maulhardt, HA; Peterson, KJ; Rodgers, KE | 1 |
| Chen, SZ; Chen, YF; Lazartigues, E; Li, GZ; Olson, JE; Wang, JJ; Xia, HJ; Zheng, JL; Zhu, YL | 1 |
| Abrigo, J; Cabello-Verrugio, C; Cisternas, F; Meneses, C; Morales, MG; Rivera, JC; Simon, F; Vazquez, Y | 1 |
| Bai, HY; Chisaka, T; Horiuchi, M; Iwanami, J; Kanno, H; Min, LJ; Mogi, M; Nakaoka, H; Ohshima, K; Tsukuda, K; Wang, XL | 1 |
| Cai, SM; Li, X; Li, Y; Ning, ZW; Zhang, LL; Zhang, WY | 1 |
| Fan, J; Kao, G; Su, L; Tao, X; Yin, Y; Zhang, X; Zrenner, B | 1 |
| Campagnole-Santos, MJ; de Paula, AM; dos Santos, RA; Ferreira, AV; Garcia, ZM; Guimarães, AL; Oliveira Andrade, JM; Paraíso, AF; Santos, SH; Sinisterra, RD; Sousa, FB | 1 |
| Harris, RA; Sullivan, JC; Zimmerman, MA | 1 |
| Chappell, MC; Diz, DI; Marshall, AC; Pirro, NT; Rose, JC | 1 |
| Santos, RA | 1 |
| Acuña, MJ; Brandan, E; Cabrera, D; Rebolledo, D; Riquelme, C; Santos, RA; Torrejón, J | 1 |
| Aylor, KW; Barrett, EJ; Carey, RM; Fu, Z; Liu, Z; Zhao, L | 1 |
| Chen, W; Li, G; Shan, T; Zhang, L; Zhang, Y; Zhao, C | 1 |
| Nakagawasai, O; Nemoto, W; Ogata, Y; Tadano, T; Tan-No, K; Yaoita, F | 1 |
| Banegas, RD; Bartke, A; Burghi, V; Dominici, FP; Fang, Y; Giani, JF; Miquet, JG; Muñoz, MC; Toblli, JE; Wang, F | 1 |
| Etelvino, GM; Peluso, AA; Santos, RA | 1 |
| Bai, R; Bian, YF; Liang, B; Liu, M; Wang, X; Xiao, CS; Yan, F; Yang, HY; Yang, ZM; Zhang, NN | 1 |
| Dong, M; Jiang, F; Liu, FF; Wang, S; Yang, J; Zhang, C; Zhang, K; Zhang, Q; Zhang, Y | 1 |
| Li, C; Li, Y; Li, Z; Liu, M; Sun, X; Wang, Y; Wu, H; Xu, D | 1 |
| Alenina, N; Bader, M; Faraci, FM; Hasan, DM; Heistad, DD; Kung, DK; Mitchell, IJ; Peña Silva, RA; Santos, RA | 1 |
| Drummond, GR; Kuruppu, S; Smith, AI; Sobey, CG | 1 |
| Li, XY; Li, Y; Lu, CL; Wang, Y; Yuan, L | 2 |
| Bihl, J; Buck, J; Chen, S; Chen, Y; Lazartigues, E; Li, G; Olson, JE; Xia, H; Zheng, J; Zhu, Y | 1 |
| Carreón-Torres, E; Castrejón-Tellez, V; Del Valle-Mondragón, L; Díaz-Díaz, E; Guarner-Lans, V; Rubio-Ruíz, ME | 1 |
| Cao, L; Gao, Q; Jiang, T; Lu, J; Tan, L; Tan, MS; Wang, HF; Yu, JT; Zhang, QQ; Zhang, YD; Zhu, XC | 1 |
| Cerniello, FM; Cerrato, BD; Gironacci, MM; Goldstein, J; Longo Carbajosa, NA | 1 |
| Brosnihan, KB; Ebert, TJ; Merrill, DC; Mertz, HL; Smith, TL; Yamaleyeva, LM | 1 |
| Ji, L; Shi, J; Tian, M; Xie, W; Xu, C; Zhu, D | 1 |
| Bujak-Gizycka, B; Huras, H; Korbut, R; Olszanecki, R; Rytlewski, K; Stettner, D | 1 |
| Beltz, TG; Guo, F; Hay, M; Johnson, AK; Xue, B; Zhang, Z | 1 |
| Li, G; Wang, X | 1 |
| de Oliveira, AM; Gomes, MS; Pernomian, L; Restini, CB | 1 |
| Alzayadneh, EM; Chappell, MC; Marshall, AC; Wilson, BA | 1 |
| Jarajapu, YP; Pawar, R; Singh, N; Vasam, G | 1 |
| Alsaadon, H; Habiyakare, B; Hayes, A; Mathai, ML; Zulli, A | 1 |
| Alzayadneh, EM; Chappell, MC | 2 |
| Nematbakhsh, M; Safari, T | 1 |
| Cai, Y; Huang, W; Tang, L; Zhang, L; Zheng, Y | 1 |
| Chen, WJ; Chen, X; Chen, YP; Hocher, B; Li, J; Liang, XJ; Liu, ZW; Lu, YP; Reichetzeder, C; Wen, WR; Xiao, XM | 1 |
| Andrade, JM; Santos, SH | 1 |
| Bhatia, M; Chambers, S; Gaddam, RR | 1 |
| de Leeuw, PW; Kroon, AA; van Twist, DJ | 1 |
| Shi, CR; Yu, LZ | 1 |
| Bai, L; Chen, ZQ; Guo, Q; Jia, R; Ma, EW; Ma, Y; Xu, J; Zhang, JH | 1 |
| Desnoyer, R; Karnik, SS; Speth, RC; Tirupula, KC | 1 |
| Chen, X; Dong, B; Hao, QQ; Li, SY; Wang, N; Wang, XY; Yu, QT; Zhang, YH; Zhu, L | 1 |
| Guo, T; Hao, P; Kong, J; Li, D; Meng, X; Yang, J; Zhang, C; Zhang, K; Zhang, M; Zhang, Y | 1 |
| Carver, KA; Gallagher, PE; Smith, TL; Tallant, EA | 1 |
| Chen, Y; Li, T; Li, W; Li, X; Li, Y; Meng, Y; Pang, MX; Yu, CH; Zhang, WY; Zhou, GS | 1 |
| Chen, Y; Gu, Y; Li, S; Niu, J; Qiao, Z; Tian, J; Xiao, J; Zhang, L; Zhou, Y | 1 |
| Andrade, HM; Andrade, JM; da Fonseca Pires, S; de Paula, AM; de Sousa, FB; Feltenberger, JD; Guimarães, AL; Lemos, Fde O; Lopes, MT; Millán, RD; Neto, JT; Qureshi, M; Santos, RA; Santos, SH | 1 |
| Chen, L; Gao, P; Oudit, GY; Zhang, Z; Zhong, J | 1 |
| Li, G; Li, J; Liu, E; Qi, L; Yang, W; Zhao, J | 1 |
| Dai, H; Gong, Y; Guang, X; Xiao, Z; Yin, X | 1 |
| Bíbová, J; Červenka, L; Hampl, V; Herget, J; Husková, Z; Jíchová, Š; Kramer, HJ; Sadowski, J; Vaňourková, Z | 1 |
| Baňasová, A; Bíbová, J; Červenka, L; Hampl, V; Herget, J; Husková, Z; Jíchová, Š; Kujal, P; Sadowski, J; Vaňourková, Z; Vernerová, Z | 1 |
| Cai, SX; Chen, QH; Chun, P; Guo, FM; Han, JB; He, HL; Hu, SL; Huang, YZ; Liu, L; Qiu, HB; Yang, Y | 1 |
| Andrews, KL; Chin-Dusting, JP; Dominiczak, AF; Graham, D; Head, GA; Jennings, GL; McBride, MW; Sampson, AK; Thomas, MC | 1 |
| Bi, J; Chappell, MC; Chen, K; Contag, SA; Figueroa, JP; Rose, JC; Su, Y | 1 |
| Abrigo, J; Brandan, E; Cabello-Verrugio, C; Cisternas, F; Meneses, C; Morales, MG; Simon, F; Vazquez, Y | 1 |
| Bai, R; Bian, Y; Liang, B; Liu, M; Wang, X; Xiao, C; Yang, H; Yang, Z | 1 |
| Grobe, JL; Sigmund, CD | 1 |
| Daniell, H; Francis, J; Jin, G; Katovich, MJ; Kwon, KC; Li, Q; Lin, S; Nair, A; Qi, Y; Raizada, MK; Rathinasabapathy, A; Shenoy, V; Shil, P; Song, C | 1 |
| Daniell, H; Kwon, KC; Li, Q; Shil, PK; Verma, A; Zhu, P | 1 |
| Brzozowski, T | 1 |
| Alenina, N; Andrade-Navarro, MA; Bader, M; Santos, RA | 1 |
| Abrigo, J; Brandan, E; Cabello-Verrugio, C; Meneses, C; Morales, MG; Simon, F | 1 |
| Guo, RW; Kuang, CW; Liu, B; Xi, YY; Yang, LX | 1 |
| Amorim, MJ; Bento-Leite, A; Brás-Silva, C; Castro-Chaves, P; Cerqueira, R; Leite-Moreira, AF; Mendes-Ferreira, P; Mendonça, L; Pinho, P | 1 |
| Akhtar, S; Benter, IF; El-Hashim, AZ; Makki, B; Yousif, MH | 1 |
| Cosic, A; Drenjancevic, I; Falck, JR; Kibel, A; Mihaljevic, Z; Novak, S | 1 |
| Arthur, JM; Fitzgibbon, WR; Hicks, MP; Janech, MG; Morinelli, TA; Rodgers, J; Self, SE; Velez, JC | 1 |
| Baraldi Araújo Restini, C; Pernomian, L | 1 |
| Li, Q; Prasad, T; Verma, A | 1 |
| Carroll, MA; Chander, PN; Kang, Y; Stier, CT | 1 |
| Costa-Fraga, FP; da Silva, RF; Faye, Y; Fraga-Silva, RA; Mach, F; Montecucco, F; Pelli, G; Raizada, MK; Santos, RA; Shenoy, V; Stergiopulos, N; Sturny, M | 1 |
| Cui, L; Li, H; Liu, R; Qi, H; Wang, J; Wang, Y; Wen, Y; Yin, C | 1 |
| Campagnole-Santos, MJ; de Castro, LG; Fontes, MA; Martins Lima, A; Müller-Ribeiro, FC; Oscar, CG; Santos, RA; Xavier, CH | 1 |
| Feltenberger, JD; Guimarães, TA; Moreira de Macêdo, S; Sousa Santos, SH | 1 |
| He, Y; Li, X; Niu, X; Xu, M; Xue, Y; Zhao, L; Zhao, X | 1 |
| Abdo, S; Chan, JS; Chenier, I; Filep, JG; Ingelfinger, JR; Lo, CS; Padda, R; Shi, Y; Zhang, SL | 1 |
| Wang, D; Wu, J; Wu, S; Zhao, D | 1 |
| Brzozowski, B; Brzozowski, T; Konturek, SJ; Krzysiek-Maczka, G; Kwiecien, S; Pajdo, R; Pawlik, MW; Ptak-Belowska, A; Strzalka, M | 1 |
| Abreu, SC; Barcelos, LS; Caliari, MV; Campagnole-Santos, MJ; Magalhães, GS; Motta-Santos, D; Prata, LO; Rocco, PR; Rodrigues-Machado, MG; Santos, RA; Silva, AR | 1 |
| Chappell, MC; Cruz-Diaz, N; Gwathmey, TM; Marshall, AC; Pirro, NT; Rose, JC; Su, Y; Wilson, BA | 1 |
| Fan, X; Fan, Y; He, J; Li, X; Wang, L; Wang, W; Wu, H; Yang, H; Yang, Z | 1 |
| Flores-Monroy, J; Martínez-Aguilar, L; Valencia-Hernández, I | 1 |
| Brosnihan, KB; Gallagher, PE; Neves, LA; Pulgar, VM; Yamaleyeva, LM | 1 |
| Bennion, DM; Haltigan, E; Regenhardt, RW; Steckelings, UM; Sumners, C | 1 |
| Burns, KD; Gutsol, A; Touyz, R; Xiao, F; Zimmerman, DL; Zimpelmann, J | 1 |
| Cao, Y; Jiang, W; Li, Y; Liang, M; Xi, C; Xue, Y; Zeng, Z; Zhou, M | 1 |
| Becher, PM; Danser, AH; De Vries, R; Roks, AJ; Sevá Pessôa, B; Sneep, S; Tempel, D; Van Beusekom, H; Van Der Velden, VH; Van Veghel, R; Westermann, D | 1 |
| Harris, RA; Rodriguez-Miguelez, P; Sullivan, JC; Zimmerman, MA | 1 |
| Kalesnykas, G; Uusitalo, H; Vaajanen, A; Vapaatalo, H | 1 |
| Lu, X; Pan, D; Qin, Y; Wang, S; Wang, X; Wu, C; Xu, S; Xu, X; Ye, G | 1 |
| Jiang, Y; Liu, B; Liu, Y | 1 |
| Chen, X; Dong, B; Dong, XF; Hao, QQ; Li, SY; Tengbeh, AF; Yu, QT; Zhang, Y; Zhang, YH; Zhou, XM | 1 |
| Chen, YG; Hao, PP; Yang, JM; Zhang, C; Zhang, K; Zhang, MX; Zhang, Y | 1 |
| Chodavarapu, H; Di Fulvio, M; Elased, KM; Grobe, N; Kashkari, N; Singh, R; Somineni, HK | 1 |
| Chen, Y; Gao, F; Hao, P; Liu, Y; Yang, J; Zhang, C; Zhang, K; Zhang, M; Zhang, Y | 1 |
| Furukawa, H; Hashimoto, T; Kanematsu, Y; Kitazato, KT; Kuwabara, A; Lawton, MT; Nagahiro, S; Shikata, F; Shimada, K; Tada, Y; Wada, K; Wei, Y | 1 |
| Del Valle-Mondragón, L; Guzmán-Hernández, EA; Ibarra-Barajas, M; Pastelín-Hernández, G; Sánchez-Mendoza, MA; Villalobos-Molina, R | 1 |
| Dong, M; Guo, T; Kong, J; Meng, X; Yang, J; Yang, X; Zhang, C; Zhang, K; Zhang, Y | 1 |
| Bian, YF; Gao, F; Liang, B; Xiao, CS; Yang, HY; Yang, ZM; Zhang, N | 1 |
| He, J; Liu, H; Ma, Q; Meng, R; Song, R; Tao, T; Wang, S; Yang, L; Yang, X; Yang, Y; Zheng, S | 1 |
| Aragão, DS; Casarini, DE; Ceroni, A; Fernandes, FB; Michelini, LC; Ruggeri, A; Silva, SD; Zampieri, TT | 1 |
| Chlopicki, S; Kij, A; Olkowicz, M; Radulska, A; Smolenski, RT; Suraj, J; Walczak, M | 1 |
| Cheang, WS; Huang, Y; Lan, HY; Lau, CW; Liu, J; Luo, JY; Raizada, MK; Tian, XY; Wang, L; Wong, CM; Wong, WT; Xu, J; Yao, X; Zhang, Y | 1 |
| Basu, R; Das, SK; Grant, MB; Hall, DA; Kassiri, Z; Oudit, GY; Patel, VB; Ramprasath, T; Takawale, A | 1 |
| Hirasawa, M; Kageji, T; Kanematsu, Y; Kitazato, KT; Kuwayama, K; Matsushita, N; Matsuura, E; Nagahiro, S; Nishi, K; Satomi, J; Shimada, K; Tada, Y; Uno, M; Yagi, K | 1 |
| Castor, MG; Duarte, ID; Romero, TR; Santos, RA | 1 |
| Bader, M; Barkhausen, J; Raasch, W; Santos, RA; Schuchard, J; Schuster, F; Stölting, I; Thorns, C; Vogt, FM; Winkler, M | 1 |
| Dong, M; Guan, J; Meng, X; Niu, R; Sun, Y; Yang, J; Yang, X; Zhang, C; Zhang, Y | 1 |
| Bai, R; Bian, Y; Liang, B; Liu, M; Wang, X; Xiao, C; Yang, H; Yang, Z; Zhang, N | 1 |
| Červenka, L; Husková, Z; Melenovský, V; Nishiyama, A; Sadowski, J; Škaroupková, P | 1 |
| Han, Z; Jia, S; Li, Y; Liang, B; Wang, C; Xue, J; Zhang, Y | 1 |
| Campagnole-Santos, MJ; Guimaraes, PS; Kangussu, LM; Melo, MB; Nadu, AP; Santos, RA | 1 |
| Yoshizumi, M | 1 |
| Brandan, E; Cabello-Verrugio, C; Di Capua, G; Morales, MG; Olguín, H; Simon, F | 1 |
| Luo, H; Xiao, Q; Zhang, D; Zhao, K | 1 |
| Cui, Z; Hu, Y; Huang, H; Wang, B; Zhou, J | 1 |
| de Leeuw, PW; Krekels, MM; Kroon, AA | 1 |
| Leung, PS; Liang, J; Wang, L | 1 |
| Gao, Q; Jiang, T; Lu, H; Tan, L; Tian, YY; Yu, JT; Zhang, YD; Zhao, HD; Zhou, JS; Zhu, XC | 1 |
| Bürgelová, M; Červenka, L; Hammock, BD; Husková, Z; Hwang, SH; Imig, JD; Melenovský, V; Sadowski, J; Škaroupková, P; Sporková, A | 1 |
| Calò, LA; Davis, PA; Maiolino, G; Pagnin, E | 1 |
| Alves, MN; Campagnole-Santos, MJ; de Almeida, PW; Dos Santos, RA; Gavioli, M; Greco, L; Guatimosim, S; Jesus, IC; Lima, Rde F; Melo, MB; Mitraud, L; Nocchi, E; Parreira, A; Resende, RR; Santiago, NM | 1 |
| Cheng, CP; Cheng, HJ; Ferrario, CM; Li, T; Zhou, P | 1 |
| Shen, F; Xu, X; Zhang, N | 1 |
| Bihl, JC; Chen, S; Chen, Y; Liu, L; Ma, X; Miao, H; Wang, J; Xiao, X; Zeng, R; Zhang, C | 1 |
| da Silva, CHTP; de Oliveira, AM; do Prado, AF; Gerlach, RF; Gomes, MS; Pernomian, L | 1 |
| Basu, R; Das, SK; Grant, MB; Lopaschuk, GD; McLean, BA; Mori, J; Oudit, GY; Parajuli, N; Patel, VB; Penninger, JM; Ramprasath, T | 1 |
| Chen, Y; Hao, P; Li, B; Li, G; Liu, Y; Shang, R; Wang, J; Wang, X; Yang, J; Zhang, C; Zhang, M; Zhang, Y | 1 |
| Bian, X; Hu, N; Sun, T; Wei, X; Xu, J; Zhang, X; Zhu, X | 1 |
| Lu, J; Ma, J; Pan, H; Ren, D; She, X; Wu, H | 1 |
| Chen, LJ; Gao, PJ; Jin, HY; Oudit, GY; Song, B; Xu, R; Xu, YL; Zhang, ZZ; Zhong, JC; Zhu, DL | 1 |
| Chen, Y; Fu, L; Gao, W; Huang, M; Li, F; Wang, J; Zhao, P | 1 |
| Aires, RD; Cortes, SF; Lemos, VS; Olivon, VC; Ramalho, LZ; Santiago, LB | 1 |
| Bihl, JC; Chen, S; Chen, Y; Ma, X; Xiao, X; Zhang, C; Zhao, B; Zhao, Y | 1 |
| Gironacci, MM | 1 |
| Huang, W; Luo, L; Ren, F; Tang, L; Yan, R; Zhang, L; Zheng, Y | 1 |
| Baker, MB; Castellano, RK; Guo, L; Jarajapu, YP; Joshi, S; Li, Y; Raizada, MK; Singh, N | 1 |
| Böhme, I; Gembardt, F; Greenberg, B; Meinert, C; Tetzner, A; Walther, T; Wieland, T | 1 |
| Alzamora, AC; Campagnole-Santos, MJ; Ferreira, PM; Santos, RA; Xavier, CH | 1 |
| Hou, L; Hu, H; Lin, Z; Ni, Y; Song, L; Wu, Y; Yang, D; Zhang, J | 1 |
| Han, Y; Li, P; Sun, HJ; Zhang, F | 1 |
| Aragão, DS; Arita, DY; Bertoncello, N; Casarini, DE; Cunha, TS; Dantas, PS; Mattar-Rosa, R; Moreira, RP; Santos, R; Watanabe, IK; Yokota, R | 1 |
| Liu, M; Shi, P; Sumners, C | 1 |
| Andrä, M; Greilberger, J; Hauser, S; Ortner, A; Russ, M; Wintersteiger, R | 1 |
| Chen, W; Li, G; Shan, T; Shang, W; Zhang, L; Zhang, Y; Zhao, C | 1 |
| Echeverría-Rodríguez, O; Gallardo-Ortíz, IA; Villalobos-Molina, R | 2 |
| Cheng, Y; Li, Q; Wen, Q; Zhang, Y; Zhao, J | 1 |
| Deng, C; Liao, X; Long, M; Luo, C; Luo, D; Wang, L; Zhuang, X | 1 |
| Abwainy, A; Akhtar, S; Babiker, F; Benter, IF | 1 |
| Akhtar, S; Attur, S; Benter, IF; Chandrasekhar, B; Dhaunsi, GS; Yousif, MH | 1 |
| Bae, EH; Kim, CS; Kim, IJ; Kim, SW; Lee, J; Ma, SK | 1 |
| Bueno-Betí, C; Gironacci, MM; Hermenegildo, C; Lázaro-Franco, M; Mompeón, A; Monsalve, E; Novella, S; Pérez-Cremades, D; Vidal-Gómez, X | 1 |
| Xi, L; Yang, F | 1 |
| Fontes, MA; Martins Lima, A; Santos, RA | 1 |
| Bernardi, S; Bossi, F; Bramante, A; Candido, R; Carretta, R; De Nardo, D; Fabris, B; Fischetti, F | 1 |
| Gopallawa, I; Uhal, BD | 1 |
| Ai, Y; Liu, Z; Ma, X; Ming, G; Xu, D; Zhang, L; Zhao, S | 1 |
| Bastos, CP; Lazaroni, TL; Moraes, MF; Pereira, GS; Santos, RS | 1 |
| Chen, B; Chen, X; Du, H; Katovich, MJ; Li, A; Li, H; Li, J; Pei, N; Qi, Y; Sumners, C; Wan, R; Wei, W; Zhang, Y; Zheng, H | 1 |
| Costa, AR; de Souza Júnior, A; Feitosa, LC; Gonçalves, GK; Honorato-Sampaio, K; Machado, FB; Pereira, AM; Reis, AM; Santos, RA | 1 |
| Ren, CZ; Su, DF; Sun, JC; Wang, WZ; Wang, YK; Wu, ZT; Yang, YH; Zhang, RW | 1 |
| Huang, Y; Lau, CW; Lau, WC; Lau, YS; Murugan, D; Mustafa, MR | 1 |
| Barreto-Chaves, ML; Carneiro-Ramos, MS; Diniz, GP; Santos, RA; Senger, N | 1 |
| Cai, SM; Chen, Y; Li, DH; Li, X; Li, Y; Luo, W; Ning, ZW; Pan, MX; Yang, RQ; Zhang, LL; Zhou, GS | 1 |
| Bracey, DN; Callahan, MF; Emory, CL; Gallagher, PE; Smith, TL; Tallant, EA; Wiggins, WF; Willey, JS | 1 |
| Aboye, T; Camarero, JA; Majumder, S; Meeks, CJ; Rodgers, K; Shekhtman, A | 1 |
| Hao, Y; Liu, Y | 1 |
| Červenka, L; Červenková, L; Doleželová, Š; Husková, Z; Kompanowska-Jezierska, E; Kopkan, L; Kramer, HJ; Nishiyama, A; Sadowski, J; Škaroupková, P; Vaňourková, Z | 1 |
| Abrigo, J; Acuña, MJ; Bader, M; Brandan, E; Cabello-Verrugio, C; Cabrera, D; Morales, MG; Olguin, H; Santos, RA; Simon, F | 1 |
| Açikalin, Ö; Bölükbaşi Hatip, FF; Hatip-Al-Khatib, I; Tan, RF | 1 |
| Ren, CZ; Shen, D; Sun, JC; Wang, YK; Wu, ZT; Yang, YH; Zhang, RW | 1 |
| Cao, X; Li, H; Li, S; Shi, T; Xie, R; Xin, Z; Yang, F; Yang, JK; Yuan, M | 1 |
| Gembardt, F; Kohse, F; Kuebler, WM; Supé, S; Walther, T | 1 |
| Gao, Q; Jiang, T; Lu, H; Tan, L; Zhang, YD; Zhou, JS; Zhu, XC | 1 |
| Meeks, CJ; Papinska, AM; Rodgers, KE; Soto, M | 1 |
| Ananthalakshmi, KV; Fateel, MM; Khajah, MA; Luqmani, YA | 2 |
| Arnold, AC; Biaggioni, I; Bracy, DP; Otero, YF; Wasserman, DH; Williams, IM | 1 |
| Brzozowski, T; Konturek, SJ; Korbut, R; Kwiecien, S; Madej, J; Olszanecki, R; Pajdo, R; Pawlik, MW; Ptak-Belowska, A; Suski, M; Targosz, A | 1 |
| Chang, Q; Chen, LJ; Jin, HY; Oudit, GY; Song, B; Xu, R; Xu, YL; Yu, HM; Zhang, ZZ; Zhong, JC; Zhu, DL | 1 |
| de Haan, MW; de Leeuw, PW; Houben, AJ; Kroon, AA; van Twist, DJ | 1 |
| Chang, RL; Day, CH; Ho, TJ; Hsieh, DJ; Huang, CY; Kuo, WW; Lin, JW; Shen, CY; Viswanadha, VP; Yeh, YL | 1 |
| Cai, C; Meng, X; Shen, Q; Tang, W; Wang, B; Wang, Y; Yu, C; Zou, F | 1 |
| Chang, P; Jiang, C; Li, NY; Liang, W; Lin, X; Wang, QY; Xu, H; Yang, MN; Yu, H; Yu, J | 1 |
| Beyer, AM; Durand, MJ; Gutterman, DD; Hijjawi, JB; Nasci, VL; North, PE; Reuben, CF; Riedel, M; Salato, VK; Zinkevich, NS | 1 |
| Grant, MB; Oudit, GY; Patel, VB; Zhong, JC | 1 |
| Cervantes-Pérez, LG; Del Valle-Mondragón, L; Ibarra-Lara, L; Oidor-Chan, VH; Pastelín-Hernández, GS; Pérez-Severiano, F; Ramírez-Ortega, M; Sánchez-Aguilar, M; Sánchez-Mendoza, A; Soria-Castro, E; Torres-Narváez, JC; Zarco-Olvera, G | 1 |
| Machado-Silva, A; Passos-Silva, D; Santos, RA; Sinisterra, RD | 1 |
| Al-Maghrebi, M; Renno, WM | 1 |
| Hasegawa, Y; Kim-Mitsuyama, S; Koibuchi, N; Ma, M; Nakagata, N; Nakagawa, T; Senju, S; Uekawa, K | 1 |
| Aguiar, DC; Almeida-Santos, AF; Campagnole-Santos, MJ; Kangussu, LM; Moreira, FA; Santos, RA | 1 |
| Gebolys, K; Klein, S; Meinert, C; Tetzner, A; Trebicka, J; Uhlich, A; Villacañas, Ó; Walther, T | 1 |
| Araújo, TS; Cerqueira, GS; Costa, DS; Martins, CS; Medeiros, JV; Nicolau, LA; Pacífico, DM; Silva, RO; Sousa, FB; Sousa, NA; Souza, FM; Souza, LK; Souza, MH | 1 |
| Dolkart, O; Foichtwanger, S; Knoll, E; Limor, R; Marcus, Y; Nevo, N; Shefer, G; Stern, N | 1 |
| Chen, Y; Jin, L; Lin, S; Liu, D; Wu, S; Yu, H; Zhang, C; Zhang, P; Zhong, J | 1 |
| Brosnihan, KB; Chappell, MC; Cruz-Diaz, N; Marshall, AC; Pirro, NT; Wilson, BA | 1 |
| Ahmadian, E; Eftekhari, A; Eghbal, MA; Heidari, R; Pennefather, PS | 1 |
| Kibel, A | 1 |
| Batich, CD; Byrne, BJ; Cogle, CR; Ferreira, LF; Handberg, EM; Huo, T; Pepine, CJ; Petersen, JW; Qi, Y; Rocca, DG; Rubiano, A; Ruchaya, PJ; Simmons, CS; Wate, PS; Willenberg, BJ; Wise, EA | 1 |
| Dobashi, S; Hisatake, S; Ikeda, T; Kabuki, T; Kiuchi, S; Oka, T | 1 |
| Cao, Q; Gong, J; Liu, Y; Song, Y; Yu, M; Zhang, L | 1 |
| Červenka, L; Doleželová, Š; Falck, JR; Husková, Z; Imig, JD; Jíchová, Š; Kompanowska-Jezierska, E; Kopkan, L; Kramer, HJ; Kujal, P; Neckář, J; Reddy, RN; Sadowski, J; Vernerová, Z | 1 |
| Cao, X; Liu, C; Wang, L; Wang, YY; Yang, JK; Zhang, F | 1 |
| Chen, W; Hao, P; Li, H; Li, J; Li, W; Meng, X; Yang, J; Zhang, C; Zhang, Y | 1 |
| Chabielska, E; Gromotowicz-Poplawska, A; Kolodziejczyk, P; Kramkowski, K; Szoka, P; Wojewodzka-Zelezniakowicz, M | 1 |
| Huang, S; Jin, SY; Li, X; Li, Y; Ma, XX; Wang, D; Zhang, LL; Zhang, WY; Zhang, YP | 1 |
| An, L; Li, CS; Liu, QT; Tong, N; Xiao, HL; Yang, J; Zhao, LX | 1 |
| Apostolopoulos, V; Qaradakhi, T; Zulli, A | 1 |
| Fu, EQ; Li, ZC; Liu, ML; Wang, YX; Zhang, B | 1 |
| Miranda, AS; Rocha, NP; Rodrigues Prestes, TR; Simoes-E-Silva, AC; Teixeira, AL | 1 |
| Demkow, U; Radkowski, M; Winklewski, PJ | 1 |
| Ali, Q; Dhande, I; Hussain, T; Samuel, P | 1 |
| Bricca, G; Kobeissy, F; Marcelo, P; Nasser, R; Nehme, A; Zibara, K | 1 |
| Bellani, G; Sigurta', A; Zambelli, V | 1 |
| Arnold, MR; Forte, BL; Hay, M; Largent-Milnes, TM; Slosky, LM; Staatz, WD; Vanderah, TW; Zhang, H | 1 |
| Feng, Y; Gu, CJ; Li, N; Li, QY; Tang, W; Wan, HY; Zhou, JP | 1 |
| Carretero, OA; Cerrato, BD; Gironacci, MM; Grecco, HE; Janic, B | 1 |
| Gonçalves, LR; Lima, KF; Moraes, KC; Silva, Bde O; Silveira, MB | 1 |
| Hu, K; Kang, J; Li, Y; Lu, W; Tang, S; Xu, L; Yu, S; Zhou, X | 1 |
| Korpela, R; Siltari, A; Vapaatalo, H | 1 |
| Chappell, MC; Diz, DI; Nixon, PA; O'Shea, TM; Rose, JC; Russell, GB; Shaltout, HA; Snively, BM; South, AM; Washburn, LK | 1 |
| Antlanger, M; Bader, M; Domenig, O; Elased, KM; Grobe, N; Gurley, SB; Kaltenecker, CC; Königshausen, E; Kovarik, JJ; Linker, RA; Manzel, A; Motta-Santos, D; Poglitsch, M; Säemann, MD; Santos, RA; Stegbauer, J; van Oyen, D | 1 |
| Lombard, JH; Raffai, G | 1 |
| Carden, TR; Gironacci, MM; Goldstein, J; Höcht, C; Perez, MJ; Taira, CA | 1 |
| Nicklin, SA | 1 |
| Banères, JL; Boularan, C; Denis, C; Dubroca, C; Galandrin, S; Galés, C; M'Kadmi, C; Marie, J; N'Guyen, D; Nicaise, Y; Pathak, A; Pilette, C; Seguelas, MH; Sénard, JM | 1 |
| Berg, S; Dombrowski, F; Döring, P; Drews, G; Gürtler, S; Krippeit-Drews, P; Lendeckel, U; Maczewsky, J; Sahr, A; Tetzner, A; van den Brandt, J; Venz, S; Walther, T; Wolke, C | 1 |
| Cruz, JS; Ferreira, AJ; Joca, HC; Joviano-Santos, JV; Santos-Miranda, A | 1 |
| Chen, SF; Lo, WY; Wang, HJ | 1 |
| Han, C; Li, N; Ma, L; Peng, T; Yang, X; Zhang, B; Zhen, X | 1 |
| Al-Jarallah, A; Babiker, F; Joseph, S | 1 |
| Aleligne, Y; Froogh, G; Huang, A; Kandhi, S; Le, Y; Pinto, JT; Sun, D | 1 |
| Alenina, N; Bader, M; Barcelos, LS; Campagnole-Santos, MJ; Magalhães, GS; Motta-Santos, D; Rodrigues-Machado, MG; Santos, RA | 1 |
| Ábrigo, J; Cabello-Verrugio, C; Cabrera, D; Simon, F | 1 |
| Bartelmez, SH; Cassis, LA; Jarajapu, YP; Joshi, S; Thatcher, SE; Vasam, G | 1 |
| Bai, N; Chen, B; Chen, S; Chen, X; Du, H; Li, A; Li, H; Li, J; Mao, Y; Pei, N; Sumners, C; Wang, S; Yan, R; Zhang, Y | 1 |
| Gutberlet, T; Preu, J; Tiefenauer, L | 1 |
| Al Mulhim, N; Kehoe, PG; Miners, JS; Palmer, LE; Wong, S | 1 |
| Abreu, GR; Bissoli, NS; Claudio, ER; Endlich, PW; Lemos, VS; Lima, LC; Peluso, AA; Ribeiro Júnior, RF; Santos, RA; Stefanon, I | 1 |
| Chen, J; Cheng, F; Feng, J; Lan, J; Lei, Y; Mei, W; Xu, Q; Zeng, B; Zhai, Y; Zhang, W; Zhen, Y; Zheng, D | 1 |
| Cheng, M; Guan, M; Le, Y; Xue, J; Xue, Y; Zheng, Z | 1 |
| Batlle, D; David, NV; Fogo, A; Kanwar, Y; Khattab, AM; Martin, A; Osborn, M; Wysocki, J; Ye, M | 1 |
| Czesnikiewicz-Guzik, M; Guzik, TJ; Jawien, J; Korbut, R; Mikolajczyk, TP; Montezano, AC; Nosalski, R; Olszanecki, R; Rios, FJ; Siedlinski, M; Skiba, DS; Touyz, RM | 1 |
| Gu, J; Li, H; Liu, X; Lu, Y; Ren, Z; Wang, X; Zhang, L | 1 |
| Cassis, L; Powell, D; Shoemaker, R; Su, W; Thatcher, S; Wang, Y | 1 |
| Barnes, CA; Constantopoulos, E; Hay, M; Konhilas, J; Samareh-Jahani, F; Uprety, AR; Vanderah, TW | 1 |
| Hu, K; Kang, J; Lu, W; Tang, S; Xu, L; Yu, S; Zhou, X | 1 |
| Didier, DN; Exner, EC; Greene, AS; Hoffmann, BR; Lombard, JH; Stodola, TJ; Wagner, JR | 1 |
| Brosnihan, KB; Chappell, MC | 1 |
| Ferreira, AJ; Fraga-Silva, RA; Lautner, RQ; Santos, RA | 1 |
| A, MK; Aziz, NM; E, MA; Rifaai, RA | 1 |
| Chen, JL; Pu, D; Sun, Y; Xiao, Q; Zhang, DL; Zhao, KX; Zhao, YX | 1 |
| Crowley, SD; Rudemiller, NP | 1 |
| Adams, GN; Bader, M; Batlle, D; Flask, CA; Haber, PK; Hoit, BD; Kanwar, Y; Maier, C; Schadock, I; Schmaier, AH; Wysocki, J; Ye, M; Yu, X | 1 |
| Burrell, LM; Gayed, D; Griggs, K; Patel, SK; Velkoska, E | 1 |
| Karnik, SS; Singh, KD; Tirupula, K; Unal, H | 1 |
| Cabello-Verrugio, C; Garcia, D; Rivera, JC | 1 |
| Bi, J; Chappell, MC; Pulgar, VM; Rose, JC; Su, Y | 1 |
| Brown, MA; Casley, D; Davis, GC; Gibson, KJ | 1 |
| Chen, W; Liu, H; Tang, X; Wen, J; Weng, C; Wu, Y; Yang, K; Yang, X | 1 |
| Chen, X; Lezutekong, JN; Oudit, GY; Patel, VB | 1 |
| Chen, H; Cui, Y; Li, S; Liu, J; Song, J; Zhang, F | 1 |
| Campagnole-Santos, MJ; de Oliveira, ML; Hamamoto, D; Limborço-Filho, M; Moreira, FA; Moura Santos, D; Peliky Fontes, MA; Ribeiro Marins, F; Santos, RA; Xavier, CH | 1 |
| Garabadu, D; Goyal, A; Pachauri, P; Upadhyay, PK | 1 |
| Akhtar, S; Benter, IF; Dhaunsi, GS; Makki, B; Yousif, M | 1 |
| Abrigo, J; Aravena, J; Araya-Durán, I; Cabello-Verrugio, C; González-Nilo, FD; Márquez-Miranda, V; Pacheco, N; Rivera, JC; Simon, F | 1 |
| Alves, PH; Castro, CH; Colugnati, DB; Macedo, LM; Mendes, EP; Nunes, AD; Pedrino, GR; Santos, RA; Souza, AP | 1 |
| Batlle, D; Jin, J; Liu, P; Serfozo, P; Souma, T; Wysocki, J; Ye, M | 1 |
| Gobeil, F; Regoli, D | 1 |
| Camargos, MG; Casalechi, M; Cavallo, IK; Del Puerto, HL; Dela Cruz, C; Dias, JA; Lobach, VN; Oliveira, ML; Reis, AM; Reis, FM; Santos, RA | 1 |
| Guo, L; O'Rourke, ST; Sun, C; Yin, A; Zhang, Q; Zhong, T | 1 |
| Botion, LM; Chaves, VE; Lourenço, FC; Mario, ÉG; Moreira, CCL; Santos, RAS | 1 |
| Abuohashish, HM; Ahmed, MM; Al-Rejaie, SS; Khattab, MM; Sabry, D | 3 |
| Bader, M; Bertagnolli, M; Casali, KR; Dartora, DR; Irigoyen, MC; Moraes-Silva, IC; Santos, RAS | 1 |
| Alonso, KC; Azevedo, ER; Casarini, DE; Cliquet, A; Costa E Silva, AA; de Rossi, G; Gorla, JI; Matos-Souza, JR; Nadruz, W; Nogueira, CD; Paim, LR; Palomino, Z; Schreiber, R; Sposito, AC | 1 |
| Cassis, LA; Thatcher, SE; Wang, Y | 1 |
| Aguiar, DC; Almeida-Santos, AF; Campagnole-Santos, MJ; Fontes, MAP; Kangussu, LM; Moreira, FA; Santos, RAS | 1 |
| Nakagawasai, O; Nemoto, W; Ogata, Y; Tadano, T; Tan-No, K; Yamagata, R | 1 |
| Barrow, BM; Brar, GS; Choung, E; Griesbach, R; Raleigh, DP; Ruzsicska, B; Watson, M; Welch, A; Zraika, S | 1 |
| Mogi, C; Okajima, F; Sato, K; Tobo, A; Tomono, S; Uchiyama, T | 1 |
| Bento-Bernardes, T; Conte-Junior, CA; Fernandes, T; Fernandes-Santos, C; Frantz, EDC; Gaique, TG; Giori, IG; Lima, JBS; Medeiros, RF; Nobrega, ACL; Oliveira, EM; Oliveira, KJ; Vieira, CP | 1 |
| Coletta, RD; de Oliveira, CE; Hinsley, EE; Hunt, S; Lambert, DW | 1 |
| Guo, L; Han, S; He, W; Li, H; Shen, D; Wang, J; Zhang, Y | 1 |
| De Silva, TM; Faraci, FM; Hu, C; Kinzenbaw, DA; Modrick, ML; Sigmund, CD | 1 |
| Chi, C; Cui, L; Hou, F; Li, C; Liu, R; Liu, X; Wang, C; Yin, C; Yu, X | 1 |
| Chappell, MC; Devocelle, M; Gallagher, PE; Paradisi, F; Tallant, EA; Wester, A | 1 |
| Bader, M; Rein, J | 1 |
| Cota, J; de Farias Lelis, D; Mafra, V; Oliveira Andrade, JM | 1 |
| Magalhaes, DM; Nunes-Silva, A; Rocha, GC; Salviano de Faria, MH; Simoes E Silva, AC; Vaz, LN | 1 |
| Almeida, AP; Castro, CH; de Moraes, PL; Ferreira, AJ; Kangussu, LM; Santos, RAS | 1 |
| Pearson, JT; Shirai, M; Sukumaran, V; Tatsumi, E; Tsuchimochi, H | 1 |
| Lin, S; Lu, J; Pan, H; Ren, D; Wu, H | 1 |
| Chen, Q; Hu, Q; Hu, Z; Huang, Y; Mao, Z; Xu, F; Zhou, X | 1 |
| Antunes-Rodrigues, J; Dos-Santos, RC; Lustrino, D; Mecawi, AS; Monteiro, LDRN; Paes-Leme, B; Reis, LC | 1 |
| Fraidenburg, DR; Han, Y; Ren, X; Sun, S; Tang, H; Zhang, F; Zhao, M; Zhao, Z | 1 |
| Carretero, OA; Cerniello, FM; Cerrato, BD; Gironacci, MM; Grecco, HE; Longo Carbajosa, NA; Santos, RA | 1 |
| Alzamora, AC; Barbosa, CM; Campagnole-Santos, MJ; Santos, RAS; Soares, ER | 1 |
| Barbosa-da-Silva, S; de Oliveira Fraga, SR; de Oliveira Sá, G; Dos Santos Neves, V; Souza-Mello, V | 1 |
| Chen, YY; Jin, LJ; Liu, D; Yu, HM; Zhang, CJ; Zhang, P; Zhong, JC; Zhou, XM | 1 |
| Abrao, EP; Bouvier, M; Bruder-Nascimento, T; Costa, RM; Costa-Neto, CM; Duarte, DA; Ferreira, PAB; Oliveira, EB; Parreiras-E-Silva, LT; Rodríguez, DY; Silva, CAA; Simões, SC; Teixeira, LB; Tostes, RC | 1 |
| Healy, V; Johns, EJ; O'Neill, J | 1 |
| Fu, X; Li, Y; Shi, C; Song, Y; Zhang, Y; Zhao, L | 1 |
| Boehler, T; Fiedler, R; Girndt, M; Hulko, M; Martus, P; Schindler, R; Storr, M; Trojanowicz, B; Ulrich, C; Werner, K; Willy, K; Zickler, D | 1 |
| Bilodeau, MS; Leiter, JC | 1 |
| Fukuhara, S; Hosoi, H; Ikoma, K; Kawabe, Y; Kodo, K; Matoba, S; Mori, J; Morimoto, H; Nakajima, H; Oudit, GY; Tsuma, Y | 1 |
| Meng, Y; Pan, MX; Sun, NN; Yang, QJ; Yu, CH; Zhang, Y; Zheng, BJ; Zheng, ZM | 1 |
| Costa-Besada, MA; Garrido-Gil, P; Labandeira-Garcia, JL; Lanciego, JL; Parga, JA; Valenzuela, R; Villar-Cheda, B | 1 |
| Campbell, WB; Herrnreiter, A; Kopf, PG; Krause, C; Park, SK; Roques, BP | 1 |
| Chen, SA; Chen, YC; Chen, YJ; Cheng, CC; Lin, YK; Lu, YY; Wu, WS | 1 |
| Chi, C; Cui, L; Hou, F; Li, C; Liu, R; Liu, X; Wang, Y; Wen, Y; Yin, C; Yu, X | 1 |
| Cole-Jeffrey, CT; Grant, MB; Hazra, S; Katovich, MJ; Pepine, CJ; Raizada, MK | 1 |
| Greenberg, G; Hamias, R; Rudich, A; Szendro, G; Wolak, T | 1 |
| Chen, WQ; Cheng, J; Ji, XP; Mao, Y; Qiao, L; Tie, YY; Xu, QB; Xu, YY; Zhai, CG; Zhang, C; Zhang, Y | 1 |
| Montezano, AC; Touyz, RM | 1 |
| Chan, JSD; Chenier, I; Filep, JG; Ghosh, A; Ingelfinger, JR; Lo, CS; Scholey, JW; Zhang, SL; Zhao, S | 1 |
| Deng, H; Gao, F; Huang, C; Li, W; Ma, X; Wang, S; Wang, Y; Xuan, X; Yuan, L | 1 |
| Chen, WY; Li, ZX; Liang, ML; Shi, H; Sun, XT; Wang, X; Yang, YY; Yang, ZS; Zeng, WT | 1 |
| Cui, L; Liu, R; Wang, G; Wang, Y; Xiao, H; Yin, C | 1 |
| Al-Bader, M; Al-Kandari, S; Alsalem, A; Babiker, F; Ghadhanfar, E; Naser, J | 2 |
| Kompanowska-Jezierska, E; Kuczeriszka, M; Navar, LG; Prieto, MC; Sadowski, J | 1 |
| Alenina, N; Alzamora, AC; Bader, M; Campagnole-Santos, MJ; Motta-Santos, D; Sampaio, WO; Santos, RAS | 1 |
| Grandoch, M; Hendgen-Cotta, U; Hering, L; Höges, S; Istas, G; Mergia, E; Rassaf, T; Rodriguez-Mateos, A; Rump, LC; Stegbauer, J; Yakoub, M; Yang, G | 1 |
| Liu, X; Wang, G; Wang, Y; Xiao, H; Yin, C | 1 |
| Abd El Fattah, MA; Abdallah, DM; El-Abhar, HS; Nassar, NN; Rabie, MA | 2 |
| Barcelos, LS; Barroso, LC; Campagnole-Santos, MJ; Gregório, JF; Magalhaes, GS; Motta-Santos, D; Oliveira, AC; Perez, DA; Pinho, V; Reis, AC; Rodrigues-Machado, MG; Santos, RAS; Teixeira, MM | 1 |
| Bai, N; Chen, B; Chen, H; Chen, X; Du, H; Li, A; Li, H; Li, J; Mao, Y; Pei, N; Sumners, C; Wang, S; Wang, X; Yan, R; Zhang, Y | 1 |
| Chen, J; Chen, W; Feng, J; Li, C; Wang, Z; Xu, Q; Xu, Z; Zhang, J; Zhang, W; Zhang, Y; Zhen, Y | 1 |
| de Miranda, AS; Feracin, V; Ferreira, RN; Machado, CA; Prestes, TRR; Rocha, NP; Simoes E Silva, AC; Teixeira, AL | 1 |
| Cook, JF; Gerdes, L; Lee, SW; Shaltout, HA; Simpson, SL; Tegeler, CH; Tegeler, CL | 1 |
| Abd El-Rahman, SS; Abdelkader, NF; Emara, M; Kamel, AS; Khattab, MM; Zaki, HF | 1 |
| Alberici, LC; da Silveira, MB; de Oliveira da Silva, B; Dechant, CRP; Friedman, SL; Gonçalves, LR; Moraes, KCM; Ramos, LF; Sakane, KK; Silva, CM | 1 |
| Campagnole-Santos, MJ; Carvalho Santuchi, M; da Silva, RF; de Morais E Silva, M; de Souza-Neto, FP | 1 |
| Bennion, DM; Dang, AN; Donnangelo, LL; Graham, JT; Isenberg, JD; Jones, CH; Rodriguez, V; Santos, RAS; Sinisterra, RDM; Sousa, FB; Sumners, C | 1 |
| Gao, Q; Jiang, T; Li, M; Lu, J; Tang, XH; Zhang, SG; Zhang, YD; Zhou, Y; Zhu, DL | 1 |
| Gao, Q; Jiang, T; Ou, Z; Shi, JQ; Wang, QG; Wu, L; Xue, LJ; Xue, X; Yang, Y; Zhang, YD | 1 |
| Hao, Q; He, L; Li, M; Li, W; Ma, X; Pang, Z; Wang, S; Xue, X; Zhang, C; Zhang, K; Zhang, W; Zhang, Y; Zhou, J | 1 |
| Barreto-Chaves, MLM; Campagnole-Santos, MJ; Diniz, GP; Melo, MB; Santos, RAS; Senger, N | 1 |
| Li, SM; Liu, F; Wang, XY; Yang, XH | 1 |
| Du, J; Han, Z; Li, X; Lin, Z; Lu, A; Pan, X; Qu, A; Shao, Y; Tian, H; Wang, B; Wang, Y; Wu, F; Xiong, R; Xu, A; Xu, H; Yang, T; Zhang, Y; Zheng, J | 1 |
| Ho, JK; Nation, DA | 1 |
| Greenhill, C | 1 |
| Otto, G | 1 |
| Cerezo, G; Gironacci, MM; Silva, MG; Vicario, A | 1 |
| Domińska, K; Habrowska-Górczyńska, DE; Kowalska, K; Ochędalski, T; Okła, P; Piastowska-Ciesielska, AW; Urbanek, KA | 2 |
| Barbosa, IG; de Campos-Carli, SM; Miranda, AS; Mohite, S; Rocha, NP; Salgado, JV; Sharma, S; Simoes-E-Silva, AC; Teixeira, AL | 1 |
| Jiang, LN; Liu, GQ; Liu, JF; Niu, CY; Wang, HH; Wang, ZJ; Zhang, LM; Zhao, ZG | 1 |
| Adams, J; Anthony, T; Chen, X; Frazer, J; Gaidarov, I; Gatlin, J; Semple, G; Unett, DJ | 1 |
| Becker, LK; Campagnole-Santos, MJ; Coelho, D; Kangussu, L; Millán, RDS; Motta-Santos, D; Moura, S; Santos, RAS; Totou, N | 1 |
| Chen, QF; Hao, H; Huang, YH; Kuang, XD; Yuan, QF; Zhang, T; Zhou, XY | 1 |
| Gaffney, K; Louie, S; Rodgers, K; Soto, M; Weinberg, M | 1 |
| Chen, Q; Huang, F; Liu, J; Liu, S; Yang, X; Zhang, Y | 1 |
| Bruce, EB; Carter, CS; Kirichenko, N; Morgan, D; Sakarya, Y; Scarpace, PJ; Sumners, C; Toklu, HZ; Tümer, N | 1 |
| Chen, J; Li, Z; Liu, M; Niu, W; Sun, X; Wang, Y; Wu, H | 1 |
| El-Shoura, EAM; Hemeida, RAM; Messiha, BAS; Sharkawi, SMZ | 1 |
| Andrade, RF; Bader, M; Honorato-Sampaio, K; Martins, AS; Reis, AM; Santos, RAS | 1 |
| Baev, OR; Ivanets, TY; Karapetyan, AO; Khlestova, GV; Nizyaeva, NV; Romanov, AY | 1 |
| Luo, X; Ma, Q; Wu, Y; Yu, J; Zhang, L; Zhang, Y | 1 |
| Hattori, N; Itcho, K; Kobuke, K; Ohno, H; Oki, K; Yoneda, M | 1 |
| Angus, P; Casey, S; Herath, C; Jones, R; Rajapaksha, I | 1 |
| Akasaka, H; Fujimoto, T; Fukada, SI; Hamano, G; Hanasaki-Yamamoto, H; Hongyo, K; Imaizumi, Y; Inagaki, T; Itoh, N; Kawai, T; Nagasawa, M; Nakagami, H; Nozato, S; Nozato, Y; Rakugi, H; Shirai, M; Sugimoto, K; Takahashi, T; Takami, Y; Takeda, M; Takeda, S; Takeshita, H; Takeya, Y; Tsuchimochi, H; Yamamoto, K; Yokoyama, S | 1 |
| Gao, L; Jiang, T; Lu, JL; Tao, MX; Xue, X; Zhang, YD; Zhou, JS | 1 |
| Li, X; Liang, B; Wang, X; Wu, J; Xie, J | 1 |
| Fuentevilla-Álvarez, G; Gamboa, R; Huesca-Gómez, C; Martínez-Alvarado, R; Sánchez-Muñoz, F; Soto, ME; Torres-Paz, YE; Torres-Tamayo, M | 1 |
| Du, X; Huang, Y; Jin, S; Li, X; Li, Y; Wang, D; Wang, G; Wu, B; You, Y; Zhu, X | 1 |
| Fiedler, R; Girndt, M; Imdahl, T; Trojanowicz, B; Ulrich, C | 1 |
| Chen, WS; Cui, W; Ebenezer, PJ; Francis, J; Fu, LY; Hou, YK; Kang, YM; Li, HB; Li, Y; Liu, KL; Miao, YW; Mu, JJ; Shi, XL; Su, Q; Yu, XJ; Zhu, GQ | 1 |
| Gao, Y; Jin, F; Yu, G; Zhang, M; Zhao, W | 1 |
| Ka, SM; Liao, MH; Shih, CC; Tsai, HJ; Tsao, CM; Wu, CC | 1 |
| Ichikawa, H; Kimura, Y; Narita, I; Narita, M; Okumura, K; Osanai, T; Tanaka, M; Tanno, T; Tomita, H; Yokono, Y | 1 |
| Chien, CY; Chuang, HC; Hsu, YC; Lin, YT; Wang, HC; Yang, MY | 1 |
| Katsi, V; Maragkoudakis, S; Marketou, M; Parthenakis, F; Tousoulis, D; Tsioufis, C | 1 |
| Graus-Nunes, F; Souza-Mello, V | 1 |
| Chappell, MC; Diz, DI; Nixon, PA; O'Shea, TM; Russell, GB; Shaltout, HA; South, AM; Washburn, LK | 1 |
| Chen, QF; Hao, H; Hu, QD; Huang, YH; Kuang, XD; Zhou, XY | 1 |
| Furukawa, T; Nakagawasai, O; Nemoto, W; Ogata, Y; Shimoyama, S; Tan-No, K; Ueno, S; Yamagata, R | 1 |
| Ban, TH; Chang, YS; Choi, BS; Jang, IA; Kim, EN; Kim, MY; Lim, JH; Park, CW; Yoon, HE | 1 |
| Papinska, AM; Rodgers, KE | 1 |
| Alenina, N; Bader, M | 1 |
| Huang, W; Jiang, M; Luo, L; Ren, F; Tang, L; Wang, Z; Xia, N; Yan, R; Zhou, J | 1 |
| Franklin, R; Kuipers, A; Moll, GN; Wagner, E | 1 |
| Chappell, MC; Diz, DI; Nautiyal, M; Shaltout, HA | 1 |
| Anders, HJ; Gaikwad, AB; Sharma, N | 1 |
| Ding, W; Gan, L; Gao, L; He, H; Li, X; Li, Y; Liu, J; Ou, S; Wang, M; Wu, W | 1 |
| Horiuchi, M | 1 |
| Chen, G; Gu, Y; Jin, X; Niu, J; Zhang, L | 1 |
| Chappell, MC; Diz, DI; Hendricks, AS; Shaltout, HA; South, AM; Washburn, LK | 1 |
| Fasching, A; Palm, F; Persson, P | 1 |
| Bader, M; Canta, G; Oudit, GY; Santos, RAS; Steckelings, UM; Verano-Braga, T | 1 |
| Bartlett, MJ; Doyle, KP; Falk, T; Hay, M; Heien, ML; Konhilas, JP; Largent-Milnes, TM; Polt, R; Rodgers, K; Vanderah, TW | 1 |
| Bhattacharya, SK; Chen, Y; Liu, C; Meng, W; Sun, Y; Zhao, T; Zhao, W | 1 |
| Bartha, JL; Erusalimsky, JD; León, R; Michalska, P; Pajuelo-Lozano, N; Peiró, C; Romacho, T; Romero, A; San Hipólito-Luengo, Á; Sánchez-Ferrer, CF; Sánchez-Pérez, I; Sanz, MJ; Valencia, I; Vallejo, S; Villalobos, LA | 1 |
| Bitker, L; Burrell, LM | 1 |
| Arroja, MMC; Holmes, WM; McCabe, C; Nicklin, SA; Reid, E; Roy, LA; Vallatos, AV; Work, LM | 1 |
| Amundson, E; Kashani, N; Kelland, EE; Lee, S; Levy, AM; Lund, BT; Rodgers, KE; Stone, R | 1 |
| Chandrashekar, K; Dibo, P; Juncos, LA; Juncos, LI; Marañón, RO; Mazzuferi, F; Silva, GB | 1 |
| Cao, L; Chen, YL; Fan, J; Han, TL; Ling, Z; Xu, Y; Yin, Y; Zeng, M | 1 |
| Chen, A; Han, Y; Li, P; Luo, Y; Ren, X; Sun, S; Tang, H; Xu, Y; Zhang, F | 1 |
| Crespo, TS; Freitas, DF; Lelis, DF; Machado, AS; Santos, SHS | 1 |
| Davidge, ST; Fan, H; Liao, W; Wu, J | 1 |
| da Silva Filha, R; de Almeida, TCS; de Andrade De Maria, ML; Ferreira, AJ; Kangussu, LM; Prestes, TRR; Silva, ACSE; Vieira, MAR | 1 |
| Chappell, MC; Diz, DI; Figueroa, JP; Hendricks, AS; Lawson, MJ; Shaltout, HA | 1 |
| Cao, C; Hasegawa, Y; Hayashi, K; Kim-Mitsuyama, S; Takemoto, Y | 1 |
| Arruda-Junior, DF; Benetti, A; Beraldo, JI; Borges-Júnior, FA; Dariolli, R; Girardi, ACC; Jensen, L; Luchi, WM; Martins, FL; Seguro, AC; Shimizu, MH | 1 |
| Américo, ALV; Evangelista, FS; Fonseca-Alaniz, MH; Martucci, LF; Muller, CR; Vecchiatto, B | 1 |
| Bosomtwi, A; Dardzinski, BJ; Janatpour, ZC; Korotcov, A; Symes, AJ | 1 |
| Andrades, ME; Biolo, A; Caetano, DSL; Clausell, N; Leitão, SAT; Lopes, A; Nascimento, TG; Pinto, GH; Rohde, LEP; Soares, DDS | 1 |
| Chen, M; Chen, Q; Cheng, L; Guo, T; Huang, F; Liu, J; Liu, S; Lu, J; Wang, W; Yang, X | 1 |
| Burckhardt, BB; Suessenbach, FK | 1 |
| Aragão, DS; Casarini, DE; Farah, V; Fiorino, P; Jara, ZP; Leite, APO; Nogueira, MD; Pereira, RO | 1 |
| Casarini, DE; Sanches Aragão, D; Stoll, D; Yokota, R | 1 |
| Gao, X; Li, S; Wang, R; Wei, Z; Xu, D; Xu, H; Yang, F; Yi, X; Zhang, B; Zhang, G; Zhang, H; Zhang, L; Zhang, X; Zhang, Y; Zhu, Y | 1 |
| Chen, X; Gong, J; Kong, X; Li, P; Li, Y; Shen, Y; Sheng, Y; Zhao, K; Zhou, B | 1 |
| Chen, YH; Hsiao, CC; Huang, CC; Li, SH; Lo, CM; Lu, HI | 1 |
| Cassali, GD; Galvão, I; Kraemer, L; Melo, EM; Rago, F; Russo, RC; Santos, RAS; Teixeira, MM | 1 |
| Gao, XM; Xu, H; Yang, F; Zhang, BN; Zhang, GZ; Zhang, X | 1 |
| Hong, L; Lin, C; Lin, L; Liu, GY; Pan, YX; Peng, WW; Wang, SZ; Zhao, XL | 1 |
| Hall, SE; Winslow, MA | 1 |
| Antlanger, M; Böhmig, GA; Domenig, O; Eskandary, F; Kain, R; Kaltenecker, CC; Kopecky, C; Kovarik, JJ; Poglitsch, M; Säemann, MD; Schmaldienst, S; Werzowa, J | 1 |
| Cao, Y; Guo, Y; Li, Y; Liu, Y; Ping, F; Shang, J; Yao, S; Yuan, Z | 1 |
| Cai, W; Gao, X; Hao, X; Jin, F; Li, D; Li, S; Liu, H; Liu, Y; Mao, N; Tao, T; Wei, Z; Xu, D; Xu, H; Yang, F; Zhang, B; Zhang, G; Zhang, H; Zhang, L | 1 |
| Alghazaly, GM; El-Bermawy, M; El-Saka, MH; Elshwaikh, S; Ibrahim, RR; Madi, NM | 1 |
| Abbate, M; Benigni, A; Cassis, P; Cerullo, D; Corna, D; Locatelli, M; Remuzzi, G; Rottoli, D; Villa, S; Zoja, C | 1 |
| Tsuda, K | 1 |
| Arnold, AC; Bingaman, SS; Lindsey, SH; Loloi, J; Miller, AJ; Shen, B; Silberman, Y; Wang, M; White, MC | 1 |
| Ihm, CG; Jeong, KH; Jung, SW; Kim, DJ; Kim, DO; Kim, JS; Kim, YG; Lee, SH; Lee, SY; Lee, TW; Lee, YH; Moon, JY; Park, SH; Sohn, IS; Song, SJ | 1 |
| Chen, Y; Liang, T; Liu, D; Yu, H; Zhang, P; Zhou, X | 1 |
| Berrino, L; Capuano, A; De Angelis, A; Mascolo, A; Rosano, GMC; Rossi, F; Scavone, C; Sessa, M; Urbanek, K | 1 |
| Guan, CX; Guan, XX; He, XF; Jiang, HL; Luo, XQ; Shao, M; Sun, CC; Wen, ZB; Xiong, JB; Yang, HH; Zhang, CY; Zhong, WJ; Zhou, Y | 1 |
| Fang, Y; Gao, F; Liu, Z | 1 |
| Gómez-Mendoza, DP; Kjeldsen, F; Marques, FD; Melo-Braga, MN; Santos, RA; Sinisterra, RD; Sprenger, RR; Verano-Braga, T | 1 |
| Ferreira, AJ; Galvão, I; Mesquita, RA; Queiroz-Junior, CM; Sá, MA; Santos, ACPM; Souto, GR | 1 |
| Cassis, LA; Ensor, CM; Gong, M; Gurley, SB; Shoemaker, R; Su, W; Tannock, LR; Thatcher, SE; Yiannikouris, F | 1 |
| Ahmed, AF; Ali, FF; Elroby Ali, DM | 1 |
| Bessa, ASM; Biancardi, MF; Castro, CH; Colugnati, DB; Costa, JM; Dos Santos, FCA; Jesus, ÉF; Lacerda, IS; Lino-Júnior, RS; Mazaro-Costa, R; Mendes, EP; Nunes, ADC; Pedrino, GR; Pontes, CNR; Souza, EJ | 1 |
| Akasaka, H; Fujimoto, T; Hongyo, K; Horiuchi, M; Imaizumi, Y; Mogi, M; Nagasawa, M; Nozato, S; Nozato, Y; Rakugi, H; Sugimoto, K; Takami, Y; Takeda, M; Takeshita, H; Takeya, Y; Yamamoto, K; Yokoyama, S | 1 |
| Li, X; Li, Y; Lou, A; Su, L; Tong, H; Zhang, M; Zhu, X | 1 |
| Arora, D; Kinra, M; Mudgal, J; Nampoothiri, M; Sankhe, R | 1 |
| Batlle, D; Marquez, A | 1 |
| Aquino, V; Buford, TW; Carter, CS; Li, Q; Lobaton, G; Morgan, D; Raizada, M; Sumners, E; Verma, A | 1 |
| Arnold, AC; Medina, D | 1 |
| Bujak-Gizycka, B; Bystrowska, B; Jawien, J; Kolton-Wroz, M; Kus, K; Madej, J; Olszanecki, R; Toton-Zuranska, J | 1 |
| Cheng, C; Cheng, J; Li, H; Lu, L; Ma, J; Sui, W; Xu, J; Xu, X; Xue, F; Yang, J; Zhang, C; Zhang, J; Zhang, M; Zhang, Y | 1 |
| Akhtar, S; Babyson, RS; Benter, IF; El-Hashim, AZ; Ezeamuzie, CI; Khajah, MA; Renno, WM | 1 |
| Franklin, R; Krakovsky, M; Kuipers, A; Levy, A; Moll, GN | 1 |
| Awwad, ZM; El-Ganainy, SO; El-Khatib, AS; ElMallah, AI; Khattab, MM; Khedr, SM | 1 |
| Bergler-Czop, B; Brzezińska-Wcisło, L; Kopeć-Mędrek, M; Kotyla, P; Kucharz, E; Miziołek, B; Sieńczyk, M; Widuchowska, M | 1 |
| Carretero, OA; Cerniello, FM; Gironacci, MM; Silva, MG | 1 |
| Bao, C; Chen, A; Han, Y; Li, P; Pan, Y; Sun, S; Tang, H; Wang, J; Xu, Y; Zhang, F | 1 |
| Bastos, AC; Bezerra, FS; Campagnole Santos, MJ; Gregório, JF; Magalhães, GS; Matos, NA; Motta-Santos, D; Rodrigues-Machado, MG; Santos, RAS | 1 |
| Alenina, N; Bader, M; Del Valle-Mondragon, L; Fuentes-Romero, R; Guevara-Cruz, M; Hong, E; Pichardo-Ontiveros, E; Schcolnik-Cabrera, A; Tobon-Cornejo, S; Torre-Villalvazo, I; Torres, N; Tovar, AR; Vargas-Castillo, A; Vidal-Puig, A | 1 |
| Bertoldi, G; Calò, LA; Rigato, M | 1 |
| Dang, Z; Ge, R; Jin, G; Li, Z; Lu, D; Ma, L; Nan, X; Su, S | 1 |
| Almeida-Santos, AF; de Melo, LA | 1 |
| Agirregoitia, E; Agirregoitia, N; Beitia, M; Casis, L; Corcostegui, B; Cortés, L; Irazusta, J; Matorras, R; Totorikaguena, L; Valdivia, A | 1 |
| He, Q; Huang, Y; Yang, L | 1 |
| Campos, GV; Chianca, D; De Menezes, RCA; De Souza, AMA; Ji, H; Linares, A; Sandberg, K; Speth, RC | 1 |
| Fujita, M; Hung, WY; Nakagawa, K; Nakagawasai, O; Nemoto, W; Tadano, T; Tan-No, K; Yamagata, R | 1 |
| Nakagawasai, O; Nemoto, W; Takahashi, K; Tan-No, K; Yamagata, R | 1 |
| Deng, CY; Guo, HM; Li, X; Liu, FZ; Liu, Y; Rao, F; Wang, ZY; Wei, W; Wu, SL; Xue, YM; Yang, H; Zhang, MZ | 1 |
| Costa, LB; de Paula Gonzaga, ALAC; de Sá Rodrigues, KE; Palmeira, VA; Ribeiro, TFS; Simões-E-Silva, AC | 1 |
| Abrigo, J; Aguirre, F; Aravena, J; Cabello-Verrugio, C; Gonzalez, A; Gonzalez, F; Simon, F | 1 |
| Cao, XR; Dong, B; Hei, NH; Li, JL; Ma, H; Wang, YL; Yan, WJ | 1 |
| Arnold, AC; Barber, AJ; Dennis, MD; Dierschke, SK; Toro, AL | 1 |
| Gallagher, PE; Kirby, J; Rahimi, O; Tallant, EA; Varagic, J; Westwood, B | 1 |
| Balazova, L; Cacanyiova, S; Dobrocsyova, V; Krskova, K; Olszanecki, R; Slamkova, M; Suski, M; Zorad, S | 1 |
| Feng, P; Li, X; Liu, H; Shen, Y; Shen, Z; Wu, Z; Yao, X | 1 |
| Jiang, Y; Ren, Y; Sheng, S; Wu, D; Xie, W; Yang, S; Zhang, H | 1 |
| Cheng, H; Wang, GQ; Wang, Y | 1 |
| Gholampour, Y; Javanmardi, K; Soltani Hekmat, A; Tavassoli, A | 1 |
| Del Valle-Mondragón, L; Gomez-Arroyo, J; Gonzalez-Pacheco, H; Masso, F; Olmedo-Ocampo, R; Paez-Arenas, A; Pastelin-Hernandez, G; Pulido, T; Sandoval, J; Sisniega, C; Teijeiro, R; Voelkel, NF; Zayas, N | 1 |
| Moncada, S; Peiró, C | 1 |
| Holappa, M; Vaajanen, A; Vapaatalo, H | 1 |
| Jarajapu, YPR | 1 |
| Casati, M; Dsouza, NR; Exner, EC; Geurts, AM; Greene, AS; Hoffmann, BR; Lombard, JH; Stodola, T; Zimmermann, M | 1 |
| Antunes-Rodrigues, J; Batalhão, ME; Bendhack, LM; Carnio, EC; de Lima Faim, F; Kanashiro, A; Passaglia, P; Ulloa, L | 1 |
| Chappell, MC; Diz, DI; Jensen, ET; Nixon, PA; O'Shea, TM; Shaltout, HA; South, AM; Washburn, LK | 1 |
| Mogi, M | 1 |
| Fei, C; Hao-Ran, C; Hao-Ran, W; Jing, Y; Run-Qian, L; Ya-Bin, L; Yang, G | 1 |
| Elgazzar, EM; Hasan, HF; Mostafa, DM | 1 |
| Aazami, H; Kamali, M; Khoshmirsafa, M; Mansouri, D; Mohsenzadegan, M; Pornour, M; Seif, F | 1 |
| Antlanger, M; Berlakovich, G; Böhmig, GA; Domenig, O; Eskandary, F; Fajkovic, H; Grobe, N; Gruber, C; Hellinger, R; Kain, R; Kaltenecker, CC; Kopecky, C; Kovarik, JJ; Poglitsch, M; Rahman, M; Säemann, MD; Stegbauer, J | 1 |
| Heffernan, KS; Jae, SY | 1 |
| Araújo, FA; Assis, AD; Mascarenhas, FNADP; Santos, RAS; Zanon, RG | 1 |
| Lin, X; Liu, Q; Lu, J; Shi, J; Sun, M; Yue, Y; Zhu, D | 1 |
| Banerjee, A; Buford, TW; Carter, CS; Knighton, A; Li, Q; Morgan, D; Peramsetty, S; Roberts, LM; Sun, Y; Torres, GE; Verma, A | 1 |
| Dobashi, S; Fujii, T; Hisatake, S; Ikeda, T; Kabuki, T; Kiuchi, S; Oka, T | 1 |
| Bi, C; Hu, B; Huang, X; Li, M; Qu, H; Song, J; Wang, L; Zhang, M | 1 |
| Mohammed El Tabaa, M | 1 |
| Acconcia, F | 1 |
| Chappell, MC; Diz, DI; Gwathmey, TM; Jensen, ET; Nixon, PA; Shaltout, HA; South, AM; Washburn, LK | 1 |
| Abrigo, J; Aguirre, F; Cabello-Verrugio, C; Gonzalez, A; Gonzalez, F; Simon, F | 1 |
| Barcelos, LS; Baroni, IF; Campagnole-Santos, MJ; Cançado-Ribeiro, ATP; Gregório, JF; Magalhães, GS; Pinho, V; Ramos, KE; Rodrigues-Machado, MG; Santos, RAS; Teixeira, MM | 1 |
| Borges, CL; Castro, CH; Colugnati, DB; de Ávila, RI; Gava, E; Kitten, GT; Lima, EM; Macedo, LM; Pedrino, GR; Valadares, MC | 1 |
| Liao, W; Wu, J | 1 |
| Diamond, B | 1 |
| Pinho, V; Sousa, LP; Teixeira, MM | 1 |
| Beer, JH; Saeedi Saravi, SS | 1 |
| Malek Mahdavi, A | 1 |
| Delpino, MV; Quarleri, J | 1 |
| Dang, R; Feng, Q; Geng, C; Guo, Y; Han, W; Jiang, P; Wang, C; Wei, Z; Zhang, H | 1 |
| Domińska, K | 1 |
| Motta-Santos, D; Santos, RAS; Santos, SHS | 1 |
| Caldas, IS; Diniz, LF; Gonçalves, RV; Gonçalves-Santos, E; Mazzeti, AL; Novaes, RD; Souza-Silva, TG; Vilas-Boas, DF | 1 |
| Cui, T; Hu, W; Liu, M; Liu, R; Wang, X; Yin, C; Yu, X | 1 |
| Geng, L; He, J; Li, J; Liu, Y; Wang, X; Xu, T; Yang, J; Zhu, R | 1 |
| Franco, R; Labandeira-García, JL; Navarro, G; Rivas-Santisteban, R; Rodríguez-Pérez, AI; Serrano-Marín, J | 1 |
| Chen, Q; Deng, H; Gao, F; Ma, X; Wang, Y; Xuan, X; Yang, F; Yuan, L | 1 |
| Arnold, AC; Bingaman, SS; Medina, D; Mehay, D; Miller, AJ | 1 |
| Duan, R; E, Y; Gong, PY; Jiang, T; Wang, SY; Xue, X; Zhang, QQ; Zhang, YD | 1 |
| Long, CM; Tan, CS; Yeoh, SF | 1 |
| Bazan, SGZ; Casarini, DE; Cicogna, AC; da Silva, VL; de Campos, DHS; de Oliveira, EM; de Souza, SLB; Fernandes, T; Gatto, M; Gomes, ERM; Mota, GAF; Padovani, CR; Sant'Ana, PG; Sugizaki, MM; Vileigas, DF | 1 |
| Lu, K; Shi, C; Xia, H; Zhang, B; Zhang, P | 1 |
| Gan, R; Georgius, P; Henshaw, DJE; Noble, EP; Rosoman, NP; Sommerfeld, N | 1 |
| Pérez-Vizcaíno, F | 1 |
| Manolis, AA; Manolis, AS; Manolis, TA; Melita, H | 1 |
| Borel, AL; Epaulard, O; Le Gouellec, A; Méry, G; Toussaint, B | 1 |
| Correa, AMB; de Almeida, JFQ; Ferreira, AJ; Fontes, MAP; Kushmerick, C; Moreira, FA; Patel, KP; Sharma, NM; Silva, CC | 1 |
| Braga, PPP; Castro, CH; Colugnati, DB; de Lima, CQ; Ghazale, PP; Gomes, KP; Mendes, EP; Pansani, AP; Pedrino, GR; Xavier, CH | 1 |
| Casalechi, M; Pereira, VM; Reis, AM; Reis, FM | 1 |
| Gao, F; Huang, H; Liu, Z; Wang, J | 1 |
| Casalechi, M; Cassali, GD; Pereira, VM; Reis, AM; Reis, FM; Santos, RAS; Santos, SHS | 1 |
| Bhering Martins, L; Braga Tibaes, JR; Ferreira, AVM; Gomez, RS; Rodrigues, AMDS; Silva de Miranda, A; Teixeira, AL | 1 |
| Benoit, JL; Benoit, SW; Berger, BA; Henry, BM; Lavie, CJ; Lippi, G; Pulvino, C | 1 |
| Chen, R; Du, X; Ge, W; Kan, H; Pan, K; Song, L; Sun, Q; Xie, Y; Zeng, X; Zhang, J; Zhao, J; Zhou, J; Zhou, L | 1 |
| Alzamora, AC; Barbosa, CM; Barbosa, MA; Campagnole-Santos, MJ; de Sousa, GG; Lima, TC; Souza Dos Santos, RA | 1 |
| Akamine, EH; Barreto-Chaves, MLM; C Parletta, A; Campagnole-Santos, MJ; Diniz, GP; Marques, BVD; Santos, RAS; Senger, N | 1 |
| Gaikwad, AB; Sharma, N | 1 |
| Cen, Y; Cheng, K; Liu, Y; Rao, L; Zhang, H | 1 |
| Gao, X; Ge, X; Jin, F; Li, S; Li, Y; Mao, N; Wei, Z; Xu, H; Yang, F; Yang, Y; Zhang, M; Zhang, Y | 1 |
| Costa-Ferreira, W; Crestani, CC; Marchi-Coelho, C; Moreno-Santos, B | 1 |
| Heng, CKM; Liao, W; Mei, D; Tan, WSD; Wong, WSF | 1 |
| Chai, CY; Chen, IC; Dai, ZK; Hsu, JH; Lin, JY; Liu, YC; Wu, BN; Yeh, JL | 1 |
| Bomfim, GF; Bressan, AFM; Carneiro, FS; Freitas, RA; Giachini, FR; Junior, RRP; Justina, VD; Lima, VV | 1 |
| Cao, X; Liu, JY; Shi, TT; Song, LN; Xin, Z; Yang, JK; Zhang, YC | 1 |
| Lv, B; Meng, L; Shen, M; Wang, M; Zhang, B | 1 |
| Li, WX; Li, Y; Lin, FH; Lin, WP; Poon, CC; Sha, NN; Shi, W; Wang, YF; Wang, YJ; Zhang, JL; Zhang, Y | 1 |
| Dai, C; Wang, F; Xia, X; Xu, L; Zhang, D; Zhang, J | 1 |
| Almeida-Santos, AF; Campagnole-Santos, MJ; de Melo, LA; Gonçalves, SCA; Kangussu, LM; Oliveira Amaral, LB; Santos, RAS | 1 |
| A-Gonzalez, N; Aranda-Pardos, I; Bader, M; Campagnole-Santos, MJ; Cassali, GD; Del Sarto, J; Gonçalves, APF; Ludwig, S; Machado, AV; Machado, MG; Melo, EM; Pinho, V; Rago, F; Santos, RAS; Sousa, LP; Tavares, LP; Teixeira, MM; Vago, JP; Valiate, BVS | 1 |
| Reis, AM; Reis, FM | 1 |
| Rakugi, H; Takeshita, H; Yamamoto, K | 1 |
| Mescheder, A; Moll, GN; Namsolleck, P; Richardson, A | 1 |
| Girndt, M; Trojanowicz, B; Ulrich, C | 1 |
| Bogaerts, P; Pucci, F; Rooman, M | 1 |
| Abrigo, J; Bader, M; Brandan, E; Cabello-Verrugio, C; Chiong, M; Rivera, JC; Santos, RA; Simon, F; Tacchi, F | 1 |
| Cohen, JB; Edmonston, DL; South, AM; Sparks, MA | 1 |
| Corrêa, HL; Costa, F; Deus, LA; Haro, AS; Maia, BCH; Maya, AT; Moraes, MR; Neves, RVP; Prestes, J; Rosa, TS; Silva, JAB; Simões, HG; Souza, MK; Stone, W; Tzanno-Martins, C | 1 |
| Du, T; Li, Q; Liang, Z; Liao, S; Raizada, MK; Verma, A; Xu, K; Zhu, P | 1 |
| Chen, A; Desai, AA; Han, Y; Pan, Y; Tang, H; Wang, X; Xu, Y; Zhang, F | 1 |
| Li, Y; Liu, J; Liu, Y; Pan, W | 1 |
| Chappell, MC; Gwathmey, TM; Pirro, NT; South, AM | 1 |
| Polak, Y; Speth, RC | 1 |
| Ahmed, A; Hasan, M; Rahman, MM | 1 |
| Antunes-Rodrigues, J; Batalhão, ME; Bendhack, LM; Capellari Carnio, E; de Lima Faim, F; Lacchini, R; Passaglia, P; Stabile, AM | 1 |
| Chang, KY; Liao, MH; Liaw, WJ; Shih, CC; Tsai, HJ; Tsao, CM; Wu, CC | 1 |
| Amin, S; Bakouny, Z; Bhasin, M; Bhatt, RS; Catalano, P; Chen, CH; Choueiri, TK; Joslin, PN; Khanna, P; McKay, R; Moore, A; Naughton, M; O'Callaghan, C; Saxena, R; Signoretti, S; Soh, HJ; Walther, T | 1 |
| Aghazadeh-Habashi, A; Khajehpour, S | 2 |
| Garabadu, D; Varshney, V | 2 |
| Kuriakose, J; Montezano, AC; Touyz, RM | 1 |
| Bernasconi, L; Conen, A; Domenig, O; Gregoriano, C; Haubitz, S; Koch, D; Kutz, A; Mueller, B; Schuetz, P | 1 |
| Chen, M; Guo, Y; Hong, L; Jiang, S; Liu, S; Pan, R; Shi, J; Wang, Q; Yuan, X | 1 |
| Caroccia, B; Domenig, O; Iacobone, M; Lenzini, L; Piazza, M; Poglitsch, M; Prisco, S; Rossi, GP; Seccia, TM; Torresan, F; Vanderriele, PE | 1 |
| Deminice, R; Hyatt, HW; Nguyen, BL; Ozdemir, M; Powers, SK; Yoshihara, T | 1 |
| Abdel-Fattah, MM; Elgendy, ANAM; Mohamed, WR | 1 |
| Bernstein, EA; Bernstein, KE; Cao, D; Giani, JF; Gonzalez-Villalobos, RA; Khan, Z; Okwan-Duodu, D; Shen, JZY; Veiras, LC | 1 |
| Hoang, T; Revoori, R; Rianto, F; Sparks, MA | 1 |
| Chen, S; Gu, T; Li, Y; Ren, L; Wang, C; Yang, Y; Zheng, H | 1 |
| Cantero-Navarro, E; Fernández-Fernández, B; Ortiz, A; Ramos, AM; Rayego-Mateos, S; Rodrigues-Diez, RR; Ruiz-Ortega, M; Sánchez-Niño, MD; Sanz, AB | 1 |
| Addai, D; Alexandrova, R; Ananiev, J; Rashev, P; Todev, A; Tolekova, A; Uzunova, VV; Zarkos, J | 1 |
| Arfsten, H; Bartko, PE; Domenig, O; Goliasch, G; Hengstenberg, C; Hülsmann, M; Mascherbauer, J; Pavo, N; Poglitsch, M; Prausmüller, S; Spinka, G; Strunk, G; Uyanik-Ünal, K; Wurm, R; Zuckermann, A | 1 |
| Chabbra, A; Puthentharayil, J; Rigatto, K; Speth, RC; Stoyell-Conti, FF | 1 |
| Ahmad, S; Ferrario, CM; Groban, L; Hodge, H; Sun, X; Wang, H; Wright, KN | 1 |
| Fan, TM; Gladysheva, IP; Mehta, RM; Reed, GL; Sullivan, RD; Tripathi, R | 1 |
| Nakano, H; Shiina, K; Tomiyama, H | 1 |
| Cao, Y; Chen, J; Huang, LP; Liu, Z; Wang, BJ; Yang, XP; Yang, ZL; Zhou, HR; Zhu, L | 1 |
| Fujita, M; Nakagawasai, O; Nemoto, W; Tan-No, K; Yamagata, R | 1 |
| Becker, LK; Coelho, DB; de Lima, WG; de Moura, SS; de Oliveira, EC; de Sousa, FB; Dos Santos, RAS; Martins Júnior, FAD; Totou, NL | 1 |
| Ding, YJ; Feng, Y; Geng, YL; Ji, R; Le, VM; Ni, L; Xu, KD | 1 |
| Kouketsu, T; Otsubo, Y; Shimada, H; Sugawara, A; Suzuki, S; Yokoyama, A | 1 |
| Białas, M; Bujak-Giżycka, B; Jawień, J; Kiepura, A; Kuś, K; Olszanecki, R; Stachowicz, A; Stachyra, K; Suski, M; Totoń-Żurańska, J; Wiśniewska, A; Łomnicka, M | 1 |
| von Bohlen Und Halbach, O | 1 |
| Nozato, Y; Yamamoto, K | 1 |
| Brouqui, P; Devaux, CA; La Scola, B; Lagier, JC; Meddeb, L; Mege, JL; Melenotte, C; Million, M; Osman, IO; Parola, P; Raoult, D; Stein, A | 1 |
| Barcelos, LS; Campagnole-Santos, MJ; Cassini-Vieira, P; Gonzaga, KER; Gregório, JF; Magalhães, GS; Motta-Santos, D; Rodrigues-Machado, MG; Santos, RAS; Vieira, MAR | 1 |
| Esmaili Dahej, M; Hafizi Barjin, Z; Moradi, A; Safari, F; Soltan, F; Yadegari, M | 1 |
| Campagnole-Santos, MJ; Carvalho-Ribeiro, IA; Gregório, JF; Magalhães, GS; Nunes, OM; Oliveira, IFA; Rodrigues-Machado, MDG; Santos, RAS; Vasconcellos, AVO | 1 |
| An, X; Fu, M; He, X; Li, C; Niu, L; Tian, J; Wang, Q; Xu, H | 1 |
| Abdulla, MH; Barry, EF; Johns, EJ; O'Neill, J | 1 |
| Andrade, JMO; Brandi, IV; da Costa, DV; de Carvalho, BMA; de F Lelis, D; de Oliveira Costa, T; de Paula, AMB; Guimarães, ALS; Guimarães, VHD; Machado, A; Oliveira, JR; Pereira, UA; Santos, RAS; Santos, SHS; Vieira, CR | 1 |
| Gao, W; Hu, W; Miao, J; Sun, L; Xu, Z | 1 |
| Abreu, MAD; de Oliveira, TA; Moreira, FRC; Ramos, NE; Simões E Silva, AC | 1 |
| Alenina, N; Alves, DT; Bader, M; Campagnole-Santos, MJ; Coimbra-Campos, LMC; Ferreira, AJ; Martins, AS; Mendes, LF; Popova, E; Qadri, F; Sampaio, WO; Santos, RAS; Todiras, M; Vieira, MAR | 1 |
| Cui, C; Dang, R; Geng, C; Han, W; Jiang, P; Wang, C; Yang, M; Zhang, W | 1 |
| Cao, L; Dong, B; Huang, X; Jiang, Y; Li, S; Li, Y; Song, J; Xiao, C; Yang, X | 1 |
| Jiang, P; Sun, W; Zhao, S | 1 |
| Galal, SM; Hasan, HF; Mohmed, HK | 1 |
| Del Valle-Mondragón, L; Echeverría-Rodríguez, O; Gallardo-Ortíz, IA; Godínez-Chaparro, B; Gómez-García, MV; Mata-Bermúdez, A; Villalobos-Molina, R | 1 |
| Billheimer, D; Doyle, KP; Hay, M; Hoyer-Kimura, C; Konhilas, JP; Mansour, HM; Polt, R | 1 |
| Apparsundaram, S; Goyal, RK; Kumar, S; Patil, CR; Sahu, S | 1 |
| Aimbire, F; Aragão, DS; Bertoncello, N; Casarini, DE; Cunha, TS; de Alcantara Santos, R; de Paula Vieira, R; Guzzoni, V; Schor, N; Silva, KAS | 1 |
| Albadrani, H; Ammar, T; Bader, M; Renaud, JM | 1 |
| Benetti, A; Caramelli, B; Girardi, ACC; Krieger, JE; Malagrino, PA; Martins, FL; Pereira, GMD; Rentz, T; Rios, TMS; Tavares, CAM; Teixeira, SK | 1 |
| de Castro, CH; de Souza Lino Junior, R; Dos Santos, RAS; Dutra, JBR; Ferreira, PM; Pacheco, LF; Ulhoa, CJ | 1 |
| Boytsova, EB; Lopatina, OL; Morgun, AV; Salmin, VV; Salmina, AB | 1 |
| Colombo, D; Del Nonno, F; Gheblawi, M; Kassiri, Z; MacIntyre, E; Munan, M; Nikhanj, A; O'Neil, C; Oudit, GY; Poglitsch, M; Sligl, W; Wang, K | 1 |
| Javanmardi, K; Soltani Hekmat, A | 1 |
| Baranowska, I; Dobrowolski, L; Kompanowska-Jezierska, E; Kuczeriszka, M; Sitek, JD; Walkowska, A | 1 |
| Cao, L; Chen, Y; Fan, J; Liu, Y; Lu, L; Yin, Y | 1 |
| Campagnole-Santos, MJ; Campolina-Silva, GH; Cramer, A; Galvão, I; Grossi, LC; Lima, KM; Miranda, TC; Negreiros-Lima, GL; Pinho, V; Santos, RA; Sousa, LP; Souza, JA; Sugimoto, MA; Tavares, LP; Teixeira, LC; Teixeira, MM; Vago, JP; Valiate, BV; Zaidan, I | 1 |
| Abrigo, J; Cabello-Verrugio, C; Cabrera, D; Simon, F; Vilos, C | 1 |
| Bartosova, L; Galis, P; Goncalvesova, E; Klimas, J; Paulis, L; Rajtik, T | 1 |
| Azuelos, I; Baglole, CJ; Eidelman, DH; Haidar, Z; Huang, MJ; Morganstein, T; Trivlidis, J | 1 |
| Kuruppu, S; Rajapakse, NW; Tran, S | 1 |
| Buford, TW; Carter, CS; Coward, L; Gorman, G; Jumbo-Lucioni, P; Li, Q; Roberts, L; Smith, CA; Smith, H; Verma, A | 1 |
| Belfiore, A; Cammalleri, M; Chiurazzi, M; Colantuoni, A; Dal Monte, M; Damiano, S; De Conno, B; Di Maro, M; Guida, B; Lapi, D; Mondola, P; Nasti, G; Santillo, M; Serao, N; Trio, R | 1 |
| Carletti, R; Castoldi, G; di Gioia, CRT; Ippolito, S; Pelucchi, S; Stella, A; Zatti, G; Zerbini, G | 1 |
| Alfie, J; Corradi, GR; Falcoff, NL; Gironacci, MM; Guman, GR; Iglesias, LI; Nuñez, M; Seguel, RF; Silva, MG; Tabaj, GC | 1 |
| Chen, J; Cheng, F; Fu, F; Guo, Z; Lai, G; Lan, J; Li, S; Liu, J; Shen, B; Tu, C; Zhang, X | 1 |
| Hao, H; Hao, Y; Li, C; Xu, Y; Zhang, F | 1 |
| Melo, EM; Sousa, LP; Tavares, LP; Teixeira, MM | 1 |
| De la Cuesta, F; Peiró, C; Romero, A; Sánchez-Ferrer, CF; Shamoon, L | 1 |
| Gallagher, PE; Grier, RDM; Melo, AC; Rahimi, O; Tallant, EA; Westwood, B | 1 |
| Arslan, B; Ergun, NU; Kalkan, A; Kocatas, A; Onal, H; Semerci, SY; Suner, N; Topuz, S; Topuzogullari, M; Ugurel, OM; Yoldemir, SA | 1 |
| Abdul Hamid, H; Che Mohd Nassir, CMN; Mustapha, M; Norman, HH; Ramli, MD; Zolkefley, MKI | 1 |
| Annoni, F; Caruso, E; Moro, F; Taccone, FS; Zanier, ER; Zoerle, T | 1 |
| Ceroni, A; Manica, LA; Michelini, LC; Raquel, HA | 1 |
| Ayre, M; Ferri, DM; Gattelli, A; Kordon, EC; Raimondi, AR; Schere-Levy, C; Suberbordes, M; Walther, T | 1 |
| He, J; Li, X; Liu, J; Peng, L; Song, G; Wang, X | 1 |
| Cui, T; Guo, Y; Hu, W; Li, C; Liu, R; Wang, X; Yin, C | 1 |
| de Oliveira, AA; Gheblawi, M; Grant, MB; John, R; Oudit, GY; Scholey, JW; Williams, VR | 1 |
| Banday, AA; Zaman, A | 1 |
| Gupta, S; Hanif, K; Mishra, A; Shukla, S; Tiwari, P; Tiwari, V | 1 |
| Abdel Hafez, SMN; Abdel-Hakeem, EA; Abdel-Hamid, HA; Kamel, BA | 1 |
| Ajambo, M; Albdeirat, L; Albekairi, N; Ali, R; Alotaibi, H; Amanya, G; Attia, H; Badr, A; Elayeete, S; Ghaffar, A; Harris, JR; Hussain, R; Kadobera, D; Khan, A; Kwesiga, B; Li, K; Li, X; Mwanje, W; Nampeera, R; Nansikombi, HT; Naseem, S; Nsubuga, EJ; Rajab, R; Riolexus, AA; Soliman, A | 1 |
| Ciechanowicz, AK; Kucia, M; Lay, WX; Leszczak, C; Leszczak, S; Prado Paulino, J; Suchocki, E | 1 |
| Almeida-Santos, AF; Colpo, GD; Furr Stimming, E; Guatimosim, C; Joviano-Santos, JV; Kangussu, LM; Latham, LB; Machado, TCG; Miranda, AS; Rocha, NP; Simões E Silva, AC; Soares, KB; Teixeira, AL; Valadão, PAC | 1 |
| D'Armiento, JM; Eiseman, KA; Elisman, K; Fonseca, LD; Gerber, A; Goldklang, MP; Wagener, G | 1 |
| Godoy-Lugo, JA; Mendez, DA; Nakano, D; Nishiyama, A; Ortiz, RM; Rodriguez, R; Soñanez-Organis, JG | 1 |
| Asgharpour, S; Bandala, CR; Chi, LA; Correa-Basurto, J; Martínez-Archundia, M | 1 |
| Gu, Y; Liu, Y; Niu, J; Tong, J; Yang, L; Yu, Y; Zhai, R | 1 |
| Abbate, M; Benigni, A; Cerullo, D; Corna, D; Remuzzi, G; Rottoli, D; Zoja, C | 1 |
| Banerjee, A; Baptista, L; Buford, TW; Carter, CS; Hernandez, A; Li, Q; Sun, Y; Verma, A; Yang, Y | 1 |
| Gupta, S; Hanif, K; Shukla, S; Tiwari, P; Tiwari, V | 1 |
| Bersanetti, PA; Carmona, AK; da Silva, RL; Nakaie, CR; Papakyriakou, A; Spyroulias, GA; Sturrock, ED | 1 |
| Ballasy, NN; Belke, D; Fedak, PWM; Gomes, KP; Jadli, AS; Mackay, CDA; Meechem, M; Patel, VB; Thompson, J; Wijesuriya, TM | 1 |
| Cudnoch-Jedrzejewska, A; Girstun, A; Koperski, L; Sobczuk, P; Trzcinska-Danielewicz, J | 1 |
| Chittimalli, K; Ericsson, AC; Jahan, J; Jarajapu, YPR; McAdams, ZL; Sakamuri, A | 1 |
| Abassi, Z; Aronson, D; Cohen-Segev, R; Hamoud, S; Kabala, A; Karram, T; Kinaneh, S; Nativ, O | 1 |
| Asgharpour, S; Blanco-Rodríguez, RG; Chi-Uluac, LA; Martínez-Archundia, M | 1 |
199 review(s) available for angiotensin ii, des-phe(8)- and angiotensin i
| Article | Year |
|---|---|
Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling.
Topics: Angiotensin I; Heart; Humans; Peptide Fragments; Renin-Angiotensin System | 2014 |
Novel players in cardioprotection: Insulin like growth factor-1, angiotensin-(1-7) and angiotensin-(1-9).
Topics: Angiotensin I; Animals; Cardiovascular Agents; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Cardiovascular System; Humans; Insulin-Like Growth Factor I; Models, Cardiovascular; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 2; Receptor, IGF Type 1; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction | 2015 |
ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Cardiovascular Diseases; Humans; Hypertension; Kidney Diseases; Mice; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Rats; Renin-Angiotensin System | 2015 |
ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Heart Diseases; Humans; Kidney Diseases; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2016 |
Angiotensin-converting enzyme 2-Angiotensin 1-7/1-9 system: novel promising targets for heart failure treatment.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cardiovascular Agents; Heart Failure; Humans; Molecular Mimicry; Molecular Targeted Therapy; Peptide Fragments; Peptidyl-Dipeptidase A; Signal Transduction; Treatment Outcome | 2018 |
Hypertension regulating angiotensin peptides in the pathobiology of cardiovascular disease.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensinogen; Angiotensins; Animals; Blood Pressure; Humans; Hypertension; Oligopeptides; Peptide Fragments; Protective Factors; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Signal Transduction; Vasoconstriction | 2018 |
Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?
Topics: ADAM17 Protein; Angiotensin I; Angiotensin-Converting Enzyme 2; COVID-19; COVID-19 Drug Treatment; Gene Expression Regulation, Enzymologic; Humans; Peptide Fragments; Renin-Angiotensin System; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Up-Regulation | 2021 |
Angiotensin-(1-7): a new hormone of the angiotensin system.
Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Angiotensins; Animals; Biotransformation; Humans; Peptide Fragments; Renin; RNA, Messenger | 1991 |
Pathways of angiotensin formation and function in the brain.
Topics: Angiotensin I; Angiotensin II; Animals; Brain; Humans; Models, Biological; Peptide Fragments | 1990 |
[Endothelial mechanisms in vasomotor effects of ACE inhibitors].
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Culture Techniques; Endothelium, Vascular; Hemodynamics; Humans; Nitric Oxide; Peptide Fragments; Receptors, Bradykinin; Vasomotor System | 1994 |
Central and peripheral actions of angiotensin-(1-7).
Topics: Angiotensin I; Angiotensin II; Animals; Baroreflex; Blood Pressure; Brain; Medulla Oblongata; Peptide Fragments; Rats; Receptors, Angiotensin; Renin-Angiotensin System | 1994 |
Angiotensin receptor heterogeneity in the dorsal medulla oblongata as defined by angiotensin-(1-7).
Topics: Angiotensin I; Angiotensin II; Animals; Cardiovascular Physiological Phenomena; Cardiovascular System; Genetic Heterogeneity; Medulla Oblongata; Motor Neurons; Neurons, Afferent; Peptide Fragments; Receptors, Angiotensin; Vagus Nerve | 1996 |
Counterregulatory actions of angiotensin-(1-7).
Topics: Angiotensin I; Angiotensin II; Animals; Endothelium, Vascular; Humans; Kidney; Muscle, Smooth, Vascular; Peptide Fragments; Vasodilator Agents | 1997 |
Angiotensin-(1-7): a novel vasodilator of the coronary circulation.
Topics: Angiotensin I; Angiotensin II; Animals; Bradykinin; Coronary Circulation; Dogs; Peptide Fragments; Vasodilator Agents | 1998 |
Differential actions of angiotensin-(1-7) in the kidney.
Topics: Angiotensin I; Angiotensin II; Humans; Kidney; Peptide Fragments; Renin-Angiotensin System | 1998 |
Effect of the angiotensin-(1-7) peptide on nitric oxide release.
Topics: Angiotensin I; Angiotensin II; Animals; Bradykinin; Dose-Response Relationship, Drug; Drug Interactions; Humans; Muscle, Smooth, Vascular; Nitric Oxide; Peptide Fragments; Vasoconstrictor Agents; Vasodilation | 1998 |
Antihypertensive effects of angiotensin-(1-7).
Topics: Angiotensin I; Angiotensin II; Blood Pressure; Hypertension; Peptide Fragments; Renin-Angiotensin System | 1998 |
Angiotensin-(1-7): a bioactive fragment of the renin-angiotensin system.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Receptors, Angiotensin; Renin-Angiotensin System | 1998 |
Interactions among ACE, kinins and NO.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Biological Availability; Cardiovascular Diseases; Endothelium, Vascular; Humans; Hypertension; Kinins; Myocardial Ischemia; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Peptide Fragments; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Ventricular Remodeling | 1999 |
Angiotensin-(1-7): an update.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Vessels; Central Nervous System; Humans; Kidney; Losartan; Models, Biological; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Protein Binding; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction; Vasoconstriction | 2000 |
Pathways of angiotensin-(1-7) metabolism in the kidney.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Dipeptides; Humans; Hypertension; Kidney; Microvilli; Peptide Fragments; Protease Inhibitors | 2001 |
Interactions between angiotensin-(1-7), kinins, and angiotensin II in kidney and blood vessels.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Vessels; Humans; Kidney; Kinins; Models, Biological; Peptide Fragments; Renin-Angiotensin System | 2001 |
New insights into actions of the renin-angiotensin system in the kidney: concentrating on the Ang II receptors and the newly described Ang-(1-7) and its receptor.
Topics: Angiotensin I; Angiotensin II; Humans; Kidney; Peptide Fragments; Receptors, Angiotensin; Renin-Angiotensin System | 2001 |
Angiotensin-(1-7): an active member of the renin-angiotensin system.
Topics: Angiotensin I; Animals; Cardiovascular Physiological Phenomena; Cell Division; Humans; Kidney; Peptide Fragments; Receptors, Angiotensin; Renin-Angiotensin System; Thrombosis | 2002 |
Cellular targets for angiotensin II fragments: pharmacological and molecular evidence.
Topics: Angiotensin I; Angiotensin II; Animals; Cells; Cystinyl Aminopeptidase; Humans; Peptide Fragments; Receptors, Angiotensin | 2002 |
Contribution of angiotensin-(1-7) to cardiovascular physiology and pathology.
Topics: Angiotensin I; Animals; Blood Pressure; Cardiovascular Diseases; Hemodynamics; Humans; Hypertension; Peptide Fragments; Renin-Angiotensin System | 2003 |
Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact?
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Endothelium, Vascular; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Receptors, Bradykinin | 2003 |
Prologue: kinins and related systems. New life for old discoveries.
Topics: Angiotensin I; Animals; Cardiovascular Physiological Phenomena; Endothelium, Vascular; Humans; Kallikreins; Kininogens; Kinins; Peptide Fragments; Peptidyl-Dipeptidase A; Receptors, Bradykinin | 2003 |
Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation.
Topics: Angiotensin I; Animals; Cardiovascular Physiological Phenomena; Dimerization; Humans; Isoenzymes; Kidney; Peptide Fragments; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Receptors, Cell Surface; Renin; Renin-Angiotensin System | 2003 |
Angiotensin peptides: ready to re(de)fine the angiotensin system?
Topics: Angiotensin I; Animals; Blood Pressure; Peptide Fragments; Renin-Angiotensin System | 2003 |
Novel aspects of the renal renin-angiotensin system: angiotensin-(1-7), ACE2 and blood pressure regulation.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Carboxypeptidases; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Receptors, Angiotensin; Renin-Angiotensin System | 2004 |
Enhanced expression of Ang-(1-7) during pregnancy.
Topics: Angiotensin I; Animals; Biomarkers; Female; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Pre-Eclampsia; Pregnancy; Rats; Renin-Angiotensin System | 2004 |
Novel angiotensin peptides.
Topics: Angiotensin I; Angiotensin II; Animals; Heart; Humans; Kidney; Peptide Fragments; Reproduction | 2004 |
The renin-angiotensin system: peptides and enzymes beyond angiotensin II.
Topics: Aminopeptidases; Angiotensin I; Angiotensin II; Animals; Humans; Peptide Fragments; Renin-Angiotensin System | 2005 |
Cardiovascular actions of angiotensin-(1-7).
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiovascular Physiological Phenomena; Coronary Vessels; Endothelial Cells; Humans; Peptide Fragments; Renin-Angiotensin System | 2005 |
Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs.
Topics: Angiotensin I; Animals; Cardiotonic Agents; Cardiovascular Diseases; Drug Delivery Systems; Drugs, Investigational; Humans; Peptide Fragments; Receptors, Angiotensin | 2005 |
Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Biochemistry; Blood Pressure; Carboxypeptidases; Cardiovascular System; Feedback; Humans; Hypertension; Myocardial Infarction; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2005 |
Regulation of ACE2 and ANG-(1-7) in the aorta: new insights into the renin-angiotensin system in the control of vascular function.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Aorta; Carboxypeptidases; Cardiovascular Diseases; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2005 |
Angiotensin and diabetic retinopathy.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Animals, Genetically Modified; Diabetic Retinopathy; Humans; Hypertension; Neovascularization, Pathologic; Peptide Fragments; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System; Retina | 2006 |
Angiotensin-(1-7): blood, heart, and blood vessels.
Topics: Angiotensin I; Animals; Animals, Genetically Modified; Blood Vessels; Heart; Hematopoietic System; Peptide Fragments; Rats | 2005 |
A place in our hearts for the lowly angiotensin 1-7 peptide?
Topics: Angiotensin I; Animals; Cardiotonic Agents; Heart; Humans; Peptide Fragments | 2006 |
The therapeutic potential of Angiotensin-(1-7) as a novel Renin-Angiotensin System mediator.
Topics: Angiotensin I; Animals; Genitalia, Male; Humans; Liver; Male; Peptide Fragments; Rats; Renin-Angiotensin System | 2006 |
ACE2 of the heart: From angiotensin I to angiotensin (1-7).
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Disease Progression; Heart Failure; Humans; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Ventricular Remodeling | 2007 |
A novel approach based on nanotechnology for investigating the chronic actions of short-lived peptides in specific sites of the brain.
Topics: Angiotensin I; Animals; Blood Pressure; Brain; Heart Rate; Liposomes; Nanotechnology; Peptide Fragments; Peptides; Rats | 2007 |
Angiotensin-(1-7) and the renin-angiotensin system.
Topics: Angiotensin I; Endothelium, Vascular; Heart; Humans; Kidney; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction | 2007 |
[Effects of ACE2-Ang 1-7-Mas axis on blood vessel].
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blood Vessels; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction | 2007 |
Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Cardiovascular Diseases; Humans; Peptide Fragments; Renin-Angiotensin System; Treatment Outcome; Vasodilation | 2007 |
Angiotensin-(1-7): pharmacology and new perspectives in cardiovascular treatments.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Brain; Cardiovascular Diseases; Heart; Humans; Kidney; Peptide Fragments; Renin-Angiotensin System | 2007 |
ACE2: a new target for cardiovascular disease therapeutics.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Drug Delivery Systems; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Signal Transduction | 2007 |
Genetically altered animal models for Mas and angiotensin-(1-7).
Topics: Angiotensin I; Animals; Animals, Genetically Modified; Gene Expression Regulation; Mice; Mice, Knockout; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction | 2008 |
Opposite effects of angiotensin II and angiotensin (1-7) on impulse propagation, excitability and cardiac arrhythmias. Is the overexpression of ACE2 arrhythmogenic?
Topics: Action Potentials; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Arrhythmias, Cardiac; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Signal Transduction | 2009 |
Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Humans; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2008 |
Regulatory mechanisms of atrial fibrotic remodeling in atrial fibrillation.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Atrial Fibrillation; Endomyocardial Fibrosis; Heart Atria; Humans; Inflammation; Matrix Metalloproteinases; Models, Biological; Oxidative Stress; Peptide Fragments; ras GTPase-Activating Proteins; Signal Transduction; Tissue Inhibitor of Metalloproteinases; Transforming Growth Factor beta1; Ventricular Remodeling | 2008 |
Angiotensin-converting enzyme 2 gene targeting studies in mice: mixed messages.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensins; Animals; Blood Pressure; Gene Targeting; Heart; Mice; Mice, Knockout; Mice, Transgenic; Peptide Fragments; Peptidyl-Dipeptidase A | 2008 |
Angiotensin-(1-7): pharmacological properties and pharmacotherapeutic perspectives.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Bone Marrow Cells; Diabetes Mellitus; Heart Diseases; Humans; Hypertension; Peptide Fragments; Renin-Angiotensin System; Ventricular Remodeling | 2008 |
Liver disease and the renin-angiotensin system: recent discoveries and clinical implications.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Humans; Hypertension, Portal; Kallikreins; Kinins; Liver; Liver Cirrhosis; Liver Diseases; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2008 |
Angiotensin-(1-7) as an antihypertensive, antifibrotic target.
Topics: Angiotensin I; Antihypertensive Agents; Blood Pressure; Bradykinin; Cardiotonic Agents; Fibrinolytic Agents; Humans; Hypertension; Nitric Oxide; Peptide Fragments; Receptors, Cell Surface; Renin-Angiotensin System; Signal Transduction | 2008 |
Renin-angiotensin system revisited.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptors, Cell Surface; Renin-Angiotensin System; Vacuolar Proton-Translocating ATPases | 2008 |
The sweeter side of ACE2: physiological evidence for a role in diabetes.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus; Humans; Insulin Resistance; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2009 |
The renin-angiotensin system and diabetes: an update.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin-Converting Enzyme 2; Angiotensinogen; Animals; Diabetes Mellitus; Endothelium, Vascular; Humans; Hyaluronan Receptors; Insulin; Peptide Fragments; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System; Signal Transduction | 2008 |
[Angiotensin (1-7): a new link in the renin-angiotensin-aldosterone system (RAAS)].
Topics: Angiotensin I; Cardiovascular Diseases; Humans; Peptide Fragments; Renin-Angiotensin System | 2009 |
Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction | 2009 |
[Angiotensin- (1-7)].
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Vessels; Catalysis; Humans; Kidney; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2009 |
Angiotensin-(1-7) and its effects in the kidney.
Topics: Angiotensin I; Animals; Hemodynamics; Humans; Kidney; Mitogen-Activated Protein Kinases; Models, Biological; Peptide Fragments; Receptors, Angiotensin; Renin-Angiotensin System; Signal Transduction | 2009 |
Vasodilator factors in the systemic and local adaptations to pregnancy.
Topics: Angiotensin I; Animals; Epoprostenol; Female; Hemodynamics; Humans; Kallikreins; Nitric Oxide; Peptide Fragments; Pregnancy; Vascular Endothelial Growth Factor A | 2009 |
Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Chronic Disease; Exercise; Heart; Heart Failure; Humans; Medulla Oblongata; Neurons; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Signal Transduction; Sympathetic Nervous System; Transcription Factor AP-1; Transcription, Genetic; Up-Regulation | 2009 |
The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Blood Pressure; Humans; Hypertension; Nephrons; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Signal Transduction | 2010 |
Novel neurohormonal insights with therapeutic potential in chronic heart failure.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Cardiovascular Physiological Phenomena; Heart Failure; Humans; Intercellular Signaling Peptides and Proteins; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Prorenin Receptor; Receptors, Cell Surface; Relaxin; Renin; Urocortins | 2010 |
Angiotensin (1-7) reduces the cell volume of swollen cardiac cells and decreases the swelling-dependent chloride current. Implications for cardiac arrhythmias and myocardial ischemia.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Arrhythmias, Cardiac; Cell Size; Chlorides; Humans; Models, Biological; Myocardial Ischemia; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2010 |
ACE2: more of Ang-(1-7) or less Ang II?
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Humans; Hypertension; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Signal Transduction | 2011 |
ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Cardiovascular Diseases; Hemodynamics; Humans; NADPH Oxidases; Nitric Oxide; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction; Superoxides | 2011 |
Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Gene Expression; Heart; Heart Failure; Humans; Molecular Targeted Therapy; Myocardium; Myofibroblasts; Organ Specificity; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Translational Research, Biomedical; Ventricular Remodeling | 2011 |
ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Brain; Humans; Mice; Models, Animal; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction | 2011 |
Angiotensin II and angiotensin-1-7 redox signaling in the central nervous system.
Topics: Angiotensin I; Angiotensin II; Animals; Brain; Cardiovascular Diseases; Humans; Neurons; Nitric Oxide; Oxidation-Reduction; Peptide Fragments; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase | 2011 |
Angiotensin peptides and central autonomic regulation.
Topics: Aging; Angiotensin I; Angiotensin II; Animals; Autonomic Nervous System; Baroreflex; Blood Pressure; Brain; Humans; Hypertension; MAP Kinase Signaling System; Medulla Oblongata; Peptide Fragments; Phosphatidylinositol 3-Kinases | 2011 |
Recombinant human angiotensin-converting enzyme 2 as a new renin-angiotensin system peptidase for heart failure therapy.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Diastole; Heart Failure; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Recombinant Proteins; Renin-Angiotensin System; Signal Transduction | 2011 |
Role of ACE2 in diastolic and systolic heart failure.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Heart Failure; Humans; Hypertension; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Signal Transduction | 2012 |
Role of angiotensin in ovarian follicular development and ovulation in mammals: a review of recent advances.
Topics: Angiotensin I; Angiotensin II; Animals; Autocrine Communication; Cattle; Female; Models, Biological; Ovarian Follicle; Ovulation; Paracrine Communication; Peptide Fragments; Rabbits; Rats; Receptors, Angiotensin; Renin-Angiotensin System; Signal Transduction | 2012 |
[Research progress in relations between renin angiotensin system and diabetic cardiomyopathy].
Topics: Angiotensin I; Angiotensin II; Animals; Apoptosis; Diabetic Cardiomyopathies; Humans; NF-kappa B; Oligopeptides; Peptide Fragments; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction; Transforming Growth Factor beta1 | 2011 |
Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetic Nephropathies; Humans; Kidney; Peptide Fragments; Peptidyl-Dipeptidase A; Recombinant Proteins | 2012 |
Angiotensin signalling in pulmonary fibrosis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensins; Animals; Apoptosis; Cytoprotection; Humans; Lung Injury; MAP Kinase Kinase 4; Peptide Fragments; Peptidyl-Dipeptidase A; Pulmonary Fibrosis; Respiratory Mucosa; Signal Transduction | 2012 |
Angiotensin peptides and nitric oxide in cardiovascular disease.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Cardiovascular Diseases; Heart Failure; Humans; Nitric Oxide; Peptide Fragments; Peptides; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2013 |
Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin-angiotensin system: a patent review.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cardiovascular Agents; Drug Design; Enzyme Activation; Enzyme Activators; Humans; Legislation, Drug; Molecular Structure; Patents as Topic; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction; Structure-Activity Relationship | 2012 |
The renin-angiotensin system, bone marrow and progenitor cells.
Topics: Adipogenesis; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bone Marrow; Erythropoiesis; Hematopoiesis; Humans; Kidney; Mesenchymal Stem Cells; Metabolic Syndrome; Myocytes, Cardiac; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Stem Cells; Tetrazoles; Valine; Valsartan | 2012 |
Angiotensin-(1-7) in kidney disease: a review of the controversies.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Diabetic Nephropathies; Humans; Kidney Diseases; Mice; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Signal Transduction | 2012 |
[Angiotensin-converting enzyme 2 in the kidney].
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Diabetic Nephropathies; Humans; Hypertension; Kidney; Kidney Diseases; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2012 |
[The ACE2/Ang(1-7)/Mas receptor axis in cardiovascular and renal diseases].
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cardiovascular Diseases; Humans; Kidney Diseases; Peptide Fragments; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2012 |
Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2013 |
New therapeutic pathways in the RAS.
Topics: Angiotensin I; Angiotensin Receptor Antagonists; Animals; Cardiovascular Diseases; Humans; Peptide Fragments; Receptor, Angiotensin, Type 2; Recombinant Proteins; Renin-Angiotensin System | 2012 |
Angiotensin (1-7) and other angiotensin peptides.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cardiovascular Diseases; Glucose; Humans; Kidney Diseases; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2013 |
Opportunities for targeting the angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor pathway in hypertension.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Antihypertensive Agents; Humans; Hypertension; Peptide Fragments; Peptidyl-Dipeptidase A; Protein-Tyrosine Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, Angiotensin; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2013 |
The renin angiotensin aldosterone system and insulin resistance in humans.
Topics: Adipose Tissue; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensinogen; Animals; Blood Pressure; Glucose; Hemodynamics; Humans; Insulin Resistance; Models, Animal; Muscle, Skeletal; Obesity; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2013 |
Angiotensin-(1-7): beyond the cardio-renal actions.
Topics: Angiogenesis Inhibitors; Angiotensin I; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Brain Ischemia; Cell Proliferation; Female; Fibrosis; Glucose; Humans; Insulin; Kidney; Lipid Metabolism; Male; Metabolic Syndrome; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Reproduction; Signal Transduction | 2013 |
Regulation of cardiovascular remodeling by the counter-regulatory axis of the renin-angiotensin system.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Blood Pressure; Cardiovascular Agents; Cardiovascular Diseases; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Ventricular Remodeling | 2013 |
ACE2, angiotensin-(1–7), and Mas: the other side of the coin.
Topics: Angiotensin I; Angiotensin III; Angiotensin-Converting Enzyme 2; Animals; Brain; Gene Expression; Humans; Kidney; Lung; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2013 |
ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cell Proliferation; Fibrosis; Humans; Kidney; Leukocytes; Models, Biological; Nephritis; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Signal Transduction | 2013 |
Neuromodulatory role of angiotensin-(1-7) in the central nervous system.
Topics: Angiotensin I; Animals; Central Nervous System; Humans; Neurotransmitter Agents; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Synapses | 2013 |
Pathophysiological role of the renin-angiotensin system on erectile dysfunction.
Topics: Angiotensin I; Angiotensin II; Erectile Dysfunction; Humans; Male; Penile Erection; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2013 |
Interactions of neuropeptide y, catecholamines, and angiotensin at the vascular neuroeffector junction.
Topics: Angiotensin I; Angiotensin II; Animals; Catecholamines; Humans; Hypertension; Neuroeffector Junction; Neuropeptide Y; Peptide Fragments; Sympathetic Nervous System | 2013 |
Cerebroprotective action of angiotensin peptides in stroke.
Topics: Angiotensin I; Animals; Humans; Peptide Fragments; Peptides; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Stroke; Translational Research, Biomedical; Vasodilator Agents | 2014 |
Angiotensin-converting enzyme 2 as a therapeutic target for heart failure.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Cardiovascular Agents; Heart Failure; Humans; Hypertension; Molecular Targeted Therapy; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Ventricular Remodeling | 2014 |
Autonomic, locomotor and cardiac abnormalities in a mouse model of muscular dystrophy: targeting the renin-angiotensin system.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Animals; Autonomic Nervous System; Cardiomyopathies; Disease Models, Animal; Genotype; Heart; Humans; Mice, Knockout; Motor Activity; Muscle, Skeletal; Muscular Dystrophies, Limb-Girdle; Myocardium; Peptide Fragments; Phenotype; Renin-Angiotensin System; Sarcoglycans; Ventricular Dysfunction, Left; Ventricular Function, Left | 2014 |
Alamandine: a new member of the angiotensin family.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensins; Animals; Humans; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction | 2014 |
Modulation of the action of insulin by angiotensin-(1-7).
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction | 2014 |
ACE2: angiotensin II/angiotensin-(1-7) balance in cardiac and renal injury.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cardiovascular Diseases; Heart Diseases; Humans; Hypertension; Kidney Diseases; Peptide Fragments; Peptidyl-Dipeptidase A | 2014 |
Angiotensin-(1-7): a peptide hormone with anti-cancer activity.
Topics: Amino Acid Sequence; Angiotensin I; Animals; Antineoplastic Agents; Cell Proliferation; Clinical Trials as Topic; Humans; Neoplasms; Peptide Fragments; Peptide Hormones | 2014 |
Angiotensin 1 - 7 stimulation of platelet recovery.
Topics: Angiotensin I; Animals; Blood Platelets; Humans; Peptide Fragments; Renin-Angiotensin System; Thrombocytopenia; Treatment Outcome | 2014 |
Angiotensin-(1-7).
Topics: Angiotensin I; Animals; Humans; Models, Cardiovascular; Peptide Fragments; Receptors, Angiotensin; Renin-Angiotensin System; Vasodilation | 2014 |
New components of the renin-angiotensin system: alamandine and the MAS-related G protein-coupled receptor D.
Topics: Angiotensin I; Angiotensin II; Antihypertensive Agents; Cardiovascular Diseases; Humans; Hypertension; Oligopeptides; Peptide Fragments; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Risk Assessment; Sensitivity and Specificity | 2014 |
Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Cardiovascular Agents; Cardiovascular Diseases; Humans; Peptide Fragments; Peptidyl-Dipeptidase A | 2014 |
Protective axis of the renin-angiotensin system in the brain.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Baroreflex; Blood Pressure; Brain; Neurotransmitter Agents; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction | 2014 |
The ins and outs of angiotensin processing within the kidney.
Topics: Angiotensin I; Angiotensins; Animals; Humans; Kidney Tubules, Proximal; Peptide Fragments; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2014 |
Angiotensin 1-7: a peptide for preventing and treating metabolic syndrome.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Humans; Metabolic Syndrome; Peptide Fragments; Peptidyl-Dipeptidase A | 2014 |
ACE and ACE2 in inflammation: a tale of two enzymes.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Humans; Inflammation; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2014 |
Angiotensin-(1-7) as a strategy in the treatment of hypertension?
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Blood Pressure; Drug Design; Enzyme Activation; Enzyme Activators; Humans; Hypertension; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction; Treatment Outcome | 2014 |
ACE2/Ang-(1-7) signaling and vascular remodeling.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Blood Vessels; Humans; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Signal Transduction; Vascular Remodeling; Vasculitis | 2014 |
Role of renin-angiotensin system and metabolites of angiotensin in the mechanism of gastric mucosal protection.
Topics: Angiotensin I; Animals; Gastric Mucosa; Helicobacter pylori; Humans; Peptide Fragments; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Vasodilation | 2014 |
MAS and its related G protein-coupled receptors, Mrgprs.
Topics: Angiotensin I; Animals; Ganglia, Spinal; Humans; Ligands; Mast Cells; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Sensory Receptor Cells; Species Specificity | 2014 |
Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Vessels; Humans; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Reactive Oxygen Species; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction; Vascular Diseases | 2014 |
The role of renin-angiotensin system modulation on treatment and prevention of liver diseases.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Humans; Liver Diseases; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2014 |
Neuroprotective mechanisms of the ACE2-angiotensin-(1-7)-Mas axis in stroke.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Humans; Neuroprotective Agents; Peptide Fragments; Peptidyl-Dipeptidase A; Signal Transduction; Stroke | 2015 |
Sodium Intake as a Modulator of Kidney Function.
Topics: Angiotensin I; Arginine; Blood Pressure; Homeostasis; Humans; Kidney; Peptide Fragments; Sodium, Dietary | 2015 |
Angiotensin-(1-7): beyond its central effects on blood pressure.
Topics: Angiotensin I; Animals; Blood Pressure; Brain; Humans; Norepinephrine; Peptide Fragments; Renin-Angiotensin System | 2015 |
Brain angiotensin-(1-7)/Mas axis: A new target to reduce the cardiovascular risk to emotional stress.
Topics: Angiotensin I; Animals; Brain; Cardiovascular Diseases; Emotions; Humans; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Risk Factors; Stress, Psychological | 2016 |
Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Heart Failure; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Signal Transduction | 2016 |
Therapeutic uses for Angiotensin-(1-7).
Topics: Angiotensin I; Angiotensin II; Animals; Clinical Trials as Topic; Drug Design; Humans; Neoplasms; Patents as Topic; Peptide Fragments; Renin-Angiotensin System | 2016 |
Role of renin-angiotensin system in liver diseases: an outline on the potential therapeutic points of intervention.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Antioxidants; Enzyme Activation; Enzyme Activators; Humans; Liver; Liver Diseases; Molecular Targeted Therapy; NADPH Oxidases; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Reactive Oxygen Species; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction; Treatment Outcome | 2016 |
New agents modulating the renin-angiotensin-aldosterone system-Will there be a new therapeutic option?
Topics: Aldosterone; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cytochrome P-450 CYP11B2; Humans; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2016 |
Angiotensin (1-7) and Alamandine: Similarities and differences.
Topics: Angiotensin I; Animals; Atherosclerosis; Endothelium, Vascular; Humans; Nitric Oxide; Oligopeptides; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction; Vasodilation; Vasodilator Agents | 2016 |
The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Anti-Inflammatory Agents; Cytokines; Fibrosis; Gene Expression Regulation; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Signal Transduction | 2017 |
Measurement of Angiotensin Peptides: HPLC-RIA.
Topics: Angiotensin I; Angiotensin II; Animals; Chromatography, High Pressure Liquid; Humans; Peptide Fragments; Radioimmunoassay; Renin-Angiotensin System | 2017 |
Immunologic Effects of the Renin-Angiotensin System.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System | 2017 |
Significance of angiotensin 1-7 coupling with MAS1 receptor and other GPCRs to the renin-angiotensin system: IUPHAR Review 22.
Topics: Angiotensin I; Animals; Humans; Membrane Proteins; Peptide Fragments; Protein Binding; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction | 2017 |
Skeletal muscle wasting: new role of nonclassical renin-angiotensin system.
Topics: Angiotensin I; Humans; Muscle, Skeletal; Muscular Atrophy; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction | 2017 |
Recombinant Human ACE2 and the Angiotensin 1-7 Axis as Potential New Therapies for Heart Failure.
Topics: Angiotensin I; Heart Failure; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Recombinant Proteins; Renin-Angiotensin System; Vasodilator Agents | 2017 |
Kallikrein-kinin system as the dominant mechanism to counteract hyperactive renin-angiotensin system.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Cardiovascular System; Humans; Kallikrein-Kinin System; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction | 2017 |
Renin-Angiotensin System in Diabetes.
Topics: Angiotensin I; Angiotensin II; Animals; Diabetes Mellitus; Humans; Peptide Fragments; Renin-Angiotensin System | 2017 |
The Angiotensin Converting Enzyme 2 (ACE2), Gut Microbiota, and Cardiovascular Health.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cardiovascular Diseases; Gastrointestinal Microbiome; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2017 |
Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Exercise; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Physical Conditioning, Animal; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction; Vasoconstriction | 2017 |
Role of the ACE2‑Ang‑(1‑7)‑Mas axis in blood pressure regulation and its potential as an antihypertensive in functional foods (Review).
Topics: Angiotensin I; Animals; Antihypertensive Agents; Blood Pressure; Functional Food; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2017 |
The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Brain; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction | 2018 |
RAS in the Central Nervous System: Potential Role in Neuropsychiatric Disorders.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Central Nervous System; Humans; Mental Disorders; Neurodegenerative Diseases; Peptide Fragments; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2018 |
Angiotensin-(1-7) and Alamandine on Experimental Models of Hypertension and Atherosclerosis.
Topics: Angiotensin I; Animals; Atherosclerosis; Humans; Hypertension; Models, Theoretical; Oligopeptides; Peptide Fragments; Renin-Angiotensin System; Vasodilation | 2018 |
Cognitive benefits of angiotensin IV and angiotensin-(1-7): A systematic review of experimental studies.
Topics: Angiotensin I; Angiotensin II; Animals; Cognition Disorders; Databases, Bibliographic; Dementia; Disease Models, Animal; Humans; Memory, Short-Term; Peptide Fragments | 2018 |
The depressor axis of the renin-angiotensin system and brain disorders: a translational approach.
Topics: Alzheimer Disease; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Anxiety; Brain Diseases; Cognition; Humans; Peptide Fragments; Renin-Angiotensin System; Stroke; Translational Research, Biomedical | 2018 |
The Role of Angiotensin-(1-7)/Mas Axis and Angiotensin Type 2 Receptors in the Central Nervous System in Cardiovascular Disease and Therapeutics: A Riddle to be Solved.
Topics: Angiotensin I; Angiotensin II Type 2 Receptor Blockers; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Cardiovascular System; Central Nervous System; Humans; Hypertension; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Sympathetic Nervous System | 2019 |
The renin-angiotensin system as a target to solve the riddle of endocrine pancreas homeostasis.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Drug Delivery Systems; Homeostasis; Humans; Insulin Resistance; Islets of Langerhans; Peptide Fragments; Renin-Angiotensin System | 2019 |
ACE2 in Brain Physiology and Pathophysiology: Evidence from Transgenic Animal Models.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Animals, Genetically Modified; Brain; Brain Diseases; Cardiomegaly; Models, Animal; Peptide Fragments; Peptidyl-Dipeptidase A; Phenotype; Serotonin; Stress, Psychological; Tryptophan | 2019 |
Fiend and friend in the renin angiotensin system: An insight on acute kidney injury.
Topics: Acute Kidney Injury; Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Renin-Angiotensin System; Signal Transduction | 2019 |
The Protective Arm of Renin Angiotensin System; Recent Research Progress and Expectation for New Therapeutic Approach.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2016 |
Fetal programming and the angiotensin-(1-7) axis: a review of the experimental and clinical data.
Topics: Angiotensin I; Animals; Blood Pressure; Brain; Cardiovascular System; Female; Fetus; Humans; Hypertension; Kidney; Male; Peptide Fragments; Placenta; Pregnancy; Premature Birth; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Risk Factors; Sex Factors; Signal Transduction | 2019 |
The renin-angiotensin system: going beyond the classical paradigms.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cardiovascular Agents; Cardiovascular Diseases; Cardiovascular System; Congresses as Topic; Humans; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction | 2019 |
Classic and Nonclassic Renin-Angiotensin Systems in the Critically Ill.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Angiotensin I; Angiotensin II; Blood Pressure; Critical Illness; Female; Homeostasis; Humans; Male; Middle Aged; Peptide Fragments; Renin-Angiotensin System; Respiratory Distress Syndrome; Shock, Septic; Vasoconstrictor Agents | 2019 |
Angiotensin-(1-7), Adipokines and Inflammation.
Topics: Adipokines; Adipose Tissue; Angiotensin I; Animals; Humans; Inflammation; Peptide Fragments; Proto-Oncogene Mas | 2019 |
Levels of angiotensin peptides in healthy and cardiovascular/renal-diseased paediatric population-an investigative review.
Topics: Adolescent; Age Factors; Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Child; Child, Preschool; Female; Humans; Hypertension; Infant; Infant, Newborn; Kidney Failure, Chronic; Male; Peptide Fragments; Renin-Angiotensin System | 2019 |
Muscle wasting: A review of exercise, classical and non-classical RAS axes.
Topics: Angiotensin I; Angiotensin II; Apoptosis; Exercise; Fibrosis; Humans; Mitochondria; Muscle, Skeletal; Muscular Atrophy; NADPH Oxidases; Peptide Fragments; Protein Biosynthesis; Reactive Oxygen Species; Renin-Angiotensin System; Ubiquitin-Protein Ligases | 2019 |
Angiotensin II and angiotensin 1-7: which is their role in atrial fibrillation?
Topics: Angiotensin I; Angiotensin II; Atrial Fibrillation; Atrial Remodeling; Humans; Peptide Fragments | 2020 |
Neprilysin, the kidney brush border neutral proteinase: a possible potential target for ischemic renal injury.
Topics: Angiotensin I; Animals; Humans; Ischemia; Kidney; Natriuretic Peptides; Neprilysin; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renal Insufficiency; Renin-Angiotensin System; Signal Transduction | 2020 |
Angiotensin-(1-7): Translational Avenues in Cardiovascular Control.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Blood Pressure; Cardiovascular System; Humans; Hypertension; Peptide Fragments; Renin-Angiotensin System; Signal Transduction; Vasodilator Agents | 2019 |
Neuropsychiatric Properties of the ACE2/Ang-(1-7)/Mas Pathway: A Brief Review.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Depression; Humans; Peptide Fragments; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction | 2020 |
ACE2/Angiotensin-(1-7)/Mas Receptor Axis in Human Cancer: Potential Role for Pediatric Tumors.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Child; Humans; Neoplasms; Pediatrics; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2020 |
Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
Topics: Age Factors; Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Betacoronavirus; Cardiovascular Diseases; Coronavirus Infections; COVID-19; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Prognosis; Proto-Oncogene Mas; Receptor, Angiotensin, Type 1; Receptors, Virus; SARS-CoV-2; Sex Factors; Signal Transduction; Spike Glycoprotein, Coronavirus | 2020 |
Targeting Angiotensin-Converting Enzyme-2/Angiotensin-(1-7)/Mas Receptor Axis in the Vascular Progenitor Cells for Cardiovascular Diseases.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cardiovascular Agents; Cardiovascular Diseases; Drug Delivery Systems; Hematopoietic Stem Cells; Humans; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Signal Transduction; Stem Cells | 2021 |
Effect of renin-angiotensin system on senescence.
Topics: Aging; Angiotensin I; Angiotensin II; Animals; Cellular Senescence; Humans; Longevity; Mice; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Renin-Angiotensin System; Signal Transduction | 2020 |
Potential influence of COVID-19/ACE2 on the female reproductive system.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Gene Expression Regulation; Genitalia, Female; Host-Pathogen Interactions; Humans; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Pregnancy; Protein Binding; Receptors, Virus; Renin-Angiotensin System; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2020 |
JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azetidines; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Progression; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Janus Kinases; Methotrexate; Molecular Targeted Therapy; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Purines; Pyrazoles; Receptor, Angiotensin, Type 1; SARS-CoV-2; Signal Transduction; STAT Transcription Factors; Sulfonamides | 2020 |
Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost.
Topics: Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Repositioning; Humans; Neprilysin; Pandemics; Peptide Fragments; Pneumonia, Viral; SARS-CoV-2; Signal Transduction | 2020 |
The Network of Angiotensin Receptors in Breast Cancer.
Topics: Angiotensin I; Angiotensin II; Breast Neoplasms; Female; Humans; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2020 |
The ACE2/Ang (1-7)/MasR axis as an emerging target for antihypertensive peptides.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Oligopeptides; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Inbred SHR; Receptors, G-Protein-Coupled; Vasodilation | 2021 |
Harnessing inflammation resolving-based therapeutic agents to treat pulmonary viral infections: What can the future offer to COVID-19?
Topics: Acetates; Angiotensin I; Animals; Annexin A1; Anti-Inflammatory Agents; COVID-19; COVID-19 Drug Treatment; Disease Models, Animal; Docosahexaenoic Acids; Humans; Hydrogen Peroxide; Inflammation; Inflammation Mediators; Mice; Orthomyxoviridae Infections; Oxidants; Peptide Fragments; Peptides; Phosphodiesterase 4 Inhibitors; Pneumonia, Viral; Rolipram; Vasodilator Agents | 2020 |
A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19.
Topics: Acute Lung Injury; Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Betacoronavirus; Coronavirus Infections; COVID-19; Gene Expression Regulation; Humans; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Protein Binding; Proto-Oncogene Mas; Receptor, Angiotensin, Type 1; Receptors, Virus; Renin-Angiotensin System; SARS-CoV-2; Severity of Illness Index; Spike Glycoprotein, Coronavirus; Vitamin D | 2020 |
Involvement of ACE2/Ang-(1-7)/MAS1 Axis in the Regulation of Ovarian Function in Mammals.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Female; Humans; Ovary; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2020 |
SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Inflammation; Interleukin-6; Macrophages; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Receptors, Virus; Renin-Angiotensin System; SARS-CoV-2 | 2020 |
The Controversy of Renin-Angiotensin-System Blocker Facilitation Versus Countering COVID-19 Infection.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Coronavirus Infections; COVID-19; Humans; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Recombinant Proteins; Renin-Angiotensin System; Spike Glycoprotein, Coronavirus | 2020 |
Angiotensin-converting enzyme 2 (ACE2), angiotensin-(1-7) and Mas receptor in gonadal and reproductive functions.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Female; Gonads; Humans; Male; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Reproduction | 2020 |
ACE2, angiotensin 1-7 and skeletal muscle: review in the era of COVID-19.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; COVID-19; Humans; Muscle, Skeletal; Peptide Fragments; SARS-CoV-2 | 2020 |
Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System.
Topics: Acute Lung Injury; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Comorbidity; COVID-19; Humans; Hypertension; JNK Mitogen-Activated Protein Kinases; Lung; MAP Kinase Signaling System; Peptide Fragments; Protective Factors; Receptors, Coronavirus; Renin-Angiotensin System; Risk Factors; SARS-CoV-2; Up-Regulation | 2020 |
Research Progress on Pulmonary Arterial Hypertension and the Role of the Angiotensin Converting Enzyme 2-Angiotensin-(1-7)-Mas Axis in Pulmonary Arterial Hypertension.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Pulmonary Arterial Hypertension; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2022 |
Potential detrimental role of soluble ACE2 in severe COVID-19 comorbid patients.
Topics: ADAM17 Protein; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Comorbidity; COVID-19; Humans; Peptide Fragments; SARS-CoV-2 | 2021 |
Targeting the Protective Arm of the Renin-Angiotensin System: Focused on Angiotensin-(1-7).
Topics: Angiotensin I; Animals; Antihypertensive Agents; Drug Delivery Systems; Humans; Hypoglycemic Agents; Peptide Fragments; Renin-Angiotensin System | 2021 |
ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blood Vessels; COVID-19; Humans; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin-Angiotensin System; SARS-CoV-2; Vascular Diseases | 2021 |
Novel roles of the renal angiotensin-converting enzyme.
Topics: Acute Kidney Injury; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Bradykinin; Diabetic Nephropathies; Gene Expression Regulation; Humans; Hypertension; Kidney; Mice; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Signal Transduction; Water-Electrolyte Balance | 2021 |
Angiotensin receptors in the kidney and vasculature in hypertension and kidney disease.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Gene Expression Regulation; Humans; Hypertension; Kidney Tubules, Proximal; Mice; Mice, Knockout; Peptide Fragments; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Insufficiency, Chronic; Renin-Angiotensin System; Signal Transduction; Water-Electrolyte Balance | 2021 |
Renin-angiotensin system and inflammation update.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Autoimmunity; Blood Pressure; Gene Expression Regulation; Humans; Inflammation; Kidney; Klotho Proteins; Peptide Fragments; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Signal Transduction; T-Lymphocytes; Water-Electrolyte Balance | 2021 |
Cardiovascular Outcomes in the Acute Phase of COVID-19.
Topics: Acute Disease; Angiotensin I; Angiotensin-Converting Enzyme 2; Arteries; Cardiovascular Diseases; COVID-19; Humans; Morbidity; Peptide Fragments; Vascular Stiffness | 2021 |
The angiotensin converting enzyme 2 (ACE2) system in the brain: possible involvement in Neuro-Covid.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Brain; COVID-19; Humans; Nervous System Diseases; Peptide Fragments; Proto-Oncogene Mas; Receptors, G-Protein-Coupled | 2021 |
Asthma: role of the angiotensin-(1-7)/Mas (MAS1) pathway in pathophysiology and therapy.
Topics: Angiotensin I; Asthma; Humans; Peptide Fragments; Proto-Oncogene Proteins; Quality of Life; Receptors, G-Protein-Coupled | 2021 |
The role of renin angiotensin system in the pathophysiology of rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Osteoarthritis; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction; Treatment Outcome | 2021 |
Role of the ACE2/Ang-(1-7)/Mas axis in glucose metabolism.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Glucose; Humans; Peptide Fragments | 2021 |
Role of ACE2-Ang (1-7)-Mas axis in post-COVID-19 complications and its dietary modulation.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Cardiovascular Diseases; COVID-19; Dietary Proteins; Flavonoids; Humans; Lung; Peptide Fragments; Plant Oils; Polyphenols; Proto-Oncogene Mas; Terpenes; Virus Internalization; Vitamins | 2022 |
Molecular Mechanisms of Proteins - Targets for SARS-CoV-2 (Review).
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Astrocytes; Basigin; Brain; COVID-19; Humans; Peptide Fragments; SARS-CoV-2; Serine Endopeptidases | 2021 |
Alamandine: Potential Protective Effects in SARS-CoV-2 Patients.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Oligopeptides; Peptide Fragments; Renin-Angiotensin System | 2021 |
Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; COVID-19; Humans; Hypoxia; Lung; Myocardial Infarction; Peptide Fragments; Renin-Angiotensin System; SARS-CoV-2 | 2021 |
Involvement of the ACE2/Ang-(1-7)/MasR Axis in Pulmonary Fibrosis: Implications for COVID-19.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Cannabis; Cigarette Smoking; COVID-19; Fibrosis; Humans; Idiopathic Pulmonary Fibrosis; Inflammation; Lung; Pandemics; Peptide Fragments; Proto-Oncogene Mas; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Risk Factors; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2021 |
Chronic Renin-Angiotensin System Activation Induced Neuroinflammation: Common Mechanisms Underlying Hypertension and Dementia?
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Brain; Cytokines; Dementia, Vascular; Humans; Hypertension; Inflammation; Peptide Fragments; Renin-Angiotensin System | 2022 |
Pro-resolving therapies as potential adjunct treatment for infectious diseases: Evidence from studies with annexin A1 and angiotensin-(1-7).
Topics: Angiotensin I; Annexin A1; Communicable Diseases; Humans; Inflammation; Inflammation Mediators | 2022 |
Angiotensin-(1-7) reduces doxorubicin-induced aortic arch dysfunction in male and female juvenile Sprague Dawley rats through pleiotropic mechanisms.
Topics: Angiotensin I; Angiotensin II; Animals; Aorta, Thoracic; Doxorubicin; Female; Humans; Male; Peptide Fragments; Pulse Wave Analysis; Rats; Rats, Sprague-Dawley | 2022 |
Neuroinflammation and COVID-19 Ischemic Stroke Recovery-Evolving Evidence for the Mediating Roles of the ACE2/Angiotensin-(1-7)/Mas Receptor Axis and NLRP3 Inflammasome.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; COVID-19; Humans; Inflammasomes; Ischemic Stroke; Neuroinflammatory Diseases; NLR Family, Pyrin Domain-Containing 3 Protein; Peptide Fragments; Proteins; Proto-Oncogene Mas; SARS-CoV-2; Signal Transduction | 2022 |
Angiotensin-(1-7) as a Potential Therapeutic Strategy for Delayed Cerebral Ischemia in Subarachnoid Hemorrhage.
Topics: Angiotensin I; Angiotensin II; Brain Ischemia; Humans; Peptide Fragments; Subarachnoid Hemorrhage | 2022 |
21 trial(s) available for angiotensin ii, des-phe(8)- and angiotensin i
| Article | Year |
|---|---|
Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Epoprostenol; Female; Humans; Hypertension; Male; Middle Aged; Peptide Fragments; Time Factors | 1996 |
Effect of angiotensin-(1-7) and bradykinin in patients with heart failure treated with an ACE inhibitor.
Topics: Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bradykinin; Cardiac Output, Low; Dose-Response Relationship, Drug; Drug Interactions; Female; Heart Rate; Humans; Male; Peptide Fragments | 1999 |
Effects of angiotensin-(1-7) on forearm circulation in normotensive subjects and patients with essential hypertension.
Topics: Analysis of Variance; Angiotensin I; Antihypertensive Agents; Blood Circulation; Female; Forearm; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Peptide Fragments; Regional Blood Flow | 2001 |
Angiotensin(1-7) potentiates bradykinin-induced vasodilatation in man.
Topics: Adult; Angiotensin I; Angiotensin II; Bradykinin; Cross-Over Studies; Double-Blind Method; Drug Synergism; Enzyme Inhibitors; Humans; Male; omega-N-Methylarginine; Peptide Fragments; Reference Values; Vasoconstrictor Agents; Vasodilation | 2001 |
Effects of truncated angiotensins in humans after double blockade of the renin system.
Topics: Adult; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin III; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Chromium Radioisotopes; Edetic Acid; Humans; Male; Natriuresis; Peptide Fragments; Potassium; Renin; Renin-Angiotensin System; Sodium; Vasopressins | 2003 |
Sodium status and angiotensin-converting enzyme inhibition: effects on plasma angiotensin-(1-7) in healthy man.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Diet, Sodium-Restricted; Enalapril; Humans; Male; Peptide Fragments; Placebos; Renin-Angiotensin System; Sodium, Dietary | 2005 |
Phase I/II dose escalation study of angiotensin 1-7 [A(1-7)] administered before and after chemotherapy in patients with newly diagnosed breast cancer.
Topics: Adult; Aged; Angiotensin I; Antihypertensive Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Maximum Tolerated Dose; Middle Aged; Peptide Fragments; Prospective Studies | 2006 |
Comparison of inhibitory effects of irbesartan and atorvastatin treatment on the renin angiotensin system (RAS) in veins: a randomized double-blind crossover trial in healthy subjects.
Topics: Adult; Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Atorvastatin; Biphenyl Compounds; Compliance; Cross-Over Studies; Double-Blind Method; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Irbesartan; Male; Peptide Fragments; Pyrroles; Renin-Angiotensin System; Tetrazoles; Vasoconstriction; Veins | 2007 |
Phase I and pharmacokinetic study of angiotensin-(1-7), an endogenous antiangiogenic hormone.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Angiotensin I; Biomarkers, Tumor; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Models, Biological; Neoplasms; Peptide Fragments; Peptides | 2009 |
Imidapril provides a protective effect on pulmonary hypertension induced by low ambient temperature in broiler chickens.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arterial Pressure; Chickens; Cold Temperature; Hypertension, Pulmonary; Imidazolidines; Lung; Peptide Fragments; Peptidyl-Dipeptidase A; Poultry Diseases; Proliferating Cell Nuclear Antigen; Pulmonary Artery | 2014 |
Pharmacodynamic stimulation of thrombogenesis by angiotensin (1-7) in recurrent ovarian cancer patients receiving gemcitabine and platinum-based chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin I; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Cisplatin; Deoxycytidine; Double-Blind Method; Female; Gemcitabine; Humans; Middle Aged; Ovarian Neoplasms; Peptide Fragments; Thrombocytopenia | 2013 |
Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Double-Blind Method; Female; Humans; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Recombinant Proteins | 2013 |
Imidapril inhibits right ventricular remodeling induced by low ambient temperature in broiler chickens.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animal Husbandry; Animals; Chickens; Cold Temperature; Gene Expression Regulation; Heart Ventricles; Housing, Animal; Imidazolidines; Peptide Fragments; Peptidyl-Dipeptidase A; Ventricular Remodeling | 2013 |
Angiotensin-(1-7)-induced renal vasodilation in hypertensive humans is attenuated by low sodium intake and angiotensin II co-infusion.
Topics: Angiotensin I; Angiotensin II; Diet, Sodium-Restricted; Female; Hemodynamics; Humans; Hypertension; Kidney; Male; Middle Aged; Peptide Fragments; Renal Circulation; Renin-Angiotensin System; Sodium, Dietary; Vasodilation | 2013 |
Improvement of Plasma Biomarkers after Switching Stroke Patients from Other Angiotensin II Type I Receptor Blockers to Olmesartan.
Topics: Aged; Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; beta 2-Glycoprotein I; Biomarkers; Blood Pressure; Drug Substitution; Female; Humans; Hypertension; Japan; Lipoproteins, LDL; Male; Middle Aged; Olmesartan Medoxomil; Peptide Fragments; Peroxiredoxins; Prospective Studies; Stroke; Time Factors; Treatment Outcome | 2015 |
Modulation of leucocytic angiotensin-converting enzymes expression in patients maintained on high-permeable haemodialysis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Biomarkers; Cross-Over Studies; Dialysis Solutions; Double-Blind Method; Humans; Inflammation; Inflammation Mediators; Monocytes; Peptide Fragments; Peptidyl-Dipeptidase A; Pilot Projects; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Dialysis | 2018 |
Successful use of closed-loop allostatic neurotechnology for post-traumatic stress symptoms in military personnel: self-reported and autonomic improvements.
Topics: Adult; Allostasis; Angiotensin I; Angiotensin II; Biomarkers; C-Reactive Protein; Electroencephalography; Epinephrine; Heart Rate; Humans; Interleukin-1; Interleukin-10; Interleukin-6; Male; Middle Aged; Military Personnel; Monitoring, Physiologic; Norepinephrine; North Carolina; Peptide Fragments; Pilot Projects; Self Report; Stress Disorders, Post-Traumatic; Vasopressins; Veterans | 2017 |
Eccentric Overload Muscle Damage is Attenuated By a Novel Angiotensin- (1-7) Treatment.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adult; Angiotensin I; Biomarkers; Creatine Kinase; Cytokines; Dietary Supplements; Double-Blind Method; Excipients; Exercise; Exercise Test; Female; Humans; Leukocytes, Mononuclear; Male; Muscle Strength; Muscle, Skeletal; Myalgia; Peptide Fragments; RNA, Messenger; Young Adult | 2018 |
Low-load resistance training with blood flow restriction prevent renal function decline: The role of the redox balance, angiotensin 1-7 and vasopressin
Topics: Angiotensin I; F2-Isoprostanes; Female; Humans; Male; Muscle, Skeletal; Oxidation-Reduction; Peptide Fragments; Regional Blood Flow; Resistance Training; Vasopressins | 2021 |
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Cyprinidae; DNA Damage; Flavonoids; Fresh Water; Fructose; Gills; Insecticides; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Pyridines; Rats; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Water; Water Pollutants, Chemical | 2022 |
A randomized, placebo-controlled, double-blinded pilot study of angiotensin 1-7 (TXA-127) for the treatment of severe COVID-19.
Topics: Angiotensin I; Antifibrinolytic Agents; Blood Loss, Surgical; COVID-19; Double-Blind Method; Humans; Peptide Fragments; Pilot Projects; Tranexamic Acid; Treatment Outcome | 2022 |
1249 other study(ies) available for angiotensin ii, des-phe(8)- and angiotensin i
| Article | Year |
|---|---|
Hydrolysis of angiotensin peptides by human angiotensin I-converting enzyme and the resensitization of B2 kinin receptors.
Topics: Angiotensin I; Angiotensins; Animals; Bradykinin; CHO Cells; Cricetinae; Cricetulus; Enzyme Inhibitors; Green Fluorescent Proteins; Humans; Hydrolysis; Kinetics; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphoprotein Phosphatases; Protein Kinase C; Protein-Tyrosine Kinases; Receptor, Bradykinin B2; Recombinant Fusion Proteins | 2005 |
New mass spectrometric assay for angiotensin-converting enzyme 2 activity.
Topics: Angiotensin I; Angiotensin II; Animals; Humans; Isoenzymes; Kidney; Male; Mass Spectrometry; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Peptidyl-Dipeptidase A; Recombinant Proteins; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2006 |
Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Blotting, Western; Female; In Vitro Techniques; Iodine Radioisotopes; Kidney Tubules, Proximal; Neprilysin; Peptide Fragments; Peptidyl-Dipeptidase A; Sheep | 2007 |
Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Down-Regulation; Enalapril; Hemodynamics; Male; Myocardial Infarction; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Ventricular Dysfunction; Ventricular Function, Left | 2006 |
Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; CD13 Antigens; Cells, Cultured; Glutamyl Aminopeptidase; Humans; Mesangial Cells; Mice; Neprilysin; Peptide Fragments; Peptidyl-Dipeptidase A; Podocytes; Protease Inhibitors; Renin; Renin-Angiotensin System; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2007 |
Angiotensin processing is partially carried out by carboxypeptidases in the rat mesenteric arterial bed perfusate.
Topics: Angiotensin I; Angiotensin II; Angiotensins; Animals; Carboxypeptidases; In Vitro Techniques; Kinetics; Mesenteric Arteries; Peptide Fragments; Perfusion; Phenanthrolines; Protease Inhibitors; Protein Processing, Post-Translational; Rats; Rats, Wistar; Substrate Specificity | 2008 |
Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Disease Models, Animal; Humans; Hydrolysis; Hypertension; Imidazoles; In Vitro Techniques; Kidney; Leucine; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Peptides; Peptidyl-Dipeptidase A; Recombinant Proteins | 2012 |
Adenoviral delivery of angiotensin-(1-7) or angiotensin-(1-9) inhibits cardiomyocyte hypertrophy via the mas or angiotensin type 2 receptor.
Topics: Adenoviridae; Angiotensin I; Animals; Cardiomegaly; Cell Line; Genetic Therapy; Genetic Vectors; Humans; Myocytes, Cardiac; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rabbits; Rats; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Recombinant Fusion Proteins; Transduction, Genetic | 2012 |
The influence of angiotensin-(1-7) peptidomimetic (AVE 0991) and nebivolol on angiotensin I metabolism in aorta of apoE-knockout mice.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Aorta, Thoracic; Apolipoproteins E; Atherosclerosis; Benzopyrans; Down-Regulation; Drug Therapy, Combination; Ethanolamines; Female; Imidazoles; Mice; Mice, Inbred C57BL; Mice, Knockout; Nebivolol; Peptide Fragments; Renin-Angiotensin System; Vasodilator Agents | 2013 |
Functional Local Renin-Angiotensin System in Human and Rat Periodontal Tissue.
Topics: Adult; Amino Acid Sequence; Angiotensin I; Angiotensin II; Animals; Cells, Cultured; Female; Gingiva; Humans; Inflammation; Male; Middle Aged; Peptide Fragments; Periodontitis; Periodontium; Rats, Wistar; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Young Adult | 2015 |
Production of angiotensin-(1-7) by human vascular endothelium.
Topics: Angiotensin I; Angiotensin II; Animals; Enalaprilat; Endothelium, Vascular; Humans; Iodine Radioisotopes; Peptide Fragments; Peptidyl-Dipeptidase A; Protease Inhibitors; Umbilical Veins | 1992 |
In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalaprilat; Endopeptidases; Hypertension; Male; Neprilysin; Osmolar Concentration; Peptide Fragments; Prolyl Oligopeptidases; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Serine Endopeptidases; Time Factors | 1992 |
Angiotensin-(1-7) is a potent antidiuretic peptide in rats.
Topics: Angiotensin I; Angiotensin II; Animals; Arginine Vasopressin; Diuresis; Dose-Response Relationship, Drug; Male; Peptide Fragments; Rats; Rats, Wistar; Water-Electrolyte Balance | 1992 |
Differential actions of angiotensin II and angiotensin-(1-7) on transmitter release.
Topics: Angiotensin I; Angiotensin II; Animals; Brain Chemistry; Male; Medulla Oblongata; Neurotransmitter Agents; Peptide Fragments; Potassium; Rats; Rats, Inbred Strains | 1992 |
Angiotensin II--derived peptides devoid of phenylalanine in position 8 have full psychotropic activity of the parent hormone.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Animals; Avoidance Learning; Behavior, Animal; Injections, Intraventricular; Male; Motor Activity; Peptide Fragments; Phenylalanine; Psychotropic Drugs; Rats; Rats, Wistar; Stereotyped Behavior; Time Factors | 1992 |
Increased angiotensin-(1-7) in hypophysial-portal plasma of conscious sheep.
Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Chromatography, High Pressure Liquid; Endopeptidases; Gonadotropin-Releasing Hormone; Median Eminence; Peptide Fragments; Peptides; Pituitary Gland; Portal System; Prolyl Oligopeptidases; Radioimmunoassay; Renin; Serine Endopeptidases; Sheep | 1992 |
Electrophysiological responses of angiotensin peptides on the rat isolated nodose ganglion.
Topics: Angiotensin I; Angiotensin II; Angiotensins; Animals; Electrophysiology; In Vitro Techniques; Male; Nodose Ganglion; Peptide Fragments; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Saralasin; Serotonin | 1992 |
Differential baroreceptor reflex modulation by centrally infused angiotensin peptides.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Animals; Blood Pressure; Brain; Heart Rate; Injections, Intraventricular; Male; Peptide Fragments; Pressoreceptors; Rats; Rats, Inbred Strains; Reflex | 1992 |
Evidence that prolyl endopeptidase participates in the processing of brain angiotensin.
Topics: Angiotensin I; Angiotensin II; Animals; Chromatography, High Pressure Liquid; Dogs; Endopeptidases; Hypothalamus; In Vitro Techniques; Iodine Radioisotopes; Male; Peptide Fragments; Prolyl Oligopeptidases; Radioimmunoassay; Renin-Angiotensin System; Serine Endopeptidases | 1991 |
Angiotensin-(1-7). A member of circulating angiotensin peptides.
Topics: Angiotensin I; Angiotensin II; Angiotensins; Animals; Blood Pressure; Chromatography, High Pressure Liquid; Dogs; Enalaprilat; Heart Rate; Male; Nephrectomy; Peptide Fragments; Peptides; Radioimmunoassay; Renin | 1991 |
Human astrocytes contain two distinct angiotensin receptor subtypes.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Astrocytes; Astrocytoma; Calcium; Cell Line; Cytosol; Dinoprostone; Dose-Response Relationship, Drug; Epoprostenol; Humans; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Peptide Fragments; Prostaglandins F; Receptors, Angiotensin; Signal Transduction; Tumor Cells, Cultured | 1991 |
Characterization of angiotensin receptors mediating prostaglandin synthesis in C6 glioma cells.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Glioma; Imidazoles; Losartan; Oligopeptides; Peptide Fragments; Prostaglandins; Receptors, Angiotensin; Tetrazoles; Tumor Cells, Cultured | 1991 |
Neurophysiological responses to angiotensin-(1-7).
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Animals; Brain; Electrophysiology; Female; Iontophoresis; Neurons; Oligopeptides; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Rats; Rats, Inbred WKY; Vasopressins | 1991 |
Biological activity of angiotensin-(1-7) heptapeptide in the hamster heart.
Topics: Angiotensin I; Angiotensin II; Animals; Cardiac Output; Cardiomyopathies; Coronary Circulation; Cricetinae; Heart; Male; Mesocricetus; Peptide Fragments; Perfusion; Pressure; Reference Values | 1990 |
Actions of angiotensin peptides after partial denervation of the solitary tract nucleus.
Topics: Angiotensin I; Angiotensin II; Angiotensins; Animals; Binding Sites; Denervation; Male; Medulla Oblongata; Peptide Fragments; Peptides; Rats; Rats, Inbred Strains; Sinus of Valsalva | 1990 |
Angiotensin II and angiotensin (1-7) excite neurons in the canine medulla in vitro.
Topics: Action Potentials; Angiotensin I; Angiotensin II; Animals; Dogs; In Vitro Techniques; Male; Medulla Oblongata; Peptide Fragments; Vagus Nerve | 1990 |
Prostaglandin production in response to angiotensin-(1-7) in rabbit isolated vasa deferentia.
Topics: Adrenergic Fibers; Angiotensin I; Angiotensin II; Angiotensin III; Animals; Male; Muscle Contraction; Muscle, Smooth; Peptide Fragments; Prostaglandins E; Rabbits; Stimulation, Chemical; Vas Deferens | 1990 |
Cardiovascular effects of angiotensin-(1-7) injected into the dorsal medulla of rats.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Heart Rate; Male; Medulla Oblongata; Peptide Fragments; Rats; Rats, Inbred Strains | 1989 |
Identification of angiotensin-(1-7) in rat brain. Evidence for differential processing of angiotensin peptides.
Topics: Adrenal Glands; Angiotensin I; Angiotensin II; Angiotensins; Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Hypothalamus; Immune Sera; Male; Peptide Fragments; Protein Processing, Post-Translational; Radioimmunoassay; Rats; Rats, Inbred Strains | 1989 |
Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide.
Topics: Angiotensin I; Angiotensin II; Animals; Arginine Vasopressin; Dose-Response Relationship, Drug; Hypothalamo-Hypophyseal System; In Vitro Techniques; Peptide Fragments; Rats; Receptors, Angiotensin; Saralasin | 1988 |
Biological activities of angiotensin II-(1-6)-hexapeptide and angiotensin II-(1-7)-heptapeptide in man.
Topics: Adolescent; Adult; Angiotensin I; Angiotensin II; Bartter Syndrome; Blood Pressure; Humans; Hyperaldosteronism; Infusions, Parenteral; Kinetics; Male; Peptide Fragments; Reference Values; Time Factors | 1986 |
Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin-(1-7).
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Heart Rate; Hypertension; Infusions, Intravenous; Injections, Intravenous; Male; Peptide Fragments; Phenylephrine; Pressoreceptors; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reflex; Time Factors; Vasoconstrictor Agents | 1995 |
Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Blood Pressure; Bradykinin; Dose-Response Relationship, Drug; Drug Synergism; Enalaprilat; Indomethacin; Male; Peptide Fragments; Prostaglandins; Rats; Rats, Wistar; Renin-Angiotensin System; Vasoconstrictor Agents | 1995 |
Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension.
Topics: Amino Acid Oxidoreductases; Angiotensin I; Angiotensin II; Angiotensins; Animals; Arginine; Biphenyl Compounds; Dogs; Hemodynamics; Hypertension, Renovascular; Imidazoles; Lisinopril; Losartan; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Peptide Fragments; Peptidyl-Dipeptidase A; Tetrazoles | 1995 |
Identification of atypical (non-AT1, non-AT2) angiotensin binding sites with high affinity for angiotensin I on IEC-18 rat intestinal epithelial cells.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Binding Sites; Binding, Competitive; Biphenyl Compounds; Cell Line; Epithelium; Imidazoles; Intestinal Mucosa; Intestine, Small; Losartan; Oligopeptides; Peptide Fragments; Pyridines; Rats; Receptors, Angiotensin; Tetrazoles | 1995 |
Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Arginine; Coronary Vessels; Data Interpretation, Statistical; Dogs; In Vitro Techniques; Kinins; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitrites; Peptide Fragments; Receptors, Angiotensin; Stimulation, Chemical | 1995 |
Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Diuresis; Heart Rate; Hypertension; Infusions, Intravenous; Male; Natriuresis; Peptide Fragments; Prostaglandins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reference Values; Time Factors; Vasopressins | 1995 |
Angiotensin-(1-7) binding at angiotensin II receptors in the rat brain.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin I; Angiotensin II; Animals; Autoradiography; Binding, Competitive; Brain; Cell Nucleus; Dose-Response Relationship, Drug; In Vitro Techniques; Kinetics; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin | 1995 |
Angiotensin-(1-7) and nitric oxide synthase in the hypothalamo-neurohypophysial system.
Topics: Amino Acid Oxidoreductases; Angiotensin I; Angiotensin II; Animals; Cerebral Ventricles; Hypothalamo-Hypophyseal System; Immunohistochemistry; Male; NADP; Nitric Oxide Synthase; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Rats; Rats, Sprague-Dawley; Supraoptic Nucleus | 1993 |
Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds.
Topics: Amino Acid Oxidoreductases; Angiotensin I; Angiotensin II; Angiotensin III; Animals; Arginine; Biphenyl Compounds; Cats; Hindlimb; Imidazoles; Losartan; Meclofenamic Acid; Mesenteric Artery, Superior; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptide Fragments; Perfusion; Tetrazoles; Vascular Resistance; Vasoconstriction | 1993 |
On the plasticity of the cerebellar renin-angiotensin system: localization of components and effects of mechanical perturbation.
Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Cerebellum; Glial Fibrillary Acidic Protein; Immunohistochemistry; In Situ Hybridization; Male; Microscopy, Confocal; Neuroglia; Neuronal Plasticity; Peptide Fragments; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; RNA, Messenger | 1994 |
Angiotensin(1-7) is an antagonist at the type 1 angiotensin II receptor.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Imidazoles; In Vitro Techniques; Losartan; Male; Peptide Fragments; Rabbits; Rats; Rats, Sprague-Dawley; Tetrazoles | 1994 |
Association between the natriuretic action of angiotensin-(1-7) and selective stimulation of renal prostaglandin I2 release.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin I; Angiotensin II; Animals; Body Water; Electrolytes; Epoprostenol; Glomerular Filtration Rate; Indomethacin; Kidney; Male; Natriuresis; Peptide Fragments; Rats; Rats, Sprague-Dawley; Renal Circulation; Vascular Resistance | 1995 |
Opposing actions of angiotensin-(1-7) and angiotensin II in the brain of transgenic hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Animals; Animals, Genetically Modified; Brain; Female; Hypertension; Immune Sera; Peptide Fragments; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System | 1995 |
Angiotensin 1-7 has a biphasic effect on fluid absorption in the proximal straight tubule.
Topics: Adsorption; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Bicarbonates; Biphenyl Compounds; Imidazoles; In Vitro Techniques; Ion Transport; Kidney Tubules, Proximal; Kinetics; Losartan; Male; Peptide Fragments; Perfusion; Permeability; Pyridines; Rats; Rats, Sprague-Dawley; Tetrazoles | 1994 |
[7-D-ALA]-angiotensin-(1-7): selective antagonism of angiotensin-(1-7) in the rat paraventricular nucleus.
Topics: Action Potentials; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Male; Neurons; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin | 1994 |
Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors.
Topics: Adrenal Glands; Amino Acid Sequence; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Diuresis; Female; Heart Rate; In Vitro Techniques; Injections, Intraventricular; Male; Medulla Oblongata; Molecular Sequence Data; Muscle Contraction; Muscle, Smooth; Peptide Fragments; Rats; Rats, Wistar; Receptors, Angiotensin; Uterine Contraction | 1994 |
Evidence that angiotensin-(1-7) plays a role in the central control of blood pressure at the ventro-lateral medulla acting through specific receptors.
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Imidazoles; Losartan; Male; Medulla Oblongata; Oligopeptides; Peptide Fragments; Rats; Rats, Wistar; Tetrazoles | 1994 |
Plasma angiotensin(1-7) immunoreactivity is increased by salt load, water deprivation, and hemorrhage.
Topics: Angiotensin I; Angiotensin II; Animals; Hemorrhage; Male; Peptide Fragments; Radioimmunoassay; Rats; Rats, Wistar; Sodium Chloride; Water Deprivation; Water-Electrolyte Imbalance | 1994 |
Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Animals; Animals, Genetically Modified; Cerebral Cortex; Female; Hypertension; Hypothalamus; Medulla Oblongata; Peptide Fragments; Rats; Rats, Sprague-Dawley; Renin | 1994 |
Analysis of responses to angiotensin IV in the pulmonary vascular bed of the cat.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Gas Analysis; Blood Pressure; Cats; Dose-Response Relationship, Drug; Female; Imidazoles; Male; Peptide Fragments; Pulmonary Circulation; Pyridines; Tetrazoles; Vascular Resistance | 1994 |
Natriuretic action of angiotensin(1-7).
Topics: Angiotensin I; Angiotensin II; Animals; Diuresis; Glomerular Filtration Rate; Kidney; Kidney Tubules; Male; Natriuresis; Peptide Fragments; Rats; Rats, Sprague-Dawley; Vascular Resistance | 1994 |
Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor.
Topics: Amino Acid Sequence; Angiotensin I; Angiotensin II; Animals; Arginine; Bradykinin; Coronary Vessels; Endothelium, Vascular; In Vitro Techniques; Isoquinolines; Molecular Sequence Data; Muscle Relaxation; Nitric Oxide; Nitroarginine; Peptide Fragments; Receptors, Angiotensin; Swine; Tetrahydroisoquinolines; Vasodilator Agents | 1994 |
Effects of angiotensin II and angiotensin-(1-7) on the release of [3H]norepinephrine from rat atria.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Drug Interactions; Electric Stimulation; Female; Heart; Heart Atria; Imidazoles; Losartan; Myocardium; Norepinephrine; Peptide Fragments; Pyridines; Rats; Rats, Wistar; Receptors, Angiotensin; Saralasin; Tetrazoles | 1994 |
Cardiovascular effects produced by micro-injection of angiotensin-(1-7) on vasopressor and vasodepressor sites of the ventrolateral medulla.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Heart Rate; Male; Medulla Oblongata; Microinjections; Organ Specificity; Peptide Fragments; Rats; Rats, Wistar; Renin-Angiotensin System | 1993 |
Comparative effects of angiotensin-(1-7) and angiotensin II on piglet pial arterioles.
Topics: Angiotensin I; Angiotensin II; Animals; Animals, Newborn; Arterioles; Cerebral Arteries; Female; Indomethacin; Male; Peptide Fragments; Pia Mater; Prostaglandins; Swine; Vasodilator Agents | 1993 |
Modulation of phospholipase A2 activity and sodium transport by angiotensin-(1-7).
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin I; Angiotensin II; Animals; Biological Transport; Cells, Cultured; Kidney Tubules, Proximal; Lysophosphatidylcholines; Male; Peptide Fragments; Phospholipases A; Phospholipases A2; Rabbits; Sodium | 1993 |
The effect of the putative AT2 agonist, p-aminophenylalanine6 angiotensin II, on thirst and sodium appetite in rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Appetite; Biphenyl Compounds; Drinking; Imidazoles; Injections, Intraventricular; Losartan; Male; Oligopeptides; Peptide Fragments; Pyridines; Rats; Rats, Wistar; Receptors, Angiotensin; Sodium Chloride, Dietary; Tetrazoles; Thirst | 1993 |
Alterations in prostaglandin production in spontaneously hypertensive rat smooth muscle cells.
Topics: Angiotensin I; Angiotensin II; Animals; Cells, Cultured; Dinoprostone; Epoprostenol; Hypertension; Muscle, Smooth, Vascular; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin | 1993 |
Converting enzyme inhibition and its withdrawal in spontaneously hypertensive rats.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Pressure; Hypertension; Indoles; Male; Peptide Fragments; Perindopril; Radioimmunoassay; Rats; Rats, Inbred SHR; Renin; Tissue Distribution | 1995 |
Angiotensin II and angiotensin-(1-7) effects on free cytosolic sodium, intracellular pH, and the Na(+)-H+ antiporter in vascular smooth muscle.
Topics: Amiloride; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Arrhythmia Agents; Cells, Cultured; Cytosol; Hydrogen-Ion Concentration; Intracellular Membranes; Male; Muscle, Smooth, Vascular; Ouabain; Peptide Fragments; Rats; Rats, Sprague-Dawley; Sodium; Sodium-Hydrogen Exchangers | 1996 |
Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide.
Topics: Angiotensin I; Angiotensin II; Animals; Coronary Vessels; Dogs; Kinins; Male; Nitric Oxide; Peptide Fragments; Receptors, Angiotensin; Vasodilation | 1996 |
Evidence for a physiological role of angiotensin-(1-7) in the control of hydroelectrolyte balance.
Topics: Angiotensin I; Angiotensin II; Animals; Male; Peptide Fragments; Rats; Rats, Wistar; Renin-Angiotensin System; Water-Electrolyte Balance | 1996 |
The association of thirst, sodium appetite and vasopressin release with c-fos expression in the forebrain of the rat after intracerebroventricular injection of angiotensin II, angiotensin-(1-7) or carbachol.
Topics: Angiotensin I; Angiotensin II; Animals; Appetite; Carbachol; Drinking Behavior; Injections, Intraventricular; Male; Peptide Fragments; Prosencephalon; Proto-Oncogene Proteins c-fos; Rats; Rats, Inbred Strains; Sodium; Thirst; Vasopressins | 1995 |
Angiotensin-(1-7) inhibits vascular smooth muscle cell growth.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Cattle; Cell Count; Cell Division; Cells, Cultured; Data Interpretation, Statistical; Male; Muscle, Smooth, Vascular; Peptide Fragments; Rats; Receptors, Angiotensin; Thymidine | 1996 |
Renal actions of angiotensin-(1-7): in vivo and in vitro studies.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Dose-Response Relationship, Drug; Hemodynamics; Kidney; Kidney Tubules, Proximal; Male; Nystatin; Osmolar Concentration; Ouabain; Oxygen Consumption; Peptide Fragments; Rats; Rats, Wistar; Renal Circulation; Sodium-Potassium-Exchanging ATPase | 1996 |
Effect of acute volume expansion associated with salt load on the profile of plasma angiotensins in rats.
Topics: Angiotensin I; Angiotensin II; Angiotensins; Animals; Arginine Vasopressin; Male; Peptide Fragments; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; Sodium Chloride; Water-Electrolyte Balance | 1996 |
Pressor action of angiotensin I at the ventrolateral medulla: effect of selective angiotensin blockade.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Imidazoles; Losartan; Male; Medulla Oblongata; Microinjections; Peptide Fragments; Ramipril; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles | 1996 |
Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension.
Topics: Angiotensin I; Angiotensin II; Antihypertensive Agents; Blood Pressure; Captopril; Epoprostenol; Humans; Hypertension; Peptide Fragments | 1996 |
Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor.
Topics: Angiotensin I; Angiotensin II; Animals; Binding, Competitive; Cattle; Endothelium, Vascular; Peptide Fragments; Receptor, Angiotensin, Type 1; Receptors, Angiotensin | 1997 |
Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Indomethacin; Male; Peptide Fragments; Vasodilation | 1997 |
Hypothalamic substance P release. Attenuated angiotensin responses in mRen2(27) transgenic rats.
Topics: Angiotensin I; Angiotensin II; Animals; Animals, Genetically Modified; Hypothalamus; Male; Peptide Fragments; Rats; Substance P; Vasoconstrictor Agents | 1997 |
Angiotensin II activates distinct signal transduction pathways in astrocytes isolated from neonatal rat brain.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Astrocytes; Biphenyl Compounds; Bradykinin; Brain; Cells, Cultured; Cerebellum; Cerebral Cortex; Epoprostenol; Humans; Hypothalamus; Imidazoles; Losartan; Medulla Oblongata; Peptide Fragments; Phosphatidylinositol Diacylglycerol-Lyase; Pyridines; Rats; Rats, Sprague-Dawley; Signal Transduction; Tetrazoles; Type C Phospholipases | 1997 |
Cardiovascular effects produced by microinjection of angiotensins and angiotensin antagonists into the ventrolateral medulla of freely moving rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Heart Rate; Imidazoles; Losartan; Male; Medulla Oblongata; Microinjections; Oligopeptides; Peptide Fragments; Rats; Rats, Wistar; Tetrazoles; Time Factors | 1997 |
Possible participation of nitric oxide in the increase of norepinephrine release caused by angiotensin peptides in rat atria.
Topics: Angiotensin I; Angiotensin II; Animals; Drug Interactions; Electrophysiology; Enzyme Inhibitors; Female; Heart Atria; Heart Rate; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Peptide Fragments; Rats; Rats, Wistar; Sympathomimetics | 1997 |
Angiotensin-(1-7) induces bradykinin-mediated hypotensive responses in anesthetized rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Drug Synergism; Hypotension; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley | 1997 |
Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1-7) in normotensive and hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Bradykinin; Drug Synergism; Hypertension; Male; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Wistar | 1997 |
Role of angiotensin-(1-7) in the modulation of the baroreflex in renovascular hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Enalapril; Heart Rate; Hypertension, Renovascular; Injections, Intraventricular; Male; Peptide Fragments; Pressoreceptors; Rats; Rats, Wistar; Reflex | 1997 |
Angiotensin-(1-7) and the rat aorta: modulation by the endothelium.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Animals; Antihypertensive Agents; Aorta, Thoracic; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Losartan; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin | 1997 |
Effect of intratubular application of angiotensin 1-7 on nephron function.
Topics: Absorption; Angiotensin I; Angiotensin II; Animals; Feedback; Infusions, Parenteral; Kidney Function Tests; Kidney Tubules; Loop of Henle; Male; Nephrons; Peptide Fragments; Rats; Rats, Wistar | 1997 |
Signal transduction mechanisms involved in angiotensin-(1-7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells.
Topics: Angiotensin I; Angiotensin II; Animals; Aorta; Arachidonic Acid; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Male; Muscle, Smooth, Vascular; Oligonucleotides, Antisense; Peptide Fragments; Phospholipases A; Phospholipases A2; Prostaglandins; Rabbits; Rats; Rats, Sprague-Dawley; Signal Transduction | 1998 |
Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS.
Topics: Angiotensin I; Angiotensin II; Animals; Animals, Genetically Modified; Aorta, Thoracic; Blood Pressure; Estradiol; Estrogen Replacement Therapy; Female; Hypertension; Kidney; Mice; Models, Cardiovascular; Muscle, Smooth, Vascular; Ovariectomy; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Renin; Renin-Angiotensin System; Vasoconstriction; Vasodilation | 1997 |
Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Dipeptides; Heart Rate; Hypertension; Kinetics; Lisinopril; Losartan; Male; Neprilysin; Organophosphonates; Peptide Fragments; Peptides, Cyclic; Phenylalanine; Protease Inhibitors; Rats; Rats, Inbred SHR; Renin-Angiotensin System | 1998 |
Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Cell Membrane; Dogs; Humans; Kinetics; Lisinopril; Lung; Models, Chemical; Peptide Fragments; Peptidyl-Dipeptidase A | 1998 |
Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antibodies, Monoclonal; Antihypertensive Agents; Blood Pressure; Heart Rate; Imidazoles; Immunoglobulin G; Lisinopril; Losartan; Male; Mice; Mice, Inbred BALB C; Peptide Fragments; Pyridines; Rats; Rats, Inbred SHR; Vasodilation | 1998 |
Characterization of angiotensin-(1-7) in the urine of normal and essential hypertensive subjects.
Topics: Adult; Age Factors; Angiotensin I; Angiotensin II; Cross-Sectional Studies; Female; Humans; Hypertension; Kidney; Male; Middle Aged; Peptide Fragments | 1998 |
N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arachidonic Acid; Bradykinin; Chlorides; CHO Cells; Cricetinae; Enzyme Repression; Humans; Hydrolysis; Peptide Fragments; Peptidyl-Dipeptidase A; Substrate Specificity; Transfection | 1998 |
Angiotensin 1-7 induces bradykinin-mediated relaxation in porcine coronary artery.
Topics: Angiotensin I; Angiotensin II; Animals; Bradykinin; Coronary Vessels; Imidazoles; In Vitro Techniques; Peptide Fragments; Peptidyl-Dipeptidase A; Pyridines; Receptor, Bradykinin B2; Receptors, Bradykinin; Substance P; Swine; Vasodilation | 1998 |
Angiotensin-(1-7) immunoreactivity in the hypothalamus of the (mRen-2d)27 transgenic rat.
Topics: Angiotensin I; Angiotensin II; Animals; Animals, Genetically Modified; Female; Hypothalamus; Image Processing, Computer-Assisted; Immunohistochemistry; Male; Mice; Oxytocin; Peptide Fragments; Rats; Rats, Sprague-Dawley; Renin; Tissue Distribution; Vasopressins | 1998 |
[7-D-ALA]-angiotensin 1-7 blocks renal actions of angiotensin 1-7 in the anesthetized rat.
Topics: Anesthesia; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Kidney; Kidney Function Tests; Kidney Tubules, Proximal; Losartan; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Renal Circulation | 1998 |
Diuresis and natriuresis produced by long term administration of a selective Angiotensin-(1-7) antagonist in normotensive and hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Animals; Diuresis; Male; Natriuresis; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Wistar; Time Factors | 1998 |
Converting enzyme determines plasma clearance of angiotensin-(1-7).
Topics: Administration, Oral; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Blood Pressure; Chromatography, High Pressure Liquid; Drug Combinations; Half-Life; Lisinopril; Losartan; Male; Metabolic Clearance Rate; Peptide Fragments; Radioimmunoassay; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Species Specificity | 1998 |
Effect of angiotensin-(1-7) on ATPase activities in several tissues.
Topics: Angiotensin I; Angiotensin II; Animals; Brain; Ca(2+) Mg(2+)-ATPase; Kidney; Liver; Myocardium; Peptide Fragments; Rats; Rats, Wistar; Sheep; Sodium-Potassium-Exchanging ATPase; Synaptosomes | 1998 |
Interaction of bradykinin and angiotensin-(1-7) in the central modulation of the baroreflex control of the heart rate.
Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Animals; Baroreflex; Bradykinin; Bradykinin Receptor Antagonists; Drug Synergism; Heart Rate; Injections, Intraventricular; Male; Peptide Fragments; Rats; Rats, Wistar | 1998 |
Effect of selective angiotensin antagonists on the antidiuresis produced by angiotensin-(1-7) in water-loaded rats.
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Diuresis; Drinking; Kidney; Losartan; Male; Peptide Fragments; Rats; Rats, Wistar; Receptors, Angiotensin; Renal Agents | 1998 |
Angiotensin-(1-7) reduces smooth muscle growth after vascular injury.
Topics: Angiotensin I; Angiotensin II; Animals; Carotid Artery Injuries; Carotid Artery, Common; Catheterization; Cell Division; Infusions, Intravenous; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Tunica Intima | 1999 |
Differential response of angiotensin peptides in the urine of hypertensive animals.
Topics: Administration, Oral; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Pressure; Body Weight; Drinking; Electrolytes; Hemodynamics; Hypertension; Lisinopril; Losartan; Male; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley | 1999 |
Angiotensin-(1-7) can interact with the rat proximal tubule AT(4) receptor system.
Topics: Angiotensin I; Angiotensin II; Animals; Cattle; Cells, Cultured; Kidney Tubules, Proximal; Oxygen Consumption; Peptide Fragments; Rats; Receptors, Angiotensin; Sodium | 1999 |
Angiotensin-(1-7) is a modulator of the human renin-angiotensin system.
Topics: Adult; Aged; Angiotensin I; Angiotensin II; Data Interpretation, Statistical; Female; Heart Atria; Humans; In Vitro Techniques; Male; Mammary Arteries; Middle Aged; Muscle Contraction; Muscle, Smooth, Vascular; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Vasoconstriction | 1999 |
Potentiation of the hypotensive effect of bradykinin by angiotensin-(1-7)-related peptides.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Drug Synergism; Infusions, Intravenous; Injections, Intravenous; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Wakefulness | 1999 |
Haemorrhage increases the pressor effect of angiotensin-(1-7) but not of angiotensin II at the rat rostral ventrolateral medulla.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Heart Rate; Hemorrhage; Male; Peptide Fragments; Pressoreceptors; Rats; Rats, Wistar; Sympathetic Nervous System | 1999 |
State-of-the-Art lecture. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle.
Topics: Angiotensin I; Angiotensin II; Animals; Cardiovascular Diseases; Cell Division; Humans; Muscle, Smooth, Vascular; Peptide Fragments | 1999 |
Cardiovascular effects of angiotensin-(1-7) in conscious spontaneously hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Drug Interactions; Hypertension; Infusions, Intravenous; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors | 1999 |
Angiotensin-(1-7) binds at the type 1 angiotensin II receptors in rat renal cortex.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Binding Sites; Imidazoles; Iodine Radioisotopes; Kidney Cortex; Losartan; Male; Peptide Fragments; Pyridines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Angiotensin | 1999 |
Synergistic effect of angiotensin-(1-7) on bradykinin arteriolar dilation in vivo.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arterioles; Bradykinin; Bradykinin Receptor Antagonists; Drug Synergism; Enalaprilat; Mesenteric Arteries; Nitric Oxide; Peptide Fragments; Prostaglandins; Rats; Rats, Wistar; Receptor, Bradykinin B2; Vasodilation; Vasodilator Agents | 1999 |
Angiotensin III depressor action in the conscious rabbit is blocked by losartan but not PD 123319.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Imidazoles; Losartan; Male; Peptide Fragments; Pyridines; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin | 2000 |
Release of angiotensin-(1-7) from the rat hindlimb: influence of angiotensin-converting enzyme inhibition.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Chromatography, High Pressure Liquid; Dipeptides; Hindlimb; Lisinopril; Male; Neprilysin; Peptide Fragments; Peptidyl-Dipeptidase A; Perfusion; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System | 2000 |
Opposing actions of angiotensins on angiogenesis.
Topics: Angiotensin I; Angiotensin II; Animals; Cell Division; Male; Mice; Neovascularization, Physiologic; Peptide Fragments; Wound Healing | 2000 |
Effect of intrarenal infusion of angiotensin-(1-7) in the dog.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Diuresis; Dogs; Female; Glomerular Filtration Rate; Imidazoles; Infusions, Intra-Arterial; Kidney; Losartan; Male; Peptide Fragments; Receptors, Angiotensin; Renal Artery; Renal Circulation; Tetrazoles; Urodynamics; Vasodilator Agents | 2000 |
Angiotensin-(1-7) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man.
Topics: Angiotensin I; Angiotensin II; Arteries; Drug Interactions; Forearm; Humans; Male; Norepinephrine; Peptide Fragments; Regional Blood Flow; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2000 |
Angiotensin-(1-7) potentiates the coronary vasodilatatory effect of bradykinin in the isolated rat heart.
Topics: Analysis of Variance; Angiotensin I; Animals; Bradykinin; Cardiovascular Agents; Coronary Vessels; Drug Synergism; Enzyme Inhibitors; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Rats; Rats, Wistar; Vasodilator Agents | 2000 |
Angiotensin-(1-7) reduces norepinephrine release through a nitric oxide mechanism in rat hypothalamus.
Topics: Angiotensin I; Angiotensin Receptor Antagonists; Animals; Bradykinin; Cyclooxygenase Inhibitors; Hypothalamus; Indomethacin; Male; Neurons; Nitric Oxide; Norepinephrine; Peptide Fragments; Potassium Chloride; Prostaglandins; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2 | 2000 |
Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system.
Topics: Angiotensin I; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Cyclooxygenase Inhibitors; Heart Rate; Lisinopril; Losartan; Male; Peptide Fragments; Prostaglandins; Rats; Rats, Inbred SHR; Receptors, Angiotensin; Renin-Angiotensin System | 2000 |
Metabolism alters the selectivity of angiotensin-(1-7) receptor ligands for angiotensin receptors.
Topics: Angiotensin I; Angiotensins; Animals; Binding, Competitive; Cattle; Cell Line; Kidney; Ligands; Peptide Fragments; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin | 2000 |
Angiotensin-(1-7) causes endothelium-dependent relaxation in canine middle cerebral artery.
Topics: Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin Receptor Antagonists; Cerebral Arteries; Cyclic GMP; Cyclooxygenase Inhibitors; Dogs; Endothelium, Vascular; In Vitro Techniques; Peptide Fragments | 2000 |
Angiotensin-(1-7) modulates the ouabain-insensitive Na+-ATPase activity from basolateral membrane of the proximal tubule.
Topics: Adenosine Triphosphatases; Angiotensin I; Animals; Cation Transport Proteins; Cell Membrane; Cells, Cultured; Enzyme Activation; Imidazoles; Kidney Tubules, Proximal; Natriuresis; Ouabain; Peptide Fragments; Pyridines; Receptors, Angiotensin; Sodium-Potassium-Exchanging ATPase; Swine | 2000 |
Angiotensin-(1-7) increases osmotic water permeability in isolated toad skin.
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Anura; Humans; Losartan; Oxytocin; Peptide Fragments; Permeability; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Skin; Skin Absorption; Vasoconstrictor Agents; Vasotocin; Water | 2000 |
The cardiovascular effects of angiotensin-(1-7) in the rostral and caudal ventrolateral medulla of the rabbit.
Topics: Adrenergic Fibers; Angiotensin I; Animals; Antihypertensive Agents; Blood Pressure; Female; Heart Rate; Male; Medulla Oblongata; Peptide Fragments; Rabbits; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin | 2000 |
Contribution of angiotensin-(1-7) to blood pressure regulation in salt-depleted hypertensive rats.
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Animals; Animals, Genetically Modified; Blood Pressure; Blood Pressure Determination; Diet, Sodium-Restricted; Dipeptides; Dose-Response Relationship, Drug; Hypertension; Male; Peptide Fragments; Protease Inhibitors; Rats; Rats, Inbred SHR; Renin | 2000 |
Angiotensin peptides acting at rostral ventrolateral medulla contribute to hypertension of TGR(mREN2)27 rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modified; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Heart Rate; Hypertension; Male; Medulla Oblongata; Microinjections; Peptide Fragments; Rats; Rats, Sprague-Dawley; Renin; Tetrazoles | 2000 |
Pathways for angiotensin-(1---7) metabolism in pulmonary and renal tissues.
Topics: Aminopeptidases; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Membrane; Chromatography, High Pressure Liquid; Hydrolysis; In Vitro Techniques; Kidney; Lung; Male; Microvilli; Neprilysin; Peptide Fragments; Peptidyl-Dipeptidase A; Protease Inhibitors; Rats | 2000 |
Effects of des-aspartate-angiotensin I on angiotensin II-induced incorporation of phenylalanine and thymidine in cultured rat cardiomyocytes and aortic smooth muscle cells.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Aorta, Thoracic; Cells, Cultured; DNA; Imidazoles; Indomethacin; Losartan; Muscle, Smooth, Vascular; Myocardium; Peptide Fragments; Phenylalanine; Protein Biosynthesis; Pyridines; Rats; Rats, Wistar; Receptors, Angiotensin; Thymidine | 2000 |
Angiotensin-(1-7) regulates the levels of angiotensin II receptor subtype AT1 mRNA differentially in a strain-specific fashion.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Aorta, Thoracic; Crosses, Genetic; Gene Expression Regulation; Male; Muscle, Smooth, Vascular; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Species Specificity; Transcription, Genetic | 2000 |
Angiotensin-(1-7) does not affect norepinephrine neuronal uptake or catabolism in rat hypothalamus and atria.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Biological Transport; Catechol O-Methyltransferase; Female; Heart Atria; Hypothalamus; Monoamine Oxidase; Myocardium; Neurons; Norepinephrine; Peptide Fragments; Rats; Rats, Wistar | 2000 |
Modulation of the baroreflex control of heart rate by angiotensin-(1-7) at the nucleus tractus solitarii of normotensive and spontaneously hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Animals; Baroreflex; Blood Pressure; Heart Rate; Hypertension; Male; Microinjections; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Wistar; Receptors, Angiotensin; Solitary Nucleus | 2000 |
Angiotensin-(1--7) in the ovine fetus.
Topics: Allantois; Amniotic Fluid; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Female; Fetal Blood; Fetus; Gene Expression Regulation, Developmental; Gestational Age; Glomerular Filtration Rate; Kidney; Mice; Peptide Fragments; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Sheep | 2001 |
Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arterioles; Bradykinin; Drug Synergism; Hypertension; Male; Mesenteric Arteries; Peptide Fragments; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vasodilation | 2001 |
Effects of angiotensin IV and angiotensin-(1-7) on basal and angiotensin II-stimulated cytosolic Ca2+ in mesangial cells.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Calcium; Cell Culture Techniques; Cytosol; Dose-Response Relationship, Drug; Glomerular Mesangium; Inositol Phosphates; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Vasoconstrictor Agents | 2001 |
Mechanisms of angiotensin-(1-7)-induced inhibition of angiogenesis.
Topics: Analysis of Variance; Angiogenesis Inhibitors; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Imidazoles; Losartan; Male; Mice; Neovascularization, Pathologic; Neovascularization, Physiologic; Peptide Fragments; Prostheses and Implants; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2 | 2001 |
Measurement of immunoreactive angiotensin-(1-7) heptapeptide in human blood.
Topics: Adult; Angiotensin I; Humans; Middle Aged; Peptide Fragments; Radioimmunoassay; Reference Values; Reproducibility of Results | 2001 |
Downregulation of the AT1A receptor by pharmacologic concentrations of Angiotensin-(1-7).
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Down-Regulation; Inositol Phosphates; Peptide Fragments; Radioligand Assay; Receptor, Angiotensin, Type 1; Receptors, Angiotensin | 2001 |
Sodium intake influences hemodynamic and neural responses to angiotensin receptor blockade in rostral ventrolateral medulla.
Topics: Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Baroreflex; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Heart Failure; Heart Rate; Hemodynamics; Kidney; Losartan; Male; Medulla Oblongata; Microinjections; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Sodium, Dietary; Sympathetic Nervous System; Tetrazoles | 2001 |
Angiotensin-(1-7) does not affect vasodilator or TPA responses to bradykinin in human forearm.
Topics: Adult; Angiotensin I; Antihypertensive Agents; Bradykinin; Drug Synergism; Female; Forearm; Humans; Male; Peptide Fragments; Regional Blood Flow; Statistics, Nonparametric; Tissue Plasminogen Activator; Vasodilation; Vasodilator Agents | 2001 |
Angiotensin-(1-7) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells.
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Binding, Competitive; Cells, Cultured; Down-Regulation; Imidazoles; Male; Muscle, Smooth, Vascular; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Regression Analysis; Tetrazoles; Type C Phospholipases | 2001 |
[Role of angiotensin-(1-7) in amino-acid-neurotransmitter-mediated blood pressure regulation in rat rostral ventrolateral medulla].
Topics: Amino Acids; Angiotensin I; Animals; Antihypertensive Agents; Blood Pressure; Male; Medulla Oblongata; Microinjections; Neurotransmitter Agents; Peptide Fragments; Rats; Rats, Wistar | 2001 |
Baroreflex improvement in shr after ace inhibition involves angiotensin-(1-7).
Topics: Analysis of Variance; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Baroreflex; Blood Pressure; Heart Rate; Injections, Intraventricular; Male; Peptide Fragments; Rats; Rats, Inbred SHR; Renin-Angiotensin System | 2001 |
The differential effect of angiotensin II and angiotensin 1-7 on norepinephrine, epinephrine, and dopamine concentrations in rat hypothalamus: the involvement of angiotensin receptors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Catecholamines; Dopamine; Epinephrine; Homovanillic Acid; Hydroxyindoleacetic Acid; Hypothalamus; Male; Neurons; Norepinephrine; Peptide Fragments; Rats; Rats, Wistar; Receptors, Angiotensin | 2001 |
Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade.
Topics: Adolescent; Adult; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Captopril; Coronary Vessels; Drug Synergism; Female; Humans; In Vitro Techniques; Isoquinolines; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Protein Structure, Tertiary; Receptor, Bradykinin B2; Receptors, Bradykinin; Swine; Tetrahydroisoquinolines; Vasodilation | 2001 |
Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion.
Topics: Angiotensin I; Angiotensin II; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bradykinin; Heart Ventricles; In Vitro Techniques; Indomethacin; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Peptide Fragments; Rats; Rats, Wistar | 2001 |
Autoradiographic analysis and regulation of angiotensin receptor subtypes AT(4), AT(1), and AT((1-7)) in the kidney.
Topics: Angiotensin I; Angiotensins; Animals; Autoradiography; Chickens; Female; Gerbillinae; Guinea Pigs; Iodine Radioisotopes; Isotope Labeling; Kidney; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Rabbits; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Songbirds; Species Specificity; Tissue Distribution; Turkeys | 2001 |
Angiotensin-(1-7) reverts the stimulatory effect of angiotensin II on the proximal tubule Na(+)-ATPase activity via a A779-sensitive receptor.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Cell Membrane; Dose-Response Relationship, Drug; Imidazoles; In Vitro Techniques; Kidney Tubules, Proximal; Losartan; Peptide Fragments; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Saralasin; Sodium-Potassium-Exchanging ATPase; Swine | 2002 |
Long-lasting cardiovascular effects of liposome-entrapped angiotensin-(1-7) at the rostral ventrolateral medulla.
Topics: Angiotensin I; Animals; Blood Pressure; Circadian Rhythm; Delayed-Action Preparations; Heart Rate; Liposomes; Male; Medulla Oblongata; Peptide Fragments; Rats; Rats, Wistar | 2001 |
Angiotensin peptides modulate bradykinin levels in the interstitium of the dog heart in vivo.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Bradykinin; Dogs; Heart; Hemodynamics; Imidazoles; Microdialysis; Myocardium; Peptide Fragments; Peptides; Pyridines | 2002 |
Effect of angiotensin-(1-7) on jejunal absorption of water in rats.
Topics: Angiotensin I; Angiotensin II; Animals; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Imidazoles; Indomethacin; Jejunum; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Prostaglandin-Endoperoxide Synthases; Protein Binding; Pyridines; Rats; Rats, Wistar; Time Factors; Water | 2002 |
1A-779 attenuates angiotensin-(1-7) depressor response in salt-induced hypertensive rats.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Body Weight; Cyclic GMP; Dinoprostone; Epoprostenol; Hypertension; Male; Nitric Oxide; Peptide Fragments; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Dahl; Rats, Inbred SHR; Salts; Thromboxane A2; Thromboxane B2; Time Factors | 2002 |
Angiotensin 1-7 increases quantal content and facilitation at the frog neuromuscular junction.
Topics: Acetylcholine; Angiotensin I; Animals; Antihypertensive Agents; Dose-Response Relationship, Drug; Evoked Potentials; In Vitro Techniques; Muscle, Skeletal; Neuromuscular Junction; Peptide Fragments; Rana catesbeiana | 2002 |
[Inhibition of PKC and ERK1/2 in cultured rat vascular smooth muscle cells by angiotensin-(1-7)].
Topics: Angiotensin I; Animals; Cell Division; Cells, Cultured; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Peptide Fragments; Protein Kinase C; Rats; Rats, Wistar | 2001 |
Enhancement of phosphatidylcholine biosynthesis by angiotensin-(1-7) in the rat renal cortex.
Topics: Angiotensin I; Angiotensin Receptor Antagonists; Animals; Kidney Cortex; Male; Peptide Fragments; Phosphatidylcholines; Phospholipids; Rats; Rats, Wistar; Signal Transduction | 2002 |
The antithrombotic effect of angiotensin-(1-7) closely resembles that of losartan.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Blood Pressure; Collagen; Fibrinolytic Agents; Hemostasis; Losartan; Male; Peptide Fragments; Platelet Adhesiveness; Rats; Rats, Inbred SHR; Rats, Wistar; Venous Thrombosis | 2000 |
Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensins; Female; Humans; Lactation; Menstrual Cycle; Peptide Fragments; Pregnancy; Vasoconstriction; Vasodilation | 2001 |
Formation of angiotensin-(1-7) from angiotensin II by the venom of Conus geographus.
Topics: Angiotensin I; Angiotensin II; Animals; CHO Cells; Cricetinae; Humans; omega-Conotoxin GVIA; Peptide Fragments; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tritium | 2002 |
Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles.
Topics: Afferent Pathways; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arterioles; Dose-Response Relationship, Drug; Imidazoles; In Vitro Techniques; Kidney Glomerulus; Male; Norepinephrine; Peptide Fragments; Pyridines; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2002 |
Does angiotensin-(1-7) contribute to cardiac adaptation and preservation of endothelial function in heart failure?
Topics: Adaptation, Physiological; Angiotensin I; Animals; Endothelium, Vascular; Heart; Heart Failure; Myocardial Infarction; Peptide Fragments; Rats; Rats, Inbred Lew; Renin-Angiotensin System | 2002 |
Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats.
Topics: Angiotensin I; Animals; Aorta; Coronary Circulation; Culture Techniques; Endothelium, Vascular; Heart Failure; Hemodynamics; Infusions, Intravenous; Male; Myocardial Infarction; Peptide Fragments; Rats; Rats, Sprague-Dawley; Vasodilation | 2002 |
Angiotensin-(1-7) is involved in the endothelium-dependent modulation of phenylephrine-induced contraction in the aorta of mRen-2 transgenic rats.
Topics: Analysis of Variance; Angiotensin I; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modified; Antihypertensive Agents; Aorta; Bradykinin Receptor Antagonists; Captopril; Drug Interactions; Endothelium, Vascular; In Vitro Techniques; Male; Mice; Peptide Fragments; Phenylephrine; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Adrenergic, alpha; Receptors, Angiotensin; Receptors, Bradykinin; Vasoconstriction | 2002 |
Accelerated recovery from irradiation injury by angiotensin peptides.
Topics: Angiotensin I; Angiotensin II; Animals; Bone Marrow Cells; Colony-Forming Units Assay; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Leukocyte Count; Lymphocyte Count; Megakaryocytes; Mice; Mice, Inbred C57BL; Peptide Fragments; Peptides; Platelet Count; Radiation Injuries, Experimental; Recombinant Proteins; Stem Cells | 2002 |
Effects of angiotensins on day-night fluctuations and stress-induced changes in blood pressure.
Topics: Angiotensin I; Angiotensin II; Animals; Autonomic Nervous System; Blood Pressure; Circadian Rhythm; Drug Administration Schedule; Heart Rate; Injections, Subcutaneous; Male; Peptide Fragments; Rats; Rats, Wistar; Restraint, Physical; Stress, Physiological; Telemetry | 2002 |
Differential effects of angiotensin II and angiotensin-(1-7) at the nucleus tractus solitarii of transgenic rats with low brain angiotensinogen.
Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Baroreflex; Blood Pressure; Brain; Cardiovascular System; Heart Rate; Male; Medulla Oblongata; Microinjections; Peptide Fragments; Rats; Rats, Sprague-Dawley; Reference Values; Solitary Nucleus | 2002 |
Renal microvascular actions of angiotensin II fragments.
Topics: Angiotensin I; Angiotensin II; Animals; Hydronephrosis; In Vitro Techniques; Male; Microcirculation; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renal Circulation; Vasoconstrictor Agents; Vasodilation | 2002 |
L-158,809 and (D-Ala(7))-angiotensin I/II (1-7) decrease PAI-1 release from human umbilical vein endothelial cells.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Dose-Response Relationship, Drug; Endothelium, Vascular; Fibrinolytic Agents; Humans; Imidazoles; Peptide Fragments; Plasminogen Activator Inhibitor 1; Tetrazoles; Tissue Plasminogen Activator; Umbilical Veins | 2002 |
Metabolism of angiotensin I in the coronary circulation of normal and diabetic rats.
Topics: Angiotensin I; Animals; Chromatography, High Pressure Liquid; Coronary Circulation; Diabetes Mellitus, Experimental; Heart; Male; Peptide Fragments; Perfusion; Rats; Rats, Sprague-Dawley | 2002 |
Vasodilator effect of angiotensin-(1-7) in mature and sponge-induced neovasculature.
Topics: Angiotensin I; Angiotensin Receptor Antagonists; Animals; Blood Flow Velocity; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluorescein; Male; Mice; Neovascularization, Physiologic; Peptide Fragments; Skin; Surgical Sponges; Tissue Distribution; Vasodilation; Vasodilator Agents; Vasomotor System | 2002 |
Angiotensin-(1-7) and bradykinin interaction in diabetes mellitus: in vivo study.
Topics: Angiotensin I; Animals; Blood Glucose; Bradykinin; Diabetes Mellitus; Enalapril; Insulin; Male; Mesenteric Arteries; Peptide Fragments; Rats; Rats, Wistar | 2002 |
Angiotensin-(1-7) improves the post-ischemic function in isolated perfused rat hearts.
Topics: Analysis of Variance; Angiotensin I; Animals; Antihypertensive Agents; Blood Pressure; Heart Rate; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Peptide Fragments; Rats; Rats, Wistar | 2002 |
Vasopeptidase inhibition and Ang-(1-7) in the spontaneously hypertensive rat.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Male; Peptide Fragments; Pyridines; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Thiazepines | 2002 |
Hypotensive effect of ANG II and ANG-(1-7) at the caudal ventrolateral medulla involves different mechanisms.
Topics: Adrenergic Antagonists; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Cardiac Output; Cholinergic Antagonists; Depression, Chemical; Heart Rate; Male; Medulla Oblongata; Microinjections; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Peptide Fragments; Rats; Rats, Wistar; Renin-Angiotensin System | 2002 |
Angiotensin-(1-7) inhibits angiotensin II-induced signal transduction.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Enzyme Activation; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Peptide Fragments; Rats; Rats, Wistar; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction | 2002 |
Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7).
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Epoprostenol; Fibrinolytic Agents; Hypertension, Renal; Imidazoles; Infusions, Intravenous; Losartan; Male; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Venous Thrombosis | 2002 |
Intrarenal infusion of angiotensin-(1-7) modulates renal functional responses to exogenous angiotensin II in the rat.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Glomerular Filtration Rate; Imidazoles; In Vitro Techniques; Kidney; Kidney Function Tests; Male; Organ Size; Peptide Fragments; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Renal Circulation; Sodium; Urodynamics | 2002 |
Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Heart Failure; Humans; Myocardial Infarction; Peptide Fragments; Rats; Vasodilation | 2002 |
Angiotensin-(1-7) in normal and preeclamptic pregnancy.
Topics: Adult; Angiotensin I; Angiotensin II; Female; Hormones; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Pre-Eclampsia; Pregnancy; Pregnancy Trimester, Third; Reference Values; Renin | 2002 |
AVE 0991, a nonpeptide mimic of the effects of angiotensin-(1-7) on the endothelium.
Topics: Angiotensin I; Animals; Binding, Competitive; Cattle; Cells, Cultured; Cricetinae; Electrochemistry; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Humans; Imidazoles; Losartan; Molecular Mimicry; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Peptide Fragments; Pyridines; Radioligand Assay; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Substrate Specificity; Superoxides; Tetrazoles | 2002 |
Angiotensin-(1-7) reduces renal angiotensin II receptors through a cyclooxygenase-dependent mechanism.
Topics: Angiotensin I; Angiotensin Receptor Antagonists; Animals; Dose-Response Relationship, Drug; Kidney; Male; Peptide Fragments; Prostaglandin-Endoperoxide Synthases; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin | 2003 |
Bradykinin counteracts the stimulatory effect of angiotensin-(1-7) on the proximal tubule Na+ -ATPase activity through B2 receptor.
Topics: Adenosine Triphosphatases; Angiotensin I; Animals; Bradykinin; Bradykinin B2 Receptor Antagonists; Cation Transport Proteins; Kidney Tubules, Proximal; Peptide Fragments; Receptor, Bradykinin B2; Swine | 2003 |
Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Cardiac Output; Hemodynamics; Male; Peptide Fragments; Rats; Rats, Wistar; Regional Blood Flow; Vascular Resistance; Vasodilator Agents | 2003 |
Acceleration of healing, reduction of fibrotic scar, and normalization of tissue architecture by an angiotensin analogue, NorLeu3-A(1-7).
Topics: Angiotensin I; Angiotensin II; Animals; Cicatrix; Female; Mice; Mice, Inbred NOD; Peptide Fragments; Rats; Rats, Sprague-Dawley; Time Factors; Wound Healing | 2003 |
Characterization of a new selective antagonist for angiotensin-(1-7), D-pro7-angiotensin-(1-7).
Topics: Angiotensin I; Angiotensin II; Animals; Aorta; Culture Techniques; Male; Peptide Fragments; Rats; Rats, Wistar; Renal Agents; Vasodilation | 2003 |
Effect of angiotensin II and angiotensin(1-7) on hematopoietic recovery after intravenous chemotherapy.
Topics: Angiotensin I; Angiotensin II; Animals; Antineoplastic Agents; Blood Platelets; Cyclophosphamide; Female; Fluorouracil; Hematopoiesis; Hematopoietic Stem Cells; Leukocytes; Mice; Peptide Fragments | 2003 |
Angiotensin-(1-7): a novel peptide in the ovary.
Topics: Angiotensin I; Angiotensin II; Animals; Chorionic Gonadotropin; Estrus; Female; Horses; In Vitro Techniques; Osmolar Concentration; Ovary; Peptide Fragments; Proestrus; Rats; Rats, Wistar | 2003 |
Characterization of angiotensin-(1-7) receptor subtype in mesenteric arteries.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Endothelin-1; Male; Mesenteric Arteries; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Vasodilation | 2003 |
Biphasic effects of angiotensin (1-7) and its interactions with angiotensin II in rat aorta.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Aorta, Thoracic; Drug Interactions; Imidazoles; In Vitro Techniques; Losartan; Male; Peptide Fragments; Pyridines; Rats; Rats, Wistar; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2003 |
14C-labeled and large-scale synthesis of the angiotensin-(1-7)-receptor agonist AVE 0991 by cross-coupling reactions.
Topics: Angiotensin I; Carbon Radioisotopes; Catalysis; Combinatorial Chemistry Techniques; Imidazoles; Isotope Labeling; Molecular Structure; Peptide Fragments; Receptors, Angiotensin; Thiophenes | 2003 |
Effects of angiotensin-(1-7) and other bioactive components of the renin-angiotensin system on vascular resistance and noradrenaline release in rat kidney.
Topics: Aminopeptidases; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin III; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Kidney; Male; Norepinephrine; Peptide Fragments; Rats; Rats, Inbred WKY; Renin-Angiotensin System; Synaptic Transmission; Vascular Resistance; Vasoconstrictor Agents | 2003 |
Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas.
Topics: Angiotensin I; Animals; Aorta; Arachidonic Acid; Chlorocebus aethiops; CHO Cells; COS Cells; Cricetinae; Cricetulus; Diuresis; Kidney; Ligands; Mice; Mice, Knockout; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Recombinant Fusion Proteins; Transfection; Vasodilation | 2003 |
Pregnancy enhances the angiotensin (Ang)-(1-7) vasodilator response in mesenteric arteries and increases the renal concentration and urinary excretion of Ang-(1-7).
Topics: Angiotensin I; Animals; Female; Kidney; Mesenteric Arteries; Peptide Fragments; Pregnancy; Pregnancy, Animal; Rats; Rats, Sprague-Dawley; Vasodilation | 2003 |
Effects of different angiotensins during acute, double blockade of the renin system in conscious dogs.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Angiotensin III; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Consciousness; Diuresis; Dogs; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Natriuresis; Peptide Fragments; Renin; Renin-Angiotensin System; Vasoconstrictor Agents; Vasopressins | 2003 |
Enhanced renal immunocytochemical expression of ANG-(1-7) and ACE2 during pregnancy.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Carboxypeptidases; Female; Immunohistochemistry; Kidney; Peptide Fragments; Peptidyl-Dipeptidase A; Pregnancy; Pregnancy, Animal; Rats; Rats, Sprague-Dawley | 2003 |
Effects of electroacupuncture on pressor response to angiotensin-(1-7) by amino acid release in the rostral ventrolateral medulla.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Blood Pressure; Brain Chemistry; Electroacupuncture; Excitatory Amino Acids; Heart Rate; Hypertension; Injections, Intraventricular; Male; Medulla Oblongata; Microdialysis; Microinjections; Neurotransmitter Agents; Peptide Fragments; Rats; Rats, Wistar; Transfer RNA Aminoacylation | 2003 |
Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7).
Topics: Angiotensin I; Angiotensin II; Animals; Cell Division; Cells, Cultured; Cyclic AMP; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Peptide Fragments; Prostaglandins; Rats; Rats, Sprague-Dawley | 2003 |
Levels of plasma angiotensin-(1-7) in patients with hypertension who have the angiotensin-I-converting enzyme deletion/deletion genotype.
Topics: Adult; Angiotensin I; Angiotensin II; Antihypertensive Agents; Female; Gene Deletion; Genetic Predisposition to Disease; Genotype; Humans; Hypertension; Male; Middle Aged; Peptide Fragments; Peptidyl-Dipeptidase A; Vasoconstrictor Agents | 2003 |
Angiotensin-(1-7) formation in the intact human heart: in vivo dependence on angiotensin II as substrate.
Topics: Adult; Angiotensin I; Angiotensin II; Coronary Vessels; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Peptide Fragments | 2003 |
Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Carboxypeptidases; Cardiac Output, Low; Female; Heart Ventricles; Humans; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Up-Regulation | 2003 |
Cardiac angiotensin-(1-7) in ischemic cardiomyopathy.
Topics: Angiotensin I; Animals; Cardiomyopathies; Disease Models, Animal; Hemodynamics; Immunohistochemistry; Ligation; Male; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Peptide Fragments; Rats; Rats, Inbred Lew | 2003 |
Angiotensin-(1-7) stimulates water transport in rat inner medullary collecting duct: evidence for involvement of vasopressin V2 receptors.
Topics: Angiotensin I; Angiotensin II; Animals; Antidiuretic Hormone Receptor Antagonists; Biological Transport; Colforsin; Cyclic AMP; Kidney Tubules, Collecting; Osmosis; Peptide Fragments; Permeability; Protein Isoforms; Rats; Receptors, Vasopressin; Signal Transduction; Water | 2003 |
Hypotensive function of the brain angiotensin-(1-7) in Sprague Dawley and renin transgenic rats.
Topics: Adaptation, Physiological; Angiotensin I; Angiotensin II; Animals; Animals, Genetically Modified; Blood Pressure; Cerebral Ventricles; Cerebrospinal Fluid; Heart Rate; Hemorrhage; Hypertension; Hypotension; Hypothalamus; Injections, Intraventricular; Peptide Fragments; Rats; Rats, Sprague-Dawley; Renin; Shock, Hemorrhagic; Species Specificity | 2003 |
Synergistic effects of co-administration of angiotensin 1-7 and Neupogen on hematopoietic recovery in mice.
Topics: Angiotensin I; Animals; Blood Platelets; Bone Marrow; Drug Synergism; Female; Filgrastim; Flow Cytometry; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cells; Immunosuppressive Agents; Leukocyte Count; Leukocytes; Mice; Mice, Inbred C57BL; Peptide Fragments; Platelet Count; Recombinant Proteins | 2004 |
The role of Ang (1-7) in mediating the chronic hypotensive effects of losartan in normal rats.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Chronic Disease; Drug Interactions; Heart Rate; Hypotension; Losartan; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley | 2003 |
Localization of carboxypeptidase A-like enzyme in rat kidney.
Topics: Angiotensin I; Angiotensin II; Animals; Carboxypeptidases A; Kidney; Peptide Fragments; Peptides; Rats | 2003 |
PLA2/PGE2 are involved in the inhibitory effect of bradykinin on the angiotensin-(1-7)-stimulated Na(+)-ATPase activity of the proximal tubule.
Topics: Angiotensin I; Animals; Bradykinin; Bradykinin B2 Receptor Antagonists; Cell Membrane; Cyclooxygenase Inhibitors; Diclofenac; Dinoprostone; Dose-Response Relationship, Drug; Indomethacin; Kidney Tubules, Proximal; Peptide Fragments; Phospholipases A; Phospholipases A2; Quinacrine; Receptor, Bradykinin B2; Sodium-Potassium-Exchanging ATPase; Swine | 2004 |
Angiotensin-(1-7) modulates vascular resistance and sympathetic neurotransmission in kidneys of spontaneously hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Dose-Response Relationship, Drug; Electric Stimulation; Hypertension; Kidney; Male; Norepinephrine; Organ Culture Techniques; Peptide Fragments; Perfusion; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Stimulation, Chemical; Sympathetic Nervous System; Vascular Resistance | 2004 |
The role of bradykinin, AT2 and angiotensin 1-7 receptors in the EDRF-dependent vasodilator effect of angiotensin II on the isolated mesenteric vascular bed of the rat.
Topics: Angiotensin I; Angiotensin II; Animals; Bradykinin; Endothelium-Dependent Relaxing Factors; In Vitro Techniques; Male; Mesenteric Arteries; Mesenteric Veins; Peptide Fragments; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Vasodilation | 2004 |
Angiotensin-(1-7) inhibits the angiotensin II-enhanced norepinephrine release in coarcted hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Aortic Coarctation; Bradykinin; Hypertension; Hypothalamus; Imidazoles; In Vitro Techniques; Nitric Oxide; Norepinephrine; Peptide Fragments; Potassium; Pyridines; Rats; Rats, Wistar | 2004 |
Site-specific microinjection of liposomes into the brain for local infusion of a short-lived peptide.
Topics: Angiotensin I; Animals; Blood Pressure; Brain; Drug Carriers; Heart Rate; Liposomes; Male; Membrane Fluidity; Membranes; Microinjections; Peptide Fragments; Peptides; Pharmaceutical Vehicles; Polyethylene Glycols; Rats; Rats, Wistar; Surface Properties | 2004 |
Depletion of tissue angiotensin-converting enzyme differentially influences the intrarenal and urinary expression of angiotensin peptides.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Carboxypeptidases; Diuresis; Gene Expression Regulation; Hypotension; Kidney; Mice; Mice, Knockout; Organ Specificity; Peptide Fragments; Peptidyl-Dipeptidase A; Polyuria; Renin-Angiotensin System; RNA, Messenger | 2004 |
Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Carboxypeptidases; Cardiomyopathy, Hypertrophic; Coronary Vessels; Disease Models, Animal; Enzyme Induction; Imidazoles; Ligation; Losartan; Male; Myocardial Infarction; Myocardium; Olmesartan Medoxomil; Peptide Fragments; Peptidyl-Dipeptidase A; Pyridines; Rats; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Ventricular Remodeling | 2004 |
Angiotensin type-1 receptor blockade increases ACE 2 expression in the heart.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Carboxypeptidases; Down-Regulation; Enzyme Induction; Heart; Humans; Imidazoles; Losartan; Mice; Myocardial Infarction; Myocardium; Olmesartan Medoxomil; Peptide Fragments; Peptidyl-Dipeptidase A; Pyridines; Rats; Rats, Inbred Lew; Tetrazoles | 2004 |
Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats.
Topics: Angiotensin I; Animals; Animals, Genetically Modified; Arrhythmias, Cardiac; Cardiomegaly; Cardiotonic Agents; Gene Expression; Heart Rate; Male; Myocardial Contraction; Organ Culture Techniques; Peptide Fragments; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins; RNA, Messenger; Testis | 2004 |
Angiotensin-(1-7) antagonist A-779 attenuates the potentiation of bradykinin by captopril in rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bradykinin; Captopril; Drug Synergism; Hypertension; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Peptide Fragments; Rats; Rats, Wistar | 2004 |
Angiotensin II stimulates nitric oxide production in pulmonary artery endothelium via the type 2 receptor.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Cattle; Cells, Cultured; Dithiothreitol; Dose-Response Relationship, Drug; Endothelium, Vascular; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Peptide Fragments; Pulmonary Artery; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction; Vasoconstriction; Vasoconstrictor Agents | 2004 |
Angiotensin II and angiotensin-(1-7) inhibit the inner cortex Na+ -ATPase activity through AT2 receptor.
Topics: Adjuvants, Immunologic; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Antihypertensive Agents; Cholera Toxin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; GTP-Binding Proteins; Guanosine Diphosphate; Guanosine Triphosphate; Imidazoles; Kidney Cortex; Losartan; Peptide Fragments; Pertussis Toxin; Pyridines; Receptor, Angiotensin, Type 2; Sodium-Potassium-Exchanging ATPase; Swine; Vasoconstrictor Agents | 2004 |
The renin angiotensin system in childhood hypertension: selective increase of angiotensin-(1-7) in essential hypertension.
Topics: Adolescent; Angiotensin I; Angiotensin II; Calcium Channel Blockers; Case-Control Studies; Child; Child, Preschool; Female; Humans; Hypertension; Male; Peptide Fragments; Renin; Renin-Angiotensin System | 2004 |
Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Binding Sites; Carboxypeptidases; CHO Cells; Cricetinae; Cricetulus; Humans; Hydrolysis; Kinetics; Neprilysin; Peptide Fragments; Peptidyl-Dipeptidase A; Substrate Specificity | 2004 |
Inhibition of human lung cancer cell growth by angiotensin-(1-7).
Topics: Angiotensin I; Antineoplastic Agents; Cell Division; Cell Line, Tumor; Culture Media; DNA Replication; Humans; Kinetics; Lung Neoplasms; Mitogen-Activated Protein Kinase 3; Peptide Fragments | 2004 |
Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney.
Topics: Angiotensin I; Animals; Blood Pressure; Chlorocebus aethiops; CHO Cells; COS Cells; Cricetinae; Diuresis; Imidazoles; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, Angiotensin; Receptors, G-Protein-Coupled; Transfection | 2004 |
Vascular responses to Angiotensin-(1-7) during the estrous cycle.
Topics: Angiotensin I; Animals; Diestrus; Dose-Response Relationship, Drug; Endothelin-1; Estradiol; Estrous Cycle; Female; Mesenteric Arteries; Ovariectomy; Peptide Fragments; Placebos; Proestrus; Rats; Rats, Sprague-Dawley; Vasodilation | 2004 |
Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Carboxypeptidases; Cardiac Output, Low; Case-Control Studies; Coronary Circulation; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Peptide Fragments; Peptidyl-Dipeptidase A | 2004 |
Angiotensin-(1-7) inhibitory mechanism of norepinephrine release in hypertensive rats.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Cyclic GMP-Dependent Protein Kinases; Hypertension; Hypothalamus; Nitric Oxide; Norepinephrine; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Wistar; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Sympathetic Nervous System | 2004 |
The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Kidney Tubules, Proximal; Male; Mass Spectrometry; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; RNA, Messenger | 2005 |
Angiotensin-(1-7) attenuates neointimal formation after stent implantation in the rat.
Topics: Angiotensin I; Animals; Aorta, Abdominal; Aorta, Thoracic; Hypertrophy; Infusion Pumps, Implantable; Infusions, Intravenous; Male; Methacholine Chloride; Peptide Fragments; Phenylephrine; Rats; Rats, Wistar; Sodium Nitrite; Stents; Tunica Intima; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2005 |
Chronic infusion of angiotensin-(1-7) reduces heart angiotensin II levels in rats.
Topics: Angiotensin I; Angiotensin II; Animals; Calcium; DNA Primers; Male; Myocardium; Peptide Fragments; Peptides; Polymerase Chain Reaction; Protein Structure, Tertiary; Radioimmunoassay; Rats; Rats, Wistar; Renin-Angiotensin System; RNA, Messenger; Time Factors | 2005 |
Low sodium diet inhibits the local counter-regulator effect of angiotensin-(1-7) on angiotensin II.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Diet, Sodium-Restricted; Endothelium, Vascular; In Vitro Techniques; Male; Peptide Fragments; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Vasoconstriction | 2004 |
Comparative studies of vasodilating effects of angiotensin-(1-7) on the different vessels.
Topics: Angiotensin I; Animals; Endothelium, Vascular; Female; Male; Nitric Oxide; Peptide Fragments; Rabbits; Receptor, Angiotensin, Type 1; Vasodilator Agents | 2004 |
Angiotensin-(1-7) and bradykinin in norepinephrine release in the central nervous system of hypertension.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Bradykinin; Hypertension; Hypothalamus; Norepinephrine; Peptide Fragments; Rats; Vasoconstrictor Agents | 2005 |
Pharmacological concentration of angiotensin-(1-7) activates NADPH oxidase after ischemia-reperfusion in rat heart through AT1 receptor stimulation.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Dose-Response Relationship, Drug; Enzyme Activation; Heart; In Vitro Techniques; Losartan; Male; Myocardial Ischemia; Myocardium; NADPH Oxidases; Peptide Fragments; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Reperfusion | 2005 |
Role of PGI2 and effects of ACE inhibition on the bradykinin potentiation by angiotensin-(1-7) in resistance vessels of SHR.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arterioles; Blood Pressure; Bradykinin; Enalaprilat; Epoprostenol; Male; Mesentery; Peptide Fragments; Rats; Rats, Inbred SHR | 2005 |
Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Drug Combinations; Imidazoles; Male; Peptide Fragments; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 2; Tetrazoles; Vasoconstrictor Agents | 2005 |
Effects of angiotensin-(1-7) blockade on renal function in rats with enhanced intrarenal Ang II activity.
Topics: Angiotensin I; Angiotensin II; Animals; Animals, Genetically Modified; Diuresis; Glomerular Filtration Rate; Kidney; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System | 2005 |
Angiotensin (1-7) re-establishes impulse conduction in cardiac muscle during ischaemia-reperfusion. The role of the sodium pump.
Topics: Angiotensin I; Animals; Electric Conductivity; Female; In Vitro Techniques; Membrane Potentials; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocytes, Cardiac; Neural Conduction; Papillary Muscles; Patch-Clamp Techniques; Peptide Fragments; Rats; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Sodium-Potassium-Exchanging ATPase | 2004 |
Cardiovascular effects of angiotensin II and angiotensin-(1-7) at the RVLM of trained normotensive rats.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Heart Rate; Male; Medulla Oblongata; Microinjections; Peptide Fragments; Physical Conditioning, Animal; Rats; Rats, Wistar | 2005 |
Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Aorta, Thoracic; Atenolol; Carboxypeptidases; Carotid Arteries; Gene Expression Regulation, Enzymologic; Hydralazine; Hypertension; Imidazoles; Male; Olmesartan Medoxomil; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; RNA, Messenger; Tetrazoles; Vasodilator Agents | 2005 |
Parallel ion parking: improving conversion of parents to first-generation products in electron transfer dissociation.
Topics: Angiotensin I; Anions; Electron Transport; Ions; Nitrobenzenes; Peptide Fragments; Peptides; Protons; Sequence Analysis, Protein; Tandem Mass Spectrometry | 2005 |
Chronic administration of angiotensin-(1-7) attenuates pressure-overload left ventricular hypertrophy and fibrosis in rats.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Aortic Coarctation; Blood Pressure; Fibrosis; Hypertrophy, Left Ventricular; Male; Myocardium; Peptide Fragments; Random Allocation; Rats; Rats, Sprague-Dawley; Ventricular Function, Left | 2005 |
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Carboxypeptidases; Gene Expression Regulation; Lisinopril; Losartan; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Lew; RNA, Messenger | 2005 |
Amino acids modulate the hypotensive effect of angiotensin-(1-7) at the caudal ventrolateral medulla in rats.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Blood Pressure; Excitatory Amino Acid Antagonists; Glutamic Acid; Hypotension; Male; Medulla Oblongata; Microinjections; Peptide Fragments; Rats; Rats, Wistar; Receptors, Glutamate; Taurine | 2005 |
Modulation of the (Na(+)+K+)ATPase activity by Angiotensin-(1-7) in MDCK cells.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Cell Line; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Kidney Tubules, Distal; Peptide Fragments; Signal Transduction; Sodium-Potassium-Exchanging ATPase | 2005 |
Angiotensin-(1-7) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Animals; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Hippocampus; Learning; Long-Term Potentiation; Male; Memory; Mice; Mice, Knockout; Neurons; Organ Culture Techniques; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Up-Regulation | 2005 |
Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor.
Topics: Angiotensin I; Animals; Animals, Newborn; Antihypertensive Agents; Cell Division; Cells, Cultured; MAP Kinase Signaling System; Myocytes, Cardiac; Oligonucleotides, Antisense; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; RNA, Messenger; Ventricular Remodeling | 2005 |
[Angiotensin-(1-7) modulates fibrinolytic imbalance induced by oxidized low-density lipoprotein in cultured human umbilical vein endothelial cells].
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Cells, Cultured; Endothelium, Vascular; Humans; Lipoproteins, LDL; Peptide Fragments; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator; Umbilical Veins | 2005 |
Impaired heart rate baroreflex in older rats: role of endogenous angiotensin-(1-7) at the nucleus tractus solitarii.
Topics: Aging; Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Animals; Baroreflex; Benzimidazoles; Biphenyl Compounds; Heart Rate; Injections; Male; Neprilysin; Peptide Fragments; Rats; Rats, Sprague-Dawley; RNA, Messenger; Solitary Nucleus; Tetrazoles | 2005 |
Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects.
Topics: Angiotensin I; Animals; Binding Sites; Calcium; Cells, Cultured; Collagen; Dose-Response Relationship, Drug; Fibroblasts; Fibrosis; Growth Substances; Heart Ventricles; Male; Peptide Fragments; Protein Binding; Rats; Rats, Sprague-Dawley | 2005 |
Blockade of endogenous angiotensin-(1-7) in the hypothalamic paraventricular nucleus reduces renal sympathetic tone.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Dose-Response Relationship, Drug; Imidazoles; Kidney; Microinjections; Muscimol; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sympathetic Nervous System | 2005 |
Short-term angiotensin(1-7) receptor MAS stimulation improves endothelial function in normotensive rats.
Topics: Acetylcholine; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Dose-Response Relationship, Drug; Drug Synergism; Endothelium, Vascular; Enzyme Inhibitors; Hypotension; Imidazoles; Injections, Intravenous; Male; NG-Nitroarginine Methyl Ester; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Reference Values; Vasodilator Agents | 2005 |
In vivo characterization of the angiotensin-(1-7)-induced dopamine and gamma-aminobutyric acid release in the striatum of the rat.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Chromatography; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; gamma-Aminobutyric Acid; Imidazoles; Male; Microdialysis; NG-Nitroarginine Methyl Ester; Peptide Fragments; Pyridines; Rats; Rats, Wistar; Sulfonic Acids; Tetrazoles; Time Factors | 2005 |
The endothelium-dependent vasodilator effect of the nonpeptide Ang(1-7) mimic AVE 0991 is abolished in the aorta of mas-knockout mice.
Topics: Angiotensin I; Angiotensin II; Animals; Aorta, Thoracic; Endothelium, Vascular; Enzyme Inhibitors; Imidazoles; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Oligopeptides; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Vasoconstrictor Agents; Vasodilator Agents | 2005 |
Evidence for a functional interaction of the angiotensin-(1-7) receptor Mas with AT1 and AT2 receptors in the mouse heart.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Drug Synergism; Enzyme Inhibitors; Imidazoles; In Vitro Techniques; Indomethacin; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; NG-Nitroarginine Methyl Ester; Peptide Fragments; Perfusion; Pressure; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Vasoconstrictor Agents | 2005 |
Angiotensin-(1-7) enhances anti-aggregatory effects of the nitric oxide donor sodium nitroprusside.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Aged; Angiotensin I; Angiotensin II; Antihypertensive Agents; Coronary Disease; Drug Synergism; Female; Humans; Male; Myocardial Infarction; Nitric Oxide Donors; Nitroprusside; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Vasoconstrictor Agents | 2005 |
Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Aorta, Thoracic; Carboxypeptidases; Cell Hypoxia; Cells, Cultured; Chronic Disease; Disease Models, Animal; Female; Hepatitis C, Chronic; Hepatocytes; Humans; Immunoenzyme Techniques; Liver; Liver Cirrhosis; Male; Nitroimidazoles; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation; Vasodilation | 2005 |
Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Astrocytes; Carboxypeptidases; Cells, Cultured; Cerebellum; Female; Gene Expression Regulation; Imidazoles; Losartan; Medulla Oblongata; Peptide Fragments; Peptidyl-Dipeptidase A; Pregnancy; Pyridines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tetrazoles; Valine; Valsartan; Vasoconstrictor Agents | 2006 |
Alterations in aortic vascular reactivity to angiotensin 1-7 in 17-beta-estradiol-treated female SD rats.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Aorta; Estradiol; Female; Muscle, Smooth, Vascular; Peptide Fragments; Pregnancy; Rats; Rats, Sprague-Dawley | 2006 |
Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Carboxypeptidases; Gene Expression Regulation, Enzymologic; Hypertension, Renal; Kidney; Lisinopril; Losartan; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Lew; Receptors, Angiotensin; Renin-Angiotensin System | 2005 |
Effect of hypertension on angiotensin-(1-7) levels in rats with different angiotensin-I converting enzyme polymorphism.
Topics: Angiotensin I; Angiotensin II; Animals; Female; Genotype; Hypertension; Hypertrophy, Left Ventricular; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Rats; Rats, Inbred Lew; Rats, Mutant Strains | 2006 |
Baroreflex modulation by angiotensins at the rat rostral and caudal ventrolateral medulla.
Topics: Angiotensin I; Angiotensin II; Animals; Baroreflex; Blood Pressure; Heart Rate; Male; Medulla Oblongata; Microinjections; Models, Biological; Nitric Oxide Synthase Type I; Peptide Fragments; Rats; Rats, Wistar; Renin-Angiotensin System; Sympathetic Nervous System | 2006 |
Angiotensin 1-7 and risk for breast cancer recurrence.
Topics: Angiotensin I; Breast Neoplasms; Cell Division; Peptide Fragments; Recurrence; Risk Factors | 2006 |
Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Carboxypeptidases; Cardiovascular Physiological Phenomena; Peptide Fragments; Peptidyl-Dipeptidase A; Renin | 2006 |
Megalin binds and internalizes angiotensin-(1-7).
Topics: Angiotensin I; Antihypertensive Agents; Cell Culture Techniques; Epithelium; Flow Cytometry; Humans; Kidney; Low Density Lipoprotein Receptor-Related Protein-2; Peptide Fragments; Renin-Angiotensin System; Yolk Sac | 2006 |
Involvement of the Gi/o/cGMP/PKG pathway in the AT2-mediated inhibition of outer cortex proximal tubule Na+-ATPase by Ang-(1-7).
Topics: Adenosine Triphosphatases; Angiotensin I; Angiotensin II Type 2 Receptor Blockers; Animals; Cation Transport Proteins; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; GTP-Binding Protein alpha Subunits, Gi-Go; Kidney Cortex; Kidney Tubules, Proximal; Peptide Fragments; Receptor, Angiotensin, Type 2; Signal Transduction; Swine | 2006 |
Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Blood Pressure; Diuresis; Enzyme Inhibitors; Heart; Hypertension; Kidney; Male; Myocardial Ischemia; Myocardium; NG-Nitroarginine Methyl Ester; Peptide Fragments; Proteinuria; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Recovery of Function; Reperfusion Injury; Severity of Illness Index; Vasomotor System | 2006 |
Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension.
Topics: Angiotensin I; Animals; Blood Pressure; Cardiomegaly; Collagen; Coronary Vessels; Desoxycorticosterone; Dose-Response Relationship, Drug; Fibrosis; Heart Diseases; Hypertension; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Ventricular Remodeling | 2006 |
Are multiple angiotensin receptor types involved in angiotensin (1-7) actions on isolated rat portal vein.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptide Fragments; Portal Vein; Rats; Receptors, Angiotensin | 2005 |
Does angiotensin (1-7) contribute to the anti-proteinuric effect of ACE-inhibitors.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antibiotics, Antineoplastic; Blood Pressure; Body Weight; Creatine; Creatinine; Doxorubicin; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Proteinuria; Rats; Rats, Wistar | 2005 |
Localized accumulation of angiotensin II and production of angiotensin-(1-7) in rat luteal cells and effects on steroidogenesis.
Topics: Angiotensin I; Angiotensin II; Animals; Cells, Cultured; Female; Luteal Cells; Peptide Fragments; Rats; Signal Transduction; Steroids; Subcellular Fractions; Tissue Distribution | 2006 |
Impairment of in vitro and in vivo heart function in angiotensin-(1-7) receptor MAS knockout mice.
Topics: Angiotensin I; Animals; Calcium Channels; Collagen; Coronary Vessels; Echocardiography; Electrophysiology; Heart; Heart Rate; In Vitro Techniques; Mice; Mice, Knockout; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Systole; Vascular Resistance; Ventricular Function | 2006 |
Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blotting, Western; Cells, Cultured; Cyclic AMP; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; JNK Mitogen-Activated Protein Kinases; Kidney Tubules, Proximal; Male; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2006 |
Hypothalamic cardiovascular effects of angiotensin-(1-7) in spontaneously hypertensive rats.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Blood Pressure; Cardiovascular System; Heart Rate; Hypothalamus; Male; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2006 |
ACE and ACE2: their role to balance the expression of angiotensin II and angiotensin-(1-7).
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Hypertension; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Strains | 2006 |
Renal function in transgenic rats expressing an angiotensin-(1-7)-producing fusion protein.
Topics: Angiotensin I; Animals; Animals, Genetically Modified; Diuresis; Homeostasis; Kidney; Male; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Vasopressin; Recombinant Fusion Proteins; RNA, Messenger; Vasopressins | 2006 |
Validation of in-vitro data by in-vivo evidence: the example of angiotensin (1-7).
Topics: Angiotensin I; Animals; Antihypertensive Agents; Peptide Fragments; Rats; Renal Artery; Renal Circulation; Tissue Culture Techniques; Vascular Resistance | 2006 |
The role of angiotensin(1-7) in renal vasculature of the rat.
Topics: Anesthesia; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Arterioles; In Vitro Techniques; Kidney Glomerulus; Male; Peptide Fragments; Rats; Rats, Wistar; Renal Artery; Renal Circulation; Vasoconstrictor Agents | 2006 |
Endothelium-derived steroidogenic factor enhances angiotensin II-stimulated aldosterone release by bovine zona glomerulosa cells.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin I; Angiotensin II; Animals; Cattle; Cells, Cultured; Culture Media, Conditioned; Endothelium; Iodine Radioisotopes; Peptide Fragments; Peptides; Vasoconstrictor Agents; Zona Glomerulosa | 2007 |
Effects of genetic deletion of angiotensin-(1-7) receptor Mas on cardiac function during ischemia/reperfusion in the isolated perfused mouse heart.
Topics: Angiotensin I; Angiotensin II; Animals; Diastole; Mice; Mice, Knockout; Myocardial Ischemia; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Reperfusion; Systole | 2006 |
Circulating renin Angiotensin system in childhood chronic renal failure: marked increase of Angiotensin-(1-7) in end-stage renal disease.
Topics: Adolescent; Angiotensin I; Angiotensin II; Angiotensins; Case-Control Studies; Child; Child, Preschool; Cross-Sectional Studies; Disease Progression; Female; Humans; Hypertension; Kidney Failure, Chronic; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System | 2006 |
Influence of gender and genetic variability on plasma angiotensin peptides.
Topics: Adolescent; Adult; Angiotensin I; Angiotensin II; Angiotensinogen; Female; Genotype; Humans; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Sex Factors | 2006 |
Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7).
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Fibrosis; Heart; Hypertension; Male; Myocardium; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Time Factors; Transforming Growth Factor beta; Ventricular Remodeling | 2007 |
Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways.
Topics: Angiotensin I; Animals; Aorta; Cells, Cultured; CHO Cells; Cricetinae; Cricetulus; Endothelial Cells; Enzyme Activation; Humans; Nitric Oxide; Nitric Oxide Synthase Type III; Peptide Fragments; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, G-Protein-Coupled; Transfection | 2007 |
Evidence for a new angiotensin-(1-7) receptor subtype in the aorta of Sprague-Dawley rats.
Topics: Angiotensin I; Angiotensin II; Animals; Aorta, Thoracic; In Vitro Techniques; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Vasodilation | 2007 |
The renin-angiotensin system in a rat model of hepatic fibrosis: evidence for a protective role of Angiotensin-(1-7).
Topics: Angiotensin I; Angiotensin II; Animals; Cytoprotection; Hydroxyproline; Liver; Liver Cirrhosis; Male; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Transforming Growth Factor beta1 | 2007 |
Expression of an angiotensin-(1-7)-producing fusion protein in rats induced marked changes in regional vascular resistance.
Topics: Adaptation, Physiological; Angiotensin I; Animals; Blood Flow Velocity; Blood Pressure; Male; Peptide Fragments; Rats; Recombinant Fusion Proteins; Stroke Volume; Vascular Resistance | 2007 |
Angiotensin-(1-7) prevents diabetes-induced cardiovascular dysfunction.
Topics: Angiotensin I; Animals; Blood Pressure; Cardiotonic Agents; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dose-Response Relationship, Drug; Male; Peptide Fragments; Rats; Rats, Wistar; Streptozocin; Vasoconstriction; Vasodilation; Ventricular Dysfunction, Left | 2007 |
Phosphoinositide hydrolysis increase by angiotensin-(1--7) in neonatal rat brain.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Antihypertensive Agents; Cerebral Cortex; Female; Hydrolysis; Losartan; Male; Peptide Fragments; Phosphatidylinositols; Rats; Rats, Inbred BB; Signal Transduction | 2007 |
Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Carotid Artery, External; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Enalaprilat; Male; Meclofenamic Acid; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B2; Receptors, G-Protein-Coupled; Vasoconstrictor Agents; Vasodilator Agents | 2006 |
The pregnancy-induced increase of plasma angiotensin-(1-7) is blunted in gestational diabetes.
Topics: Adult; Angiotensin I; Angiotensin II; Case-Control Studies; Diabetes, Gestational; Female; Gestational Age; Humans; Peptide Fragments; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, Third; Radioimmunoassay; Renin-Angiotensin System | 2007 |
Primary role of angiotensin-converting enzyme-2 in cardiac production of angiotensin-(1-7) in transgenic Ren-2 hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Cardiomegaly; Disease Models, Animal; Half-Life; Hypertension; Imidazoles; Kinetics; Leucine; Male; Mice; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin | 2007 |
The angiotensin-(1-7) receptor agonist AVE0991 dominates the circadian rhythm and baroreflex in spontaneously hypertensive rats.
Topics: Angiotensin I; Animals; Baroreflex; Blood Pressure; Circadian Rhythm; Heart Rate; Imidazoles; Male; Peptide Fragments; Rats; Rats, Inbred SHR; Receptors, Angiotensin; Renin-Angiotensin System | 2007 |
Effects of angiotensin 1-7 on the actions of angiotensin II in the renal and mesenteric vasculature of hypertensive and streptozotocin-induced diabetic rats.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Hypertension; Kidney; Male; Nitric Oxide; Peptide Fragments; Prostaglandins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Renal Circulation; Splanchnic Circulation; Streptozocin | 2007 |
Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Gene Expression; Imidazoles; Male; Myocardium; Nitrates; Nitrites; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; Tetrazoles; Ventricular Remodeling | 2006 |
Angiotensin-(3-7) pressor effect at the rostral ventrolateral medulla.
Topics: Anesthetics, Intravenous; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Losartan; Male; Medulla Oblongata; Microinjections; Peptide Fragments; Pulsatile Flow; Rats; Rats, Wistar; Urethane | 2007 |
Angiotensin-(1-7)-induced plasticity changes in the lateral amygdala are mediated by COX-2 and NO.
Topics: Amygdala; Angiotensin I; Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Heterozygote; Homozygote; Long-Term Potentiation; Long-Term Synaptic Depression; Male; Mice; Mice, Knockout; Neuronal Plasticity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitrobenzenes; Peptide Fragments; S-Nitroso-N-Acetylpenicillamine; Sulfonamides | 2007 |
Reduced circulating levels of angiotensin-(1--7) in systemic sclerosis: a new pathway in the dysregulation of endothelial-dependent vascular tone control.
Topics: Angiotensin I; Angiotensin II; Antihypertensive Agents; Epoprostenol; Female; Humans; Male; Middle Aged; Neprilysin; Nitric Oxide; Peptide Fragments; Peptidyl-Dipeptidase A; Scleroderma, Systemic; Vasoconstrictor Agents | 2007 |
Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2.
Topics: Adenocarcinoma; Angiotensin I; Animals; Cell Growth Processes; Cell Line, Tumor; Cyclooxygenase 2; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Peptide Fragments; RNA, Messenger; Xenograft Model Antitumor Assays | 2007 |
Potentiation of platelet responsiveness to nitric oxide by angiotensin-(1-7) is associated with suppression of superoxide release.
Topics: Angiotensin I; Blood Platelets; Humans; In Vitro Techniques; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Peptide Fragments; Platelet Aggregation; Receptor, Angiotensin, Type 1; Superoxides | 2007 |
Reduced plasma levels of angiotensin-(1-7) and renin activity in preeclamptic patients are associated with the angiotensin I- converting enzyme deletion/deletion genotype.
Topics: Adult; Angiotensin I; Angiotensin II; Case-Control Studies; Female; Gene Deletion; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Pre-Eclampsia; Pregnancy; Renin; Renin-Angiotensin System | 2007 |
Lack of potentiation of bradykinin by angiotensin-(1-7) in a type 2 diabetes model: role of insulin.
Topics: Angiotensin I; Animals; Animals, Newborn; Blood Glucose; Bradykinin; Diabetes Mellitus, Type 2; Drug Interactions; Gene Expression; Hypoglycemic Agents; Immunohistochemistry; Indomethacin; Insulin; Male; NG-Nitroarginine Methyl Ester; Ouabain; Peptide Fragments; Rats; Rats, Wistar; Receptors, Bradykinin; Reverse Transcriptase Polymerase Chain Reaction; Streptozocin; Tetraethylammonium; Vasodilation | 2007 |
Temporal-spatial expression of ANG-(1-7) and angiotensin-converting enzyme 2 in the kidney of normal and hypertensive pregnant rats.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensinogen; Animals; Blood Pressure; Body Weight; Estradiol; Female; Fluorescent Antibody Technique; Hypertension, Pregnancy-Induced; Immunohistochemistry; Kidney; Peptide Fragments; Peptidyl-Dipeptidase A; Pre-Eclampsia; Pregnancy; Pregnancy, Animal; Proteinuria; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Renin; Urodynamics; Uterus | 2007 |
Evaluation of angiotensin converting enzyme (ACE)-like activity of acellular hemoglobin.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Enzyme-Linked Immunosorbent Assay; Hemoglobins; Humans; Hydrogen Peroxide; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Spectrophotometry; Substrate Specificity; Vasoconstriction | 2007 |
Association of somatic and N-domain angiotensin-converting enzymes from Wistar rat tissue with renal dysfunction in diabetes mellitus.
Topics: Angiotensin I; Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Activation; Hypoglycemic Agents; Insulin; Kidney; Male; Molecular Weight; Peptide Fragments; Peptidyl-Dipeptidase A; Protein Structure, Tertiary; Rats; Rats, Wistar; Renin-Angiotensin System | 2007 |
Angiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors.
Topics: Androstadienes; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Dose-Response Relationship, Drug; Insulin; Insulin Receptor Substrate Proteins; Janus Kinase 2; Losartan; Male; Myocardium; Peptide Fragments; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphoproteins; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Signal Transduction; Tyrphostins; Wortmannin | 2007 |
Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain.
Topics: Angiotensin I; Animals; Brain; Cardiovascular Physiological Phenomena; Neurons; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptors, G-Protein-Coupled | 2007 |
On the mechanism of coronary vasodilation induced by angiotensin-(1-7) in the isolated guinea pig heart.
Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Antihypertensive Agents; Bradykinin; Coronary Vessels; Dose-Response Relationship, Drug; Female; Guinea Pigs; Imidazoles; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Pyridines; Vasodilation | 2007 |
Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensins; Animals; Bile Ducts; Gene Expression; In Vitro Techniques; Ligation; Liver; Liver Cirrhosis, Biliary; Liver Cirrhosis, Experimental; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Portal Vein; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Up-Regulation; Vasoconstriction | 2007 |
Angiotensin-(1-7) blocks the angiotensin II-stimulated superoxide production.
Topics: Acetophenones; Allopurinol; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Drug Antagonism; Enzyme Inhibitors; Imidazoles; In Vitro Techniques; Indomethacin; Losartan; Male; NADH, NADPH Oxidoreductases; NG-Nitroarginine Methyl Ester; Onium Compounds; Peptide Fragments; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Superoxides | 2007 |
Angiotensin II and its receptor subtypes in the human retina.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Binding, Competitive; Blotting, Western; Female; Fluorescent Antibody Technique, Indirect; Humans; Male; Microscopy, Confocal; Middle Aged; Peptide Fragments; Peptidyl-Dipeptidase A; Radioimmunoassay; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Retina; Tissue Donors | 2007 |
Evidence that the vasodilator angiotensin-(1-7)-Mas axis plays an important role in erectile function.
Topics: Angiotensin I; Angiotensin II; Animals; Desoxycorticosterone; Disease Models, Animal; Electric Stimulation; Enzyme Inhibitors; Erectile Dysfunction; Hypertension; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Penile Erection; Penis; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Sodium Chloride, Dietary; Vasodilator Agents | 2007 |
Ovariectomy is protective against renal injury in the high-salt-fed older mRen2. Lewis rat.
Topics: Aging; Angiotensin I; Angiotensin II; Animals; Animals, Congenic; Blood Pressure; C-Reactive Protein; Cell Adhesion Molecules; Disease Models, Animal; Female; Fibrosis; Hypertension; Hypertrophy; Insulin-Like Growth Factor I; Intracellular Signaling Peptides and Proteins; Kidney; Kidney Diseases; Membrane Proteins; Ovariectomy; Peptide Fragments; Proteinuria; Rats; Rats, Inbred Lew; Renin; Renin-Angiotensin System; RNA, Messenger; Sodium Chloride, Dietary | 2007 |
Increased hypothalamic angiotensin-(1-7) levels in rats with aortic coarctation-induced hypertension.
Topics: Angiotensin I; Angiotensin II; Angiotensins; Animals; Aortic Coarctation; Hypertension; Hypothalamus; Kidney; Male; Myocardium; Peptide Fragments; Rats; Rats, Wistar; Renin-Angiotensin System | 2007 |
Different responses to angiotensin-(1-7) in young, aged and diabetic rabbit corpus cavernosum.
Topics: Aging; Angiotensin I; Angiotensin II; Animals; Carbachol; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Enzyme Inhibitors; Erectile Dysfunction; Large-Conductance Calcium-Activated Potassium Channels; Male; Muscle Relaxation; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Penis; Peptide Fragments; Peptides; Potassium Channel Blockers; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rabbits; Receptors, G-Protein-Coupled; Vasoconstrictor Agents; Vasodilator Agents | 2007 |
Evidence for Mas-mediated bradykinin potentiation by the angiotensin-(1-7) nonpeptide mimic AVE 0991 in normotensive rats.
Topics: Angiotensin I; Angiotensin II; Animals; Bradykinin; Dose-Response Relationship, Drug; Drug Synergism; Endothelium, Vascular; Enzyme Inhibitors; Hypotension; Imidazoles; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rabbits; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Vasodilator Agents | 2007 |
Beneficial versus harmful effects of Angiotensin (1-7) on impulse propagation and cardiac arrhythmias in the failing heart.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Cardiomyopathies; Cricetinae; Disease Models, Animal; Heart; Heart Rate; Immunohistochemistry; Membrane Potentials; Myocardium; Peptide Fragments; Sodium Channels | 2007 |
Involvement of angiotensin-(1-7) in the hypothalamic hypotensive effect of captopril in sinoaortic denervated rats.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Aorta, Thoracic; Captopril; Denervation; Drug Synergism; Hypotension; Hypothalamus; Male; Peptide Fragments; Rats; Rats, Wistar | 2008 |
Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Activation; Gene Expression Regulation, Enzymologic; Hyperglycemia; Hypertension, Renal; Male; NADPH Oxidase 4; NADPH Oxidases; Peptide Fragments; Proteinuria; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Vasoconstriction; Vasodilation | 2008 |
Study of angiotensin-(1-7) vasoactive peptide and its beta-cyclodextrin inclusion complexes: complete sequence-specific NMR assignments and structural studies.
Topics: Angiotensin I; beta-Cyclodextrins; Circular Dichroism; Hydrogen Bonding; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Peptide Fragments; Protein Structure, Secondary; Protein Structure, Tertiary | 2007 |
ACE2 and ANG-(1-7) in the rat uterus during early and late gestation.
Topics: Amnion; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Decidua; Disease Models, Animal; Epithelial Cells; Female; Hypertension, Pregnancy-Induced; Peptide Fragments; Peptidyl-Dipeptidase A; Placenta; Pregnancy; Pregnancy, Animal; Rats; Rats, Sprague-Dawley; RNA, Messenger; Uterus; Yolk Sac | 2008 |
Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells.
Topics: Angiotensin I; Angiotensin II; Cells, Cultured; CSK Tyrosine-Protein Kinase; Endothelial Cells; Extracellular Signal-Regulated MAP Kinases; Humans; NADPH Oxidases; Peptide Fragments; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Signal Transduction; src-Family Kinases | 2007 |
Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function.
Topics: Acetylcholine; Angiotensin I; Angiotensin II; Animals; Bradykinin; Cells, Cultured; Endothelium, Vascular; Humans; In Vitro Techniques; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Vasodilation | 2007 |
Angiotensin-(1-7) inhibits in vitro endothelial cell tube formation in human umbilical vein endothelial cells through the AT(1-7) receptor.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Antihypertensive Agents; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Imidazoles; Losartan; Neovascularization, Physiologic; Peptide Fragments; Pyridines; Receptors, Angiotensin; Umbilical Veins; Vasoconstrictor Agents | 2007 |
ACE2 overexpression inhibits angiotensin II-induced monocyte chemoattractant protein-1 expression in macrophages.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cardiovascular Diseases; Cell Line; Chemokine CCL2; Gene Expression Regulation; Humans; Mice; Peptide Fragments; Peptidyl-Dipeptidase A | 2008 |
Angiotensin-(1-7) serves as an aquaretic by increasing water intake and diuresis in association with downregulation of aquaporin-1 during pregnancy in rats.
Topics: Angiotensin I; Animals; Aquaporin 1; Blood Pressure; Blotting, Western; Creatinine; Diuresis; Down-Regulation; Drinking; Female; Homeostasis; Peptide Fragments; Plasma Volume; Potassium; Pregnancy; Pregnancy, Animal; Rats; Rats, Sprague-Dawley; Sodium; Urodynamics; Vasopressins; Water-Electrolyte Balance | 2008 |
Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Diet, Sodium-Restricted; Gene Expression Regulation, Enzymologic; Kidney; Lisinopril; Male; Neprilysin; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2008 |
ACE2 and ANG-(1-7) in the gravid uterus: the new players on the block.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Female; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Pregnancy; Renin-Angiotensin System; Uterus | 2008 |
Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor.
Topics: Acetonitriles; Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Antiporters; Blotting, Western; Cations, Divalent; Chelating Agents; Female; Humans; Immunoprecipitation; Male; Middle Aged; Peptide Fragments; Peptidyl-Dipeptidase A; Plasma; Recombinant Proteins; Subcellular Fractions | 2008 |
Angiotensin (1-7) reduces intraocular pressure in the normotensive rabbit eye.
Topics: Administration, Topical; Angiotensin I; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Aqueous Humor; Dose-Response Relationship, Drug; Imidazoles; Injections; Intraocular Pressure; Male; Oligopeptides; Peptide Fragments; Pyridines; Rabbits; Receptor, Angiotensin, Type 2; Tonometry, Ocular; Vitreous Body | 2008 |
The angiotensin receptor type 1-Gq protein-phosphatidyl inositol phospholipase Cbeta-protein kinase C pathway is involved in activation of proximal tubule Na+-ATPase activity by angiotensin(1-7) in pig kidneys.
Topics: Adenosine Triphosphatases; Angiotensin I; Animals; Blood Pressure; Cation Transport Proteins; Diglycerides; Enzyme Activation; Extracellular Space; GTP-Binding Protein alpha Subunits, Gq-G11; Hydroxylamines; Kidney Tubules, Proximal; Peptide Fragments; Phosphatidylinositols; Phospholipase C beta; Phosphorylation; Protein Kinase C; Receptor, Angiotensin, Type 1; Signal Transduction; Sodium; Swine | 2008 |
Hemodynamic effect produced by microinjection of angiotensins at the caudal ventrolateral medulla of spontaneously hypertensive rats.
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Heart Rate; Hemodynamics; Male; Medulla Oblongata; Microinjections; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Wistar; Regional Blood Flow; Vasoconstrictor Agents | 2008 |
Activation of local chorionic villi angiotensin II levels but not angiotensin (1-7) in preeclampsia.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensinogen; Chorionic Villi; Female; Gene Expression; Humans; Neprilysin; Peptide Fragments; Peptidyl-Dipeptidase A; Placenta; Pre-Eclampsia; Pregnancy; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2008 |
Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Blotting, Western; Cells, Cultured; DNA; Fibroblasts; Gene Expression Regulation, Enzymologic; Humans; Indicators and Reagents; Matrix Metalloproteinases; Myocytes, Cardiac; Peptide Fragments; Reverse Transcriptase Polymerase Chain Reaction; RNA; Tetrazoles; Tissue Inhibitor of Metalloproteinases; Transcription, Genetic; Valine; Valsartan | 2008 |
Role of angiotensin-converting enzyme 2 and angiotensin(1-7) in 17beta-oestradiol regulation of renal pathology in renal wrap hypertension in rats.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Body Weight; Estradiol; Female; Heart Rate; Hypertension, Renovascular; Kidney; Kidney Glomerulus; Ovariectomy; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Up-Regulation | 2008 |
Modulation of reflex function by endogenous angiotensins in older transgenic rats with low glial angiotensinogen.
Topics: Aging; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Angiotensins; Animals; Animals, Genetically Modified; Baroreflex; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Heart Rate; Male; Neuroglia; Peptide Fragments; Rats; Renin-Angiotensin System; Solitary Nucleus; Tetrazoles | 2008 |
Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Carboxypeptidases A; Cell Proliferation; Fibrosis; Heart; Imidazoles; Immunohistochemistry; Leucine; Male; Membranes; Mice; Mice, Knockout; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Protease Inhibitors; Succinates | 2008 |
Angiotensin-(1-12) is an alternate substrate for angiotensin peptide production in the heart.
Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Angiotensins; Animals; Animals, Genetically Modified; Disease Models, Animal; Hypertension; Male; Myocardium; Peptide Fragments; Perfusion; Rats; Rats, Inbred Lew; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Time Factors | 2008 |
Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis.
Topics: Adenoviridae; Angioplasty, Balloon; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Aorta, Abdominal; Atherosclerosis; Cell Line; Cells, Cultured; Collagen; Diet, Atherogenic; Dietary Fats; Disease Models, Animal; Disease Progression; Genetic Vectors; Humans; Mice; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rabbits; Receptors, G-Protein-Coupled; Time Factors; Transduction, Genetic; Up-Regulation | 2008 |
The Bothrops legacy: vasoactive peptides from Brazil.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Atrial Natriuretic Factor; Bradykinin; Calcitonin Gene-Related Peptide; Humans; Oligopeptides; Oxytocin; Peptide Fragments; Peptidyl-Dipeptidase A; Prorenin Receptor; Receptor, Bradykinin B1; Receptors, Angiotensin; Receptors, Cell Surface; Renin-Angiotensin System; rho-Associated Kinases | 2008 |
Recent advances in the renin-angiotensin system: angiotensin-converting enzyme 2 and (pro)renin receptor.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Prorenin Receptor; Receptors, Cell Surface; Renin-Angiotensin System | 2008 |
Angiotensin-(1-7) has a dual role on growth-promoting signalling pathways in rat heart in vivo by stimulating STAT3 and STAT5a/b phosphorylation and inhibiting angiotensin II-stimulated ERK1/2 and Rho kinase activity.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blotting, Western; Dose-Response Relationship, Drug; Growth; Heart; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Peptide Fragments; Phosphorylation; Rats; Receptor, Angiotensin, Type 1; rho-Associated Kinases; Signal Transduction; STAT3 Transcription Factor; STAT5 Transcription Factor; Tyrosine | 2008 |
Selective increase of angiotensin(1-7) and its receptor in hearts of spontaneously hypertensive rats subjected to physical training.
Topics: Angiotensin I; Animals; Blood Pressure; Blotting, Western; Cardiomegaly; Immunohistochemistry; Male; Myocardium; Peptide Fragments; Physical Conditioning, Animal; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Inbred SHR; Rats, Wistar; Receptors, Angiotensin; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Swimming | 2008 |
Sex differences in circulating and renal angiotensins of hypertensive mRen(2). Lewis but not normotensive Lewis rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensinogen; Angiotensins; Animals; Animals, Genetically Modified; Blood Pressure; Disease Models, Animal; Female; Hypertension; Kidney; Male; Mice; Myocardium; Neprilysin; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Lew; Renin; Renin-Angiotensin System; Sex Factors | 2008 |
Angiotensin-(1-7) and baroreflex function in nucleus tractus solitarii of (mRen2)27 transgenic rats.
Topics: Angiotensin I; Angiotensin II; Animals; Animals, Genetically Modified; Antihypertensive Agents; Baroreflex; Biguanides; Blood Pressure; Female; Heart Rate; Male; Mice; Peptide Fragments; Phenylephrine; Rats; Rats, Sprague-Dawley; Renin; Solitary Nucleus | 2008 |
Angiotensin II relaxations of bovine adrenal cortical arteries: role of angiotensin II metabolites and endothelial nitric oxide.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenal Cortex; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin III; Animals; Arteries; Cattle; Endothelium, Vascular; Imidazoles; Losartan; Nitric Oxide; Peptide Fragments; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2008 |
Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Aorta, Abdominal; Blood Pressure; Carotid Arteries; Catheterization; Disease Models, Animal; Heart Rate; Hyperplasia; Hypertension; Imidazoles; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Tunica Intima | 2008 |
Effects of intracerebroventricular infusion of angiotensin-(1-7) on bradykinin formation and the kinin receptor expression after focal cerebral ischemia-reperfusion in rats.
Topics: Analysis of Variance; Angiotensin I; Animals; Bradykinin; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Infarction, Middle Cerebral Artery; Injections, Intraventricular; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Bradykinin; Reperfusion; RNA, Messenger | 2008 |
Chronic angiotensin (1-7) injection accelerates STZ-induced diabetic renal injury.
Topics: Angiotensin I; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; DNA, Complementary; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA | 2008 |
The functional importance of the N-terminal region of human prolylcarboxypeptidase.
Topics: Angiotensin I; Angiotensin II; Animals; Carboxypeptidases; Catalysis; Cell Line; Enzyme Stability; Humans; Peptide Fragments; Protein Conformation; Recombinant Proteins | 2008 |
Molecular mechanisms involved in the angiotensin-(1-7)/Mas signaling pathway in cardiomyocytes.
Topics: Angiotensin I; Animals; Apoptosis; Calcium Signaling; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2008 |
[Effects of angiotensin-(1-7) on oxidative stress and functional changes of isolated rat hearts induced by ischemia-reperfusion].
Topics: Angiotensin I; Animals; Heart; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Oxidative Stress; Peptide Fragments; Random Allocation; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2008 |
MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cells, Cultured; Flavonoids; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Phosphatases; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Okadaic Acid; Peptide Fragments; Peptidyl-Dipeptidase A; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; RNA, Messenger; Vanadates | 2008 |
Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function.
Topics: Acetylcholine; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Animals, Genetically Modified; Blood Pressure; Cardiomegaly; Disease Models, Animal; Endothelium, Vascular; Gene Expression Regulation, Enzymologic; Humans; Hypertension; Muscle, Smooth, Vascular; Nitroprusside; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Vasodilator Agents | 2008 |
Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Crosses, Genetic; Heart; Hypertension; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Ventricular Remodeling | 2008 |
Regulation of ACE2 in cardiac myocytes and fibroblasts.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Animals, Newborn; Atrial Natriuretic Factor; Butadienes; Cells, Cultured; Endothelin-1; Fibroblasts; Flavonoids; Gene Expression Regulation, Enzymologic; Heart Ventricles; Losartan; Mitogen-Activated Protein Kinase 1; Myocytes, Cardiac; Nitriles; Peptide Fragments; Peptidyl-Dipeptidase A; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction | 2008 |
High glucose-induced Nox1-derived superoxides downregulate PKC-betaII, which subsequently decreases ACE2 expression and ANG(1-7) formation in rat VSMCs.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blotting, Western; Down-Regulation; Glucose; Glucose Transporter Type 1; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; NADPH Oxidases; Oxidants; Peptide Fragments; Peptidyl-Dipeptidase A; Phthalimides; Protein Kinase C; Protein Kinase C beta; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Superoxides; Transfection | 2009 |
Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats.
Topics: Adipose Tissue; Angiotensin I; Animals; Diet; Drug Evaluation, Preclinical; Fructose; Glucose Tolerance Test; Hypertension; Infusion Pumps; Insulin; Insulin Resistance; Liver; Male; Muscle, Skeletal; Peptide Fragments; Rats; Rats, Sprague-Dawley; Signal Transduction; Time Factors | 2009 |
The angiotensin converting enzyme 2/Ang-(1-7) axis in the heart: a role for MAS communication?
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cardiomegaly; Female; Heart; Humans; Hypertension; Male; Mice; Mice, Knockout; Models, Animal; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2008 |
Gender differences in the effects of antenatal betamethasone exposure on renal function in adult sheep.
Topics: Age Factors; Aging; Angiotensin I; Animals; Anti-Inflammatory Agents; Betamethasone; Blood Pressure; Creatinine; Female; Gestational Age; Glomerular Filtration Rate; Hypertension; Infusions, Intravenous; Kidney; Male; Natriuresis; Peptide Fragments; Potassium; Pregnancy; Prenatal Exposure Delayed Effects; Proteinuria; Renal Plasma Flow, Effective; Sex Factors; Sheep; Sodium | 2009 |
Angiotensin-(1-7) enhances angiotensin II induced phosphorylation of ERK1/2 in mouse bone marrow-derived dendritic cells.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Bone Marrow Cells; Dendritic Cells; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Enzymologic; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphorylation; Receptors, Cell Surface; RNA, Messenger | 2009 |
Alterations in circulatory and renal angiotensin-converting enzyme and angiotensin-converting enzyme 2 in fetal programmed hypertension.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Betamethasone; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fetal Development; Glucocorticoids; Hypertension; Kidney Tubules, Proximal; Male; Neprilysin; Peptide Fragments; Peptidyl-Dipeptidase A; Pregnancy; Sheep | 2009 |
Angiotensin-(1-7) activates growth-stimulatory pathways in human mesangial cells.
Topics: Angiotensin I; Arachidonic Acid; Calcium; Cell Line; Collagen Type IV; Cyclic AMP; Cytosol; DNA; Fibronectins; Humans; MAP Kinase Signaling System; Mesangial Cells; Mitogen-Activated Protein Kinases; Peptide Fragments; Phospholipases A2; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Transforming Growth Factor beta1 | 2009 |
Effect of propranolol on the splanchnic and peripheral renin angiotensin system in cirrhotic patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin I; Angiotensin II; Angiotensins; Cross-Sectional Studies; Female; Hemodynamics; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Peptide Fragments; Portal Vein; Propranolol; Renin; Renin-Angiotensin System; Splanchnic Circulation | 2008 |
Angiotensin-(1-7) activates a tyrosine phosphatase and inhibits glucose-induced signalling in proximal tubular cells.
Topics: Angiotensin I; Animals; Collagen Type IV; Diabetic Nephropathies; Enzyme Activation; Fibronectins; Glucose; Humans; Kidney Tubules, Proximal; LLC-PK1 Cells; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Signal Transduction; Swine; Transforming Growth Factor beta1 | 2009 |
The vasoactive peptide angiotensin-(1-7), its receptor Mas and the angiotensin-converting enzyme type 2 are expressed in the human endometrium.
Topics: Adult; Angiotensin I; Angiotensin-Converting Enzyme 2; Cells, Cultured; Endometrium; Epithelial Cells; Female; Humans; Immunohistochemistry; Menstrual Cycle; Middle Aged; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Radioimmunoassay; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stromal Cells | 2009 |
Endogenous angiotensin-(1-7) reduces cardiac ischemia-induced dysfunction in diabetic hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Captopril; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Heart; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Myocardium; NF-kappa B; Nuclear Proteins; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; RNA, Messenger; Signal Transduction | 2009 |
Angiotensin-(1-7) through AT receptors mediates tyrosine hydroxylase degradation via the ubiquitin-proteasome pathway.
Topics: Angiotensin I; Animals; Cells, Cultured; Horses; Male; Peptide Fragments; Proteasome Endopeptidase Complex; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Signal Transduction; Tyrosine 3-Monooxygenase; Ubiquitin | 2009 |
Therapeutic targets in liver transplantation: angiotensin II in nonsteatotic grafts and angiotensin-(1-7) in steatotic grafts.
Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Apoptosis; Fatty Liver; Graft Survival; Health; Liver Transplantation; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Peptide Fragments; Rats; Receptors, Angiotensin | 2009 |
Angiotensin I is largely converted to angiotensin (1-7) and angiotensin (2-10) by isolated rat glomeruli.
Topics: Angiotensin I; Animals; Glutamyl Aminopeptidase; Kidney Glomerulus; Male; Neprilysin; Peptide Fragments; Rats; Rats, Sprague-Dawley; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2009 |
Defects in cutaneous angiotensin-converting enzyme 2 and angiotensin-(1-7) production in postural tachycardia syndrome.
Topics: Adolescent; Adult; Angiotensin I; Angiotensin-Converting Enzyme 2; Female; Humans; Losartan; Male; Nitroarginine; Peptide Fragments; Peptidyl-Dipeptidase A; Postural Orthostatic Tachycardia Syndrome; Skin; Vasodilation | 2009 |
Angiotensin (1-7) prevent heart dysfunction and left ventricular remodeling caused by renal dysfunction in 5/6 nephrectomy mice.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Blood Pressure; Creatinine; Heart Failure; Heart Ventricles; Kidney; Kidney Failure, Chronic; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Myocardium; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Transforming Growth Factor beta; Ventricular Dysfunction, Left; Ventricular Remodeling | 2009 |
Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Apelin; Apelin Receptors; Carrier Proteins; Endothelin-1; Gene Expression Profiling; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Intercellular Signaling Peptides and Proteins; Male; Monocrotaline; Myocardium; Peptide Fragments; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; RNA, Messenger; Ventricular Function, Right | 2009 |
Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat.
Topics: Actins; Adult; Angiotensin I; Angiotensin II; Animals; Bile Ducts; Cells, Cultured; Drug Evaluation, Preclinical; Female; Hepatitis C, Chronic; Humans; Hydroxyproline; Liver; Liver Cirrhosis; Liver Cirrhosis, Experimental; Male; Middle Aged; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Renin; Renin-Angiotensin System; RNA, Messenger; Up-Regulation | 2009 |
Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo.
Topics: Angiotensin I; Animals; Antigens, CD19; Antigens, CD34; Bone Marrow Cells; CD11a Antigen; Cells, Cultured; Cord Blood Stem Cell Transplantation; Dose-Response Relationship, Drug; Fetal Blood; Flow Cytometry; Hematopoietic Stem Cells; HLA-DR Antigens; Humans; Injections, Subcutaneous; Leukocytes, Mononuclear; Lewis X Antigen; Mice; Mice, Inbred NOD; Mice, SCID; Peptide Fragments; Spleen; Time Factors; Transplantation, Heterologous | 2009 |
Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Common Bile Duct; Gene Expression Regulation, Enzymologic; Imidazoles; Leucine; Ligation; Lisinopril; Liver; Liver Cirrhosis, Experimental; Male; Neprilysin; Peptide Fragments; Peptidyl-Dipeptidase A; Portal Pressure; Pyridines; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Severity of Illness Index; Thiazepines; Time Factors; Vascular Resistance | 2009 |
[Effect of angiotensin1-7 on alpha-smooth muscle actin protein expression in rat hepatic stellate cells].
Topics: Actins; Angiotensin I; Angiotensin II; Animals; Calcium; Cell Line; Gene Expression Regulation; Hepatic Stellate Cells; Peptide Fragments; Rats; rho-Associated Kinases; RNA, Messenger; Signal Transduction | 2009 |
Angiotensin-(1-7) and the g protein-coupled receptor MAS are key players in renal inflammation.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Cytokines; Inflammation; Kidney Diseases; Mice; Mice, Knockout; NF-kappa B; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Reperfusion Injury | 2009 |
The role of angiotensin-(1-7) receptor Mas in spermatogenesis in mice and rats.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Fertility; Male; Mice; Mice, Knockout; Peptide Fragments; Rats; Rats, Wistar; Renin-Angiotensin System; Spermatogenesis; Spermatozoa; Testis | 2009 |
Angiotensin metabolism in rat stomach wall: prevalence of angiotensin-(1-7) formation.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Chromatography, Liquid; Gastric Mucosa; Gene Expression Regulation; Indoles; Male; Neprilysin; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred WKY; Renal Artery; Renin-Angiotensin System; RNA, Messenger; Spectrometry, Mass, Electrospray Ionization; Thiorphan | 2009 |
Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis.
Topics: Angiotensin I; Angiotensin II; Animals; Cross-Sectional Studies; Female; Hemodynamics; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Peptide Fragments; Renin-Angiotensin System; Splanchnic Circulation | 2009 |
A role for the renin-angiotensin system in hematopoiesis.
Topics: Angiotensin I; Animals; Bone Marrow Cells; Cells, Cultured; Cord Blood Stem Cell Transplantation; Hematopoiesis; Hematopoietic Stem Cells; Humans; Leukocytes, Mononuclear; Mice; Peptide Fragments; Renin-Angiotensin System; Transplantation, Heterologous | 2009 |
Cell swelling, impulse conduction, and cardiac arrhythmias in the failing heart. Opposite effects of angiotensin II and angiotensin (1-7) on cell volume regulation.
Topics: Angiotensin I; Angiotensin II; Animals; Arrhythmias, Cardiac; Cardiomyopathies; Cell Size; Cells, Cultured; Cricetinae; Electrophysiology; Heart Conduction System; Heart Failure; Heart Ventricles; Hypotonic Solutions; Male; Membrane Potentials; Myocytes, Cardiac; Peptide Fragments; Pulse | 2009 |
Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor.
Topics: Angiotensin I; Animals; Blotting, Western; Cell Line, Tumor; Cells, Cultured; Chick Embryo; Chorioallantoic Membrane; Endothelial Cells; Humans; Injections, Subcutaneous; Lung Neoplasms; Mice; Mice, Nude; Neovascularization, Pathologic; Neovascularization, Physiologic; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2009 |
Endothelium-dependent relaxation factor released by perivascular adipose tissue.
Topics: Adipose Tissue; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Endothelium-Dependent Relaxing Factors; Immunohistochemistry; Male; Peptide Fragments; Potassium Channels; Pyridines; Rats; Rats, Wistar; Thiazepines | 2009 |
The uterine placental bed Renin-Angiotensin system in normal and preeclamptic pregnancy.
Topics: Alanine; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Down-Regulation; Female; Gene Expression; Humans; Imidazoles; Losartan; Peptide Fragments; Peptidyl-Dipeptidase A; Placenta; Pre-Eclampsia; Pregnancy; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Stereoisomerism; Uterus | 2009 |
Acute modulation of myocardial function by angiotensin 1-7.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Diastole; Endothelium, Vascular; Imidazoles; In Vitro Techniques; Male; Myocardial Contraction; Naphthyridines; Nitroarginine; Papillary Muscles; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyridines; Rabbits; Receptors, G-Protein-Coupled | 2009 |
Angiotensin-(1-7) antagonist, A-779, microinjection into the caudal ventrolateral medulla of renovascular hypertensive rats restores baroreflex bradycardia.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Bradycardia; Heart Rate; Hypertension; Losartan; Male; Medulla Oblongata; Microinjections; Peptide Fragments; Rats; Rats, Inbred F344 | 2009 |
Impairment of the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Disease Progression; Hypertension, Renovascular; Infusion Pumps, Implantable; Peptide Fragments; Rats; Rats, Transgenic; Surgical Instruments; Telemetry; Vasodilator Agents | 2009 |
Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Carbon Tetrachloride Poisoning; Extracellular Signal-Regulated MAP Kinases; Gene Deletion; Hepatic Stellate Cells; Ligation; Liver Cirrhosis; Mice; Mice, Knockout; Peptide Fragments; Peptidyl-Dipeptidase A; Recombinant Proteins; Renin-Angiotensin System | 2009 |
Gonadotropin stimulation increases the expression of angiotensin-(1--7) and MAS receptor in the rat ovary.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Female; Gonadotropins, Equine; Immunohistochemistry; Injections, Subcutaneous; Neprilysin; Ovary; Peptide Fragments; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Prolyl Oligopeptidases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; RNA, Messenger; Serine Endopeptidases; Spectrometry, Fluorescence; Superovulation; Up-Regulation | 2009 |
Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction.
Topics: Adaptation, Physiological; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Biphenyl Compounds; Disease Models, Animal; Enzyme Activation; Inflammation Mediators; Irbesartan; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinases; Myocardial Infarction; Myocardium; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphorylation; Receptor, Angiotensin, Type 1; RNA, Messenger; Superoxides; Tetrazoles; Time Factors; Ultrasonography; Ventricular Remodeling | 2009 |
[Effects of angiotensin (1-7) and enalaprilat on function of isolated rat heart perfused by burn serum].
Topics: Angiotensin I; Animals; Burns; Enalaprilat; Male; Myocardial Reperfusion Injury; Peptide Fragments; Rats; Rats, Sprague-Dawley; Serum; Ventricular Function, Left | 2009 |
Inhibitory effects of angiotensin-(1-7) on the nerve stimulation-induced release of norepinephrine and neuropeptide Y from the mesenteric arterial bed.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Stimulation; Hypertension; Imidazoles; Male; Mesenteric Arteries; Neuropeptide Y; NG-Nitroarginine Methyl Ester; Norepinephrine; Peptide Fragments; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 2; Sympathetic Nervous System; Synaptic Transmission | 2010 |
Decreased cardiac Ang-(1-7) is associated with salt-induced cardiac remodeling and dysfunction.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Inbred SHR; Receptors, G-Protein-Coupled; Renin; RNA, Messenger; Sodium Chloride, Dietary; Ventricular Dysfunction, Left; Ventricular Remodeling | 2010 |
Angiotensin-(1-7)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin II within the cell nucleus.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Animals; Blotting, Western; Enzyme Inhibitors; Female; Imidazoles; Kidney Cortex; Leucine; Losartan; Peptide Fragments; Peptidyl-Dipeptidase A; Pyridines; Reactive Oxygen Species; Receptors, Angiotensin; Sheep; Time Factors | 2010 |
Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension.
Topics: Anesthesia; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Dose-Response Relationship, Drug; Humans; Hypertension; Infusion Pumps; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Peptidyl-Dipeptidase A; Recombinant Proteins | 2010 |
Angiotensin-(1-7) prevents cardiomyocyte pathological remodeling through a nitric oxide/guanosine 3',5'-cyclic monophosphate-dependent pathway.
Topics: Angiotensin I; Angiotensin II; Animals; Animals, Newborn; Blood Pressure; Calcium; Cardiomegaly; Cell Size; Cells, Cultured; Cyclic GMP; Hypertension; Microscopy, Confocal; Myocytes, Cardiac; NFATC Transcription Factors; Nitric Oxide; Peptide Fragments; Protein Transport; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Signal Transduction | 2010 |
Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cell Proliferation; Cells, Cultured; Collagen Type I; Disease Models, Animal; Dose-Response Relationship, Drug; Fibronectins; Fibrosis; Gene Expression Regulation; Glomerulonephritis; Infusion Pumps, Implantable; Infusions, Subcutaneous; Isoantibodies; Kidney; Male; Mesangial Cells; Peptide Fragments; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Proteinuria; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Time Factors; Transforming Growth Factor beta1 | 2010 |
Attenuation of isoproterenol-induced cardiac fibrosis in transgenic rats harboring an angiotensin-(1-7)-producing fusion protein in the heart.
Topics: Angiotensin I; Animals; Arrhythmias, Cardiac; Blood Pressure; Calcium; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Heart Rate; Heart Ventricles; Isoproterenol; Male; Myocardial Reperfusion Injury; Myocytes, Cardiac; Myosin Heavy Chains; Peptide Fragments; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Telemetry | 2010 |
Angiotensin-(1-7) improves cardiac remodeling and inhibits growth-promoting pathways in the heart of fructose-fed rats.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Dietary Carbohydrates; Disease Models, Animal; Fructose; Hypertension; Hypertrophy, Left Ventricular; Insulin; Insulin Resistance; Male; Peptide Fragments; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Rats; Rats, Sprague-Dawley; Ventricular Remodeling | 2010 |
Angiotensin-(1-7) prevents atrial fibrosis and atrial fibrillation in long-term atrial tachycardia dogs.
Topics: Angiotensin I; Animals; Atrial Fibrillation; Base Sequence; DNA Primers; Dogs; Fibrosis; Heart Atria; Peptide Fragments; Reverse Transcriptase Polymerase Chain Reaction; Tachycardia | 2010 |
Circulating rather than cardiac angiotensin-(1-7) stimulates cardioprotection after myocardial infarction.
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Animals; Bone Marrow Cells; Heart Failure; Hemodynamics; Immunohistochemistry; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocytes, Cardiac; Peptide Fragments; Proto-Oncogene Proteins c-kit; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A | 2010 |
[The renin-angiotensin system in hypertension and in cardiovascular and renal diseases: highlights of the World Congress of Nephrology 2009]].
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiovascular Diseases; Drug Evaluation, Preclinical; Humans; Hypertension; Kidney Diseases; Nephrology; Peptide Fragments; Prorenin Receptor; Randomized Controlled Trials as Topic; Rats; Receptor, Angiotensin, Type 1; Receptors, Cell Surface; Renin; Renin-Angiotensin System | 2010 |
Simultaneous determination of angiotensins II and 1-7 by capillary zone electrophoresis in plasma and urine from hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Animals; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Hypertension; Limit of Detection; Linear Models; Male; Peptide Fragments; Rats; Rats, Wistar; Temperature | 2010 |
Angiotensin-(1-7) and angiotension II in the rostral ventrolateral medulla modulate the cardiac sympathetic afferent reflex and sympathetic activity in rats.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Losartan; Male; Medulla Oblongata; Peptide Fragments; Rats; Rats, Sprague-Dawley | 2010 |
Angiotensin-(1-7) stimulates the phosphorylation of Akt in rat extracardiac tissues in vivo via receptor Mas.
Topics: Adipose Tissue; Angiotensin I; Angiotensin II; Animals; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Immunoblotting; Immunohistochemistry; In Vitro Techniques; Liver; Male; Muscle, Skeletal; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Signal Transduction | 2010 |
Angiotensin-(1-7) stimulates high atrial pacing-induced ANP secretion via Mas/PI3-kinase/Akt axis and Na+/H+ exchanger.
Topics: Angiotensin I; Animals; Atrial Natriuretic Factor; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiac Pacing, Artificial; Cardiotonic Agents; Cyclic GMP; In Vitro Techniques; Isoproterenol; Male; Myocytes, Cardiac; Peptide Fragments; Phosphatidylinositol 3-Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Atrial Natriuretic Factor; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sodium-Hydrogen Exchangers | 2010 |
Astroglia are a possible cellular substrate of angiotensin(1-7) effects in the rostral ventrolateral medulla.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Astrocytes; Biosensing Techniques; Blood Pressure; Calcium Signaling; Catecholamines; Disease Models, Animal; Genes, Reporter; Hypertension; Losartan; Medulla Oblongata; Membrane Potentials; Microscopy, Confocal; Patch-Clamp Techniques; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Wistar; Tissue Culture Techniques | 2010 |
Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1-7).
Topics: Adipocytes; Adiponectin; Adipose Tissue; Adiposity; Angiotensin I; Angiotensin II; Animals; Biomarkers; Blood Glucose; Body Weight; Cells, Cultured; Cholesterol; Insulin; Leptin; Lipid Metabolism; Male; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Receptors, G-Protein-Coupled; Time Factors; Triglycerides; Up-Regulation | 2010 |
Oral and pulmonary delivery of thioether-bridged angiotensin-(1-7).
Topics: Administration, Cutaneous; Administration, Oral; Angiotensin I; Animals; Chromatography, High Pressure Liquid; Chromatography, Liquid; Drug Administration Routes; Male; Mass Spectrometry; Peptide Fragments; Rats; Rats, Sprague-Dawley; Trachea | 2010 |
Lifetime overproduction of circulating Angiotensin-(1-7) attenuates deoxycorticosterone acetate-salt hypertension-induced cardiac dysfunction and remodeling.
Topics: Analysis of Variance; Angiotensin I; Animals; Collagen Type I; Collagen Type III; Desoxycorticosterone; Heart Function Tests; Hypertension; Hypertrophy, Left Ventricular; Immunohistochemistry; Peptide Fragments; Rats; Rats, Transgenic; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Ventricular Remodeling | 2010 |
Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Fibrosis; Heart Ventricles; Imidazoles; Leucine; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Transgenic | 2010 |
High sucrose intake in rats is associated with increased ACE2 and angiotensin-(1-7) levels in the adipose tissue.
Topics: Adipose Tissue; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Base Sequence; Blood Glucose; Blotting, Western; Chromatography, High Pressure Liquid; DNA Primers; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Sucrose | 2010 |
Regulation of angiotensin converting enzyme II by angiotensin peptides in human cardiofibroblasts.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Fibroblasts; Humans; Mitogen-Activated Protein Kinase 3; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Signal Transduction; Up-Regulation | 2010 |
Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease.
Topics: Albuminuria; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Chronic Disease; Disease Models, Animal; Glomerular Filtration Rate; Hematocrit; Imidazoles; Infusion Pumps; Injections, Subcutaneous; Inulin; Kidney; Kidney Diseases; Leucine; Losartan; Male; Mice; Nephrectomy; Organ Size; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Time Factors | 2010 |
Angiotensin (1-7) and its receptor Mas are expressed in the human testis: implications for male infertility.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin I; Angiotensin-Converting Enzyme 2; Azoospermia; Biopsy; Gene Expression Regulation; Humans; Infertility, Male; Male; Middle Aged; Peptide Fragments; Peptidyl-Dipeptidase A; Protein Transport; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; RNA, Messenger; Testis; Young Adult | 2010 |
Angiotensin-(1-7) prevents diabetes-induced attenuation in PPAR-gamma and catalase activities.
Topics: Acetophenones; Angiotensin I; Animals; Antihypertensive Agents; Antioxidants; Blood Glucose; Blood Pressure; Catalase; Diabetes Mellitus, Experimental; Endothelin-1; Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating); Hyperglycemia; Hypertension; Kidney; Male; NADPH Oxidases; Peptide Fragments; PPAR gamma; Proteinuria; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Artery | 2010 |
Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice.
Topics: Acetylcholine; Angiotensin I; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Endothelium, Vascular; Imidazoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type III; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyridines; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Superoxides; Time Factors; Vasodilation; Vasodilator Agents | 2010 |
Vascular relaxation, antihypertensive effect, and cardioprotection of a novel peptide agonist of the MAS receptor.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Aorta; Arrhythmias, Cardiac; Disease Models, Animal; Heart; Hypertension; Male; Membrane Proteins; Mice; Mice, Knockout; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Vasodilation | 2010 |
ACE2-angiotensin-(1-7)-Mas axis in renal ischaemia/reperfusion injury in rats.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Kidney; Male; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Reperfusion Injury; Urine | 2010 |
Angiotensin II mediates epithelial-to-mesenchymal transformation in tubular cells by ANG 1-7/MAS-1-dependent pathways.
Topics: Actins; Angiotensin I; Angiotensin II; Animals; Cadherins; Cell Differentiation; Cell Line; Epithelial Cells; Imidazoles; Kidney Tubules; Mesoderm; Models, Animal; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction; Transforming Growth Factor beta1 | 2010 |
The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Bleomycin; Genetic Therapy; Hypertension, Pulmonary; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Transduction, Genetic | 2010 |
Angiotensin-(1-7) attenuates hyposmolarity-induced ANP secretion via the Na+-K+ pump.
Topics: Angiotensin I; Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic GMP; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Heart; Heart Atria; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Nitric Oxide; Osmolar Concentration; Peptide Fragments; Perfusion; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase; Stress, Physiological; Time Factors | 2010 |
Angiotensin-converting enzyme 2 autoantibodies: further evidence for a role of the renin-angiotensin system in inflammation.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Autoantibodies; Humans; Hypertension; Peptide Fragments; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Scleroderma, Systemic | 2010 |
Angiotensin-(1-7) and low-dose angiotensin II infusion reverse salt-induced endothelial dysfunction via different mechanisms in rat middle cerebral arteries.
Topics: Acetylcholine; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cerebral Arterial Diseases; Cerebral Arteries; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Imidazoles; Infusions, Intravenous; Losartan; Male; Nitroprusside; Peptide Fragments; Pyridines; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Superoxides; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2010 |
Angiotensin-(1-7), its receptor Mas, and the angiotensin-converting enzyme type 2 are expressed in the human ovary.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Autoradiography; Female; Fertilization in Vitro; Follicular Fluid; Humans; Immunohistochemistry; Iodine Radioisotopes; Middle Aged; Ovary; Ovulation Induction; Peptide Fragments; Peptidyl-Dipeptidase A; Postmenopause; Premenopause; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2011 |
Angiotensin-(1-7) upregulates cardiac nitric oxide synthase in spontaneously hypertensive rats.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Bradykinin; Disease Models, Animal; Heart Ventricles; Hypertension; Male; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Peptide Fragments; Phosphorylation; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 2; Up-Regulation | 2010 |
The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Atherosclerosis; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Enzyme Inhibitors; Humans; Imidazoles; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Monocytes; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Peptide Fragments; Peptides; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptors, G-Protein-Coupled; Tetrazoles | 2010 |
Angiotensin (1-7) receptor antagonism equalizes angiotensin II-induced hypertension in male and female spontaneously hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Blotting, Western; Female; Hypertension; Kidney Cortex; Male; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; Sex Factors; Vasoconstrictor Agents | 2010 |
Different effects of angiotensin II and angiotensin-(1-7) on vascular smooth muscle cell proliferation and migration.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Movement; Cell Proliferation; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Peptide Fragments; Phosphorylation; Receptor, Angiotensin, Type 1 | 2010 |
Angiotensin-(1-7) ameliorates myocardial remodeling and interstitial fibrosis in spontaneous hypertension: role of MMPs/TIMPs.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Collagen; Collagenases; Fibrosis; Hypertension; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardium; Myosin Heavy Chains; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tissue Inhibitor of Metalloproteinases | 2010 |
Angiotensin-(1-7) reduces fibrosis in orthotopic breast tumors.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Blotting, Western; Breast Neoplasms; Carcinoma, Ductal, Breast; Dual Specificity Phosphatase 1; Female; Fibronectins; Fibrosis; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Lung Diseases, Interstitial; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 3; Peptide Fragments; Phosphorylation; Transforming Growth Factor beta; Tumor Cells, Cultured | 2010 |
Role of the ACE2/angiotensin1-7/Mas axis in the cardiovascular system.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Cardiovascular System; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled | 2010 |
Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Antihypertensive Agents; Blood Pressure; Cardiovascular System; Female; Humans; Kidney; Male; Mice; Organ Specificity; Peptide Fragments; Peptidyl-Dipeptidase A; Pre-Eclampsia; Pregnancy; Rats; Receptors, Angiotensin; Renin-Angiotensin System | 2010 |
Angiotensin-(1-7) reduces proteinuria and diminishes structural damage in renal tissue of stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin I; Animals; Blood Pressure; Interleukin-6; Kidney; Male; Membrane Proteins; NF-kappa B; Peptide Fragments; Proteinuria; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium Chloride; Tumor Necrosis Factor-alpha | 2011 |
Angiotensin-(1-7) increases neuronal potassium current via a nitric oxide-dependent mechanism.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cell Line; Gene Expression Regulation; Membrane Potentials; Neurons; Nitric Oxide; Nitric Oxide Synthase Type I; Peptide Fragments; Potassium; Protein Isoforms; Receptors, Angiotensin; Signal Transduction | 2011 |
[Angiotensin-(1-7) reduced postangioplasty vascular fibrosis in abdominal aorta of rabbits].
Topics: Angiotensin I; Animals; Aorta, Abdominal; Collagen Type I; Collagen Type III; Fibrosis; Muscle, Smooth, Vascular; Peptide Fragments; Rabbits; Signal Transduction; Smad2 Protein; Transforming Growth Factor beta1 | 2010 |
Angiotensin II and angiotensin-(1-7) decrease sFlt1 release in normal but not preeclamptic chorionic villi: an in vitro study.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensins; Cells, Cultured; Chorionic Villi; Down-Regulation; Female; Humans; Middle Aged; Peptide Fragments; Placenta; Placental Circulation; Placental Lactogen; Pre-Eclampsia; Pregnancy; Protein Isoforms; Solubility; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Young Adult | 2010 |
Casein-derived tripeptide Ile-Pro-Pro improves angiotensin-(1-7)- and bradykinin-induced rat mesenteric artery relaxation.
Topics: Angiotensin I; Animals; Blood Pressure; Bradykinin; Captopril; Hypertension; Male; Mesenteric Arteries; Oligopeptides; Peptide Fragments; Rats; Vasodilator Agents | 2011 |
Knockout of angiotensin 1-7 receptor Mas worsens the course of two-kidney, one-clip Goldblatt hypertension: roles of nitric oxide deficiency and enhanced vascular responsiveness to angiotensin II.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Disease Progression; Hypertension, Renovascular; Male; Mice; Mice, Knockout; Nitric Oxide; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Surgical Instruments; Vasomotor System | 2010 |
Angiotensin-(1-7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiomegaly; Disease Models, Animal; Drug Evaluation, Preclinical; Hypertension; Male; Nephrectomy; Peptide Fragments; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Sprague-Dawley; Renal Insufficiency | 2011 |
Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cell Culture Techniques; Collagen; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Fibrosis; Heart; Hypertension; Male; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphorylation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Signal Transduction; Xanthones | 2011 |
[Effect of intracerebroventricular injection of angiotensin-(1-7) on pulmonary arterial pressure and body arterial pressure in rats].
Topics: Angiotensin I; Animals; Blood Pressure; Infusions, Intraventricular; Male; Peptide Fragments; Pulmonary Artery; Rats; Rats, Sprague-Dawley | 2008 |
[The effect of angiotensin-(1-7) on the mRNA expression of PDGF and TGF-beta1 in the kidney of diabetic rats].
Topics: Angiotensin I; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; Male; Peptide Fragments; Platelet-Derived Growth Factor; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta1 | 2008 |
Differential sympathetic activation induced by intermittent hypoxia and sleep loss in rats: Action of angiotensin (1-7).
Topics: Angiotensin I; Animals; Chromatography, High Pressure Liquid; Disease Models, Animal; Electrophysiology; Hemodynamics; Hypertension; Hypoxia; Male; Peptide Fragments; Rats; Rats, Wistar; Renin-Angiotensin System; Sleep Apnea Syndromes; Sleep Deprivation; Sympathetic Nervous System | 2011 |
Enhanced angiotensin-converting enzyme 2 attenuates angiotensin II-induced collagen production via AT1 receptor-phosphoinositide 3-kinase-Akt pathway.
Topics: Adenylyl Cyclase Inhibitors; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Cell Line; Collagen Type I; Collagen Type I, alpha 1 Chain; Kidney Failure, Chronic; Mesangial Cells; Mice; Molecular Targeted Therapy; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Receptor, Angiotensin, Type 1; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; RNA, Messenger; Signal Transduction; Transcriptional Activation | 2011 |
Angiotensin-(1-7): a new therapeutic strategy in the management of atrial fibrillation.
Topics: Angiotensin I; Antihypertensive Agents; Atrial Fibrillation; Humans; Peptide Fragments | 2011 |
Reciprocal changes in renal ACE/ANG II and ACE2/ANG 1-7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Disease Models, Animal; Hypertension, Renovascular; Kidney; Kidney Cortex; Kidney Medulla; Kidney Tubules, Collecting; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Renin; RNA, Messenger | 2011 |
Modulation of vein function by perivascular adipose tissue.
Topics: Adipose Tissue; Angiotensin I; Animals; Endothelium, Vascular; In Vitro Techniques; Male; Nitric Oxide; Peptide Fragments; Phenylephrine; Potassium Channels; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Vasoconstriction; Vasodilation; Vena Cava, Inferior | 2011 |
Angiotensin-converting enzyme 2 deficiency in whole body or bone marrow-derived cells increases atherosclerosis in low-density lipoprotein receptor-/- mice.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Atherosclerosis; Bone Marrow Cells; Bone Marrow Transplantation; Cell Adhesion; Cells, Cultured; Coculture Techniques; Culture Media, Conditioned; Cytokines; Dietary Fats; Disease Models, Animal; Endothelial Cells; Humans; Inflammation Mediators; Losartan; Macrophages; Male; Mice; Mice, Knockout; Monocytes; Peptide Fragments; Peptidyl-Dipeptidase A; Receptors, LDL | 2011 |
An oral formulation of angiotensin-(1-7) produces cardioprotective effects in infarcted and isoproterenol-treated rats.
Topics: Administration, Oral; Analysis of Variance; Angiotensin I; Animals; Blood Pressure; Cardiomegaly; Cardiotonic Agents; Echocardiography; Heart; Heart Rate; Isoproterenol; Male; Myocardial Infarction; Peptide Fragments; Rats; Rats, Wistar | 2011 |
Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit.
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Cardiomyopathy, Dilated; Disease Models, Animal; Enzyme Activation; Extracellular Matrix; Heart Failure; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; NADPH Oxidases; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphorylation; Stress, Mechanical; Superoxides; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2011 |
Angiotensin-(1-7) blockade attenuates captopril- or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-L-arginine methyl ester.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Brain; Captopril; Cytokines; Heart; Hydralazine; Hypertension; In Vitro Techniques; Insulin; Kidney; Leptin; Male; Myocardial Contraction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Peptide Fragments; Perfusion; Proteinuria; Rats; Rats, Inbred SHR; Ventricular Function, Left | 2011 |
Renin angiotensin system and cardiac hypertrophy after sinoaortic denervation in rats.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Carotid Sinus; Collagen; Denervation; Disease Models, Animal; Heart Ventricles; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Male; Peptide Fragments; Random Allocation; Rats; Rats, Wistar; Renin-Angiotensin System | 2010 |
Impairment of the Plasmodium falciparum erythrocytic cycle induced by angiotensin peptides.
Topics: Angiotensin I; Angiotensin II; Animals; Cells, Cultured; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Erythrocytes; Humans; Life Cycle Stages; Malaria, Falciparum; Peptide Fragments; Peptides; Plasmodium falciparum; Rats; Renin-Angiotensin System; Schizonts | 2011 |
Attenuating effect of angiotensin-(1-7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-A(y)/Ta mice.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Blotting, Western; Body Weight; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Immunohistochemistry; Mesangial Cells; Mice; NADPH Oxidases; Peptide Fragments; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Statistics, Nonparametric | 2011 |
Chronic treatment with angiotensin-(1-7) improves renal endothelial dysfunction in apolipoproteinE-deficient mice.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Apolipoproteins E; Atherosclerosis; Cyclic GMP; Dose-Response Relationship, Drug; Endothelium, Vascular; Hydrogen Peroxide; Infusion Pumps, Implantable; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Peptide Fragments; Perfusion; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Vasodilation | 2011 |
Ang-(1-7) might prevent the development of monocrotaline induced pulmonary arterial hypertension in rats.
Topics: Angiotensin I; Animals; Familial Primary Pulmonary Hypertension; Hemodynamics; Hypertension, Pulmonary; Male; Monocrotaline; Nitric Oxide Synthase Type III; Peptide Fragments; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley | 2011 |
Regulation of angiotensin-converting enzyme 2 and Mas receptor by Ang-(1-7) in heart and kidney of spontaneously hypertensive rats.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Blotting, Western; Gene Expression Regulation; Kidney; Male; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Inbred SHR; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, G-Protein-Coupled; RNA, Messenger; Systole | 2011 |
Purification and characterization of angiotensin converting enzyme 2 (ACE2) from murine model of mesangial cell in culture.
Topics: Amino Acid Sequence; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blotting, Western; Cells, Cultured; Chromatography, Ion Exchange; Electrophoresis, Polyacrylamide Gel; Kinetics; Mesangial Cells; Mice; Microscopy, Fluorescence; Peptide Fragments; Peptidyl-Dipeptidase A; Sequence Analysis, DNA | 2011 |
Inhibition of Ras-GTPase farnesylation and the ubiquitin-proteasome system or treatment with angiotensin-(1-7) attenuates spinal cord injury-induced cardiac dysfunction.
Topics: Angiotensin I; Animals; Cardiovascular Diseases; Disease Models, Animal; Peptide Fragments; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Prenylation; ras Proteins; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Ubiquitin | 2011 |
The effect of angiotensin (1-7) on survival of random pattern skin flaps with nicotine-induced ischemia in rats.
Topics: Angiogenesis Inducing Agents; Angiotensin I; Animals; Female; Graft Survival; Ischemia; Necrosis; Neovascularization, Physiologic; Nicotine; Peptide Fragments; Rats; Rats, Sprague-Dawley; Skin Transplantation; Surgical Flaps; Vasodilation; Vasodilator Agents | 2012 |
Beneficial effects of angiotensin (1-7) in diabetic rats with cardiomyopathy.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Glucose; Collagen; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Dyslipidemias; Fibrosis; Heart Ventricles; Hypertrophy, Left Ventricular; Lipids; Nitrates; Nitrites; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2011 |
The angiotensin-(1-7)/Mas receptor axis is expressed in sinoatrial node cells of rats.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Immunohistochemistry; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Sinoatrial Node | 2011 |
Different isoforms of nitric oxide synthase are involved in angiotensin-(1-7)-mediated plasticity changes in the amygdala in a gender-dependent manner.
Topics: Amygdala; Angiotensin I; Animals; Enzyme Inhibitors; Female; Isoenzymes; Long-Term Potentiation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuronal Plasticity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Sex Characteristics | 2011 |
Regulation of alveolar epithelial cell survival by the ACE-2/angiotensin 1-7/Mas axis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Bleomycin; Cell Line; Cell Survival; Epithelial Cells; Mice; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pulmonary Alveoli; Rats; Receptors, G-Protein-Coupled | 2011 |
Angiotensin-(1-7) induces ovulation and steroidogenesis in perfused rabbit ovaries.
Topics: Angiotensin I; Angiotensin II; Animals; Chorionic Gonadotropin; Estradiol; Female; Gonadotropins, Equine; Oocytes; Ovarian Follicle; Ovary; Ovulation; Peptide Fragments; Perfusion; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rabbits; Receptors, G-Protein-Coupled | 2011 |
Angiotensin (1-7) induces MAS receptor internalization.
Topics: Angiotensin I; Cells, Cultured; Clathrin; Endocytosis; Endosomes; HEK293 Cells; Humans; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2011 |
Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diminazene; Endothelin-1; Enzyme Activation; Infarction, Middle Cerebral Artery; Male; Nitric Oxide Synthase Type II; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Stroke | 2011 |
Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Interleukin-10; Interleukin-6; Lentivirus; Male; Myocardial Ischemia; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B2; Renin-Angiotensin System; Transduction, Genetic; Ventricular Remodeling | 2011 |
Role of angiotensin-(1-7) in rostral ventrolateral medulla in blood pressure regulation via sympathetic nerve activity in Wistar-Kyoto and spontaneous hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Disease Models, Animal; Hypertension; Male; Medulla Oblongata; Microinjections; Peptide Fragments; Peptides; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sympathetic Nervous System; Tetrazoles; Valine; Valsartan | 2011 |
Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation.
Topics: Adenocarcinoma; Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers, Tumor; Biphenyl Compounds; Captopril; Colorectal Neoplasms; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Gene Expression Regulation, Neoplastic; Irbesartan; Liver Neoplasms, Experimental; Mice; Mice, Inbred CBA; Molecular Targeted Therapy; Neoplasm Proteins; Neovascularization, Pathologic; Oligopeptides; Peptide Fragments; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Tetrazoles; Tumor Burden; Up-Regulation; Vascular Endothelial Growth Factor A | 2011 |
Aerobic exercise training-induced left ventricular hypertrophy involves regulatory MicroRNAs, decreased angiotensin-converting enzyme-angiotensin ii, and synergistic regulation of angiotensin-converting enzyme 2-angiotensin (1-7).
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Female; Hemodynamics; Hypertrophy, Left Ventricular; MicroRNAs; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Physical Conditioning, Animal; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2011 |
Angiotensin II and pulmonary fibrosis, a new twist on an old story.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cell Survival; Epithelial Cells; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2011 |
Angiotensin-(1-7) decreases LPS-induced inflammatory response in macrophages.
Topics: Angiotensin I; Animals; Cells, Cultured; Cytokines; HEK293 Cells; Humans; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; src-Family Kinases | 2012 |
An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect.
Topics: Angiotensin I; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinolytic Agents; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Rats; Rats, Inbred SHR; Venous Thrombosis | 2011 |
ACE2 and Ang-(1-7) confer protection against development of diabetic retinopathy.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Dependovirus; Diabetic Retinopathy; Disease Models, Animal; Enzyme Activation; Gene Expression; Gene Order; Genetic Therapy; Genetic Vectors; Intravitreal Injections; Male; Mice; Mice, Knockout; Nitric Oxide Synthase Type III; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Retina; Retinal Vessels | 2012 |
Acute and chronic angiotensin-(1-7) restores vasodilation and reduces oxidative stress in mesenteric arteries of salt-fed rats.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Blotting, Western; Ethidium; Fluorescent Dyes; Male; Mesenteric Arteries; Nitric Oxide; Oligopeptides; Oxidative Stress; Peptide Fragments; Rats; Rats, Sprague-Dawley; Sodium, Dietary; Superoxide Dismutase; Superoxides; Up-Regulation; Vasodilation; Vasodilator Agents | 2011 |
Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway.
Topics: Angiotensin I; Angiotensin II; Animals; Body Weight; Diabetes Mellitus; ErbB Receptors; Glucose; Hyperglycemia; Male; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Quinazolines; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; src-Family Kinases; Transcriptional Activation; Tyrphostins | 2012 |
Mas receptors in modulating relaxation induced by perivascular adipose tissue.
Topics: Adipose Tissue; Angiotensin I; Animals; Aorta, Thoracic; Endothelium, Vascular; Mice; Mice, Knockout; Peptide Fragments; Phenylephrine; Potassium Chloride; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Vasoconstrictor Agents; Vasodilation | 2011 |
Molecular characterization and regulation of the angiotensin-converting enzyme type 2/angiotensin-(1-7)/MAS receptor axis during the ovulation process in cattle.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cattle; Female; Follicular Fluid; Gene Expression Regulation; Granulosa Cells; Models, Animal; Neprilysin; Ovariectomy; Ovulation; Peptide Fragments; Peptidyl-Dipeptidase A; Prolyl Oligopeptidases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Reproducibility of Results; RNA, Messenger; Serine Endopeptidases; Signal Transduction; Theca Cells | 2012 |
Central angiotensin (1-7) enhances baroreflex gain in conscious rabbits with heart failure.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Baroreflex; Chronic Disease; Consciousness; Disease Models, Animal; Heart Failure; Heart Rate; Infusions, Intraventricular; Kidney; Male; Metoprolol; Peptide Fragments; Rabbits; Sympathetic Nervous System; Vagus Nerve | 2011 |
Toxicological and toxicokinetic analysis of angiotensin (1-7) in two species.
Topics: Angiotensin I; Animals; Dogs; Female; Half-Life; Injections, Intravenous; Male; Peptide Fragments; Pharmacokinetics; Rats; Rats, Sprague-Dawley | 2012 |
Effects of angiotensin (1-7) upon right ventricular function in experimental rat pulmonary embolism.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Disease Models, Animal; Immunohistochemistry; Male; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Pulmonary Embolism; Rats; Rats, Sprague-Dawley; Ventricular Dysfunction, Right; Ventricular Function, Right | 2011 |
Swimming training improves the vasodilator effect of angiotensin-(1-7) in the aorta of spontaneously hypertensive rat.
Topics: Acetylcholine; Angiotensin I; Animals; Aorta; Endothelium, Vascular; Isometric Contraction; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Inbred SHR; Rats, Wistar; Receptors, G-Protein-Coupled; Swimming; Vasodilation; Vasodilator Agents | 2011 |
[Influence of angiotensin-(1-7) on angiotensin II induced rat's tubular epithelial-myofibroblast transdifferentiation].
Topics: Actins; Angiotensin I; Angiotensin II; Animals; Cadherins; Cell Line; Cell Transdifferentiation; Epithelial Cells; Fibronectins; Gene Expression Regulation; Kidney Tubules; Matrix Metalloproteinase 2; Myofibroblasts; Peptide Fragments; Rats; RNA, Messenger | 2011 |
The angiotensin-converting enzyme 2-angiotensin-(1-7) axis: the other side of the renin-angiotensin system.
Topics: Angiotensin I; Animals; Infarction, Middle Cerebral Artery; Male; Peptide Fragments; Stroke | 2011 |
Cardioprotective effects of telmisartan against heart failure in rats induced by experimental autoimmune myocarditis through the modulation of angiotensin-converting enzyme-2/angiotensin 1-7/mas receptor axis.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Benzimidazoles; Benzoates; Biomarkers; Cytokines; Disease Models, Animal; Endoplasmic Reticulum; Heart Failure; Male; Mitogen-Activated Protein Kinases; Myocarditis; NADPH Oxidases; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Protective Agents; Protein Subunits; Rats; Signal Transduction; Superoxides; Telmisartan | 2011 |
Angiotensin-converting enzyme inhibition, but not AT(1) receptor blockade, in the solitary tract nucleus improves baroreflex sensitivity in anesthetized transgenic hypertensive (mRen2)27 rats.
Topics: Anesthesia; Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Baroreflex; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Heart Rate; Hypertension; Male; Microinjections; Oligopeptides; Peptide Fragments; Rats; Rats, Transgenic; Solitary Nucleus; Tetrazoles | 2011 |
Direct renin inhibition in a rat model of chronic allograft injury.
Topics: Amides; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Fumarates; Kidney; Kidney Transplantation; Male; Models, Animal; Peptide Fragments; Rats; Rats, Inbred F344; Rats, Inbred Lew; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Tetrazoles; Transplantation, Homologous | 2011 |
Regulation of angiotensin-(1-7) and angiotensin II type 1 receptor by telmisartan and losartan in adriamycin-induced rat heart failure.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Animals; Antibiotics, Antineoplastic; Benzimidazoles; Benzoates; Doxorubicin; Gene Expression Regulation; Heart; Heart Failure; Losartan; Male; Myocardium; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Telmisartan | 2011 |
Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist.
Topics: Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Animals; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Intubation, Intratracheal; Lipopolysaccharides; Losartan; Lung; Macrophages, Alveolar; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome | 2011 |
Maternal protein restriction reduces expression of angiotensin I-converting enzyme 2 in rat placental labyrinth zone in late pregnancy.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Diet, Protein-Restricted; Female; Fetal Growth Retardation; Male; Maternal Nutritional Physiological Phenomena; Models, Animal; Peptide Fragments; Peptidyl-Dipeptidase A; Placenta; Pregnancy; Pregnancy, Animal; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger | 2012 |
Brain-selective overexpression of angiotensin-converting enzyme 2 attenuates sympathetic nerve activity and enhances baroreflex function in chronic heart failure.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Baroreflex; Enzyme Induction; Heart Failure; Humans; Male; Medulla Oblongata; Mice; Mice, Knockout; Myocardial Ischemia; Nerve Tissue Proteins; Nitric Oxide; Norepinephrine; Organ Specificity; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, Angiotensin; Receptors, G-Protein-Coupled; Recombinant Fusion Proteins; Reflex, Abnormal; Sympathetic Nervous System | 2011 |
Angiotensin-(1-7) through Mas receptor up-regulates neuronal norepinephrine transporter via Akt and Erk1/2-dependent pathways.
Topics: Angiotensin I; Animals; Blotting, Western; Cells, Cultured; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neurons; Norepinephrine Plasma Membrane Transport Proteins; Oncogene Protein v-akt; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction; Up-Regulation | 2012 |
The arterial depressor response to chronic low-dose angiotensin II infusion in female rats is estrogen dependent.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Dose-Response Relationship, Drug; Estradiol; Estrogens; Female; Infusions, Subcutaneous; Kidney; Models, Animal; Ovariectomy; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Signal Transduction; Vasoconstrictor Agents | 2012 |
Angiotensin-(1-7) suppresses oxidative stress and improves glucose uptake via Mas receptor in adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Adiponectin; Angiotensin I; Animals; Cells, Cultured; Gene Expression; Glucose; Insulin Resistance; Male; Mice; NADPH Oxidases; Oxidative Stress; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Reactive Oxygen Species; Receptors, G-Protein-Coupled; RNA, Messenger | 2012 |
Characterization and significance of ACE2 and Mas receptor in human colon adenocarcinoma.
Topics: Adenocarcinoma; Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Caco-2 Cells; Cell Cycle; Colonic Neoplasms; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Intestinal Mucosa; Male; Middle Aged; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled | 2012 |
Angiotensin-(1-7)/Mas axis integrity is required for the expression of object recognition memory.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Hippocampus; Imidazoles; Losartan; Mice; Mice, Knockout; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyridines; Receptors, Angiotensin; Receptors, G-Protein-Coupled; Recognition, Psychology | 2012 |
Angiotensin-(1-7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the PI3K/Akt and MAPK signaling pathways.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Angiotensin I; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Lung Neoplasms; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mitogen-Activated Protein Kinase Kinases; Neoplasm Invasiveness; Neovascularization, Pathologic; Peptide Fragments; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Renin-Angiotensin System; Signal Transduction; Survival | 2012 |
Attenuation of hypertension-mediated glomerulosclerosis in conjunction with increased angiotensin (1-7).
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Animals; Atenolol; Blood Pressure; Hemodynamics; Hypertension; Imidazoles; Kidney Diseases; Kidney Glomerulus; Male; Olmesartan Medoxomil; Peptide Fragments; Rats; Rats, Inbred SHR; Sclerosis; Tetrazoles | 2011 |
Decidualized pseudopregnant rat uterus shows marked reduction in Ang II and Ang-(1-7) levels.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blastocyst; Cell Polarity; Decidua; Down-Regulation; Embryo Implantation; Female; Isoenzymes; Models, Biological; Peptide Fragments; Peptidyl-Dipeptidase A; Protein Transport; Pseudopregnancy; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; RNA, Messenger; Uterus | 2012 |
Candesartan cilexetil protects from cardiac myosin induced cardiotoxicity via reduction of endoplasmic reticulum stress and apoptosis in rats: involvement of ACE2-Ang (1-7)-mas axis.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Apoptosis Regulatory Proteins; Autoimmune Diseases; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Cell Survival; Endoplasmic Reticulum Stress; Heart Diseases; Immunohistochemistry; In Situ Nick-End Labeling; Male; Myocarditis; Myosins; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Inbred Lew; Receptors, G-Protein-Coupled; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Signal Transduction; Tetrazoles | 2012 |
Angiotensin-(1-7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Cardiomegaly; Drug Interactions; Dual Specificity Phosphatase 1; Fibrosis; Hypertension; Male; MAP Kinase Signaling System; Myocardium; Peptide Fragments; Rats; Rats, Sprague-Dawley; Up-Regulation; Vasoconstrictor Agents; Ventricular Remodeling | 2012 |
Angiotensin-(1-7)-induced activation of ERK1/2 is cAMP/protein kinase A-dependent in glomerular mesangial cells.
Topics: Acetophenones; Angiotensin I; Angiotensin II; Animals; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; MAP Kinase Signaling System; Mesangial Cells; Peptide Fragments; Phosphorylation; Rats; Rats, Sprague-Dawley | 2012 |
Angiotensin-(1-7) attenuates the chronotropic response to angiotensin II via stimulation of PTEN in the spontaneously hypertensive rat neurons.
Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Cells, Cultured; Chromones; Enzyme Inhibitors; Heart Rate; Hypothalamus; Male; Morpholines; Neurons; Peptide Fragments; PTEN Phosphohydrolase; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vanadium Compounds | 2012 |
Olmesartan attenuates the development of heart failure after experimental autoimmune myocarditis in rats through the modulation of ANG 1-7 mas receptor.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Autoimmune Diseases; Cardiotonic Agents; Endoplasmic Reticulum Stress; Heart Failure; Imidazoles; Inflammation; JNK Mitogen-Activated Protein Kinases; Membrane Glycoproteins; Myocarditis; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphatidylinositol 3-Kinases; Phosphoproteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Receptors, Interleukin-1; RNA, Messenger; Tetrazoles | 2012 |
Angiotensin-(1-7) deficiency and baroreflex impairment precede the antenatal Betamethasone exposure-induced elevation in blood pressure.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Baroreflex; Benzimidazoles; Betamethasone; Biphenyl Compounds; Blood Pressure; Disease Models, Animal; Female; Glucocorticoids; Heart Rate; Hypertension; Peptide Fragments; Pregnancy; Prenatal Exposure Delayed Effects; Receptor, Angiotensin, Type 1; Sheep; Tetrazoles | 2012 |
Evidence that angiotensin-(1-7) is an intermediate of gonadotrophin-induced oocyte maturation in the rat preovulatory follicle.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Chorionic Gonadotropin; Female; Gonadotropins, Equine; Horses; Humans; Luteinizing Hormone; Oocytes; Ovarian Follicle; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2012 |
Role of renin-angiotensin system and oxidative status on the maternal cardiovascular regulation in spontaneously hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Female; Hypertension; Nitric Oxide Synthase Type III; Peptide Fragments; Peptidyl-Dipeptidase A; Pregnancy; Pregnancy Complications, Cardiovascular; Rats; Rats, Inbred SHR; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2012 |
Postnatal ontogeny of angiotensin receptors and ACE2 in male and female rats.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Female; Gene Expression; Kidney; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; RNA, Messenger; Sex Factors | 2012 |
Hemodynamic effects of vasorelaxant compounds in mice lacking one, two or all three angiotensin II receptors.
Topics: Acetylcholine; Angiotensin I; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Bradykinin; Heart Rate; Hemodynamics; Male; Mice; Peptide Fragments; Receptors, Angiotensin; Renin-Angiotensin System; Vasodilator Agents | 2012 |
Angiotensin-(1-7) attenuates high glucose-induced proximal tubular epithelial-to-mesenchymal transition via inhibiting ERK1/2 and p38 phosphorylation.
Topics: Actins; Analysis of Variance; Angiotensin I; Animals; Blotting, Western; Cell Line; DNA Primers; Enzyme-Linked Immunosorbent Assay; Epithelial-Mesenchymal Transition; Fluorescence; Glucose; Immunohistochemistry; Kidney Tubules, Proximal; MAP Kinase Signaling System; Peptide Fragments; Phosphorylation; Rats; Real-Time Polymerase Chain Reaction | 2012 |
Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7).
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Atrial Natriuretic Factor; Diabetes Mellitus; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Peptidyl-Dipeptidase A; Random Allocation; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Renin-Angiotensin System | 2012 |
Angiotensin-(1-7) inhibits vascular remodelling in rat jugular vein grafts via reduced ERK1/2 and p38 MAPK activity.
Topics: Actins; Angiotensin I; Angiotensin II; Animals; Blood Vessel Prosthesis; Body Weight; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Hemodynamics; Infusions, Intravenous; Jugular Veins; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Transplantation, Autologous | 2011 |
Angiotensin-(1-7) abrogates mitogen-stimulated proliferation of cardiac fibroblasts.
Topics: Angiotensin I; Angiotensin II; Animals; Animals, Newborn; Cell Proliferation; Cells, Cultured; Collagen; Cyclooxygenase 2; DNA; Dual Specificity Phosphatase 1; Endothelin-1; Fibroblasts; Fibrosis; Gene Expression Regulation; Heart Diseases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardium; Peptide Fragments; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Rats; Signal Transduction | 2012 |
Angiotensin-(1-7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2- and NF-κB-dependent pathways.
Topics: Allergens; Angiotensin I; Angiotensin II; Animals; Asthma; Bronchoalveolar Lavage Fluid; Cell Proliferation; Cells, Cultured; Humans; Leukocytes, Mononuclear; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; NF-kappa B; Ovalbumin; Peptide Fragments; Phytohemagglutinins; Pneumonia; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2012 |
Differential regulation of circulating and renal ACE2 and ACE in hypertensive mRen2.Lewis rats with early-onset diabetes.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biomarkers; Blood Pressure; Blotting, Western; C-Reactive Protein; Chromatography, High Pressure Liquid; Collagen; Diabetes Mellitus, Experimental; Female; Hypertension; Immunohistochemistry; Kidney; Male; Muscle Contraction; Muscle, Smooth, Vascular; Neprilysin; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Lew; Renin; Renin-Angiotensin System; Sex Characteristics; Vascular Endothelial Growth Factor A | 2012 |
Accelerated hematopoietic recovery with angiotensin-(1-7) after total body radiation.
Topics: Anemia; Angiotensin I; Animals; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Administration Schedule; Female; Hematopoiesis; Hematopoietic Stem Cells; Leukopenia; Mice; Mice, Inbred C57BL; Peptide Fragments; Radiation-Protective Agents; Renin-Angiotensin System; Thrombocytopenia; Whole-Body Irradiation | 2012 |
Angiotensin-(1-7) administration reduces oxidative stress in diabetic bone marrow.
Topics: Angiotensin I; Animals; Bone Marrow; Diabetes Mellitus; Male; Mice; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidative Stress; Peptide Fragments; Reactive Oxygen Species | 2012 |
Angiotensin-(1-7) suppresses the number and function of the circulating fibrocytes by upregulating endothelial nitric oxide synthase expression.
Topics: Angiotensin I; Angiotensin II; Apoptosis; Blood Cells; Cell Proliferation; Cells, Cultured; Collagen Type I; Fibroblasts; Humans; Hydroxyproline; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Peptide Fragments; Up-Regulation | 2012 |
Angiotensin-(1-7) receptor Mas agonist ameliorates progress of atherosclerosis in apoE-knockout mice.
Topics: Angiotensin I; Animals; Antigens, CD; Aorta; Apolipoproteins E; Atherosclerosis; CD4-Positive T-Lymphocytes; Dendritic Cells; Female; Imidazoles; Lipids; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Perindopril; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, Angiotensin; Receptors, G-Protein-Coupled; Thiorphan | 2012 |
Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 mice.
Topics: 3T3-L1 Cells; Adipocytes; Adiposity; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Diet, High-Fat; Disease Models, Animal; Estrogens; Female; Gene Expression Regulation, Enzymologic; Hypertension; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Ovariectomy; Peptide Fragments; Peptidyl-Dipeptidase A; Progesterone; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Risk Factors; RNA, Messenger; Sex Factors; Testosterone; Time Factors; Weight Gain | 2012 |
Angiotensin-(1-7) attenuates hypertension in exercise-trained renal hypertensive rats.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Blood Pressure; Cardiotonic Agents; Disease Models, Animal; Heart Ventricles; Hypertension, Renal; Hypertrophy, Left Ventricular; Kidney; Male; Nitric Oxide Synthase Type III; Peptide Fragments; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Surgical Instruments; Swimming | 2012 |
Angiotensin-(1-7) upregulates central nitric oxide synthase in spontaneously hypertensive rats.
Topics: Angiotensin I; Animals; Blood Pressure; Hypertension; Hypothalamus; Male; Nitric Oxide Synthase Type I; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Up-Regulation | 2012 |
Angiotensin-(1-7) attenuates diabetic nephropathy in Zucker diabetic fatty rats.
Topics: Acute-Phase Proteins; Angiotensin I; Animals; Blood Pressure; Diabetic Nephropathies; Fibrosis; Hypertriglyceridemia; Hypoxia-Inducible Factor 1, alpha Subunit; Interleukin-6; Kidney; Lipocalin-2; Lipocalins; Male; Oxidative Stress; Peptide Fragments; Proteinuria; Proto-Oncogene Proteins; Rats; Rats, Zucker; Tumor Necrosis Factor-alpha | 2012 |
Olmesartan medoxomil treatment potently improves cardiac myosin-induced dilated cardiomyopathy via the modulation of ACE-2 and ANG 1-7 mas receptor.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Biomarkers; Cardiac Myosins; Cardiomyopathy, Dilated; Endopeptidases; Fibrosis; Gene Expression Regulation; Heart; Hypertrophy, Left Ventricular; Imidazoles; Mitogen-Activated Protein Kinases; Olmesartan Medoxomil; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptors, G-Protein-Coupled; RNA, Messenger; Tetrazoles | 2012 |
Time-resolved quantitative phosphoproteomics: new insights into Angiotensin-(1-7) signaling networks in human endothelial cells.
Topics: Active Transport, Cell Nucleus; Angiotensin I; Aorta; Cell Line, Tumor; Cell Nucleus; Endothelial Cells; Forkhead Box Protein O1; Forkhead Transcription Factors; Humans; Molecular Sequence Annotation; Peptide Fragments; Phosphoproteins; Phosphorylation; Protein Interaction Maps; Protein Processing, Post-Translational; Proteome; Proteomics; Signal Transduction | 2012 |
The cardiac expression of Mas receptor is responsive to different physiological and pathological stimuli.
Topics: Angiotensin I; Animals; Cardiomegaly; Desoxycorticosterone; Hypertension; Isoproterenol; Male; Motor Activity; Myocardial Infarction; Myocardium; Peptide Fragments; Physical Conditioning, Animal; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, G-Protein-Coupled | 2012 |
Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Blotting, Western; Cardiotonic Agents; Cells, Cultured; Drug Synergism; Enzyme Activation; Female; Heart; Heart Failure; Irbesartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; NADPH Oxidases; Peptide Fragments; Peptidyl-Dipeptidase A; Reverse Transcriptase Polymerase Chain Reaction; Superoxides; Systole; Tetrazoles | 2012 |
Modeling of angiotensin II-angiotensin-(1-7) counterbalance in disease progression in spontaneously hypertensive rats treated with/without perindopril.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Hypertension; Male; Models, Biological; Peptide Fragments; Perindopril; Rats; Rats, Inbred SHR | 2012 |
In vivo expression of angiotensin-(1-7) lowers blood pressure and improves baroreflex function in transgenic (mRen2)27 rats.
Topics: Angiotensin I; Animals; Arterial Pressure; Autonomic Nervous System; Baroreflex; Brain; Disease Models, Animal; Dual Specificity Phosphatase 1; Gene Expression Regulation; Gene Transfer Techniques; Genetic Therapy; Heart Rate; Hypertension; Injections; Male; Mice; Neprilysin; Peptide Fragments; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Rats; Rats, Transgenic; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; RNA, Messenger; Time Factors | 2012 |
Counteraction between angiotensin II and angiotensin-(1-7) via activating angiotensin type I and Mas receptor on rat renal mesangial cells.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blotting, Western; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; Drug Interactions; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Glomerular Mesangium; Imidazoles; Losartan; MAP Kinase Signaling System; Mesangial Cells; Microscopy, Confocal; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyridines; Rats; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Receptors, G-Protein-Coupled; Transforming Growth Factor beta1 | 2012 |
The Mas receptor mediates modulation of insulin signaling by angiotensin-(1-7).
Topics: Adipose Tissue; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Dyslipidemias; Fructose; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; GTPase-Activating Proteins; Hypertension; Insulin; Insulin Resistance; Liver; Male; Muscle, Skeletal; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Signal Transduction | 2012 |
Characterization of Angiotensin-(1-7) effects on the cardiovascular system in an experimental model of type-1 diabetes.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Captopril; Cardiovascular System; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Endothelin-1; Hyperglycemia; Kidney; Losartan; Male; NADPH Oxidases; Peptide Fragments; Peptides; Peptidyl-Dipeptidase A; Prostaglandins; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Reperfusion Injury | 2012 |
High Na intake increases renal angiotensin II levels and reduces expression of the ACE2-AT(2)R-MasR axis in obese Zucker rats.
Topics: Actins; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensinogen; Animals; Blood Pressure; Chromatography, High Pressure Liquid; Hypertension, Renal; Kidney; Kidney Cortex; Male; Mass Spectrometry; Obesity; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Zucker; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin; Sodium, Dietary; Spectrometry, Mass, Electrospray Ionization | 2012 |
Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1.
Topics: Adenocarcinoma; Angiotensin I; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Humans; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Peptide Fragments; Placenta Growth Factor; Pregnancy Proteins; Prostatic Neoplasms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Xenograft Model Antitumor Assays | 2013 |
Angiotensin-(1-7) attenuates metastatic prostate cancer and reduces osteoclastogenesis.
Topics: Adenocarcinoma; Aged; Angiotensin I; Animals; Antineoplastic Agents; Bone Marrow Cells; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Humans; Male; Mice; Mice, Nude; Mice, SCID; Middle Aged; Neoplasm Metastasis; Osteoclasts; Peptide Fragments; Prostatic Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2013 |
Regulation of the renin-angiotensin system (RAS) in BeWo and HTR-8/SVneo trophoblast cell lines.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Cell Line, Transformed; Cell Line, Tumor; Choriocarcinoma; Cyclic AMP; Gene Expression Regulation; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Protein Precursors; Proto-Oncogene Mas; Proto-Oncogene Proteins; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Secretory Pathway; Signal Transduction; Trophoblasts | 2012 |
Chronic infusion of angiotensin-(1-7) into the lateral ventricle of the brain attenuates hypertension in DOCA-salt rats.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Brain; Collagen Type I; Collagen Type III; Desoxycorticosterone; Disease Models, Animal; Heart Rate; Heart Ventricles; Hypertension; Infusions, Intraventricular; Kidney; Lateral Ventricles; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sympathetic Nervous System; Time Factors | 2012 |
Possible involvement of angiotensin-converting enzyme 2 and Mas activation in inhibitory effects of angiotensin II Type 1 receptor blockade on vascular remodeling.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Femoral Artery; Immunohistochemistry; Mice; Mice, Inbred C57BL; Mice, Knockout; Neointima; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; Tunica Intima | 2012 |
Tissue specific localization of angiotensin-(1-7) and its receptor Mas in the uterus of ovariectomized rats.
Topics: Angiotensin I; Animals; Estrogens; Female; Gene Expression Regulation; Humans; Immunohistochemistry; Medroxyprogesterone Acetate; Myometrium; Ovariectomy; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Uterus | 2012 |
Intrarenal angiotensin III is the predominant agonist for proximal tubule angiotensin type 2 receptors.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin III; Animals; Benzimidazoles; Biphenyl Compounds; Female; Imidazoles; Kidney Tubules, Proximal; Models, Animal; Natriuresis; Peptide Fragments; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Tetrazoles | 2012 |
Central ventilatory and cardiovascular actions of angiotensin peptides in trout.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Animals; Blood Pressure; Cardiovascular Physiological Phenomena; Dose-Response Relationship, Drug; Female; Gills; Heart Rate; Injections, Intraventricular; Male; Peptide Fragments; Time Factors; Trout | 2012 |
Angiotensin-(1-7) via the mas receptor alleviates the diabetes-induced decrease in GFAP and GAP-43 immunoreactivity with concomitant reduction in the COX-2 in hippocampal formation: an immunohistochemical study.
Topics: Angiotensin I; Animals; Cyclooxygenase 2; Diabetes Mellitus, Experimental; GAP-43 Protein; Glial Fibrillary Acidic Protein; Hippocampus; Male; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled | 2012 |
Angiotensin-(1-7) inhibits neuronal activity of dorsolateral periaqueductal gray via a nitric oxide pathway.
Topics: Angiotensin I; Animals; Citrulline; Female; Male; Neurons; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Patch-Clamp Techniques; Peptide Fragments; Periaqueductal Gray; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Signal Transduction; Thiourea | 2012 |
Captopril intake decreases body weight gain via angiotensin-(1-7).
Topics: Adipocytes; Adipose Tissue; Adiposity; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cell Size; Cells, Cultured; Epididymis; Glycerol; Lipolysis; Male; Peptide Fragments; Primary Cell Culture; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Sterol Esterase; Weight Gain | 2012 |
Increased circulating angiotensin-(1-7) protects white adipose tissue against development of a proinflammatory state stimulated by a high-fat diet.
Topics: Adipokines; Adiposity; Angiotensin I; Animals; Blood Glucose; Cholesterol, HDL; Diet, High-Fat; Epididymis; Inflammation; Inflammation Mediators; Interleukin-1beta; Intra-Abdominal Fat; Male; Obesity; Oxidative Stress; Peptide Fragments; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Tumor Necrosis Factor-alpha | 2012 |
[Angiotensin(1-7) attenuates left ventricular dysfunction and myocardial apoptosis on rat model of adriamycin-induced dilated cardiomyopathy].
Topics: Angiotensin I; Animals; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Cardiomyopathy, Dilated; Caspase 3; Doxorubicin; Heart; Male; Myocytes, Cardiac; Peptide Fragments; Rats; Rats, Wistar; Ventricular Dysfunction, Left | 2012 |
Angiotensin II-induced mitochondrial Nox4 is a major endogenous source of oxidative stress in kidney tubular cells.
Topics: Acetophenones; Angiotensin I; Angiotensin II; Animals; Apoptosis Inducing Factor; Cell Survival; Cells, Cultured; Cytochromes c; Gene Expression Regulation; Hydrogen Peroxide; Kidney Tubules; Membrane Potential, Mitochondrial; Mitochondria; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; Peptide Fragments; Rats; Signal Transduction; Superoxides | 2012 |
Upregulation of ACE2-ANG-(1-7)-Mas axis in jejunal enterocytes of type 1 diabetic rats: implications for glucose transport.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Biological Transport; Caco-2 Cells; Cells, Cultured; Diabetes Mellitus, Type 1; Enterocytes; Glucose; Humans; Hyperglycemia; Hypoglycemic Agents; In Vitro Techniques; Injections, Intravenous; Jejunum; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Protein Kinase C; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; RNA, Messenger; Up-Regulation | 2012 |
Suppressing inflammation by inhibiting the NF-κB pathway contributes to the neuroprotective effect of angiotensin-(1-7) in rats with permanent cerebral ischaemia.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Anti-Inflammatory Agents; Behavior, Animal; Cerebrovascular Circulation; Imidazoles; Infarction, Middle Cerebral Artery; Inflammation; Male; Neuroprotective Agents; NF-kappa B; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled | 2012 |
[Prolonged angiotensin-(1-7) infusion inhibits hepatic fibrosis in rats with bile duct ligation].
Topics: Angiotensin I; Animals; Bile Ducts; Infusions, Parenteral; Ligation; Liver Cirrhosis, Experimental; Male; Peptide Fragments; Rats; Rats, Wistar | 2012 |
Inhibition of angiotensin II-induced contraction of human airway smooth muscle cells by angiotensin-(1-7) via downregulation of the RhoA/ROCK2 signaling pathway.
Topics: Actins; Angiotensin I; Angiotensin II; Bronchi; Cells, Cultured; Humans; Muscle Contraction; Myocytes, Smooth Muscle; Peptide Fragments; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction | 2012 |
[Influence of angiotensin-(1-7) on cell activation in rat renal interstitial fibroblasts induced by aldosterone].
Topics: Actins; Aldosterone; Angiotensin I; Animals; Cell Line; Collagen Type I; Fibroblasts; Kidney; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Peptide Fragments; Phosphorylation; Rats; Renin-Angiotensin System | 2012 |
Superoxide anions modulate the effects of angiotensin-(1-7) in the rostral ventrolateral medulla on cardiac sympathetic afferent reflex and sympathetic activity in rats.
Topics: Afferent Pathways; Angiotensin I; Animals; Antihypertensive Agents; Autonomic Denervation; Blood Pressure; Capsaicin; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Heart Rate; Male; Medulla Oblongata; Microinjections; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Oxidants; Peptide Fragments; Rats; Rats, Sprague-Dawley; Reflex; Superoxides; Sympathetic Nervous System; Vagotomy | 2012 |
Angiotensin-(1-7) central administration induces anxiolytic-like effects in elevated plus maze and decreased oxidative stress in the amygdala.
Topics: Amygdala; Angiotensin I; Animals; Anti-Anxiety Agents; Anxiety; Male; Maze Learning; Oxidative Stress; Peptide Fragments; Rats; Rats, Wistar | 2013 |
Decreased hepatic gluconeogenesis in transgenic rats with increased circulating angiotensin-(1-7).
Topics: Angiotensin I; Animals; Gluconeogenesis; Liver; Peptide Fragments; Rats; Rats, Sprague-Dawley; Rats, Transgenic | 2012 |
Differences in oxidative stress status and expression of MKP-1 in dorsal medulla of transgenic rats with altered brain renin-angiotensin system.
Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Disease Models, Animal; Dual Specificity Phosphatase 1; Gene Expression Regulation; Hypertension; Ion Channels; JNK Mitogen-Activated Protein Kinases; Male; Medulla Oblongata; Mitochondria; Mitochondrial Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NADPH Oxidases; Oligonucleotides, Antisense; Oxidative Stress; Peptide Fragments; Phosphorylation; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Reactive Oxygen Species; Renin; Renin-Angiotensin System; Signal Transduction; Uncoupling Protein 2 | 2012 |
Exercise induces renin-angiotensin system unbalance and high collagen expression in the heart of Mas-deficient mice.
Topics: Angiotensin I; Angiotensin II; Animals; Collagen; Collagen Type I; Collagen Type III; Gene Expression Regulation; Heart; Hypertrophy, Left Ventricular; Male; Mice; Mice, Knockout; Peptide Fragments; Physical Conditioning, Animal; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Ventricular Remodeling | 2012 |
Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diet, High-Fat; Dietary Carbohydrates; Energy Intake; Glucose; Glucose Intolerance; Glucose Transporter Type 4; Homeostasis; Insulin Resistance; MEF2 Transcription Factors; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Skeletal; Myoblasts; Myogenic Regulatory Factors; Peptide Fragments; Peptidyl-Dipeptidase A | 2013 |
Upregulation of the angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas receptor axis in the heart and the kidney of growth hormone receptor knock-out mice.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Kidney; Mice; Mice, Knockout; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Receptors, Somatotropin; Up-Regulation | 2012 |
Reverse translation of phase I biomarker findings links the activity of angiotensin-(1-7) to repression of hypoxia inducible factor-1α in vascular sarcomas.
Topics: Adult; Aged; Analysis of Variance; Angiotensin I; Animals; Biomarkers, Tumor; Cell Proliferation; Female; Gene Expression Profiling; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Middle Aged; Neoplasms, Vascular Tissue; Peptide Fragments; Placenta Growth Factor; Pregnancy Proteins; Real-Time Polymerase Chain Reaction; Sarcoma | 2012 |
[Dynamic alterations of angiotensin-converting enzyme, angiotensin-(1-7), and insulin-like growth factor binding protein-2 in fibrotic rat liver].
Topics: Angiotensin I; Animals; Insulin-Like Growth Factor Binding Protein 2; Liver; Liver Cirrhosis, Experimental; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Wistar | 2012 |
Captopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin 1-7 and angiotensin II-induced perfusion pressure in isolated kidney in SHR.
Topics: Aging; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Hypertension; Kidney; Kidney Cortex; Kidney Medulla; Male; Peptide Fragments; Prehypertension; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Specific Pathogen-Free Organisms; Vascular Resistance | 2012 |
Angiotensin-(1-7) treatment ameliorates angiotensin II-induced apoptosis of human umbilical vein endothelial cells.
Topics: Angiotensin I; Angiotensin II; Apoptosis; Blotting, Western; Caspase 3; Cell Culture Techniques; Dose-Response Relationship, Drug; Endothelial Cells; Flow Cytometry; Human Umbilical Vein Endothelial Cells; Humans; Peptide Fragments; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Scavenger Receptors, Class E; Up-Regulation | 2012 |
[Angiotensin (1-7) inhibits angiotensin II-stimulated expression of connective tissue growth factor mRNA in hepatic stellate cells].
Topics: Angiotensin I; Angiotensin II; Cells, Cultured; Connective Tissue Growth Factor; Hepatic Stellate Cells; Humans; Peptide Fragments; rho-Associated Kinases; rhoA GTP-Binding Protein; RNA, Messenger; Signal Transduction | 2012 |
Central angiotensin-(1-7) improves vagal function independent of blood pressure in hypertensive (mRen2)27 rats.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Antioxidants; Baroreflex; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blotting, Western; Cerebrospinal Fluid; Cyclic N-Oxides; Heart Rate; Hypertension; Infusions, Intraventricular; Medulla Oblongata; Mice; Mitogen-Activated Protein Kinases; NADPH Oxidases; Peptide Fragments; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Reactive Oxygen Species; Renin; Spin Labels; Tetrazoles; Vagus Nerve | 2012 |
Angiotensin-(1-7) reduces the perfusion pressure response to angiotensin II and methoxamine via an endothelial nitric oxide-mediated pathway in cirrhotic rat liver.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Blotting, Western; Endothelium, Vascular; In Situ Hybridization; Liver; Liver Circulation; Liver Cirrhosis; Male; Methoxamine; Nitric Oxide; Nitric Oxide Synthase Type III; Peptide Fragments; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Vasoconstrictor Agents | 2013 |
Free and protein-bound angiotensin II(1-7)in the regulation of drinking behavior and hemodynamics in rats.
Topics: Angiotensin I; Animals; Carrier Proteins; Drinking Behavior; Hemodynamics; Injections, Intraperitoneal; Male; Multiprotein Complexes; Nerve Growth Factors; Peptide Fragments; Rats; Rats, Wistar; Renin-Angiotensin System; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Serum Albumin | 2012 |
Angiotensin-(1-7) modulates renin-angiotensin system associated with reducing oxidative stress and attenuating neuronal apoptosis in the brain of hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Apoptosis; Blood Pressure; Hypertension; Male; Malondialdehyde; Neurons; Nitric Oxide Synthase Type II; Oxidative Stress; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Superoxide Dismutase | 2013 |
Mechanism of [Ca2+]i rise induced by angiotensin 1-7 in MDCK renal tubular cells.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Calcium; Calcium Signaling; Dogs; Dose-Response Relationship, Drug; Estrenes; Fura-2; Kidney; Madin Darby Canine Kidney Cells; Peptide Fragments; Phospholipases A2; Pyrrolidinones; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Thapsigargin; Type C Phospholipases | 2012 |
Angiotensin-(1-7) in paraventricular nucleus modulates sympathetic activity and cardiac sympathetic afferent reflex in renovascular hypertensive rats.
Topics: Adenine; Afferent Pathways; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Body Weight; Bucladesine; Cyclic AMP; Heart; Hypertension, Renovascular; Kidney; Male; Microinjections; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Reflex; Sympathetic Nervous System; Thionucleotides | 2012 |
[Effects of valsartan on aortic angiotensin converting enzyme 2 expression after aortic balloon injury in rats].
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Intra-Aortic Balloon Pumping; Male; Muscle, Smooth, Vascular; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Tetrazoles; Valine; Valsartan | 2012 |
Impact of ACE2 deficiency and oxidative stress on cerebrovascular function with aging.
Topics: Acetylcholine; Aging; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Cerebral Arteries; Cerebrovascular Circulation; Disease Models, Animal; Endothelium, Vascular; Male; Mice; Mice, Knockout; NADPH Oxidases; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; RNA, Messenger; Vasculitis; Vasodilation; Vasodilator Agents | 2012 |
Antenatal betamethasone exposure alters renal responses to angiotensin-(1-7) in uninephrectomized adult male sheep.
Topics: Aging; Angiotensin I; Animals; Betamethasone; Blood Pressure; Body Weight; Female; Glomerular Filtration Rate; Kidney; Male; Nephrectomy; Organ Size; Peptide Fragments; Pregnancy; Prenatal Exposure Delayed Effects; Regional Blood Flow; Sheep; Sodium | 2013 |
Interaction between TGF-β and ACE2-Ang-(1-7)-Mas pathway in high glucose-cultured NRK-52E cells.
Topics: Amino Acid Sequence; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Benzamides; Cells, Cultured; Chromones; Dioxoles; Fibronectins; Gene Expression Regulation; Glucose; Janus Kinase 2; LLC-PK1 Cells; Molecular Sequence Data; Morpholines; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptor, Transforming Growth Factor-beta Type I; Receptors, G-Protein-Coupled; Receptors, Transforming Growth Factor beta; RNA, Messenger; Signal Transduction; Swine; Transcription, Genetic; Transforming Growth Factor beta; Tyrphostins | 2013 |
Angiotensin-(1-7) regulates Angiotensin II-induced VCAM-1 expression on vascular endothelial cells.
Topics: Angiotensin I; Angiotensin II; Atherosclerosis; Cell Line; Endothelium, Vascular; Humans; NF-kappa B; Peptide Fragments; Protein Transport; Receptors, G-Protein-Coupled; Vascular Cell Adhesion Molecule-1 | 2013 |
Activation of the ACE2/angiotensin-(1-7)/Mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitors.
Topics: Adult; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Antigens, CD34; Case-Control Studies; Cohort Studies; Diabetes Mellitus; Endothelial Cells; Female; Gene Expression Regulation; Humans; Male; Mice; Middle Aged; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Stem Cells | 2013 |
Functional cross-talk between aldosterone and angiotensin-(1-7) in ventricular myocytes.
Topics: Aldosterone; Angiotensin I; Animals; Calcium; Calcium Signaling; Cyclic AMP-Dependent Protein Kinases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Nitric Oxide; Peptide Fragments; Rats; Rats, Sprague-Dawley | 2013 |
Angiotensin (1-7) ameliorates angiotensin II-induced inflammation by inhibiting LOX-1 expression.
Topics: Angiotensin I; Angiotensin II; Animals; Cell Adhesion; Chemokine CCL2; DNA; Endothelial Cells; Female; Humans; Inflammation; Male; NF-kappa B; Peptide Fragments; Rabbits; Scavenger Receptors, Class E; Vascular Cell Adhesion Molecule-1 | 2013 |
Angiotensin-(1-7) decreases glycated albumin-induced endothelial interleukin-6 expression via modulation of miR-146a.
Topics: Angiotensin I; Cells, Cultured; Culture Media, Conditioned; Cytoprotection; Down-Regulation; Endothelium, Vascular; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Interleukin-6; MicroRNAs; Peptide Fragments; Serum Albumin | 2013 |
Angiotensin 1-7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model.
Topics: Adipose Tissue; Angiotensin I; Animals; Cardiovascular Agents; Dietary Carbohydrates; Disease Models, Animal; Drug Administration Schedule; Epididymis; Extracellular Signal-Regulated MAP Kinases; Fructose; Gene Expression Regulation; Male; Metabolic Syndrome; Muscle, Skeletal; Oxidative Stress; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Reactive Oxygen Species; Receptors, G-Protein-Coupled; Transcription Factor RelA | 2013 |
Dietary sodium intake modulates renal excretory responses to intrarenal angiotensin (1-7) administration in anesthetized rats.
Topics: Anesthetics, General; Angiotensin I; Animals; Glomerular Filtration Rate; Kidney; Male; Peptide Fragments; Rats; Rats, Wistar; Renal Circulation; Sodium, Dietary | 2013 |
Angiotensin II and angiotensin-(1-7) in paraventricular nucleus modulate cardiac sympathetic afferent reflex in renovascular hypertensive rats.
Topics: Afferent Pathways; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Body Weight; Heart; Heart Rate; Hypertension, Renovascular; Kidney; Losartan; Male; Microinjections; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Reflex; Sympathetic Nervous System; Systole | 2012 |
Angiotensin-(1-7) inhibits vascular calcification in rats.
Topics: Actins; Alkaline Phosphatase; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Biomarkers; Calcium-Binding Proteins; Calponins; Cholecalciferol; Cytoskeletal Proteins; Disease Models, Animal; Gene Expression Regulation; Male; Microfilament Proteins; Muscle Proteins; Muscle, Smooth, Vascular; Nicotine; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Vascular Calcification | 2013 |
Osthole protects lipopolysaccharide-induced acute lung injury in mice by preventing down-regulation of angiotensin-converting enzyme 2.
Topics: Acute Lung Injury; Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Cell Line; Coumarins; Down-Regulation; Interleukin-6; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; RNA, Messenger; Tumor Necrosis Factor-alpha | 2013 |
The nonpeptide ANG-(1-7) mimic AVE 0991 attenuates cardiac remodeling and improves baroreflex sensitivity in renovascular hypertensive rats.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rate; Hypertension, Renovascular; Imidazoles; Kidney; Male; Myocardium; Peptide Fragments; Rats; Rats, Inbred F344; Ventricular Remodeling | 2013 |
Utero-placental expression of angiotensin-(1-7) and ACE2 in the pregnant guinea-pig.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Decidua; Endothelial Cells; Female; Gestational Age; Guinea Pigs; Immunohistochemistry; Models, Animal; Muscle, Smooth, Vascular; Peptide Fragments; Peptidyl-Dipeptidase A; Placenta; Pregnancy; Trophoblasts; Uterine Artery; Uterus | 2013 |
Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation.
Topics: Angiotensin I; Angiotensin II; Animals; Bleeding Time; Blood Platelets; Bone Marrow Transplantation; Cyclic AMP; Cyclic GMP; Epoprostenol; Immunoblotting; Mice; Mice, 129 Strain; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Thrombosis; Time Factors | 2013 |
Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Carboxypeptidases; Dipeptides; Imidazoles; Kidney; Leucine; Male; Mice; Mice, Knockout; Peptide Fragments; Peptidyl-Dipeptidase A; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2013 |
Diet composition modulates expression of sirtuins and renin-angiotensin system components in adipose tissue.
Topics: Adipose Tissue; Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Cholesterol, HDL; Diet, High-Fat; Dietary Fats; Dietary Proteins; Dietary Sucrose; Glucose; Lipids; Male; Mice; Mice, Inbred Strains; Peptide Fragments; Peptidyl-Dipeptidase A; Real-Time Polymerase Chain Reaction; Renin; Renin-Angiotensin System; Sirtuins; Triglycerides | 2013 |
Angiotensin-(1-7) in the rostral ventrolateral medulla modulates enhanced cardiac sympathetic afferent reflex and sympathetic activation in renovascular hypertensive rats.
Topics: Afferent Pathways; Angiotensin I; Animals; Antihypertensive Agents; Arterial Pressure; Autonomic Pathways; Disease Models, Animal; Hypertension, Renovascular; Male; Medulla Oblongata; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Rats; Rats, Sprague-Dawley; Reflex; Sympathetic Nervous System | 2013 |
Prolonged treatment with angiotensin 1-7 improves endothelial function in diet-induced obesity.
Topics: Angiotensin I; Animals; Base Sequence; Diet; DNA Primers; Endothelium, Vascular; Male; Mice; Mice, Inbred C57BL; Obesity; Peptide Fragments; Reverse Transcriptase Polymerase Chain Reaction | 2013 |
Up-regulation of components of the renin-angiotensin system in liver fibrosis in the rat induced by CCL₄.
Topics: Angiotensin I; Angiotensin II; Animals; Blotting, Western; Carbon Tetrachloride; Gene Expression Regulation, Enzymologic; Liver Cirrhosis; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Random Allocation; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Renin-Angiotensin System; RNA; Statistics, Nonparametric; Up-Regulation | 2013 |
The balance between human maternal plasma angiotensin II and angiotensin 1-7 levels in early gestation pregnancy is influenced by fetal sex.
Topics: Angiotensin I; Angiotensin II; C-Reactive Protein; Female; Fetus; Humans; Male; Maternal Welfare; Peptide Fragments; Peptidyl-Dipeptidase A; Pregnancy; Renin-Angiotensin System; Sex Characteristics | 2014 |
Discovery and characterization of alamandine: a novel component of the renin-angiotensin system.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; Drug Discovery; Humans; Male; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Inbred F344; Rats, Inbred SHR; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2013 |
Glucose dependence of glycogen synthase activity regulation by GSK3 and MEK/ERK inhibitors and angiotensin-(1-7) action on these pathways in cultured human myotubes.
Topics: Aminophenols; Angiotensin I; Butadienes; Cells, Cultured; Enzyme Activation; Glucose; Glycogen Synthase; Glycogen Synthase Kinase 3; Humans; Maleimides; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Muscle Fibers, Skeletal; Nitriles; Peptide Fragments; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2013 |
Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Hypertension; Imidazoles; Male; Olmesartan Medoxomil; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Inbred Lew; Rats, Transgenic; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin; Renin-Angiotensin System; Tetrazoles | 2013 |
Complete blockade of the vasorelaxant effects of angiotensin-(1-7) and bradykinin in murine microvessels by antagonists of the receptor Mas.
Topics: Angiotensin I; Angiotensin II; Animals; Bradykinin; Human Umbilical Vein Endothelial Cells; Humans; Male; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Knockout; Microvessels; Nitric Oxide; Nitric Oxide Synthase Type III; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Vasodilation; Vasodilator Agents | 2013 |
Usefulness of angiotensin-(1-7) to predict myocardial salvage after percutaneous coronary intervention in patients with acute myocardial infarction.
Topics: Angiotensin I; Biomarkers; Female; Humans; Male; Middle Aged; Myocardial Infarction; Peptide Fragments; Percutaneous Coronary Intervention; Predictive Value of Tests; Salvage Therapy | 2013 |
Angiotensin-(1-7) inhibits autophagy in the brain of spontaneously hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Antihypertensive Agents; Autophagy; Blood Pressure; Brain; Hypertension; Imidazoles; Male; Peptide Fragments; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2013 |
Dose-dependent effects of angiotensin-(1-7) on the NHE3 exchanger and [Ca(2+)](i) in in vivo proximal tubules.
Topics: Angiotensin I; Animals; Bicarbonates; Calcium; Dose-Response Relationship, Drug; Egtazic Acid; Guanidines; Kidney Tubules, Proximal; Male; Methacrylates; Peptide Fragments; Rats; Rats, Wistar; Signal Transduction; Sodium-Hydrogen Exchangers; Thapsigargin | 2013 |
Association of an oral formulation of angiotensin-(1-7) with atenolol improves lipid metabolism in hypertensive rats.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Angiotensin I; Animals; Atenolol; Hypertension; Lipid Metabolism; Male; Peptide Fragments; Rats; Rats, Inbred SHR | 2013 |
Effects of felodipine combined with puerarin on ACE2-Ang (1-7)-Mas axis in renovascular hypertensive rat.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Drug Therapy, Combination; Felodipine; Hypertension, Renovascular; Isoflavones; Kidney; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Vasodilator Agents | 2013 |
Angiotensin (1-7) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs.
Topics: Angiotensin I; Angiotensin II; Animals; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enzyme Activation; Human Umbilical Vein Endothelial Cells; Humans; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Mesenteric Arteries; Mice; Nitric Oxide; Nitric Oxide Synthase Type III; Peptide Fragments; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, G-Protein-Coupled; Signal Transduction; Vasodilation | 2013 |
The pressor effect of angiotensin-(1-7) in the rat rostral ventrolateral medulla involves multiple peripheral mechanisms.
Topics: Angiotensin I; Animals; Antidiuretic Hormone Receptor Antagonists; Arterial Pressure; Heart Rate; Hexamethonium; Male; Medulla Oblongata; Microinjections; Peptide Fragments; Rats; Rats, Wistar; Time Factors; Vasodilator Agents | 2013 |
Role of angiotensin II and angiotensin-(1-7) in diabetes-induced oxidative DNA damage in the corpus cavernosum.
Topics: Angiotensin I; Angiotensin II; Animals; Diabetes Mellitus, Experimental; DNA Damage; Male; Oxidative Stress; Penis; Peptide Fragments; Proto-Oncogene Mas; Random Allocation; Rats; Rats, Wistar; Signal Transduction | 2013 |
Sex differences in angiotensin-converting enzyme modulation of Ang (1-7) levels in normotensive WKY rats.
Topics: Administration, Oral; Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Female; Kidney Cortex; Kidney Medulla; Male; Models, Animal; Neprilysin; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred WKY; Sex Characteristics; Sex Factors | 2013 |
Prolyl carboxypeptidase: a forgotten kidney angiotensinase. Focus on "Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry".
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Carboxypeptidases; Male; Peptide Fragments; Peptidyl-Dipeptidase A | 2013 |
Overexpression of catalase prevents hypertension and tubulointerstitial fibrosis and normalization of renal angiotensin-converting enzyme-2 expression in Akita mice.
Topics: Albuminuria; Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensinogen; Animals; Apoptosis; Catalase; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Fibrosis; Hypertension; Kidney; Kidney Tubules; Kidney Tubules, Proximal; Male; Mice; Mice, Transgenic; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A | 2013 |
The never-ending story of angiotensin peptides: beyond angiotensin I and II.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Drug Discovery; Humans; Male; Oligopeptides; Peptide Fragments; Renin-Angiotensin System | 2013 |
Anti-inflammatory effects of angiotensin-(1-7) in ischemic stroke.
Topics: Angiotensin I; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain Ischemia; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Gene Expression Regulation; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Microglia; Nerve Tissue Proteins; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase Type II; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Specific Pathogen-Free Organisms; Stroke | 2013 |
AT1, AT2, and AT(1-7) receptor expression in the uteroplacental unit of normotensive and hypertensive rats during early and late pregnancy.
Topics: Angiotensin I; Animals; Female; Gene Expression; Gestational Age; Myometrium; Peptide Fragments; Placenta; Pre-Eclampsia; Pregnancy; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Uterus | 2013 |
Abrogation of ER stress-induced apoptosis of alveolar epithelial cells by angiotensin 1-7.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Antineoplastic Agents; Apoptosis; Autocrine Communication; Cells, Cultured; Endoplasmic Reticulum Stress; Epithelial Cells; Humans; Leupeptins; Peptide Fragments; Pulmonary Alveoli; Pulmonary Surfactant-Associated Protein C; Receptors, Angiotensin; Signal Transduction; Vasoconstrictor Agents | 2013 |
Angiotensin 1-7 promotes cardiac angiogenesis following infarction.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Female; Matrix Metalloproteinase 9; Myocardial Infarction; Myocardium; Neovascularization, Pathologic; Neovascularization, Physiologic; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Vascular Endothelial Growth Factor D; Ventricular Remodeling | 2015 |
Ang(1-7) treatment attenuates β-cell dysfunction by improving pancreatic microcirculation in a rat model of Type 2 diabetes.
Topics: Angiotensin I; Angiotensin II; Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Insulin; Insulin Secretion; Islets of Langerhans; Male; Microcirculation; Nitric Oxide; Nitric Oxide Synthase Type III; Pancreas; Peptide Fragments; Rats; Rats, Wistar | 2013 |
ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Arterial Pressure; Cytoprotection; Disease Models, Animal; Endothelium, Vascular; Enzyme Activation; Enzyme Activators; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Naphthalenes; Neointima; Peptide Fragments; Peptidyl-Dipeptidase A; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Resorcinols; Severity of Illness Index; Time Factors; Vasodilation | 2013 |
Antinociceptive response in transgenic mice expressing rat tonin.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Behavior, Animal; Disease Models, Animal; Losartan; Male; Mice; Mice, Transgenic; Nociception; Nociceptive Pain; Pain Measurement; Peptide Fragments; Rats; Receptors, G-Protein-Coupled; Tissue Kallikreins | 2013 |
Association of plasma angiotensin-(1-7) level and left ventricular function in patients with type 2 diabetes mellitus.
Topics: Aged; Angiotensin I; Diabetes Mellitus, Type 2; Female; Humans; Male; Peptide Fragments; Stroke Volume; Ventricular Dysfunction, Left | 2013 |
Stabilization of the angiotensin-(1-7) receptor Mas through interaction with PSD95.
Topics: Angiotensin I; Animals; Blotting, Western; Cell Line; Cell Line, Tumor; COS Cells; Cricetinae; Disks Large Homolog 4 Protein; Humans; Immunoprecipitation; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Peptide Fragments; Protein Binding; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rabbits; Real-Time Polymerase Chain Reaction; Receptors, G-Protein-Coupled; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2013 |
Oral Angiotensin-(1-7) prevented obesity and hepatic inflammation by inhibition of resistin/TLR4/MAPK/NF-κB in rats fed with high-fat diet.
Topics: Angiotensin I; Animals; Blood Glucose; Cholesterol; Diet, High-Fat; Glucose Tolerance Test; Inflammation; Insulin; Insulin Resistance; Lipoproteins, HDL; Liver; Male; Mitogen-Activated Protein Kinases; NF-kappa B; Obesity; Peptide Fragments; Rats; Rats, Sprague-Dawley; Resistin; Toll-Like Receptor 4; Triglycerides | 2013 |
Angiotensin II type 1 receptor blockade restores angiotensin-(1-7)-induced coronary vasodilation in hypertrophic rat hearts.
Topics: Angiotensin I; Animals; Cardiomegaly; Imidazoles; In Vitro Techniques; Losartan; Male; NG-Nitroarginine Methyl Ester; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyridines; Rats; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Vasodilation | 2013 |
Angiotensin-(1-7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells.
Topics: Angiotensin I; Animals; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Blood Pressure; Body Weight; Cell Movement; Cell Proliferation; Collagen; Dose-Response Relationship, Drug; Lipids; Macrophages; Matrix Metalloproteinases; Mice; Mice, Knockout; Microfilament Proteins; Muscle Proteins; Muscle, Smooth, Vascular; Peptide Fragments; Receptor, Angiotensin, Type 2; RNA, Messenger; Vasodilator Agents | 2013 |
Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Adhesion; Chemokine CXCL1; Disease Models, Animal; Female; Hyperalgesia; Inflammation; Interleukin-1beta; Leukocyte Rolling; Losartan; Male; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Tumor Necrosis Factor-alpha | 2013 |
[Angiotensin-(1-7) inhibits hypoxia-induced renal tubular epithelial-to-mesenchymal transition in rats].
Topics: Actins; Angiotensin I; Animals; Cell Line; Cobalt; Collagen Type I; Epithelial-Mesenchymal Transition; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney Tubules, Proximal; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Peptide Fragments; Rats | 2013 |
Oral formulation of angiotensin-(1-7) improves lipid metabolism and prevents high-fat diet-induced hepatic steatosis and inflammation in mice.
Topics: Administration, Oral; Angiotensin I; Animals; Chemistry, Pharmaceutical; Diet, High-Fat; Fatty Liver; Inflammation; Interleukin-6; Lipid Metabolism; Male; Mice; Peptide Fragments; Sterol Regulatory Element Binding Protein 1; Tumor Necrosis Factor-alpha | 2013 |
Beneficial effects of the activation of the angiotensin-(1-7) MAS receptor in a murine model of adriamycin-induced nephropathy.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Animals; Disease Models, Animal; Doxorubicin; Gene Expression Regulation; Humans; Imidazoles; Kidney Diseases; Kidney Glomerulus; Kidney Tubules; Losartan; Mice; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; RNA, Messenger; Time Factors | 2013 |
The components of the angiotensin-(1-7) system are differentially expressed during follicular wave in cattle.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cattle; Estradiol; Female; Follicular Atresia; Fulvestrant; Gene Expression Profiling; Granulosa Cells; Neprilysin; Ovarian Follicle; Peptide Fragments; Peptidyl-Dipeptidase A; Prolyl Oligopeptidases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; RNA, Messenger; Serine Endopeptidases; Theca Cells | 2015 |
Fetal sex and the circulating renin-angiotensin system during early gestation in women who later develop preeclampsia or gestational hypertension.
Topics: Adult; Angiotensin I; Angiotensin II; Biomarkers; Blood Pressure; Case-Control Studies; Female; Gestational Age; Humans; Hypertension, Pregnancy-Induced; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Pre-Eclampsia; Pregnancy; Renin; Renin-Angiotensin System; Risk Assessment; Risk Factors; Sex Determination Analysis; Sex Factors; Ultrasonography, Doppler; Ultrasonography, Prenatal; Young Adult | 2014 |
The renin angiotensin system regulates Kupffer cells in colorectal liver metastases.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Colorectal Neoplasms; Disease Models, Animal; Gadolinium; Kupffer Cells; Liver Neoplasms; Macrophages; Male; Mice; Mice, Inbred CBA; Peptide Fragments; Renin-Angiotensin System | 2013 |
Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Humans; Liver Cirrhosis, Experimental; Mesenteric Arteries; Nitric Oxide; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Vascular Resistance; Vasodilation | 2013 |
Central endogenous angiotensin-(1-7) protects against aldosterone/NaCl-induced hypertension in female rats.
Topics: Aldosterone; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Disease Models, Animal; Female; Hypertension; NADPH Oxidases; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, G-Protein-Coupled; Renin-Angiotensin System; RNA, Messenger; Sex Factors; Sodium Chloride | 2013 |
Primacy of angiotensin converting enzyme in angiotensin-(1-12) metabolism.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Pressure; Chymases; Disease Models, Animal; Hypertension; Infusions, Intravenous; Lisinopril; Male; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2013 |
Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury.
Topics: Angiotensin I; Animals; Animals, Newborn; Apoptosis; Blotting, Western; Bronchoalveolar Lavage; Cell Proliferation; Hyperoxia; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung Injury; Male; Oxygen; Peptide Fragments; Pneumonia; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2013 |
Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Blood Pressure; Cell Line; Disease Models, Animal; Glomerular Filtration Rate; Humans; Hypertension; Kidney Cortex; Male; Natriuresis; Obesity; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin; Renin-Angiotensin System; Time Factors; Up-Regulation | 2013 |
Activation of angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis attenuates the cardiac reactivity to acute emotional stress.
Topics: Adrenergic beta-Agonists; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Arterial Pressure; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Activators; Heart Rate; Hemodynamics; Hypothalamus; Injections, Intravenous; Injections, Intraventricular; Male; Myocytes, Cardiac; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Stress, Psychological; Sympathetic Nervous System; Tachycardia | 2013 |
AVE 0991, a non-peptide mimic of angiotensin-(1-7) effects, attenuates pulmonary remodelling in a model of chronic asthma.
Topics: Airway Remodeling; Angiotensin I; Angiotensin II; Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Chronic Disease; Cytokines; Disease Models, Animal; Hypertrophy, Right Ventricular; Imidazoles; Lung; Male; Mice; Mice, Inbred BALB C; Molecular Mimicry; Ovalbumin; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pulmonary Artery; Pulmonary Veins; Receptors, G-Protein-Coupled; Time Factors | 2013 |
An oral formulation of angiotensin-(1-7) reverses corpus cavernosum damages induced by hypercholesterolemia.
Topics: Administration, Oral; Angiotensin I; Animals; Apolipoproteins E; Collagen; Cyclodextrins; Disease Models, Animal; Endothelium, Vascular; Fibrosis; Hypercholesterolemia; Impotence, Vasculogenic; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Oxidative Stress; Penile Erection; Penis; Peptide Fragments; Phosphoproteins; Proto-Oncogene Mas; Proto-Oncogene Proteins; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Vasodilation; Vasodilator Agents | 2013 |
Angiotensin-(1-7) attenuates lung fibrosis by way of Mas receptor in acute lung injury.
Topics: Acute Lung Injury; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Disease Models, Animal; Lipopolysaccharides; Losartan; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pulmonary Fibrosis; Receptors, G-Protein-Coupled; Respiratory Distress Syndrome; Vasodilator Agents | 2013 |
Protective effects of angiotensin-(1-7) administrated with an angiotensin-receptor blocker in a rat model of chronic kidney disease.
Topics: Angiopoietins; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Disease Models, Animal; Fibronectins; Losartan; Male; Nephrectomy; Peptide Fragments; Plasminogen Activator Inhibitor 1; Rats, Sprague-Dawley; Receptor, TIE-2; Renal Insufficiency, Chronic; Systole | 2013 |
Dysregulated renin-angiotensin system contributes to acute lung injury caused by hind-limb ischemia-reperfusion in mice.
Topics: Acute Lung Injury; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Gene Expression Regulation; Genotype; Hindlimb; Lung; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Organ Size; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Reperfusion Injury; RNA, Messenger | 2013 |
Antenatal betamethasone exposure is associated with lower ANG-(1-7) and increased ACE in the CSF of adult sheep.
Topics: Age Factors; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Baroreflex; Betamethasone; Blood Pressure; Choroid Plexus; Down-Regulation; Female; Gestational Age; Glucocorticoids; Hypertension; Male; Neprilysin; Peptide Fragments; Peptidyl-Dipeptidase A; Pregnancy; Prenatal Exposure Delayed Effects; Renin-Angiotensin System; Sheep; Up-Regulation | 2013 |
Angiotensin-(1-7) protects from experimental acute lung injury.
Topics: Acute Lung Injury; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Electric Impedance; Endothelial Cells; Hemodynamics; Imidazoles; Irbesartan; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Respiratory Mechanics; Tetrazoles | 2013 |
The effects of angiotensin II and angiotensin-(1-7) in the rostral ventrolateral medulla of rats on stress-induced hypertension.
Topics: Amino Acids; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Gene Expression Regulation; Heart Rate; Hypertension; Male; Medulla Oblongata; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Stress, Psychological | 2013 |
Angiotensin (1-7) contributes to nitric oxide tonic inhibition of vasopressin release during hemorrhagic shock in acute ethanol intoxicated rodents.
Topics: Alcoholic Intoxication; Angiotensin I; Angiotensin II; Animals; Arginine Vasopressin; Enzyme Inhibitors; Hemodynamics; Injections, Intraventricular; Male; Nitric Oxide; Nitric Oxide Synthase; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Shock, Hemorrhagic; Up-Regulation | 2013 |
Angiotensin-(1-7) prevents radiation-induced inflammation in rat primary astrocytes through regulation of MAP kinase signaling.
Topics: Angiotensin I; Animals; Astrocytes; Cells, Cultured; Drug Evaluation, Preclinical; Dual Specificity Phosphatase 1; Inflammation; MAP Kinase Signaling System; Peptide Fragments; Primary Cell Culture; Radiation-Protective Agents; Rats | 2013 |
Angiotensin-(1-7) attenuates the anxiety and depression-like behaviors in transgenic rats with low brain angiotensinogen.
Topics: Angiotensin I; Angiotensinogen; Animals; Anxiety; Brain; Depression; Disease Models, Animal; Drug Administration Routes; Fluoxetine; Male; Maze Learning; Peptide Fragments; Psychotropic Drugs; Rats; Rats, Sprague-Dawley; Rats, Transgenic; RNA, Antisense; Selective Serotonin Reuptake Inhibitors; Swimming | 2013 |
Propofol up-regulates Mas receptor expression in dorsal root ganglion neurons.
Topics: Anesthetics, Intravenous; Angiotensin I; Animals; Blotting, Western; Cells, Cultured; Dactinomycin; Ganglia, Spinal; Imidazoles; Indicators and Reagents; Neurons; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Propofol; Protein Kinase Inhibitors; Protein Synthesis Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Real-Time Polymerase Chain Reaction; Receptors, G-Protein-Coupled; RNA, Messenger | 2013 |
[Anti-fibrotic effects of angiotensin1-7 on bleomycin-induced pulmonary fibrosis in rats].
Topics: Angiotensin I; Animals; Bleomycin; Collagen Type I; Male; Peptide Fragments; Pulmonary Fibrosis; Rats; Rats, Wistar; Transforming Growth Factor beta1 | 2013 |
Angiotensin II-independent angiotensin-(1-7) formation in rat hippocampus: involvement of thimet oligopeptidase.
Topics: Angiotensin I; Animals; Epilepsy; Female; Hippocampus; Metalloendopeptidases; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2013 |
Role of angiotensin-(1-7) in gastroprotection against stress-induced ulcerogenesis. The involvement of mas receptor, nitric oxide, prostaglandins, and sensory neuropeptides.
Topics: Angiotensin I; Angiotensin II; Animals; Anti-Ulcer Agents; Capsaicin; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytokines; Denervation; Enzyme Inhibitors; Gastric Mucosa; Interleukin-1beta; Male; Neuropeptides; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Prostaglandins; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Regional Blood Flow; Renin-Angiotensin System; Sensory Receptor Cells; Stomach; Stomach Ulcer; Tumor Necrosis Factor-alpha | 2013 |
Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Biphenyl Compounds; Cardiomegaly; Cardiotonic Agents; Collagen; Connective Tissue Growth Factor; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Gene Expression Regulation; Irbesartan; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphorylation; PPAR alpha; PPAR delta; PPAR gamma; Receptor, Angiotensin, Type 1; RNA, Messenger; Signal Transduction; Tetrazoles; Transforming Growth Factor beta | 2013 |
The expression of angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas receptor axis are upregulated after acute cerebral ischemic stroke in rats.
Topics: Acute Disease; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Brain Ischemia; Cerebral Cortex; Infarction, Middle Cerebral Artery; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Stroke; Up-Regulation | 2013 |
Angiotensin-(1-7) synergizes with colony-stimulating factors in hematopoietic recovery.
Topics: Angiotensin I; Animals; Antimetabolites, Antineoplastic; Bone Marrow Cells; Cell Proliferation; Deoxycytidine; Drug Synergism; Epoetin Alfa; Erythroid Precursor Cells; Erythropoietin; Female; Filgrastim; Gemcitabine; Granulocyte Colony-Stimulating Factor; Hematinics; Megakaryocytes; Mice; Mice, Inbred C57BL; Myeloid Progenitor Cells; Peptide Fragments; Recombinant Proteins; Stem Cells; Time Factors | 2013 |
Endothelial metabolism of angiotensin II to angiotensin III, not angiotensin (1-7), augments the vasorelaxation response in adrenal cortical arteries.
Topics: Adrenal Glands; Angiotensin I; Angiotensin II; Angiotensin III; Animals; Cattle; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Gene Expression Regulation; Peptide Fragments; Vasodilation | 2013 |
Centrally administered angiotensin-(1-7) increases the survival of stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin I; Animals; Blood Pressure; Body Weight; Corpus Striatum; Corticosterone; Heart; Hypertension; Infusions, Intraventricular; Kidney; Male; Microglia; Peptide Fragments; Rats; Rats, Inbred SHR; Stroke | 2014 |
Oral administration of angiotensin-(1-7) ameliorates type 2 diabetes in rats.
Topics: Administration, Oral; Angiotensin I; Animals; Animals, Newborn; Deoxyglucose; Diabetes Mellitus, Type 2; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Myocytes, Cardiac; Peptide Fragments; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction | 2014 |
Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-β signalling.
Topics: Angiotensin I; Animals; Disease Models, Animal; Extracellular Matrix; Fibroblasts; Fibrosis; Humans; Male; Mice; Mice, Inbred mdx; Mice, Knockout; MicroRNAs; Muscle Strength; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Peptide Fragments; Receptors, Cell Surface; Signal Transduction; Transforming Growth Factor beta | 2014 |
Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; bcl-X Protein; Bleomycin; Cells, Cultured; Collagen Type I; Disease Models, Animal; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Humans; Infusions, Subcutaneous; Lung; Male; MAP Kinase Signaling System; NF-kappa B; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphorylation; Pneumonia; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pulmonary Fibrosis; Rats; Rats, Wistar; Receptors, G-Protein-Coupled | 2014 |
[Expression and significance of ACE2-Ang-(1-7)-Mas axis in the endometrium of patients with polycystic ovary syndrome].
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Case-Control Studies; Endometrium; Female; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Polycystic Ovary Syndrome; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, Angiotensin; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Young Adult | 2013 |
Apelin is a positive regulator of ACE2 in failing hearts.
Topics: Adipokines; Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Apelin; Apelin Receptors; Feedback, Physiological; Gene Expression Regulation; Heart Failure; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Contraction; Peptide Fragments; Peptidyl-Dipeptidase A; Promoter Regions, Genetic; ras Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Recombinant Fusion Proteins; Renin-Angiotensin System; Signal Transduction | 2013 |
Angiotensin 1-7 improves insulin sensitivity by increasing skeletal muscle glucose uptake in vivo.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Glucose; Insulin Resistance; Male; Muscle, Skeletal; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Renin-Angiotensin System | 2014 |
Angiotensin-(1-7) modulates renal vascular resistance through inhibition of p38 mitogen-activated protein kinase in apolipoprotein E-deficient mice.
Topics: Angiotensin I; Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Blood Pressure; Disease Models, Animal; Female; Hypertension, Renal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Naphthalenes; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyrazoles; Receptors, G-Protein-Coupled; Renal Circulation; Vascular Resistance | 2014 |
Ang-(1-7) offers cytoprotection against ischemia-reperfusion injury by restoring intracellular calcium homeostasis.
Topics: Angiotensin I; Animals; Calcium; Cytoprotection; Homeostasis; Male; Microscopy, Confocal; Myocardial Reperfusion Injury; Myocytes, Cardiac; Peptide Fragments; Rats; Rats, Sprague-Dawley | 2014 |
Characterization of the cardiac renin angiotensin system in oophorectomized and estrogen-replete mRen2.Lewis rats.
Topics: Angiotensin I; Angiotensinogen; Animals; Blotting, Western; Chymases; Estradiol; Estrogens; Female; Gene Expression; Immunohistochemistry; Mast Cells; Matrix Metalloproteinase 9; Mice; Myocardium; Ovariectomy; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Random Allocation; Rats; Rats, Inbred Lew; Rats, Transgenic; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction | 2013 |
Angiotensin (1-7) increases the potassium current and the resting potential of arterial myocytes from vascular resistance vessels of normal adult rats: Pathophysiological implications.
Topics: Angiotensin I; Animals; Arterial Pressure; Male; Membrane Potentials; Mesenteric Arteries; Muscle Cells; Muscle, Smooth, Vascular; Patch-Clamp Techniques; Peptide Fragments; Potassium Channels; Rats; Rats, Sprague-Dawley; Vascular Resistance | 2014 |
Angiotensin (1-7) protects against stress-induced gastric lesions in rats.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Cold Temperature; Corticosterone; H(+)-K(+)-Exchanging ATPase; Infusions, Intraventricular; Male; Norepinephrine; Peptide Fragments; Rats; Rats, Sprague-Dawley; Restraint, Physical; Stomach Ulcer; Stress, Physiological | 2014 |
An orally active angiotensin-(1-7) inclusion compound and exercise training produce similar cardiovascular effects in spontaneously hypertensive rats.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Oral; Angiotensin I; Animals; Antihypertensive Agents; beta-Cyclodextrins; Blood Pressure; Combined Modality Therapy; Drug Evaluation, Preclinical; Excipients; Exercise Therapy; Heart Rate; Hypertension; Male; Myocardium; Peptide Fragments; Physical Conditioning, Animal; Rats; Rats, Inbred SHR; Ventricular Pressure | 2014 |
Heat shock prevents insulin resistance-induced vascular complications by augmenting angiotensin-(1-7) signaling.
Topics: AMP-Activated Protein Kinases; Angiotensin I; Animals; Diet, High-Fat; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Hot Temperature; HSP72 Heat-Shock Proteins; Insulin Resistance; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Signal Transduction; Sirtuin 1; Vasodilation | 2014 |
Olmesartan blocks advanced glycation end products-induced vcam-1 gene expression in mesangial cells by restoring Angiotensin-converting enzyme 2 level.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Cell Line; Gene Expression Regulation; Glycation End Products, Advanced; Humans; Imidazoles; Mesangial Cells; Peptide Fragments; Peptidyl-Dipeptidase A; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Superoxides; Tetrazoles; Vascular Cell Adhesion Molecule-1 | 2014 |
Enhanced activity of an angiotensin-(1-7) neuropeptidase in glucocorticoid-induced fetal programming.
Topics: Aging; Angiotensin I; Animals; Baroreflex; Edetic Acid; Hypertension; Male; p-Chloromercuribenzoic Acid; Peptide Fragments; Peptidyl-Dipeptidase A; Phenanthrolines; Phenylmercuric Acetate; Sheep; Substrate Specificity | 2014 |
Ang-(1-7) activates the NO/cGMP and ATP-sensitive K+ channels pathway to induce peripheral antinociception in rats.
Topics: Adenosine Triphosphate; Analgesics; Angiotensin I; Animals; Arginine; Cyclic GMP; Dinoprostone; Dose-Response Relationship, Drug; Hyperalgesia; KATP Channels; Male; Nitric Oxide; Pain; Pain Measurement; Peptide Fragments; Rats; Rats, Wistar | 2014 |
Possible role of angiotensin-converting enzyme 2 and activation of angiotensin II type 2 receptor by angiotensin-(1-7) in improvement of vascular remodeling by angiotensin II type 1 receptor blockade.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Disease Models, Animal; Gene Expression Regulation; Immunohistochemistry; Mice; Mice, Inbred C57BL; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 2; RNA; Vascular Resistance; Vasodilator Agents | 2014 |
Angiotensin 1-7 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db/db mice by reducing lipotoxicity and inflammation.
Topics: Angiotensin I; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Diastole; Echocardiography, Doppler; Follow-Up Studies; Inflammation; Insulin Resistance; Lipids; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Function; Ventricular Pressure | 2014 |
Angiotensin-(1-7) augments endothelium-dependent relaxations of porcine coronary arteries to bradykinin by inhibiting angiotensin-converting enzyme 1.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Coronary Vessels; Endothelium; Heart; In Vitro Techniques; Isometric Contraction; Muscle Relaxation; Muscle Tonus; Nitric Oxide; Peptide Fragments; Peptidyl-Dipeptidase A; Swine; Vasodilator Agents | 2014 |
Angiotensin-converting enzyme (ACE and ACE2) imbalance correlates with the severity of cerulein-induced acute pancreatitis in mice.
Topics: Acute Disease; Amylases; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Biomarkers; Ceruletide; Disease Models, Animal; Genotype; Inflammation Mediators; Male; Mice, Inbred C57BL; Mice, Knockout; Necrosis; Pancreas; Pancreatitis; Peptide Fragments; Peptidyl-Dipeptidase A; Phenotype; Severity of Illness Index; Time Factors | 2014 |
Autocrine and paracrine function of Angiotensin 1-7 in tissue repair during hypertension.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Autocrine Communication; Disease Models, Animal; Fibrosis; Hypertension; Kidney; Male; Myocardium; Paracrine Communication; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Signal Transduction; Ventricular Remodeling | 2014 |
Receptor MAS protects mice against hypothermia and mortality induced by endotoxemia.
Topics: Angiotensin I; Animals; Cells, Cultured; Cytokines; Endotoxemia; Hypothermia; Inflammation Mediators; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2014 |
Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Diminazene; Disease Models, Animal; Glutamyl Aminopeptidase; Hypertension; Imidazoles; In Vitro Techniques; Kidney; Leucine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Xanthones | 2014 |
Novel role of aminopeptidase-A in angiotensin-(1-7) metabolism post myocardial infarction.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin-Converting Enzyme 2; Animals; Disease Models, Animal; Enzyme Inhibitors; Glutamyl Aminopeptidase; Kinetics; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Substrate Specificity; Tandem Mass Spectrometry; Ventricular Remodeling | 2014 |
Olmesartan potentiates the anti-angiogenic effect of sorafenib in mice bearing Ehrlich's ascites carcinoma: role of angiotensin (1-7).
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Female; Imidazoles; Immunohistochemistry; Insulin-Like Growth Factor I; Mice; Neovascularization, Pathologic; Niacinamide; Peptide Fragments; Phenylurea Compounds; Receptor, IGF Type 1; Sorafenib; Tetrazoles; Tumor Burden; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2014 |
The muscular expression of RAS in patients with achalasia.
Topics: Aged; Angiotensin I; Case-Control Studies; Cathepsin G; Chymases; Esophageal Achalasia; Esophagus; Female; Humans; Immunohistochemistry; Male; Mast Cells; Middle Aged; Muscles; Peptide Fragments; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin-Angiotensin System; Silver Staining | 2015 |
Role of angiotensin-(1-7) and Mas-R-nNOS pathways in amplified neuronal activity of dorsolateral periaqueductal gray after chronic heart failure.
Topics: Angiotensin I; Animals; Chronic Disease; Heart Failure; Male; Neurons; Nitric Oxide Synthase Type I; Peptide Fragments; Periaqueductal Gray; Rats, Sprague-Dawley; Receptors, Angiotensin; Signal Transduction | 2014 |
Promising neuroprotective effects of the angiotensin-(1-7)-angiotensin-converting enzyme 2-Mas axis in stroke.
Topics: Angiotensin I; Animals; Hypertension; Male; Peptide Fragments; Stroke | 2014 |
Treatment with Angiotensin-(1-7) reduces inflammation in carotid atherosclerotic plaques.
Topics: Administration, Oral; Angiotensin I; Animals; Anti-Inflammatory Agents; Apolipoproteins E; Carotid Arteries; Case-Control Studies; Disease Models, Animal; Humans; Inflammation; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Plaque, Atherosclerotic | 2014 |
Chronic oral administration of Ang-(1-7) improves skeletal muscle, autonomic and locomotor phenotypes in muscular dystrophy.
Topics: Administration, Oral; Angiotensin I; Animals; Dystrophin; Fibrosis; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Muscle, Skeletal; Muscular Dystrophies; Peptide Fragments; Phenotype; Sarcoglycans | 2014 |
Upregulation of circulating components of the alternative renin-angiotensin system in inflammatory bowel disease: A pilot study.
Topics: Adult; Aged; Angiotensin I; Angiotensin-Converting Enzyme 2; Biomarkers; Case-Control Studies; Female; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Peptide Fragments; Peptidyl-Dipeptidase A; Pilot Projects; Renin-Angiotensin System; Up-Regulation; Young Adult | 2015 |
Increasing angiotensin-(1-7) levels in the brain attenuates metabolic syndrome-related risks in fructose-fed rats.
Topics: Angiotensin I; Animals; Baroreflex; Blood Glucose; Blood Pressure; Body Weight; Brain; Dietary Carbohydrates; Disease Models, Animal; Fructose; Glycogen; Infusions, Intraventricular; Insulin; Metabolic Syndrome; Peptide Fragments; Rats; Rats, Sprague-Dawley; Risk Factors | 2014 |
Angiotensin 1-7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Diabetic Nephropathies; Fibrosis; Forkhead Box Protein O1; Forkhead Transcription Factors; Kidney; Lipase; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Reactive Oxygen Species; Sirtuin 1; STAT3 Transcription Factor; Triglycerides | 2014 |
Angiotensin converting enzyme 2/Ang-(1-7)/mas axis protects brain from ischemic injury with a tendency of age-dependence.
Topics: Age Factors; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Brain; Brain Edema; Brain Ischemia; Cell Death; Female; Glucose; Hypoxia, Brain; Infarction, Middle Cerebral Artery; Male; Membrane Glycoproteins; Mice, Transgenic; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Neurons; Peptide Fragments; Peptidyl-Dipeptidase A; Reactive Oxygen Species; Stroke; Tissue Culture Techniques | 2014 |
The Ang-(1-7)/Mas-1 axis attenuates the expression and signalling of TGF-β1 induced by AngII in mouse skeletal muscle.
Topics: Angiotensin I; Angiotensin II; Animals; Mice; Mice, Inbred C57BL; Muscle, Skeletal; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Signal Transduction; Smad4 Protein; Transforming Growth Factor beta1 | 2014 |
Role of angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis in the hypotensive effect of azilsartan.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Benzimidazoles; Blood Pressure; Cardiomegaly; Epithelial Sodium Channels; Imidazoles; Male; Mice; Mice, Inbred C57BL; Oxadiazoles; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Sodium; Tetrazoles | 2014 |
Ulinastatin activates the renin-angiotensin system to ameliorate the pathophysiology of severe acute pancreatitis.
Topics: Acute Disease; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Ceruletide; Disease Models, Animal; Gene Expression; Glycoproteins; Lipopolysaccharides; Mice, Inbred C57BL; Molecular Targeted Therapy; Pancreatitis; Peptide Fragments; Peptidyl-Dipeptidase A; Prospective Studies; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Severity of Illness Index | 2014 |
[Inhibitory effect of angiotensin (1-7) on hepatic sinusoid angiogenesis in bile duct ligation-induced hepatic fibrosis of rats].
Topics: Angiotensin I; Animals; Bile Ducts; Hepatic Veins; Ligation; Liver Cirrhosis, Experimental; Male; Neovascularization, Pathologic; Peptide Fragments; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Wistar; Vascular Endothelial Growth Factor A; von Willebrand Factor | 2013 |
Angiotensin-(1-7) attenuates angiotensin II-induced signalling associated with activation of a tyrosine phosphatase in Sprague-Dawley rats cardiac fibroblasts.
Topics: Angiotensin I; Angiotensin II; Animals; Cells, Cultured; CSK Tyrosine-Protein Kinase; Enzyme Activation; Fibroblasts; Mitogen-Activated Protein Kinases; Myocardium; Peptide Fragments; Phosphorylation; Primary Cell Culture; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Rats, Sprague-Dawley; Signal Transduction; src-Family Kinases | 2014 |
Cross talk between angiotensin-(1-7)/Mas axis and sirtuins in adipose tissue and metabolism of high-fat feed mice.
Topics: Administration, Oral; Angiotensin I; Animals; Antimetabolites; Cells, Cultured; Diet, High-Fat; Drug Evaluation, Preclinical; Gene Expression; Glucose Intolerance; Hyperinsulinism; Insulin Resistance; Intra-Abdominal Fat; Lipolysis; Male; Mice; Obesity; Peptide Fragments; Primary Cell Culture; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Resistin; Resveratrol; Sirtuins; Stilbenes | 2014 |
Female spontaneously hypertensive rats are more dependent on ANG (1-7) to mediate effects of low-dose AT1 receptor blockade than males.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cell Adhesion Molecules; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hypertension; Male; Membrane Proteins; Peptide Fragments; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Sex Factors; Tetrazoles | 2014 |
Angiotensin (1-7) re-establishes heart cell communication previously impaired by cell swelling: implications for myocardial ischemia.
Topics: Angiotensin I; Animals; Cell Communication; Cell Membrane Permeability; Cell Size; Cells, Cultured; Fluorescent Dyes; Gap Junctions; Hypertonic Solutions; Isoquinolines; Myocardial Ischemia; Myocytes, Cardiac; Peptide Fragments; Rats; Rats, Sprague-Dawley | 2014 |
Evidence for an angiotensin-(1-7) neuropeptidase expressed in the brain medulla and CSF of sheep.
Topics: Angiotensin I; Animals; Bradykinin; Chromatography, Agarose; Chromatography, DEAE-Cellulose; Chromatography, High Pressure Liquid; Electrophoresis, Polyacrylamide Gel; Hydrogen-Ion Concentration; In Vitro Techniques; Intercellular Signaling Peptides and Proteins; Kinetics; Medulla Oblongata; Mercury Compounds; Neurotensin; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Protease Inhibitors; Sheep; Substrate Specificity | 2014 |
ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cytoskeletal Proteins; Fibrosis; Humans; Inflammation; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle Fibers, Skeletal; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Peptide Fragments; Peptidyl-Dipeptidase A | 2014 |
Angiotensin-(1-7) recruits muscle microvasculature and enhances insulin's metabolic action via mas receptor.
Topics: Angiotensin I; Angiotensin II; Animals; Arteries; Blood Flow Velocity; Blotting, Western; Dose-Response Relationship, Drug; Endothelium, Vascular; Extracellular Signal-Regulated MAP Kinases; Glucose; Hindlimb; Hypoglycemic Agents; In Vitro Techniques; Infusions, Intravenous; Insulin; Male; Microvessels; Muscle, Skeletal; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Regional Blood Flow; Vasodilation | 2014 |
Angiotensin-(1-7) and angiotensin Ⅱ induce the transdifferentiation of human endometrial epithelial cells in vitro.
Topics: Actins; Angiotensin I; Angiotensin II; Cadherins; Cell Proliferation; Cell Transdifferentiation; Cells, Cultured; Collagen Type I; Endometrium; Epithelial Cells; Female; Fibronectins; Humans; Immunohistochemistry; Peptide Fragments | 2014 |
Angiotensin (1-7) prevents angiotensin II-induced nociceptive behaviour via inhibition of p38 MAPK phosphorylation mediated through spinal Mas receptors in mice.
Topics: Angiotensin I; Angiotensin II; Animals; Behavior, Animal; Injections, Spinal; Mice; Nociceptive Pain; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Spinal Cord | 2014 |
Downregulation of the ACE2/Ang-(1-7)/Mas axis in transgenic mice overexpressing GH.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cardiovascular Diseases; Down-Regulation; Female; Growth Hormone; Hypertension; Kidney Diseases; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Signal Transduction | 2014 |
Angiotensin-(1-7) upregulates (ATP-binding cassette transporter A1) ABCA1 expression through cyclic AMP signaling pathway in RAW 264.7 macrophages.
Topics: Adenylyl Cyclase Inhibitors; Angiotensin I; Animals; ATP Binding Cassette Transporter 1; Cell Line; Cyclic AMP; Imines; Macrophages; Mice; Peptide Fragments; Signal Transduction; Up-Regulation | 2014 |
Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis via modulating angiotensin-converting enzyme 2/ angiotensin-(1-7) axis in rats.
Topics: Abietanes; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Bleomycin; Humans; Inflammation; Peptide Fragments; Peptidyl-Dipeptidase A; Pulmonary Fibrosis; Rats; Transforming Growth Factor beta | 2014 |
Angiotensin 1-7 reduces mortality and rupture of intracranial aneurysms in mice.
Topics: Aneurysm, Ruptured; Angiotensin I; Animals; Blood Pressure; Humans; Intracranial Aneurysm; Mice; Mice, Knockout; Oxidative Stress; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2014 |
Angiotensin (1-7) as a therapy to prevent rupture of intracranial aneurysms?
Topics: Aneurysm, Ruptured; Angiotensin I; Animals; Humans; Intracranial Aneurysm; Peptide Fragments | 2014 |
Ang (1-7) protects islet endothelial cells from palmitate-induced apoptosis by AKT, eNOS, p38 MAPK, and JNK pathways.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Apoptosis; Cell Line, Transformed; Endothelium, Vascular; Enzyme Activation; Fatty Acids, Nonesterified; Islets of Langerhans; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mice; Microvessels; Nitric Oxide Synthase Type III; p38 Mitogen-Activated Protein Kinases; Palmitic Acid; Peptide Fragments; Protective Agents; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, G-Protein-Coupled; Signal Transduction | 2014 |
Activation of the ACE2/Ang-(1-7)/Mas pathway reduces oxygen-glucose deprivation-induced tissue swelling, ROS production, and cell death in mouse brain with angiotensin II overproduction.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Brain; Brain Edema; Brain Ischemia; CA1 Region, Hippocampal; Cell Death; Cerebral Cortex; Glucose; Hypoxia; Membrane Glycoproteins; Mice, Transgenic; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Neurons; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Signal Transduction; Stroke; Tissue Culture Techniques | 2014 |
Angiotensin II and 1-7 during aging in Metabolic Syndrome rats. Expression of AT1, AT2 and Mas receptors in abdominal white adipose tissue.
Topics: Adipose Tissue, White; Aging; Angiotensin I; Angiotensin II; Animals; Gene Expression Regulation; Humans; Hypertension; Metabolic Syndrome; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2014 |
Angiotensin-(1-7) induces cerebral ischaemic tolerance by promoting brain angiogenesis in a Mas/eNOS-dependent pathway.
Topics: Angiogenesis Inhibitors; Angiotensin I; Angiotensin II; Animals; Brain; Cerebrovascular Circulation; Endostatins; Infarction, Middle Cerebral Artery; Male; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Ornithine; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled | 2014 |
Hemodynamic responses to angiotensin-(1-7) in women in their third trimester of pregnancy.
Topics: Adult; Angiotensin I; Cardiac Output; Case-Control Studies; Female; Forearm; Humans; Microcirculation; Peptide Fragments; Pre-Eclampsia; Pregnancy; Pregnancy Trimester, Third; Regional Blood Flow; Vascular Resistance; Young Adult | 2014 |
Angiotensin-(1-7) improves cognitive function in rats with chronic cerebral hypoperfusion.
Topics: Angiotensin I; Animals; Astrocytes; Blood Pressure; Brain Ischemia; Carotid Artery, Common; Cell Death; Cell Proliferation; Chronic Disease; Cognition Disorders; Disease Models, Animal; Hippocampus; Male; Maze Learning; Neurons; Neuroprotective Agents; Nitric Oxide; Peptide Fragments; Rats, Wistar | 2014 |
Assessment of angiotensin I metabolism in the human placenta using an LC/MS method.
Topics: Angiotensin I; Chromatography, Liquid; Female; Humans; Mass Spectrometry; Metabolic Networks and Pathways; Peptide Fragments; Placenta; Pregnancy; Renin-Angiotensin System | 2013 |
Estrogen regulation of the brain renin-angiotensin system in protection against angiotensin II-induced sensitization of hypertension.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Brain; Disease Models, Animal; Estradiol; Estrogen Replacement Therapy; Female; Gene Expression Regulation; Hypertension; Infusions, Intraventricular; Male; Ovariectomy; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin-Angiotensin System; RNA, Messenger; Sex Factors; Telemetry; Time Factors | 2014 |
Angiotensin-(1-7) prevent atrial tachycardia induced sodium channel remodeling.
Topics: Angiotensin I; Animals; Atrial Remodeling; Dogs; Female; Gene Expression; Male; NAV1.5 Voltage-Gated Sodium Channel; Peptide Fragments; Tachycardia, Supraventricular | 2014 |
MAS-mediated antioxidant effects restore the functionality of angiotensin converting enzyme 2-angiotensin-(1-7)-MAS axis in diabetic rat carotid.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Antioxidants; Blood Flow Velocity; Carotid Arteries; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Hydrogen Peroxide; Male; NADPH Oxidases; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled | 2014 |
Angiotensin-(1-7) reverses angiogenic dysfunction in corpus cavernosum by acting on the microvasculature and bone marrow-derived cells in diabetes.
Topics: Angiotensin I; Animals; Bone Marrow Cells; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Flow Cytometry; Male; Mice; Mice, Inbred C57BL; Microvessels; Neovascularization, Pathologic; Penis; Peptide Fragments; Proto-Oncogene Mas; Real-Time Polymerase Chain Reaction; Vascular Endothelial Growth Factor A | 2014 |
Reduction of angiotensin A and alamandine vasoactivity in the rabbit model of atherogenesis: differential effects of alamandine and Ang(1-7).
Topics: Acetylcholine; Angiotensin I; Angiotensins; Animals; Aorta, Abdominal; Aorta, Thoracic; Atherosclerosis; Carotid Arteries; Disease Models, Animal; Dose-Response Relationship, Drug; Iliac Artery; Male; Nitric Oxide Synthase Type III; Oligopeptides; Peptide Fragments; Phenylephrine; Rabbits; Receptors, G-Protein-Coupled; Renal Artery; Vasoconstriction; Vasodilation | 2014 |
Nuclear expression of renin-angiotensin system components in NRK-52E renal epithelial cells.
Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Cattle; Cell Line; Cell Nucleus; Epithelial Cells; Kidney; Peptide Fragments; Prorenin Receptor; Protease Inhibitors; Rats; Receptors, Cell Surface; Renin; Renin-Angiotensin System; Sheep; Time Factors | 2015 |
Role of Mas receptor in renal blood flow response to angiotensin (1-7) in male and female rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Dose-Response Relationship, Drug; Female; Kidney; Male; Peptide Fragments; Perfusion; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Renal Circulation; Renin-Angiotensin System; Sex Factors | 2014 |
Effect and mechanism of the Ang-(1-7) on human mesangial cells injury induced by low density lipoprotein.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Azo Compounds; Cells, Cultured; Cholesterol; Coloring Agents; Feedback, Physiological; Humans; Intracellular Signaling Peptides and Proteins; Lipoproteins, LDL; Membrane Proteins; Mesangial Cells; Peptide Fragments; Peptidyl-Dipeptidase A; Receptors, LDL; RNA, Messenger; Sterol Regulatory Element Binding Protein 2; Transforming Growth Factor beta1 | 2014 |
Fetal and maternal angiotensin (1-7) are associated with preterm birth.
Topics: Adult; Angiotensin I; Angiotensin II; Female; Fetal Blood; Fetus; Gestational Age; Humans; Hypertension, Pregnancy-Induced; Infant, Newborn; Peptide Fragments; Pre-Eclampsia; Pregnancy; Premature Birth; Prospective Studies; Renin-Angiotensin System; Risk Factors; Term Birth | 2014 |
[Effect of tanshinone II(A) on expression of different components in renin-angiotensin system of left ventricles of hypertensive rats].
Topics: Abietanes; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Heart Ventricles; Humans; Hypertension; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System | 2014 |
[Effect of Chinese herbs for stasis removing and collaterals dredging upon angiotensin-converting enzyme 2-angiotensin-(1-7)-mas axis in the renal cortex of diabetic nephropathy rats].
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drugs, Chinese Herbal; Kidney Cortex; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled | 2014 |
Atypical signaling and functional desensitization response of MAS receptor to peptide ligands.
Topics: Amino Acid Sequence; Angiotensin I; Binding Sites; Calcium; HEK293 Cells; Humans; Inositol Phosphates; Intracellular Space; Ligands; Microscopy, Confocal; Models, Molecular; Molecular Sequence Data; Mutation; Neuropeptides; Oligopeptides; Peptide Fragments; Peptides; Protein Binding; Protein Structure, Secondary; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Signal Transduction | 2014 |
ACE2 activity was increased in atherosclerotic plaque by losartan: Possible relation to anti-atherosclerosis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Humans; Losartan; Male; Myocytes, Smooth Muscle; Peptide Fragments; Peptidyl-Dipeptidase A; Plaque, Atherosclerotic; Rabbits; Signal Transduction | 2015 |
Angiotensin(1-7) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin receptor blockade.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Proliferation; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Male; Mesangial Cells; Oxidative Stress; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Valsartan; Vascular Endothelial Growth Factor A | 2015 |
Angiotensin-(1-7) prevents angiotensin II-induced fibrosis in cremaster microvessels.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Arterioles; Blood Pressure; Chronic Disease; Connective Tissue Growth Factor; Dual Specificity Phosphatase 1; Fibrosis; Hypertension; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 3; Muscle, Skeletal; Peptide Fragments; Phosphorylation; Rats; Rats, Inbred Lew; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta; Vasoconstrictor Agents | 2015 |
The angiotensin-converting enzyme 2/angiotensin (1-7)/Mas axis protects against lung fibroblast migration and lung fibrosis by inhibiting the NOX4-derived ROS-mediated RhoA/Rho kinase pathway.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cell Movement; Cells, Cultured; Collagen Type I; Collagen Type I, alpha 1 Chain; Fibroblasts; Male; NADPH Oxidase 4; NADPH Oxidases; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pulmonary Fibrosis; Rats, Wistar; Reactive Oxygen Species; Receptors, G-Protein-Coupled; rho-Associated Kinases; rhoA GTP-Binding Protein | 2015 |
Angiotensin-(1-7) attenuates damage to podocytes induced by preeclamptic serum through MAPK pathways.
Topics: Actins; Adult; Angiotensin I; Angiotensin II; Apoptosis; Cell Survival; Female; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Signaling System; Membrane Proteins; Mitogen-Activated Protein Kinases; Peptide Fragments; Phosphorylation; Podocytes; Pre-Eclampsia; Pregnancy; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2014 |
Proteomic white adipose tissue analysis of obese mice fed with a high-fat diet and treated with oral angiotensin-(1-7).
Topics: Adipose Tissue, White; Administration, Oral; Angiotensin I; Animals; Diet, High-Fat; Electrophoresis, Gel, Two-Dimensional; Male; Mass Spectrometry; Mice; Mice, Inbred Strains; Obesity; Peptide Fragments; Proteome; Proteomics; Weight Gain | 2014 |
Effects of the angiotensin-(1-7)/Mas/PI3K/Akt/nitric oxide axis and the possible role of atrial natriuretic peptide in an acute atrial tachycardia canine model.
Topics: Acute Disease; Angiotensin I; Animals; Atrial Fibrillation; Atrial Natriuretic Factor; Disease Models, Animal; Dogs; Heart Atria; Hemodynamics; Nitric Oxide; Peptide Fragments; Phosphatidylinositol 3-Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, G-Protein-Coupled; Refractory Period, Electrophysiological; Signal Transduction; Tachycardia; Time Factors | 2015 |
Decreased levels of serum Angiotensin-(1-7) in patients with pulmonary arterial hypertension due to congenital heart disease.
Topics: Adult; Angiotensin I; Enzyme-Linked Immunosorbent Assay; Female; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Male; Peptide Fragments; Pulmonary Wedge Pressure; Vascular Remodeling | 2014 |
The angiotensin-converting enzyme 2/angiotensin (1-7)/Mas axis protects the function of pancreatic β cells by improving the function of islet microvascular endothelial cells.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cell Line; Diet, High-Fat; Endothelial Cells; Gene Silencing; In Situ Nick-End Labeling; Insulin; Insulin Secretion; Insulin-Secreting Cells; Interleukin-1beta; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type II; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2014 |
Combined suppression of the intrarenal and circulating vasoconstrictor renin-ACE-ANG II axis and augmentation of the vasodilator ACE2-ANG 1-7-Mas axis attenuates the systemic hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.
Topics: Age Factors; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Disease Models, Animal; Hypertension; Hypoxia; Kidney; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Rats, Transgenic; Receptors, G-Protein-Coupled; Renin; Renin-Angiotensin System; Signal Transduction; Vasoconstriction; Vasodilation | 2015 |
Intrapulmonary activation of the angiotensin-converting enzyme type 2/angiotensin 1-7/G-protein-coupled Mas receptor axis attenuates pulmonary hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Arterial Pressure; Disease Models, Animal; Hypertension, Pulmonary; Hypoxia; Lung; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Rats, Transgenic; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin; Renin-Angiotensin System; Signal Transduction; Vasoconstriction; Vasodilation | 2015 |
MSCs modified with ACE2 restore endothelial function following LPS challenge by inhibiting the activation of RAS.
Topics: Acute Lung Injury; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Endothelial Cells; Genetic Therapy; HEK293 Cells; Humans; Lipopolysaccharides; Mesenchymal Stem Cells; Mice; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2015 |
Origin of the Y chromosome influences intrarenal vascular responsiveness to angiotensin I and angiotensin (1-7) in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin I; Animals; Blood Pressure; Disease Models, Animal; Hypertension; Male; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Artery; Vasodilation; Vasodilator Agents; Y Chromosome | 2014 |
Angiotensin-(1-7)-induced renal vasodilation is reduced in human kidneys with renal artery stenosis.
Topics: Angiotensin I; Case-Control Studies; Essential Hypertension; Female; Humans; Hypertension; Kidney; Male; Middle Aged; Peptide Fragments; Renal Artery; Renal Artery Obstruction; Renal Circulation; Renin-Angiotensin System; Vasodilation | 2014 |
Sex-specific effect of antenatal betamethasone exposure on renal oxidative stress induced by angiotensins in adult sheep.
Topics: Angiotensin I; Angiotensins; Animals; Betamethasone; Dinoprost; Female; Glucocorticoids; Kidney; Male; NADPH Oxidases; Oxidative Stress; Peptide Fragments; Pregnancy; Prenatal Exposure Delayed Effects; Proteinuria; Sex Factors; Sheep; Superoxide Dismutase | 2014 |
Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism.
Topics: Angiotensin I; Angiotensin II; Animals; Cell Line; Gene Expression Regulation; Male; Mice, Inbred C57BL; Muscle Fibers, Skeletal; Muscle Proteins; Muscle Strength; Muscle, Skeletal; Muscular Atrophy; Myosin Heavy Chains; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, G-Protein-Coupled; Signal Transduction; SKP Cullin F-Box Protein Ligases; Tripartite Motif Proteins; Ubiquitin-Protein Ligases | 2015 |
Angiotensin-(1-7) upregulates expression of adenosine triphosphate-binding cassette transporter A1 and adenosine triphosphate-binding cassette transporter G1 through the Mas receptor through the liver X receptor alpha signalling pathway in THP-1 macrophag
Topics: Angiotensin I; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; ATP-Binding Cassette Transporters; Cell Line, Tumor; Cholesterol; Humans; Liver X Receptors; Macrophages; Membrane Transport Proteins; Orphan Nuclear Receptors; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Up-Regulation | 2014 |
Another reason to eat your greens: cardiopulmonary protection by dietary delivery of angiotensin-converting enzyme-2 and angiotensin-(1-7) made in plants.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Hypertension, Pulmonary; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2014 |
Oral delivery of Angiotensin-converting enzyme 2 and Angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension.
Topics: Administration, Oral; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Blood Pressure; Chloroplasts; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Drug Therapy, Combination; Hypertension, Pulmonary; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System | 2014 |
Oral delivery of ACE2/Ang-(1-7) bioencapsulated in plant cells protects against experimental uveitis and autoimmune uveoretinitis.
Topics: Administration, Oral; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Chloroplasts; Disease Models, Animal; Humans; Mice; Mice, Inbred C57BL; Peptide Fragments; Peptidyl-Dipeptidase A; Plants, Genetically Modified; Retinal Vasculitis; Retinitis; Uveitis | 2014 |
Angiotensin-(1-7) abolishes AGE-induced cellular hypertrophy and myofibroblast transformation via inhibition of ERK1/2.
Topics: Albumins; Angiotensin I; Animals; Enzyme Activation; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Glycation End Products, Advanced; Hypertrophy; Myofibroblasts; Peptide Fragments; Phosphorylation; Rats; Transforming Growth Factor beta | 2014 |
The angiotensin-(1-7)/Mas axis reduces myonuclear apoptosis during recovery from angiotensin II-induced skeletal muscle atrophy in mice.
Topics: Angiotensin I; Angiotensin II; Animals; Apoptosis; Disease Models, Animal; Immunoblotting; In Situ Nick-End Labeling; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Muscular Atrophy; Peptide Fragments; Polymerase Chain Reaction; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2015 |
Changes in levels of angiotensin II and its receptors in a model of inverted stress-induced cardiomyopathy.
Topics: Angiotensin I; Angiotensin II; Animals; Cardiomyopathies; Disease Models, Animal; Female; Myocardium; Peptide Fragments; Rabbits; Receptors, Angiotensin; Renin-Angiotensin System; Stress, Physiological | 2014 |
Angiotensin-(1-7) modulates angiotensin II-induced vasoconstriction in human mammary artery.
Topics: Aged; Aged, 80 and over; Angiotensin I; Angiotensin II; Endothelium, Vascular; Female; Humans; Losartan; Male; Mammary Arteries; Middle Aged; Myocytes, Smooth Muscle; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Vasoconstriction | 2014 |
Chronic treatment with Ang-(1-7) reverses abnormal reactivity in the corpus cavernosum and normalizes diabetes-induced changes in the protein levels of ACE, ACE2, ROCK1, ROCK2 and omega-hydroxylase in a rat model of type 1 diabetes.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blood Glucose; Body Weight; Cytochrome P-450 CYP4A; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Erectile Dysfunction; Male; Penis; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; rho-Associated Kinases; Streptozocin | 2014 |
Hyperbaric oxygenation modulates vascular reactivity to angiotensin-(1-7) in diabetic rats: potential role of epoxyeicosatrienoic acids.
Topics: 8,11,14-Eicosatrienoic Acid; Amides; Angiotensin I; Angiotensin II; Animals; Aorta, Thoracic; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Enzyme Induction; Enzyme Inhibitors; Hyperbaric Oxygenation; Male; Oxidative Stress; Peptide Fragments; Rats, Sprague-Dawley; Steroid 16-alpha-Hydroxylase; Vascular Resistance; Vasoconstriction; Vasodilation; Vasodilator Agents | 2015 |
Lack of renoprotective effect of chronic intravenous angiotensin-(1-7) or angiotensin-(2-10) in a rat model of focal segmental glomerulosclerosis.
Topics: Angiotensin I; Angiotensin II; Animals; Drug Administration Schedule; Glomerulosclerosis, Focal Segmental; HEK293 Cells; Humans; Hypertension; Injections, Intravenous; Male; Nephrectomy; Peptide Fragments; Podocytes; Radioligand Assay; Rats; Treatment Failure | 2014 |
Expression and cellular localization of the Mas receptor in the adult and developing mouse retina.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Animals, Newborn; Cells, Cultured; Epithelial Cells; Gene Expression Regulation, Developmental; Mice; Mice, Inbred C57BL; Neuroglia; Peptide Fragments; Peptidyl-Dipeptidase A; Photoreceptor Cells, Vertebrate; Receptor Cross-Talk; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Retinal Ganglion Cells; Retinal Pigments; RNA, Messenger | 2014 |
Azilsartan is associated with increased circulating angiotensin-(1-7) levels and reduced renovascular 20-HETE levels.
Topics: Angiotensin I; Animals; Benzimidazoles; Blood Pressure; Disease Models, Animal; Hydroxyeicosatetraenoic Acids; Hypertension; Hypertension, Renovascular; Male; Oxadiazoles; Peptide Fragments; Rats; Rats, Sprague-Dawley; Vasoconstriction | 2015 |
Diminazene protects corpus cavernosum against hypercholesterolemia-induced injury.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Apolipoproteins E; Diminazene; Down-Regulation; Erectile Dysfunction; Hypercholesterolemia; Male; Mice; Mice, Knockout; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Penile Erection; Penis; Peptide Fragments; Peptidyl-Dipeptidase A; Reactive Oxygen Species | 2015 |
The ACE2-angiotensin-(1-7)-Mas axis protects against pancreatic cell damage in cell culture.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Anti-Inflammatory Agents; Cell Line; Ceruletide; Cytoprotection; Inflammation Mediators; Interleukin-6; Interleukin-8; Nitric Oxide; Nitric Oxide Synthase Type III; Pancreas, Exocrine; Pancreatitis; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Receptors, G-Protein-Coupled; Signal Transduction; Time Factors | 2015 |
Angiotensin-(1-7) in the basolateral amygdala attenuates the cardiovascular response evoked by acute emotional stress.
Topics: Amygdala; Angiotensin I; Animals; Cardiovascular System; Hemodynamics; Male; Peptide Fragments; Rats; Rats, Wistar; Stress, Psychological | 2015 |
Effects of angiotensin-(1-7) on the proliferation and collagen synthesis of arginine vasopressin-stimulated rat cardiac fibroblasts: role of mas receptor-calcineurin-NF-κB signaling pathway.
Topics: Angiotensin I; Animals; Animals, Newborn; Arginine Vasopressin; Calcineurin; Cell Differentiation; Cell Proliferation; Collagen; Dose-Response Relationship, Drug; Fibroblasts; Fibrosis; NF-kappa B; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Signal Transduction | 2014 |
Angiotensin-(1-7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice.
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Glucose; Blotting, Western; Diabetes Mellitus, Type 1; Fibrosis; Gene Expression Regulation; Histological Techniques; Hypertension; Immunohistochemistry; Injections, Subcutaneous; Kidney Diseases; Kidney Tubules, Proximal; Male; Mice; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Real-Time Polymerase Chain Reaction; Receptors, G-Protein-Coupled | 2015 |
Ang-(1-7) exerts protective role in blood-brain barrier damage by the balance of TIMP-1/MMP-9.
Topics: Angiotensin I; Animals; Blood-Brain Barrier; Brain Ischemia; Cell Line; Endothelial Cells; Gene Expression Regulation; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Peptide Fragments; Rats; Reperfusion Injury; Tight Junction Proteins; Tissue Inhibitor of Metalloproteinase-1 | 2015 |
Esophagoprotective activity of angiotensin-(1-7) in experimental model of acute reflux esophagitis. Evidence for the role of nitric oxide, sensory nerves, hypoxia-inducible factor-1alpha and proinflammatory cytokines.
Topics: Angiotensin I; Angiotensin II; Animals; Cyclooxygenase 2; Disease Models, Animal; Esophagitis, Peptic; Esophagus; Hypoxia-Inducible Factor 1, alpha Subunit; Interleukin-1beta; Male; Mucous Membrane; Nitric Oxide; Peptide Fragments; Protective Agents; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Wistar; Receptors, G-Protein-Coupled; Regional Blood Flow; RNA, Messenger; Sensory Receptor Cells; Tumor Necrosis Factor-alpha | 2014 |
Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation.
Topics: Airway Remodeling; Angiotensin I; Animals; Anti-Inflammatory Agents; Bronchial Hyperreactivity; Bronchoconstriction; Collagen; Cytokines; Disease Models, Animal; Hypertrophy, Right Ventricular; Immunoglobulin E; Inflammation Mediators; Lung; Male; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Ovalbumin; Peptide Fragments; Phosphorylation; Pneumonia; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Respiratory Hypersensitivity; Signal Transduction | 2015 |
An angiotensin-(1-7) peptidase in the kidney cortex, proximal tubules, and human HK-2 epithelial cells that is distinct from insulin-degrading enzyme.
Topics: Angiotensin I; Animals; Cell Line; Epithelial Cells; Humans; Insulysin; Kidney Cortex; Kidney Tubules, Proximal; Peptide Fragments; Peptide Hydrolases; Sheep | 2015 |
Regulation of insulin sensitivity, insulin production, and pancreatic β cell survival by angiotensin-(1-7) in a rat model of streptozotocin-induced diabetes mellitus.
Topics: Angiotensin I; Animals; Apoptosis Regulatory Proteins; Cell Survival; Diabetes Mellitus, Experimental; Disease Models, Animal; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Peptide Fragments; Rats; Rats, Wistar | 2015 |
Ang (1-7) is a modulator of the vasoconstrictor actions of Ang I and Ang II.
Topics: Angiotensin I; Angiotensin II; Animals; Aorta; In Vitro Techniques; Male; Myocardial Infarction; Myocardium; Peptide Fragments; Rats, Wistar; Vasoconstrictor Agents | 2015 |
Local uterine Ang-(1-7) infusion augments the expression of cannabinoid receptors and differentially alters endocannabinoid metabolizing enzymes in the decidualized uterus of pseudopregnant rats.
Topics: Amidohydrolases; Angiotensin I; Animals; Arachidonic Acids; Decidua; Embryo Implantation; Endocannabinoids; Female; Gene Expression Regulation, Enzymologic; Glycerides; Infusion Pumps; Monoacylglycerol Lipases; Peptide Fragments; Pregnancy; Pseudopregnancy; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Up-Regulation; Uterus | 2015 |
The effect of angiotensin-(1-7) in mouse unilateral ureteral obstruction.
Topics: Actins; Angiotensin I; Angiotensin II; Animals; Fibronectins; Male; Mice; Muscle, Smooth; Peptide Fragments; Transforming Growth Factor beta; Ureter; Ureteral Obstruction | 2015 |
Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis prevents lipopolysaccharide-induced apoptosis of pulmonary microvascular endothelial cells by inhibiting JNK/NF-κB pathways.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Cells, Cultured; Endothelial Cells; Extracellular Signal-Regulated MAP Kinases; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Lung; MAP Kinase Signaling System; Microvessels; NF-kappa B; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; RNA, Small Interfering; Signal Transduction | 2015 |
Effect of a stable Angiotensin-(1-7) analogue on progenitor cell recruitment and cardiovascular function post myocardial infarction.
Topics: Angiogenesis Inducing Agents; Angiotensin I; Animals; Cardiomegaly; Disease Models, Animal; Endothelial Cells; Flow Cytometry; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocytes, Cardiac; Peptide Fragments; Stem Cells; Time Factors; Vasodilator Agents | 2015 |
Differences in angiotensin (1-7) between men and women.
Topics: Adult; Angiotensin I; Blood Flow Velocity; Blood Pressure; Brachial Artery; Cross-Sectional Studies; Endothelium, Vascular; Female; Health Status Disparities; Healthy Volunteers; Humans; Male; Middle Aged; Peptide Fragments; Regional Blood Flow; Sex Factors; Vasodilation; Young Adult | 2015 |
The expression of Mas-receptor of the renin-angiotensin system in the human eye.
Topics: Angiotensin I; Anterior Eye Segment; Choroid; Fluorescent Antibody Technique, Indirect; Humans; Immunoenzyme Techniques; Kidney; Ligands; Microscopy, Fluorescence; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Retina | 2015 |
The association of renin-angiotensin system genes with the progression of hepatocellular carcinoma.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Antigens, CD34; Biomarkers, Tumor; Carcinoma, Hepatocellular; Case-Control Studies; Gene Expression Regulation, Neoplastic; Humans; Liver Cirrhosis; Liver Neoplasms; Peptide Fragments; Peptidyl-Dipeptidase A; Prognosis; Reference Values; Renin-Angiotensin System; Vascular Endothelial Growth Factor A | 2015 |
Podocalyxin promotes glioblastoma multiforme cell invasion and proliferation by inhibiting angiotensin-(1-7)/Mas signaling.
Topics: Angiotensin I; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Peptide Fragments; Phosphatidylinositol 3-Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Sialoglycoproteins; Signal Transduction | 2015 |
ACE2 and Ang-(1-7) protect endothelial cell function and prevent early atherosclerosis by inhibiting inflammatory response.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Apolipoproteins E; Atherosclerosis; Cell Adhesion; Cell Movement; Chemokine CCL2; Disease Models, Animal; E-Selectin; Endothelium, Vascular; Gene Transfer Techniques; Humans; In Vitro Techniques; Inflammation; Mice; Peptide Fragments; Peptidyl-Dipeptidase A; Signal Transduction; Vascular Cell Adhesion Molecule-1 | 2015 |
Angiotensin-(1-7) treatment mitigates right ventricular fibrosis as a distinctive feature of diabetic cardiomyopathy.
Topics: Angiotensin I; Animals; Blood Glucose; Cells, Cultured; Coculture Techniques; Collagen; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Fibrosis; Heart Ventricles; Lipids; Male; Oxidative Stress; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Wistar; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Signal Transduction; Time Factors; Transforming Growth Factor beta1; Ventricular Dysfunction, Right; Ventricular Function, Right; Ventricular Remodeling | 2015 |
Functional and molecular evidence for expression of the renin angiotensin system and ADAM17-mediated ACE2 shedding in COS7 cells.
Topics: ADAM Proteins; ADAM17 Protein; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Base Sequence; Chlorocebus aethiops; COS Cells; Molecular Sequence Data; Peptide Fragments; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; RNA Interference; RNA, Messenger; Transcription, Genetic; Transfection | 2015 |
Combination of angiotensin-(1-7) with perindopril is better than single therapy in ameliorating diabetic cardiomyopathy.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Blood Glucose; Cardiomegaly; Cell Communication; Cell Differentiation; Cell Proliferation; Collagen; Diabetic Cardiomyopathies; Disease Models, Animal; Drug Therapy, Combination; Echocardiography; Fibroblasts; Fibrosis; Heart Ventricles; Hemodynamics; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Peptidyl-Dipeptidase A; Perindopril; Phosphorylation; Rats; Receptors, Angiotensin; Transforming Growth Factor beta1; Ventricular Dysfunction, Left | 2015 |
Angiotensin-(1-7) protects against the development of aneurysmal subarachnoid hemorrhage in mice.
Topics: Aneurysm, Ruptured; Angiotensin I; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Brain; Cerebral Arteries; Cytokines; Imidazoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Pyridines; Receptor, Angiotensin, Type 2; RNA, Messenger; Subarachnoid Hemorrhage | 2015 |
Early co-expression of cyclooxygenase-2 and renin in the rat kidney cortex contributes to the development of N(G)-nitro-L-arginine methyl ester induced hypertension.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Captopril; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Gene Expression Regulation; Hypertension, Renal; Kidney Cortex; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Random Allocation; Rats, Wistar; Renin; RNA, Messenger | 2015 |
Endogenous activated angiotensin-(1-7) plays a protective effect against atherosclerotic plaques unstability in high fat diet fed ApoE knockout mice.
Topics: Angiotensin I; Animals; Apolipoproteins E; Diet, High-Fat; Inflammation Mediators; Male; Mice; Mice, Knockout; Peptide Fragments; Plaque, Atherosclerotic | 2015 |
Angiotensin-(1-7) stimulates cholesterol efflux from angiotensin II-treated cholesterol-loaded THP-1 macrophages through the suppression of p38 and c-Jun N-terminal kinase signaling.
Topics: Angiotensin I; Angiotensin II; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; ATP-Binding Cassette Transporters; Cholesterol; Gene Expression Regulation, Enzymologic; Humans; JNK Mitogen-Activated Protein Kinases; Liver X Receptors; Macrophages; Orphan Nuclear Receptors; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; PPAR gamma; Renin-Angiotensin System; RNA, Messenger | 2015 |
Ang-(1-7) promotes the migration and invasion of human renal cell carcinoma cells via Mas-mediated AKT signaling pathway.
Topics: Angiotensin I; Cell Line, Tumor; Humans; Kidney Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, G-Protein-Coupled; Signal Transduction; Wound Healing | 2015 |
Downregulation of the vascular renin-angiotensin system by aerobic training - focus on the balance between vasoconstrictor and vasodilator axes - .
Topics: Aerobiosis; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensinogen; Animals; Blood Pressure; Femoral Artery; Kidney; Male; Organ Specificity; Peptide Fragments; Peptidyl-Dipeptidase A; Physical Conditioning, Animal; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Artery; Renin-Angiotensin System; Running; Vasoconstriction; Vasodilation | 2015 |
Development of a sensitive, accurate and robust liquid chromatography/mass spectrometric method for profiling of angiotensin peptides in plasma and its application for atherosclerotic mice.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensins; Animals; Apolipoproteins E; Atherosclerosis; Chromatography, Liquid; Mass Spectrometry; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Receptors, LDL | 2015 |
Upregulation of Angiotensin (1-7)-Mediated Signaling Preserves Endothelial Function Through Reducing Oxidative Stress in Diabetes.
Topics: Acetylcholine; Aged; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Aorta; Cells, Cultured; Diabetes Mellitus, Type 2; Diminazene; Female; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice, Inbred C57BL; Middle Aged; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Reactive Oxygen Species; Renal Artery; Up-Regulation; Vasodilator Agents | 2015 |
Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cardiovascular Diseases; Humans; Male; Mice; Mice, Inbred C57BL; Myocardium; Nitric Oxide Synthase Type III; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Signal Transduction | 2015 |
Angiotensin-(1-7) through Mas receptor activation induces peripheral antinociception by interaction with adrenoreceptors.
Topics: Adrenergic beta-Antagonists; Analgesics; Angiotensin I; Animals; Dinoprostone; Hyperalgesia; Norepinephrine; Pain Measurement; Peptide Fragments; Prazosin; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptors, Adrenergic, beta; Receptors, G-Protein-Coupled; Yohimbine | 2015 |
Lack of weight gain after angiotensin AT1 receptor blockade in diet-induced obesity is partly mediated by an angiotensin-(1-7)/Mas-dependent pathway.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Benzimidazoles; Benzoates; Diet; Energy Intake; Energy Metabolism; Insulin Resistance; Leptin; Male; Obesity; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptors, G-Protein-Coupled; Signal Transduction; Telmisartan; Weight Gain; Weight Loss | 2015 |
Comparison of angiotensin-(1-7), losartan and their combination on atherosclerotic plaque formation in apolipoprotein E knockout mice.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Abdominal; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Blood Pressure; Cell Line; Cell Movement; Cell Proliferation; Diet, High-Fat; Disease Models, Animal; Drug Therapy, Combination; Endothelium, Vascular; Humans; Lipids; Losartan; Macrophages; Male; Mice, Knockout; Muscle, Smooth, Vascular; Peptide Fragments; Plaque, Atherosclerotic; Renin-Angiotensin System; Superoxides; Time Factors; Vasodilation | 2015 |
Angiotensin-(1-7) Attenuates Angiotensin II-Induced ICAM-1, VCAM-1, and MCP-1 Expression via the MAS Receptor Through Suppression of P38 and NF-κB Pathways in HUVECs.
Topics: Angiotensin I; Angiotensin II; Cells, Cultured; Chemokine CCL2; Human Umbilical Vein Endothelial Cells; Humans; I-kappa B Proteins; Intercellular Adhesion Molecule-1; NF-kappa B; NF-KappaB Inhibitor alpha; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Signal Transduction; Vascular Cell Adhesion Molecule-1 | 2015 |
Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Cytochrome P-450 Enzyme System; Disease Progression; Enzyme Inhibitors; Epoxide Hydrolases; Fatty Acids, Monounsaturated; Female; Fistula; Heart Failure; Heart Rate; Hemodynamics; Kidney; Male; Peptide Fragments; Rats; Rats, Transgenic; Renin; Renin-Angiotensin System; Solubility; Time Factors; Vena Cava, Inferior | 2015 |
ACE2-Ang (1-7) axis is induced in pressure overloaded rat model.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blotting, Western; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Heart Failure; Male; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction | 2015 |
Intracellular angiotensin (1-7) increases the inward calcium current in cardiomyocytes. On the role of PKA activation.
Topics: Angiotensin I; Angiotensin II; Animals; Calcium; Calcium Channels; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Heart Ventricles; Myocytes, Cardiac; Peptide Fragments; Rats; Rats, Inbred WKY | 2015 |
Activation of angiotensin-(1-7)/Mas axis in the brain lowers blood pressure and attenuates cardiac remodeling in hypertensive transgenic (mRen2)27 rats.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Brain; Heart; Heart Rate; Hypertension; Male; Myocardium; Peptide Fragments; Rats, Sprague-Dawley; Rats, Transgenic; Renin-Angiotensin System; RNA, Messenger | 2015 |
Angiotensin (1-7), small but complicated, needs more exercise.
Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Kidney; Male; Peptide Fragments; Physical Conditioning, Animal; Renal Artery; Renin-Angiotensin System | 2015 |
Endotoxin-induced skeletal muscle wasting is prevented by angiotensin-(1-7) through a p38 MAPK-dependent mechanism.
Topics: Analysis of Variance; Angiotensin I; Animals; Cells, Cultured; In Vitro Techniques; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Muscle Strength; Muscle, Skeletal; Muscular Atrophy; Myofibrils; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Random Allocation; Systemic Inflammatory Response Syndrome; Ubiquitin-Protein Ligases; Vasodilator Agents | 2015 |
[Effects of angiotensin-(1-7) on hippocampal expressions of GFAP and GDNF and cognitive function in rats with diabetes mellitus].
Topics: Angiotensin I; Animals; Astrocytes; Caspase 3; Cognition; Cognition Disorders; Diabetes Mellitus, Experimental; Glial Cell Line-Derived Neurotrophic Factor; Glial Fibrillary Acidic Protein; Hippocampus; Male; Memory; Neurons; Peptide Fragments; Rats; Rats, Sprague-Dawley; Streptozocin | 2015 |
Angiotensin II type 1 receptor-associated protein plays a role in regulating the local renin-angiotensin system in HSC-T6 cells.
Topics: Angiotensin I; Angiotensin II; Animals; Cell Line; Gene Expression Regulation; Peptide Fragments; Rats; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger | 2015 |
The ACE2/Ang-(1-7)/Mas Axis Regulates the Development of Pancreatic Endocrine Cells in Mouse Embryos.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Animals, Newborn; Cell Differentiation; Cell Proliferation; Embryo, Mammalian; Enzyme Inhibitors; Female; Gene Expression Regulation, Developmental; Glucose Tolerance Test; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Mice, Inbred ICR; NADPH Oxidases; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Pregnancy; Proto-Oncogene Mas; Proto-Oncogene Proteins; Reactive Oxygen Species; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction | 2015 |
Angiotensin-(1-7) is Reduced and Inversely Correlates with Tau Hyperphosphorylation in Animal Models of Alzheimer's Disease.
Topics: Alzheimer Disease; Angiotensin I; Animals; Brain; Disease Models, Animal; Disease Progression; Male; Mice, Inbred C57BL; Mice, Transgenic; Peptide Fragments; Phosphorylation; tau Proteins | 2016 |
Inhibition of soluble epoxide hydrolase does not improve the course of congestive heart failure and the development of renal dysfunction in rats with volume overload induced by aorto-caval fistula.
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzoates; Disease Models, Animal; Drug Evaluation, Preclinical; Epoxide Hydrolases; Epoxy Compounds; Heart Failure; Kidney; Male; Myocardium; Peptide Fragments; Random Allocation; Rats; Renal Insufficiency; Renin-Angiotensin System; Ultrasonography; Urea | 2015 |
Rho kinase, oxidative stress, ACE2/Ang 1-7 and lung fibrosis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Humans; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Pulmonary Fibrosis; rho-Associated Kinases | 2015 |
Beneficial effects of angiotensin-(1-7) against deoxycorticosterone acetate-induced diastolic dysfunction occur independently of changes in blood pressure.
Topics: Angiotensin I; Animals; Blood Pressure; Calcium; Calcium Signaling; Desoxycorticosterone Acetate; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Failure, Diastolic; Hydralazine; Hypertension; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Rats, Transgenic | 2015 |
Modulation of cardiac L-type Ca2+ current by angiotensin-(1-7): normal versus heart failure.
Topics: Angiotensin I; Animals; Bradykinin; Calcium Channels, L-Type; Calcium Signaling; Cardiotonic Agents; Disease Models, Animal; Heart Failure; Isoproterenol; Male; Membrane Potentials; Myocytes, Cardiac; Necrosis; Nitric Oxide; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Time Factors; Ventricular Function, Left | 2015 |
[Effects of Ang-(1-7) on the expression of ACE2 and IGFBP-2 in hepatic stellate cells].
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Hepatic Stellate Cells; Insulin-Like Growth Factor Binding Protein 2; Peptide Fragments; Peptidyl-Dipeptidase A | 2015 |
Angiotensin-(1-7) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2/ROS and PI3K/NO pathways.
Topics: Angiotensin I; Angiotensin II; Apoptosis; Blotting, Western; Brain; Cells, Cultured; Endothelium, Vascular; Gene Expression Regulation; Humans; Microvessels; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Peptide Fragments; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction; Vasoconstrictor Agents; Vasodilator Agents | 2015 |
MAS receptors mediate vasoprotective and atheroprotective effects of candesartan upon the recovery of vascular angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS axis functionality.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Aorta, Thoracic; Apolipoproteins E; Atherosclerosis; Benzimidazoles; Biphenyl Compounds; Cardiotonic Agents; Cholesterol; Cytokines; Male; Mice, Inbred C57BL; Mice, Knockout; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Tetrazoles; Triglycerides; Vascular Cell Adhesion Molecule-1 | 2015 |
ACE2 Deficiency Worsens Epicardial Adipose Tissue Inflammation and Cardiac Dysfunction in Response to Diet-Induced Obesity.
Topics: Adiponectin; Adipose Tissue; AMP-Activated Protein Kinases; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blood Glucose; Blotting, Western; Diet, High-Fat; Enzyme-Linked Immunosorbent Assay; Glucose Intolerance; Heart; Heart Failure; Humans; Inflammation; Insulin Resistance; Macrophages; Mice; Mice, Knockout; Myocardium; Obesity; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Pericardium; Phosphorylation; Real-Time Polymerase Chain Reaction; Stroke Volume; Tumor Necrosis Factor-alpha; Vasodilator Agents; Weight Gain | 2016 |
Angiotensin-(1-7) Suppresses Hepatocellular Carcinoma Growth and Angiogenesis via Complex Interactions of Angiotensin II Type 1 Receptor, Angiotensin II Type 2 Receptor and Mas Receptor.
Topics: Angiotensin I; Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mitogen-Activated Protein Kinase 11; Neovascularization, Pathologic; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Xenograft Model Antitumor Assays | 2015 |
Baicalin attenuates angiotensin II-induced endothelial dysfunction.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Aorta, Thoracic; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Flavonoids; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Nitric Oxide Synthase Type III; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Signal Transduction; Tissue Culture Techniques; Vasodilation | 2015 |
Long-Term Regulation of the Local Renin-Angiotensin System in the Myocardium of Spontaneously Hypertensive Rats by Feeding Bioactive Peptides Derived from Spirulina platensis.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Blood Pressure; Humans; Hypertension; Male; Myocardium; Peptide Fragments; Peptides; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Spirulina | 2015 |
Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Apolipoproteins E; Gene Deletion; Humans; Inflammation; Kidney; Male; Membrane Proteins; Mice, Inbred C57BL; Mice, Knockout; Models, Biological; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 1; Receptors, Tumor Necrosis Factor, Type I; Recombinant Proteins; Signal Transduction; Superoxides; Tumor Necrosis Factor-alpha | 2015 |
Angiotensin1-7 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress by preventing ROS-associated mitochondrial dysfunction and activating the Akt signaling pathway.
Topics: Angiotensin I; Animals; Apoptosis; Cardiotonic Agents; Cell Hypoxia; Cell Line; Cell Survival; Drug Evaluation, Preclinical; Mitochondria, Heart; Myocytes, Cardiac; Oxidative Stress; Oxygen; Peptide Fragments; Proto-Oncogene Proteins c-akt; Rats; Reactive Oxygen Species; Signal Transduction | 2015 |
Mas receptor overexpression increased Ang-(1-7) relaxation response in renovascular hypertensive rat carotid.
Topics: Angiotensin I; Animals; Carotid Arteries; Gene Expression Regulation; Hypertension; Ibuprofen; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Vasodilation | 2015 |
Angiotensin-(1-7) counteracts the effects of Ang II on vascular smooth muscle cells, vascular remodeling and hemorrhagic stroke: Role of the NFкB inflammatory pathway.
Topics: Angiotensin I; Angiotensin II; Animals; Apoptosis; Cell Movement; Cell Proliferation; Cells, Cultured; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Infarction, Middle Cerebral Artery; Inflammation Mediators; Intracranial Hemorrhages; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neuroprotective Agents; NF-kappa B; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Signal Transduction; Vascular Remodeling; Wound Healing | 2015 |
Anti-Inflammatory Effects of Ang-(1-7) in Ameliorating HFD-Induced Renal Injury through LDLr-SREBP2-SCAP Pathway.
Topics: Acute Kidney Injury; Angiotensin I; Animals; Anti-Inflammatory Agents; Diet, High-Fat; Dyslipidemias; Inflammation; Kidney; Lipid Metabolism; Male; Mice, Inbred C57BL; Peptide Fragments; Receptors, LDL; Signal Transduction; Sterol Regulatory Element Binding Protein 2 | 2015 |
ACE2/Ang-(1-7)/Mas axis stimulates vascular repair-relevant functions of CD34+ cells.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Antigens, CD34; Cell Adhesion; Cell Movement; Cell Proliferation; Diminazene; Humans; Leukocytes, Mononuclear; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Vasoconstrictor Agents; Vasodilator Agents; Wound Healing; Xanthones | 2015 |
Identification of intracellular proteins and signaling pathways in human endothelial cells regulated by angiotensin-(1-7).
Topics: Angiotensin I; Cell Death; Cell Survival; Down-Regulation; Endothelial Cells; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Immunohistochemistry; Peptide Fragments; Protein Array Analysis; Proteins; Proteome; Proteomics; Signal Transduction | 2016 |
Differential control of vasomotion by angiotensins in the rostral ventrolateral medulla of hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Animals; Arterial Pressure; Blood Pressure; Cardiac Output; Cerebrovascular Circulation; Heart Rate; Male; Medulla Oblongata; Mesenteric Arteries; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Wistar; Regional Blood Flow; Splanchnic Circulation; Vascular Resistance | 2015 |
[Telmisartan reduces retina vessel endothelial cell apoptosis via upregulating retinal ACE2-Ang-(1-7)-Mas axis in spontaneous hypertensive rats].
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Benzimidazoles; Benzoates; Blood Pressure; Endothelial Cells; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Retina; Systole; Telmisartan; Up-Regulation | 2015 |
Angiotensin-(1-7) enhances the effects of angiotensin II on the cardiac sympathetic afferent reflex and sympathetic activity in rostral ventrolateral medulla in renovascular hypertensive rats.
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Disease Models, Animal; Drug Interactions; Hypertension, Renovascular; Losartan; Male; Medulla Oblongata; Peptide Fragments; Random Allocation; Rats; Rats, Sprague-Dawley; Reflex; Sympathetic Nervous System; Treatment Outcome | 2015 |
Diabetic Nephropathy Induced by Increased Ace Gene Dosage Is Associated with High Renal Levels of Angiotensin (1-7) and Bradykinin.
Topics: Angiotensin I; Animals; Blood Glucose; Body Weight; Bradykinin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Dosage; Gene Expression Regulation; Genetic Predisposition to Disease; Genotype; Kidney; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Spectrometry, Fluorescence | 2015 |
Direct anti-inflammatory effects of angiotensin-(1-7) on microglia.
Topics: Angiotensin I; Animals; Animals, Newborn; Anti-Inflammatory Agents; Cells, Cultured; Female; Inflammation Mediators; Microglia; Peptide Fragments; Pregnancy; Rats; Rats, Sprague-Dawley | 2016 |
Determination of Angiotensin-(1-7) with HPLC/Fluorescence-Detection.
Topics: Angiotensin I; Animals; Chromatography, High Pressure Liquid; Fluorescence; Male; Microscopy, Fluorescence; Molecular Conformation; Peptide Fragments; Rats; Rats, Wistar | 2016 |
Effect of angiotensin-(1-7) and angiotensin II on the proliferation and activation of human endometrial stromal cells in vitro.
Topics: Actins; Angiotensin I; Angiotensin II; Cell Proliferation; Collagen Type I; Endometrium; Female; Fibronectins; Humans; Insulin-Like Growth Factor I; Peptide Fragments; Stromal Cells; Transforming Growth Factor beta1 | 2015 |
Does exercise increase insulin sensitivity through angiotensin 1-7?
Topics: Angiotensin I; Exercise; Humans; Hyperinsulinism; Insulin Resistance; Peptide Fragments | 2016 |
Effects of female sex hormones on expression of the Ang-(1-7)/Mas-R/nNOS pathways in rat brain.
Topics: Angiotensin I; Animals; Brain; Female; Gene Expression Regulation; Gonadal Steroid Hormones; Nitric Oxide Synthase Type I; Ovariectomy; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Signal Transduction | 2015 |
Continuous angiotensin-(1-7) infusion improves myocardial calcium transient and calcium transient alternans in ischemia-induced cardiac dysfunction rats.
Topics: Angiotensin I; Animals; Calcium; Calcium Channels, L-Type; Heart; Hemodynamics; Male; Myocardial Ischemia; Myocardium; Peptide Fragments; Rats; Rats, Sprague-Dawley | 2015 |
Endogenous angiotensin-(1-7)/Mas receptor/NO pathway mediates the cardioprotective effects of pacing postconditioning.
Topics: Angiotensin I; Animals; Cardiac Pacing, Artificial; Creatine Kinase; Enzyme Inhibitors; Hemodynamics; Isolated Heart Preparation; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Time Factors; Ventricular Function, Left | 2016 |
Transactivation of ErbB Family of Receptor Tyrosine Kinases Is Inhibited by Angiotensin-(1-7) via Its Mas Receptor.
Topics: Angiotensin I; Animals; Blotting, Western; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; ErbB Receptors; Gene Expression Regulation; Glucose; Male; Muscle, Smooth, Vascular; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Transcriptional Activation; Vasodilator Agents | 2015 |
Angiotensin-(1-7) Attenuates Kidney Injury Due to Obstructive Nephropathy in Rats.
Topics: Angiotensin I; Angiotensin II; Animals; Apoptosis; Cell Line; Kidney; Kidney Diseases; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction; Transforming Growth Factor beta1 | 2015 |
Estradiol, acting through ERα, induces endothelial non-classic renin-angiotensin system increasing angiotensin 1-7 production.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Dose-Response Relationship, Drug; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Fulvestrant; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Piperidines; Pyrazoles | 2016 |
Postconditioning of ischemic heart by intermittent ventricular pacing at the beginning of reperfusion: novel mechanisms and potential utilities in interventional cardiology settings.
Topics: Angiotensin I; Animals; Cardiac Pacing, Artificial; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Ventricular Function, Left | 2016 |
Angiotensin 1-7 significantly reduces diabetes-induced leukocyte recruitment both in vivo and in vitro.
Topics: Angiotensin I; Animals; Cell Adhesion Molecules; Cell Movement; Cells, Cultured; Diabetes Mellitus, Experimental; Endothelium, Vascular; Gene Expression Regulation; Immunohistochemistry; Leukocyte Rolling; Leukocytes; Male; Peptide Fragments; Rats; Real-Time Polymerase Chain Reaction; RNA | 2016 |
Angiotensin-(1-7)/mas inhibits apoptosis in alveolar epithelial cells through upregulation of MAP kinase phosphatase-2.
Topics: Alveolar Epithelial Cells; Angiotensin I; Apoptosis; Cell Survival; Dual-Specificity Phosphatases; Epithelial Cells; Humans; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinase Phosphatases; Peptide Fragments; Phosphorylation; Pulmonary Alveoli; Signal Transduction; Up-Regulation | 2016 |
Angiotensin-(1-7)/Mas Signaling Inhibits Lipopolysaccharide-Induced ADAM17 Shedding Activity and Apoptosis in Alveolar Epithelial Cells.
Topics: ADAM Proteins; ADAM17 Protein; Angiotensin I; Anthracenes; Apoptosis; Epithelial Cells; Humans; Lipopolysaccharides; MAP Kinase Kinase 4; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pulmonary Alveoli; Receptors, G-Protein-Coupled; RNA, Small Interfering; Signal Transduction; Transfection | 2016 |
Angiotensin-(1-7)/Mas axis modulates fear memory and extinction in mice.
Topics: Acoustic Stimulation; Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Animals; Avoidance Learning; Conditioning, Classical; Electroshock; Extinction, Psychological; Fear; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled | 2016 |
Angiotensin-(1-7) Decreases Cell Growth and Angiogenesis of Human Nasopharyngeal Carcinoma Xenografts.
Topics: Angiogenesis Inhibitors; Angiotensin I; Animals; Carcinoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; MAP Kinase Signaling System; Membrane Proteins; Mice; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neovascularization, Pathologic; Peptide Fragments; Proto-Oncogene Mas; Receptors, Vascular Endothelial Growth Factor; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2016 |
The effect of angiotensin-converting enzyme inhibition throughout a superovulation protocol in ewes.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Embryo, Nonmammalian; Enalapril; Estradiol; Female; Ovulation; Peptide Fragments; Peptidyl-Dipeptidase A; Progesterone; Sheep; Superovulation | 2015 |
The PI3K signaling-mediated nitric oxide contributes to cardiovascular effects of angiotensin-(1-7) in the nucleus tractus solitarii of rats.
Topics: Angiotensin I; Animals; Cardiovascular System; Male; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Peptide Fragments; Phosphatidylinositol 3-Kinases; Rats; Rats, Sprague-Dawley; Signal Transduction; Solitary Nucleus | 2016 |
Angiotensin 1-7 Protects against Angiotensin II-Induced Endoplasmic Reticulum Stress and Endothelial Dysfunction via Mas Receptor.
Topics: Angiotensin I; Angiotensin II; Animals; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Endothelium; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase Type III; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Tunicamycin | 2015 |
Cardiac ACE2/angiotensin 1-7/Mas receptor axis is activated in thyroid hormone-induced cardiac hypertrophy.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cardiomegaly; Hyperthyroidism; Male; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2016 |
Angiotensin-(1-7) Improves Liver Fibrosis by Regulating the NLRP3 Inflammasome via Redox Balance Modulation.
Topics: Angiotensin I; Animals; Antioxidant Response Elements; Cells, Cultured; Collagen Type I; Collagen Type I, alpha 1 Chain; Connective Tissue Growth Factor; Humans; Inflammasomes; Liver; Liver Cirrhosis; Male; Mitochondria, Liver; Myeloid Differentiation Factor 88; NADPH Oxidase 4; NADPH Oxidases; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidation-Reduction; Oxidative Stress; Peptide Fragments; Protein Multimerization; Rats, Wistar; Reactive Oxygen Species; Renin-Angiotensin System; Signal Transduction; Smad Proteins; Toll-Like Receptor 4 | 2016 |
Angiotensin-(1-7) Attenuates Skeletal Muscle Fibrosis and Stiffening in a Mouse Model of Extremity Sarcoma Radiation Therapy.
Topics: Analysis of Variance; Angiotensin I; Animals; Biopsy, Needle; Disease Models, Animal; Fibrosis; Hindlimb; Immunohistochemistry; Male; Mice; Mice, Inbred Strains; Muscle Neoplasms; Muscle, Skeletal; Peptide Fragments; Random Allocation; Reference Values; Sarcoma, Experimental; Sensitivity and Specificity; Spasm | 2016 |
Design of a MCoTI-Based Cyclotide with Angiotensin (1-7)-Like Activity.
Topics: Angiotensin I; Animals; Cell Survival; CHO Cells; Cricetulus; Cyclotides; Humans; Myocardial Infarction; Neoplasms; Peptide Fragments; Plant Proteins; Protein Conformation; Protein Folding; Protein Stability; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2016 |
Osthole Alleviates Bleomycin-Induced Pulmonary Fibrosis via Modulating Angiotensin-Converting Enzyme 2/Angiotensin-(1-7) Axis and Decreasing Inflammation Responses in Rats.
Topics: Acute Lung Injury; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Anti-Inflammatory Agents; Bleomycin; Collagen; Coumarins; Cytokines; Edema; Lung; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Pulmonary Fibrosis; Rats, Sprague-Dawley; Transforming Growth Factor beta1 | 2016 |
Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Topics: Albuminuria; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Body Weight; Cytochrome P-450 CYP1A1; Diminazene; Enzyme Activators; Gene Expression Regulation; Hypertension, Malignant; Kidney; Mice; Peptide Fragments; Peptides; Peptidyl-Dipeptidase A; Rats; Rats, Transgenic; Renin; Renin-Angiotensin System; Sodium | 2016 |
Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas.
Topics: Angiotensin I; Animals; Insulin-Like Growth Factor I; Isometric Contraction; Male; Mice; Mice, Inbred C57BL; Muscle Fibers, Skeletal; Muscle Proteins; Muscle Strength; Muscular Atrophy; Muscular Disorders, Atrophic; Myosin Heavy Chains; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Receptors, G-Protein-Coupled; Signal Transduction; SKP Cullin F-Box Protein Ligases; Tripartite Motif Proteins; Ubiquitin-Protein Ligases | 2016 |
Effect of Angiotensin-(1-7) on Aortic Response, TNF-α, IL-1β and Receptor for Advanced Glycation Endproduct in Rat's Adjuvant-Induced Arthritis.
Topics: Acetylcholine; Angiotensin I; Animals; Aorta, Thoracic; Arthritis, Experimental; Blood Pressure; Interleukin-1beta; Male; Peptide Fragments; Phenylephrine; Potassium Chloride; Rats, Sprague-Dawley; Rats, Wistar; Receptor for Advanced Glycation End Products; Tumor Necrosis Factor-alpha; Vasoconstriction | 2016 |
Exercise Training Improves the Altered Renin-Angiotensin System in the Rostral Ventrolateral Medulla of Hypertensive Rats.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Cardiovascular System; Chromatography, High Pressure Liquid; Citrate (si)-Synthase; Hypertension; Male; Medulla Oblongata; Oxidative Stress; Peptide Fragments; Physical Conditioning, Animal; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Renin-Angiotensin System; Signal Transduction | 2016 |
Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis activates Akt signaling to ameliorate hepatic steatosis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cytosol; Fatty Liver; Gene Expression; Gene Knockout Techniques; Hep G2 Cells; Humans; Male; Mice, Knockout; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Signal Transduction; Vasodilator Agents | 2016 |
Therapeutic time window for angiotensin-(1-7) in acute lung injury.
Topics: Acute Lung Injury; Angiotensin I; Animals; Hemodynamics; Infusions, Intravenous; Male; Oleic Acid; Peptide Fragments; Rats; Rats, Sprague-Dawley; Time Factors | 2016 |
Plasma Angiotensin-(1-7) is a Potential Biomarker for Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Angiotensin I; Angiotensin-Converting Enzyme 2; Area Under Curve; Biomarkers; Case-Control Studies; Cognition Disorders; Female; Humans; Male; Neuropsychological Tests; Peptide Fragments; Peptidyl-Dipeptidase A; Psychiatric Status Rating Scales; Sensitivity and Specificity; Statistics as Topic | 2016 |
Long-term administration of angiotensin (1-7) prevents heart and lung dysfunction in a mouse model of type 2 diabetes (db/db) by reducing oxidative stress, inflammation and pathological remodeling.
Topics: Angiotensin I; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cardiotonic Agents; Cytokines; Diabetes Mellitus, Type 2; Disease Models, Animal; Fibrosis; Heart; Hypoglycemic Agents; Lipid Metabolism; Lung; Male; Mice; Myocardium; Oxidative Stress; Peptide Fragments | 2016 |
Anti-Inflammatory Action of Angiotensin 1-7 in Experimental Colitis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Anti-Inflammatory Agents; Colitis; Dextran Sulfate; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Female; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, G-Protein-Coupled | 2016 |
Chronic Angiotensin-(1-7) Improves Insulin Sensitivity in High-Fat Fed Mice Independent of Blood Pressure.
Topics: Analysis of Variance; Angiotensin I; Animals; Blood Glucose; Blood Pressure Determination; Body Composition; Cardiovascular Diseases; Diet, High-Fat; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Glucose Clamp Technique; Heart Function Tests; Hemodynamics; Hypertension; Infusions, Subcutaneous; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Obesity; Peptide Fragments; Random Allocation; Reference Values; Renin-Angiotensin System | 2016 |
The renin-angiotensin system and its vasoactive metabolite angiotensin-(1-7) in the mechanism of the healing of preexisting gastric ulcers. The involvement of Mas receptors, nitric oxide, prostaglandins and proinflammatory cytokines.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cytokines; Enzyme Inhibitors; Gastric Mucosa; Imidazoles; Indomethacin; Interleukin-1beta; Lisinopril; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Prostaglandins; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Stomach Ulcer; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2016 |
Angiotensin-converting enzyme 2 ameliorates renal fibrosis by blocking the activation of mTOR/ERK signaling in apolipoprotein E-deficient mice.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Apolipoproteins E; Atherosclerosis; Fibrosis; Kidney; Kidney Diseases; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Peptidyl-Dipeptidase A; Sirolimus; TOR Serine-Threonine Kinases | 2016 |
Renal hemodynamics and renin-angiotensin system activity in humans with multifocal renal artery fibromuscular dysplasia.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Case-Control Studies; Enzyme Inhibitors; Essential Hypertension; Female; Fibromuscular Dysplasia; Glomerular Filtration Rate; Humans; Hypertension; Hypertension, Renovascular; Male; Microvessels; Middle Aged; Nitric Oxide Synthase; Peptide Fragments; Renal Artery; Renal Circulation; Renin; Renin-Angiotensin System; Sex Factors | 2016 |
Angiotensin-(1-7) attenuated long-term hypoxia-stimulated cardiomyocyte apoptosis by inhibiting HIF-1α nuclear translocation via Mas receptor regulation.
Topics: Active Transport, Cell Nucleus; Angiotensin I; Animals; Apoptosis; Cell Hypoxia; Cell Nucleus; Cells, Cultured; Hypoxia-Inducible Factor 1, alpha Subunit; Myocytes, Cardiac; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1 | 2016 |
Downregulation of ACE2/Ang-(1-7)/Mas axis promotes breast cancer metastasis by enhancing store-operated calcium entry.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Antigens, CD; Breast Neoplasms; Cadherins; Calcium Signaling; Cell Movement; Down-Regulation; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Heterografts; Humans; MCF-7 Cells; Mice, Inbred NOD; Mice, SCID; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Transplantation; NF-kappa B; p21-Activated Kinases; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; RNA Interference; Snail Family Transcription Factors; Transfection | 2016 |
[Effect of Astragali Radix in improving early renal damage in metabolic syndrome rats through ACE2/Mas pathway].
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Astragalus Plant; Blood Glucose; Blood Pressure; Drugs, Chinese Herbal; Humans; Kidney; Male; Malondialdehyde; Metabolic Syndrome; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Signal Transduction | 2015 |
Vascular Actions of Angiotensin 1-7 in the Human Microcirculation: Novel Role for Telomerase.
Topics: Adipose Tissue; Aged; Angiotensin I; Arterioles; Case-Control Studies; Cells, Cultured; Coronary Artery Disease; Coronary Vessels; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Inhibitors; Female; Heart Atria; Humans; In Vitro Techniques; Male; Middle Aged; Nitric Oxide; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Signal Transduction; Telomerase; Vasodilation; Vasodilator Agents | 2016 |
Peroxisome proliferator-activated receptor-α stimulation by clofibrate favors an antioxidant and vasodilator environment in a stressed left ventricle.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Antioxidants; Aortic Coarctation; Captopril; Catalase; Clofibrate; Drug Synergism; Heart Ventricles; Hypertension; Lipid Peroxidation; Male; Nitric Oxide Synthase Type III; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; PPAR alpha; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Superoxide Dismutase; Vasodilation | 2016 |
The tACE/Angiotensin (1-7)/Mas Axis Protects Against Testicular Ischemia Reperfusion Injury.
Topics: Angiotensin I; Animals; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Reperfusion Injury; Testis | 2016 |
Intracerebroventricular Infusion of Angiotensin-(1-7) Ameliorates Cognitive Impairment and Memory Dysfunction in a Mouse Model of Alzheimer's Disease.
Topics: Acetazolamide; Alzheimer Disease; Amyloid beta-Peptides; Angiotensin I; Animals; Avoidance Learning; Carbonic Anhydrase Inhibitors; Cerebrovascular Circulation; Cognition Disorders; Disease Models, Animal; Drug Delivery Systems; Infusions, Intraventricular; Maze Learning; Memory Disorders; Mice; Mice, Transgenic; Peptide Fragments; Reaction Time; tau Proteins | 2016 |
Anxiolytic- and antidepressant-like effects of angiotensin-(1-7) in hypertensive transgenic (mRen2)27 rats.
Topics: Angiotensin I; Animals; Anti-Anxiety Agents; Antidepressive Agents; Enalapril; Hypertension; Male; Maze Learning; Peptide Fragments; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Swimming | 2016 |
G-Protein-Coupled Receptor MrgD Is a Receptor for Angiotensin-(1-7) Involving Adenylyl Cyclase, cAMP, and Phosphokinase A.
Topics: Adenylyl Cyclases; Angiotensin I; Animals; Blotting, Western; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Endothelial Cells; Female; HEK293 Cells; Humans; Hypertension; Male; Mesangial Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Phosphotransferases; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Sensitivity and Specificity | 2016 |
Diminazene aceturate, an angiotensin-converting enzyme II activator, prevents gastric mucosal damage in mice: Role of the angiotensin-(1-7)/Mas receptor axis.
Topics: Acetic Acid; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Diminazene; Disease Models, Animal; Ethanol; Female; Gastric Mucosa; Male; Mice; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction; Stomach Ulcer | 2016 |
Angiotensin 1-7 Is a Negative Modulator of Aldosterone Secretion In Vitro and In Vivo.
Topics: Aldosterone; Angiotensin I; Animals; Antihypertensive Agents; Fluorescent Antibody Technique; Humans; Hypertension; Peptide Fragments; Proto-Oncogene Mas; Rats; Renin-Angiotensin System; Zona Glomerulosa | 2016 |
Association between circulating levels of ACE2-Ang-(1-7)-MAS axis and ACE2 gene polymorphisms in hypertensive patients.
Topics: Adolescent; Adult; Aged; Angiotensin I; Angiotensin-Converting Enzyme 2; Blood Pressure; DNA; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Genotype; Humans; Hypertension; Male; Middle Aged; Peptide Fragments; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Prospective Studies; Signal Transduction; Young Adult | 2016 |
Identification of dipeptidyl peptidase 3 as the Angiotensin-(1-7) degrading peptidase in human HK-2 renal epithelial cells.
Topics: Angiotensin I; Angiotensin II; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Epithelial Cells; Humans; Hydrolysis; Kidney; Oligopeptides; Peptide Fragments; Reactive Oxygen Species | 2016 |
Could angiotensin-(1-7) be connected with improvement of microvascular function in diabetic patients? Angiotensin-(1-7) iontophoresis may provide the answer.
Topics: Angiotensin I; Animals; Diabetes Complications; Diabetic Angiopathies; Disease Models, Animal; Endothelial Cells; Humans; Iontophoresis; Mice; Microcirculation; Models, Theoretical; Peptide Fragments; Rats; Skin | 2016 |
An injectable capillary-like microstructured alginate hydrogel improves left ventricular function after myocardial infarction in rats.
Topics: Alginates; Angiotensin I; Animals; Biocompatible Materials; Disease Models, Animal; Echocardiography; Gelatin; Glucuronic Acid; Hexuronic Acids; Hydrogels; Injections, Intralesional; Myocardial Infarction; Peptide Fragments; Rats; Rats, Sprague-Dawley; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2016 |
Serum angiotensin-converting enzyme 2 concentration and angiotensin-(1-7) concentration in patients with acute heart failure patients requiring emergency hospitalization.
Topics: Acute Disease; Adult; Aged; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Blood Pressure; Case-Control Studies; Emergencies; Female; Heart Failure; Hospitalization; Humans; Japan; Male; Middle Aged; Peptide Fragments; Peptidyl-Dipeptidase A; Regression Analysis; Renin; Renin-Angiotensin System | 2017 |
Soluble receptor for advanced glycation end products mitigates vascular dysfunction in spontaneously hypertensive rats.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Aorta; Aortic Diseases; Gene Expression Regulation, Enzymologic; Glycation End Products, Advanced; Lactoylglutathione Lyase; NF-kappa B; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; PPAR gamma; Rats; Rats, Inbred SHR; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Vascular Remodeling | 2016 |
Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats.
Topics: 8,11,14-Eicosatrienoic Acid; Albuminuria; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Cytochrome P-450 CYP1A1; Hypertension, Malignant; Indoles; Kidney; Male; Peptide Fragments; Rats; Rats, Transgenic; Renin; Renin-Angiotensin System; Time Factors | 2016 |
Antioxidant effect of angiotensin (1‑7) in the protection of pancreatic β cell function.
Topics: Angiotensin I; Animals; Antioxidants; Calcium; Hydrogen Peroxide; Insulin; Insulin Secretion; Insulin-Secreting Cells; Oxidative Stress; Peptide Fragments; Rats | 2016 |
Imbalance between angiotensin II and angiotensin-(1-7) in human coronary atherosclerosis.
Topics: Angiotensin I; Angiotensin II; Atherosclerosis; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Peptide Fragments; Tumor Necrosis Factor-alpha | 2016 |
Angiotensin(1-7) attenuated Angiotensin II-induced hepatocyte EMT by inhibiting NOX-derived H2O2-activated NLRP3 inflammasome/IL-1β/Smad circuit.
Topics: Angiotensin I; Angiotensin II; Animals; Cells, Cultured; Collagen Type I; Collagen Type I, alpha 1 Chain; Epithelial-Mesenchymal Transition; Gene Expression; Hepatocytes; Humans; Hydrogen Peroxide; Inflammasomes; Interleukin-1beta; Liver Cirrhosis; Male; Mice; NADPH Oxidase 4; NLR Family, Pyrin Domain-Containing 3 Protein; Peptide Fragments; Rats, Wistar; Signal Transduction; Smad Proteins | 2016 |
Captopril improves postresuscitation hemodynamics protective against pulmonary embolism by activating the ACE2/Ang-(1-7)/Mas axis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Arterial Pressure; Biomarkers; Capillary Permeability; Captopril; Cardiopulmonary Resuscitation; Disease Models, Animal; Enzyme Activation; Female; Heart Arrest; Hemodynamics; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pulmonary Artery; Pulmonary Edema; Pulmonary Embolism; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction; Sus scrofa; Thrombolytic Therapy; Time Factors; Vascular Resistance; Ventricular Function, Right; Ventricular Pressure | 2016 |
Fasudil alleviated hypoxia-induced pulmonary hypertension by stabilizing the expression of angiotensin-(1-7) in rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin I; Animals; Gene Expression; Hypertension, Pulmonary; Hypoxia; Peptide Fragments; Rats; Rats, Sprague-Dawley; Signal Transduction | 2016 |
Neuroinflammatory mechanisms of hypertension: potential therapeutic implications.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Blood-Brain Barrier; Cytokines; Humans; Hypertension; Inflammation; Lipopolysaccharides; Microglia; NF-kappa B; Oxidative Stress; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Renin; Toll-Like Receptor 4 | 2016 |
Angiotensin type 2 receptor null mice express reduced levels of renal angiotensin II type 2 receptor/angiotensin (1-7)/Mas receptor and exhibit greater high-fat diet-induced kidney injury.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Biomarkers; Blood Pressure; Chromatography, Liquid; Diet, High-Fat; Gene Deletion; Kidney; Male; Mass Spectrometry; Mice, Knockout; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin; Renin-Angiotensin System; Systole | 2016 |
The kinetics of angiotensin-I metabolism in human carotid atheroma: An emerging role for angiotensin (1-7).
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Carotid Artery Diseases; Chromatography, High Pressure Liquid; Disease Progression; Humans; Mass Spectrometry; Peptide Fragments; Plaque, Atherosclerotic; Time Factors | 2016 |
Renin-angiotensin system in ventilator-induced diaphragmatic dysfunction: Potential protective role of Angiotensin (1-7).
Topics: Angiotensin I; Angiotensin II; Animals; Cell Membrane; Diaphragm; Humans; Insulin-Like Growth Factor I; Mice; Models, Theoretical; Muscle, Skeletal; Muscular Diseases; Oxidative Stress; Peptide Fragments; Rats; Renin-Angiotensin System; Respiration, Artificial | 2016 |
Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain.
Topics: Analgesics; Analysis of Variance; Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Bone Neoplasms; Cancer Pain; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hyperalgesia; Imidazoles; Losartan; Mice; Mice, Inbred BALB C; Nesting Behavior; Peptide Fragments; Pyridines; Rotarod Performance Test | 2016 |
Angiotensin-(1-7) decreases the expression of collagen I via TGF-β1/Smad2/3 and subsequently inhibits fibroblast-myofibroblast transition.
Topics: Actins; Angiotensin I; Collagen Type I; Fibroblasts; Humans; JNK Mitogen-Activated Protein Kinases; Myofibroblasts; Peptide Fragments; Phosphatidylinositol 3-Kinases; Phosphorylation; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1 | 2016 |
Heteromerization Between the Bradykinin B2 Receptor and the Angiotensin-(1-7) Mas Receptor: Functional Consequences.
Topics: Analysis of Variance; Angiotensin I; Animals; Bradykinin B2 Receptor Antagonists; Cell Membrane; Cells, Cultured; Extracellular Signal-Regulated MAP Kinases; HEK293 Cells; Humans; Peptide Fragments; Proto-Oncogene Mas; Rats; Receptor Cross-Talk; Receptor, Bradykinin B2; Renin-Angiotensin System; Sensitivity and Specificity; Transfection | 2016 |
MicroRNA Profiling of the Effect of the Heptapeptide Angiotensin-(1-7) in A549 Lung Tumor Cells Reveals a Role for miRNA149-3p in Cellular Migration Processes.
Topics: A549 Cells; Angiotensin I; Cell Movement; Diffusion Chambers, Culture; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Oligoribonucleotides, Antisense; Peptide Fragments | 2016 |
Angiotensin-(1-7) inhibits inflammation and oxidative stress to relieve lung injury induced by chronic intermittent hypoxia in rats.
Topics: Angiotensin I; Animals; Blotting, Western; Cytokines; Enzyme-Linked Immunosorbent Assay; Hypoxia; Immunohistochemistry; Inflammation; Lung; Lung Injury; Male; Malondialdehyde; Oxidative Stress; Peptide Fragments; Protective Agents; Random Allocation; Rats, Sprague-Dawley; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; Sleep Apnea, Obstructive; Vasodilator Agents | 2016 |
Bradykinin -induced vasodilatation: Role of age, ACE1-inhibitory peptide, mas- and bradykinin receptors.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Captopril; Humans; Hypertension; Mesenteric Arteries; Oligopeptides; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Receptors, G-Protein-Coupled; Vasodilation | 2016 |
Antenatal corticosteroids and the renin-angiotensin-aldosterone system in adolescents born preterm.
Topics: Adolescent; Adrenal Cortex Hormones; Angiotensin I; Angiotensin II; Cohort Studies; Female; Fetal Organ Maturity; Humans; Infant, Newborn; Infant, Premature; Male; Peptide Fragments; Pregnancy; Prenatal Exposure Delayed Effects; Renin; Renin-Angiotensin System | 2017 |
Neprilysin is a Mediator of Alternative Renin-Angiotensin-System Activation in the Murine and Human Kidney.
Topics: Aminobutyrates; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Biomarkers; Biopsy; Biphenyl Compounds; Female; Gene Expression; Humans; Immunohistochemistry; Kidney; Kidney Cortex; Mice; Mice, Knockout; Neprilysin; Peptide Fragments; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System | 2016 |
Angiotensin-(1-7) Selectively Induces Relaxation and Modulates Endothelium-Dependent Dilation in Mesenteric Arteries of Salt-Fed Rats.
Topics: Acetylcholine; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bradykinin; Dose-Response Relationship, Drug; Endothelium, Vascular; Imidazoles; In Vitro Techniques; Male; Mesenteric Arteries; Nitric Oxide; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Signal Transduction; Sodium Chloride, Dietary; Vasodilation; Vasodilator Agents | 2016 |
Angiotensin-(1-7) protects from brain damage induced by shiga toxin 2-producing enterohemorrhagic Escherichia coli.
Topics: Angiotensin I; Animals; Escherichia coli Infections; Hypothalamus; Infectious Encephalitis; Male; Neuroprotective Agents; Peptide Fragments; Rats; Rats, Wistar; Shiga Toxin 2; Shiga-Toxigenic Escherichia coli; Treatment Outcome | 2016 |
A Novel Mechanism of Action for Angiotensin-(1-7) via the Angiotensin Type 1 Receptor.
Topics: Angiotensin I; Angiotensin II; Humans; Peptide Fragments; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin | 2016 |
Cardioprotective Angiotensin-(1-7) Peptide Acts as a Natural-Biased Ligand at the Angiotensin II Type 1 Receptor.
Topics: Angiotensin I; Angiotensin II; Animals; Aorta, Abdominal; beta-Arrestins; Cardiotonic Agents; Cells, Cultured; HEK293 Cells; Humans; Muscles; Peptide Fragments; Phenylephrine; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Sensitivity and Specificity; Signal Transduction; Vasoconstriction | 2016 |
The Angiotensin-(1-7)/Mas Axis Improves Pancreatic β-Cell Function in Vitro and in Vivo.
Topics: Angiotensin I; Animals; Cyclic AMP; Homeodomain Proteins; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Maf Transcription Factors, Large; Mice; Mice, Knockout; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Signal Transduction; Trans-Activators | 2016 |
New insights into the elucidation of angiotensin-(1-7) in vivo antiarrhythmic effects and its related cellular mechanisms.
Topics: Action Potentials; Angiotensin I; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Cardiotonic Agents; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Peptide Fragments; Rats; Rats, Wistar | 2016 |
Identification of Cofilin-1 Induces G0/G1 Arrest and Autophagy in Angiotensin-(1-7)-treated Human Aortic Endothelial Cells from iTRAQ Quantitative Proteomics.
Topics: Adenine; Angiotensin I; Aorta; Apoptosis; Autophagy; Biomarkers; Cell Cycle; Cell Proliferation; Cells, Cultured; Cofilin 1; Endothelium, Vascular; G1 Phase; Gene Silencing; Homeostasis; Humans; Peptide Fragments; Proteomics; Resting Phase, Cell Cycle; RNA, Small Interfering | 2016 |
Ang-(1-7) inhibited mitochondrial fission in high-glucose-induced podocytes by upregulation of miR-30a and downregulation of Drp1 and p53.
Topics: Angiotensin I; Cells, Cultured; Dynamins; Fluorescent Antibody Technique; Glucose; GTP Phosphohydrolases; Humans; MicroRNAs; Microtubule-Associated Proteins; Mitochondrial Dynamics; Mitochondrial Proteins; Peptide Fragments; Podocytes; Tumor Suppressor Protein p53 | 2016 |
The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Captopril; Cardiac Pacing, Artificial; Heart; Hemodynamics; Irbesartan; Male; Myocardial Reperfusion Injury; Myocardium; Peptide Fragments; Rats; Rats, Wistar; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles | 2016 |
Chymase-dependent production of angiotensin II: an old enzyme in old hearts.
Topics: Aging; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blotting, Western; Chymases; Enzyme-Linked Immunosorbent Assay; Myocardium; NADPH Oxidases; Peptide Fragments; Peptidyl-Dipeptidase A; Physical Conditioning, Animal; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Inbred F344; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Superoxides | 2017 |
Chronic allergic pulmonary inflammation is aggravated in angiotensin-(1-7) Mas receptor knockout mice.
Topics: Angiotensin I; Animals; Bronchoalveolar Lavage Fluid; Cytokines; Extracellular Signal-Regulated MAP Kinases; Hypersensitivity; Lung; Mice, Knockout; Peptide Fragments; Physical Conditioning, Animal; Pneumonia; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Swimming | 2016 |
Angiotensin-(1-7) Prevents Skeletal Muscle Atrophy Induced by Transforming Growth Factor Type Beta (TGF-β) via Mas Receptor Activation.
Topics: Angiotensin I; Animals; Cell Line; Mice, Inbred C57BL; Muscle Fibers, Skeletal; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; Myosin Heavy Chains; Myosins; Peptide Fragments; Polyubiquitin; Proteasome Endopeptidase Complex; Proto-Oncogene Mas; Proto-Oncogene Proteins; Reactive Oxygen Species; Receptors, G-Protein-Coupled; Transforming Growth Factor beta; Tripartite Motif Proteins; Ubiquitin; Ubiquitin-Protein Ligases; Ubiquitination | 2016 |
Reversal of Bone Marrow Mobilopathy and Enhanced Vascular Repair by Angiotensin-(1-7) in Diabetes.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin I; Animals; Blood Vessels; Bone Marrow; Bone Marrow Cells; Cell Lineage; Cell Movement; Chemokine CXCL12; Diabetes Mellitus, Experimental; Ischemia; Male; Membrane Proteins; Mice; Neovascularization, Physiologic; Peptide Fragments; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Recovery of Function; Regeneration; rho-Associated Kinases; Stem Cells; Vascular Endothelial Growth Factor A; Vasodilator Agents | 2017 |
AAV-Mediated angiotensin 1-7 overexpression inhibits tumor growth of lung cancer in vitro and in vivo.
Topics: Angiotensin I; Animals; Carcinoma, Non-Small-Cell Lung; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dependovirus; DNA Replication; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Genetic Vectors; Humans; Immunohistochemistry; Lung; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Multienzyme Complexes; Neovascularization, Pathologic; Nuclear Proteins; Peptide Fragments; Proteolysis; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2017 |
Adhesion ability of angiotensin II with model membranes.
Topics: Amino Acids; Angiotensin I; Angiotensin II; Binding Sites; Histidine; Humans; Membranes; Molecular Weight; Peptide Fragments; Peptides; Peptidyl-Dipeptidase A; Phenylalanine; Protein Binding; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin; Renin-Angiotensin System | 2017 |
Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Angiotensin I; Angiotensin II; Apolipoproteins E; Autopsy; Brain; Case-Control Studies; Cohort Studies; Female; Humans; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Polymorphism, Single Nucleotide; Statistics as Topic; tau Proteins | 2016 |
Exercise modulates the aortic renin-angiotensin system independently of estrogen therapy in ovariectomized hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Animals; Aorta; Estradiol; Estrogens; Exercise Therapy; Humans; Hypertension; Ovariectomy; Peptide Fragments; Physical Conditioning, Animal; Rats; Rats, Inbred SHR; Renin-Angiotensin System | 2017 |
Angiotensin-(1-7) protects cardiomyocytes against high glucose-induced injuries through inhibiting reactive oxygen species-activated leptin-p38 mitogen-activated protein kinase/extracellular signal-regulated protein kinase 1/2 pathways, but not the leptin
Topics: Acetylcysteine; Angiotensin I; Animals; Anthracenes; Apoptosis; Cell Line; Glucose; Imidazoles; Leptin; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Myocytes, Cardiac; Peptide Fragments; Pyridines; Rats; Reactive Oxygen Species | 2017 |
Effects of exendin-4 on the intrarenal renin-angiotensin system and interstitial fibrosis in unilateral ureteral obstruction mice: Exendin-4 and unilateral ureteral obstruction.
Topics: Actins; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Collagen Type I; Exenatide; Fibronectins; Fibrosis; Kidney; Male; Mice, Inbred BALB C; Peptide Fragments; Peptides; Peptidyl-Dipeptidase A; Renin-Angiotensin System; RNA, Messenger; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Ureteral Obstruction; Venoms | 2016 |
Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy.
Topics: Albuminuria; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Autoantigens; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Kidney; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Peptidyl-Dipeptidase A; Recombinant Proteins; Time Factors | 2017 |
Anti-atherosclerotic effect of the angiotensin 1-7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis.
Topics: Angiotensin I; Animals; Anti-Inflammatory Agents; Aorta; Atherosclerosis; Cell Line; Cell Line, Tumor; Cytokines; Female; Humans; Imidazoles; Leukocytes; Macrophages; Mice, Inbred C57BL; Mice, Knockout, ApoE; Peptide Fragments; Plaque, Atherosclerotic; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2017 |
Effects of Diabetic Hyperglycemia on Central Ang-(1-7)-Mas-R-nNOS Pathways in Spontaneously Hypertensive Rats.
Topics: Angiotensin I; Animals; Blood Pressure; Brain; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Dinoprost; Heart Rate; Hyperglycemia; Natriuretic Peptide, Brain; Nitric Oxide Synthase Type I; Oxidative Stress; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, G-Protein-Coupled; Signal Transduction; Spin Labels; Systole | 2016 |
Differential effects of Mas receptor deficiency on cardiac function and blood pressure in obese male and female mice.
Topics: Angiotensin I; Animals; Blood Pressure; Diet, High-Fat; Echocardiography; Female; Heart; Heart Function Tests; Hypertension; Hypertrophy, Left Ventricular; Immunohistochemistry; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2017 |
Cognitive impairment in heart failure: A protective role for angiotensin-(1-7).
Topics: Angiotensin I; Animals; Cognitive Dysfunction; Disease Models, Animal; Heart Failure; Inflammation; Male; Maze Learning; Mice; Mice, Inbred C57BL; Myocardial Infarction; Peptide Fragments; Ventricular Remodeling; Visual Acuity | 2017 |
Angiotensin-(1-7) relieved renal injury induced by chronic intermittent hypoxia in rats by reducing inflammation, oxidative stress and fibrosis.
Topics: Acute Kidney Injury; Angiotensin I; Animals; Disease Models, Animal; Inflammation; Interleukin-6; Kidney; Male; Oxidative Stress; Peptide Fragments; Rats; Rats, Sprague-Dawley | 2017 |
Mechanisms of Mas1 Receptor-Mediated Signaling in the Vascular Endothelium.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Dose-Response Relationship, Drug; Electric Stimulation; Endothelial Cells; Endothelium, Vascular; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Male; Middle Cerebral Artery; Neovascularization, Physiologic; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Signal Transduction; Vasodilation | 2017 |
Vascular Reactivity of Isolated Aorta to Study the Angiotensin-(1-7) Actions.
Topics: Acetylcholine; Angiotensin I; Angiotensin II; Animals; Aorta; In Vitro Techniques; Mice; Peptide Fragments; Phenylephrine; Rats; Vasodilation; Vasodilator Agents | 2017 |
Possible contribution of nitric oxide and prostaglandin in the protective effect of angiotensin (1-7) against stress induced gastric ulceration in adult male albino rats.
Topics: Angiotensin I; Animals; Anti-Ulcer Agents; Dinoprostone; Gastric Juice; Gastric Mucosa; Indomethacin; Male; Nitric Oxide; Peptide Fragments; Prostaglandins; Protective Agents; Random Allocation; Rats; Rats, Wistar; Stomach Ulcer; Stress, Psychological | 2016 |
Angiotensin-(1-7) administration attenuates Alzheimer's disease-like neuropathology in rats with streptozotocin-induced diabetes via Mas receptor activation.
Topics: Alzheimer Disease; Angiotensin I; Animals; Diabetes Mellitus, Experimental; Hippocampus; Male; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Streptozocin; Synapses; tau Proteins | 2017 |
Prolylcarboxypeptidase deficiency is associated with increased blood pressure, glomerular lesions, and cardiac dysfunction independent of altered circulating and cardiac angiotensin II.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Carboxypeptidases; Kidney; Kidney Glomerulus; Kidney Tubules, Collecting; Male; Mice; Mice, Mutant Strains; Myocardium; Peptide Fragments | 2017 |
Adverse cardiac effects of exogenous angiotensin 1-7 in rats with subtotal nephrectomy are prevented by ACE inhibition.
Topics: Analysis of Variance; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Heart; Hypertension; Male; Myocardium; Nephrectomy; Peptide Fragments; Peptidyl-Dipeptidase A; Ramipril; Rats, Sprague-Dawley; Renal Insufficiency | 2017 |
Antenatal betamethasone attenuates the angiotensin-(1-7)-Mas receptor-nitric oxide axis in isolated proximal tubule cells.
Topics: Angiotensin I; Animals; Betamethasone; Biological Transport; Cells, Cultured; Female; Glucocorticoids; Kidney Tubules, Proximal; Male; Nitric Oxide; Peptide Fragments; Phenotype; Primary Cell Culture; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renal Reabsorption; Sex Factors; Sheep, Domestic; Signal Transduction; Sodium | 2017 |
Angiotensin II/Angiotensin (1-7) ratio and 24-h blood pressure throughout the menstrual cycle and in women using oral contraceptives.
Topics: Adolescent; Adult; Angiotensin I; Angiotensin II; Blood Pressure; Contraceptives, Oral; Estradiol; Female; Humans; Menstrual Cycle; Peptide Fragments; Progesterone; Renin-Angiotensin System; Young Adult | 2017 |
Effects and Mechanisms of Radiofrequency Ablation of Renal Sympathetic Nerve on Anti-Hypertension in Canine.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blotting, Western; Body Weight; Catechol O-Methyltransferase; Catheter Ablation; Chromatography, High Pressure Liquid; Diet, High-Fat; Dogs; Hypertension; Immunohistochemistry; Kidney; Models, Animal; Monoamine Oxidase; Norepinephrine Plasma Membrane Transport Proteins; Peptide Fragments; Peptidyl-Dipeptidase A; Random Allocation; Reference Values; Renal Artery; Reproducibility of Results; Sympathectomy; Treatment Outcome; Tyrosine 3-Monooxygenase | 2017 |
Angiotensin-(1-7) regulates angiotensin II-induced matrix metalloproteinase-8 in vascular smooth muscle cells.
Topics: Angiotensin I; Angiotensin II; Animals; Atherosclerosis; Cells, Cultured; Disease Models, Animal; Enzyme Activation; Humans; Matrix Metalloproteinase 8; Mice, Knockout, ApoE; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Plaque, Atherosclerotic; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Time Factors | 2017 |
Chronic overexpression of angiotensin-(1-7) in rats reduces cardiac reactivity to acute stress and dampens anxious behavior.
Topics: Angiotensin I; Angiotensin II; Animals; Animals, Genetically Modified; Anxiety; Heart Rate; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Stress, Psychological | 2017 |
Angiotensin (1-7) facilitates cardioprotection of ischemic preconditioning on ischemia-reperfusion-challenged rat heart.
Topics: Angiotensin I; Animals; Cardiotonic Agents; Ischemic Preconditioning; Myocardial Reperfusion Injury; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptors, G-Protein-Coupled | 2017 |
Angiotensin-(1-7) Downregulates Diabetes-Induced cGMP Phosphodiesterase Activation in Rat Corpus Cavernosum.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Angiotensin I; Animals; Cyclic GMP; Diabetes Mellitus, Experimental; Down-Regulation; Erectile Dysfunction; Gene Expression Regulation, Enzymologic; Male; Nitrites; p38 Mitogen-Activated Protein Kinases; Penis; Peptide Fragments; Rats; Rats, Wistar; Risk Factors | 2017 |
The complex of PAMAM-OH dendrimer with Angiotensin (1-7) prevented the disuse-induced skeletal muscle atrophy in mice.
Topics: Angiotensin I; Animals; Dendrimers; Electrophoretic Mobility Shift Assay; Immobilization; Injections, Intraperitoneal; Male; Mice, Inbred C57BL; Molecular Dynamics Simulation; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; Muscular Disorders, Atrophic; Myosin Heavy Chains; Peptide Fragments; Peptides; SKP Cullin F-Box Protein Ligases; Static Electricity; Tripartite Motif Proteins; Ubiquitin-Protein Ligases | 2017 |
Influence of antihypertensive drugs on aortic and coronary effects of Ang-(1-7) in pressure-overloaded rats.
Topics: Amlodipine; Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta, Abdominal; Blood Pressure; Calcium Channel Blockers; Captopril; Coronary Vessels; Losartan; Male; Mineralocorticoid Receptor Antagonists; Models, Animal; Peptide Fragments; Rats, Wistar; Reproducibility of Results; Spironolactone; Time Factors; Vasoconstriction; Vasodilation | 2017 |
A Fluorometric Method of Measuring Carboxypeptidase Activities for Angiotensin II and Apelin-13.
Topics: Amino Acid Sequence; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Carboxypeptidases; Fluorometry; HEK293 Cells; Humans; Immunoassay; Intercellular Signaling Peptides and Proteins; Kidney; Mice; Peptide Fragments; Peptidyl-Dipeptidase A; Phenylalanine; Substrate Specificity | 2017 |
Angiotensin-(1-7) in human follicular fluid correlates with oocyte maturation.
Topics: Adult; Angiotensin I; Blastocyst; Cohort Studies; Family Characteristics; Female; Fertility Agents, Female; Fertilization in Vitro; Follicular Fluid; Humans; Infertility, Female; Infertility, Male; Male; Oocyte Retrieval; Oogenesis; Ovulation Induction; Peptide Fragments; Prospective Studies; Radioimmunoassay; Solid Phase Extraction; Up-Regulation | 2017 |
Angiotensin-(1-7) attenuates angiotensin II-induced cardiac hypertrophy via a Sirt3-dependent mechanism.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cardiomegaly; Cardiotonic Agents; Cell Size; Fibrosis; Male; Myocytes, Cardiac; Peptide Fragments; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Sirtuins; Superoxide Dismutase | 2017 |
Long-term effects of angiotensin-(1-7) on lipid metabolism in the adipose tissue and liver.
Topics: Adipose Tissue; Adiposity; Angiotensin I; Animals; Fatty Acids; Hypertension; Insulin; Lipid Metabolism; Lipoprotein Lipase; Liver; Male; Mice; Obesity; Peptide Fragments; PPAR gamma; Rats; Rats, Transgenic; RNA, Messenger; Time Factors; Triglycerides | 2017 |
The ACE-2/Ang1-7/Mas cascade enhances bone structure and metabolism following angiotensin-II type 1 receptor blockade.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Female; Femur; Losartan; Minerals; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2017 |
Improved cardiovascular autonomic modulation in transgenic rats expressing an Ang-(1-7)-producing fusion protein.
Topics: Angiotensin I; Animals; Autonomic Nervous System; Gene Expression; Heart; Hemodynamics; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Recombinant Fusion Proteins | 2017 |
Reduced Sympathetic Stimulus and Angiotensin 1-7 Are Related to Diastolic Dysfunction in Spinal Cord-Injured Subjects.
Topics: Adult; Angiotensin I; Humans; Male; Norepinephrine; Peptide Fragments; Renin-Angiotensin System; Spinal Cord Injuries; Sympathetic Nervous System; Ventricular Function, Left | 2017 |
Anti-inflammatory action of angiotensin 1-7 in experimental colitis may be mediated through modulation of serum cytokines/chemokines and immune cell functions.
Topics: Angiotensin I; Angiotensin II; Animals; Anti-Inflammatory Agents; Apoptosis; Cell Movement; Chemokines; Chemotaxis; Colitis; Colon; Cytokines; Dextran Sulfate; Immunity, Cellular; Immunomodulation; Mice; Mice, Inbred BALB C; Models, Animal; Neutrophils; Peptide Fragments; Renin-Angiotensin System; Superoxides | 2017 |
Measuring Blood Pressure Using a Noninvasive Tail Cuff Method in Mice.
Topics: Angiotensin I; Animals; Blood Pressure; Blood Pressure Determination; Hypertension; Mice; Peptide Fragments; Renin-Angiotensin System; Software; Tail | 2017 |
Reduced anxiety-like behavior in transgenic rats with chronically overproduction of angiotensin-(1-7): Role of the Mas receptor.
Topics: Angiotensin I; Angiotensin II; Animals; Anxiety; Behavior, Animal; Imidazoles; Peptide Fragments; Pyridines; Rats, Sprague-Dawley; Rats, Transgenic; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2017 |
ACE-2/Ang1-7/Mas cascade mediates ACE inhibitor, captopril, protective effects in estrogen-deficient osteoporotic rats.
Topics: Administration, Oral; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Bone and Bones; Bone Density Conservation Agents; Captopril; Delayed-Action Preparations; Female; Femur; Humans; Osteolysis; Osteoporosis, Postmenopausal; Ovariectomy; Peptide Fragments; Peptidyl-Dipeptidase A; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Spectrophotometry, Atomic; X-Ray Microtomography | 2017 |
Angiotensin (1-7) ameliorates the structural and biochemical alterations of ovariectomy-induced osteoporosis in rats via activation of ACE-2/Mas receptor axis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blotting, Western; Female; Humans; Organ Size; Osteoporosis; Osteoprotegerin; Ovariectomy; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; RANK Ligand; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Uterus | 2017 |
Inhibitory effect of angiotensin (1-7) on angiotensin III-induced nociceptive behaviour in mice.
Topics: Angiotensin I; Angiotensin III; Animals; Male; Mice; Microglia; Nociception; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Phosphorylation; Posterior Horn Cells | 2017 |
Neprilysin Is Required for Angiotensin-(1-7)'s Ability to Enhance Insulin Secretion via Its Proteolytic Activity to Generate Angiotensin-(1-2).
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensins; Animals; Glucose; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mice; Mice, Inbred C57BL; Neprilysin; Peptide Fragments; Peptidyl-Dipeptidase A; Proteolysis; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction | 2017 |
Alamandine reduces leptin expression through the c-Src/p38 MAP kinase pathway in adipose tissue.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue; Angiotensin I; Animals; Cell Separation; CSK Tyrosine-Protein Kinase; GTP-Binding Protein alpha Subunits, Gq-G11; Leptin; Male; MAP Kinase Signaling System; Mice; Models, Biological; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Oligopeptides; Peptide Fragments; Plasminogen Activator Inhibitor 1; Rats, Wistar; Receptors, G-Protein-Coupled; src-Family Kinases | 2017 |
Exercise training modulates the hepatic renin-angiotensin system in fructose-fed rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Fatty Liver; Fructose; Gluconeogenesis; Interleukin-6; Lipid Metabolism; Liver; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Physical Conditioning, Animal; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tumor Necrosis Factor-alpha | 2017 |
Angiotensin 1-7 inhibits angiotensin II-stimulated head and neck cancer progression.
Topics: Angiotensin I; Angiotensin II; Cell Culture Techniques; Cell Movement; Disease Progression; Fibroblasts; Head and Neck Neoplasms; Humans; Immunoblotting; Peptide Fragments; Polymerase Chain Reaction; Renin-Angiotensin System; Signal Transduction; Transfection; Tumor Cells, Cultured | 2017 |
The ACE2-Ang (1-7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Collagen; Fibrosis; Heart Function Tests; Immunohistochemistry; Male; Myocardial Infarction; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; RNA, Messenger; Ventricular Dysfunction, Left; Ventricular Remodeling | 2017 |
Genetic Interference With Endothelial PPAR-γ (Peroxisome Proliferator-Activated Receptor-γ) Augments Effects of Angiotensin II While Impairing Responses to Angiotensin 1-7.
Topics: Amides; Angiotensin I; Angiotensin II; Animals; Animals, Genetically Modified; Carotid Arteries; Female; Interleukin-6; Male; Mice; NF-kappa B; Oxidative Stress; Peptide Fragments; PPAR gamma; Pyridines; Renin-Angiotensin System; Vascular Diseases; Vasoconstrictor Agents; Vasodilation | 2017 |
Angiotensin‑(1‑7) attenuates caerulein‑induced pancreatic acinar cell apoptosis.
Topics: Acinar Cells; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Ceruletide; Mice; Pancreas; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2017 |
Stabilization of Angiotensin-(1-7) by key substitution with a cyclic non-natural amino acid.
Topics: Amino Acid Substitution; Angiotensin I; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Protein Stability; Proteolysis | 2017 |
Vasodilator Effect of Angiotensin-(1-7) on Vascular Coronary Bed of Rats: Role of Mas, ACE and ACE2.
Topics: Angiotensin I; Angiotensin II; Animals; Coronary Vessels; Heart; Humans; In Vitro Techniques; Male; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Rats, Wistar; Vasodilation; Vasodilator Agents | 2017 |
Azilsartan ameliorates diabetic cardiomyopathy in young db/db mice through the modulation of ACE-2/ANG 1-7/Mas receptor cascade.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Benzimidazoles; Blood Pressure; Diabetic Cardiomyopathies; Male; Mice; Mice, Transgenic; Oxadiazoles; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Signal Transduction | 2017 |
BML-111 equilibrated ACE-AngII-AT1R and ACE2-Ang-(1-7)-Mas axis to protect hepatic fibrosis in rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Down-Regulation; Heptanoic Acids; Liver Cirrhosis; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Up-Regulation | 2017 |
Central angiotensin-(1-7) increases osmotic thirst.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Drinking; Injections, Intraventricular; Male; Osmotic Pressure; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Wistar; Receptors, G-Protein-Coupled; Sodium Chloride; Subfornical Organ; Supraoptic Nucleus; Thirst; Up-Regulation; Vasopressins; Water Deprivation | 2017 |
Angiotensin-(1-7) in Paraventricular Nucleus Contributes to the Enhanced Cardiac Sympathetic Afferent Reflex and Sympathetic Activity in Chronic Heart Failure Rats.
Topics: Acetophenones; Angiotensin I; Angiotensin II; Animals; Arterial Pressure; Capsaicin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic N-Oxides; Heart Failure; Hemodynamics; Kidney; Male; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Rats; Rats, Sprague-Dawley; Signal Transduction; Spin Labels; Superoxides; Sympathetic Nervous System | 2017 |
MAS1 Receptor Trafficking Involves ERK1/2 Activation Through a β-Arrestin2-Dependent Pathway.
Topics: Angiotensin I; beta-Arrestin 2; Endocytosis; Endosomes; Extracellular Signal-Regulated MAP Kinases; HEK293 Cells; Humans; Peptide Fragments; Protein Transport; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Signal Transduction | 2017 |
Hypotensive effect induced by microinjection of Alamandine, a derivative of angiotensin-(1-7), into caudal ventrolateral medulla of 2K1C hypertensive rats.
Topics: Angiotensin I; Angiotensin II Type 2 Receptor Blockers; Animals; Hypertension; Imidazoles; Male; Oligopeptides; Peptide Fragments; Pyridines; Rats; Receptor, Angiotensin, Type 2; Renin-Angiotensin System | 2017 |
High-intensity interval training has beneficial effects on cardiac remodeling through local renin-angiotensin system modulation in mice fed high-fat or high-fructose diets.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Diet, High-Fat; Fructose; Gene Expression Regulation; High-Intensity Interval Training; Hypertension; Hypertrophy, Left Ventricular; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Peptidyl-Dipeptidase A; Random Allocation; Receptor, Angiotensin, Type 2; Renin; Renin-Angiotensin System; Ventricular Remodeling | 2017 |
Relationship between genetic variants of ACE2 gene and circulating levels of ACE2 and its metabolites.
Topics: Aged; Alleles; Angiotensin I; Angiotensin-Converting Enzyme 2; Blood Pressure; Essential Hypertension; Female; Gene Frequency; Genotype; Humans; Male; Middle Aged; Peptide Fragments; Peptidyl-Dipeptidase A; Polymorphism, Single Nucleotide | 2018 |
Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT
Topics: Angiotensin I; Animals; beta-Arrestins; Cardiomegaly; Cardiotonic Agents; Diastole; Heart; HEK293 Cells; Humans; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Peptide Fragments; Phosphorylation; Rats; Rats, Inbred WF; Receptor, Angiotensin, Type 1; Signal Transduction | 2017 |
Intrarenal Mas and AT
Topics: Anesthesia, General; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Diet, Sodium-Restricted; Glomerular Filtration Rate; Hemodynamics; Infusions, Parenteral; Kidney; Losartan; Male; Natriuresis; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renal Circulation; Renal Elimination; Renin-Angiotensin System; Signal Transduction; Sodium, Dietary | 2017 |
Angiotensin-(1-7)-mediated Mas1 receptor/NF-κB-p65 signaling is involved in a cigarette smoke-induced chronic obstructive pulmonary disease mouse model.
Topics: Angiotensin I; Animals; Bronchoalveolar Lavage Fluid; Chemokine CXCL1; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Injections, Subcutaneous; Interleukin-6; Lung; Male; Mice; Mice, Inbred C57BL; NF-KappaB Inhibitor alpha; Nicotiana; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pulmonary Disease, Chronic Obstructive; Pulmonary Fibrosis; Receptors, G-Protein-Coupled; Signal Transduction; Smoke; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2018 |
Angiotensin 1-7 in the rostro-ventrolateral medulla increases blood pressure and splanchnic sympathetic nerve activity in anesthetized rats.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Adenosine Triphosphate; Angiotensin I; Angiotensin II; Animals; Astrocytes; Blood Pressure; Excitatory Amino Acid Antagonists; Glutamic Acid; Male; Medulla Oblongata; Microinjections; Peptide Fragments; Rats, Sprague-Dawley; Receptors, Glutamate; Splanchnic Nerves; Sympathetic Nervous System; Sympatholytics; Sympathomimetics | 2018 |
Angiotensin 1-7 stimulates brown adipose tissue and reduces diet-induced obesity.
Topics: Adipocytes, Brown; Adipose Tissue, Brown; Angiotensin I; Animals; Body Weight; Cell Proliferation; Diet, High-Fat; Energy Metabolism; Male; Mice; Mice, Inbred C57BL; Obesity; Peptide Fragments; Thermogenesis | 2018 |
Mir-21 Mediates the Inhibitory Effect of Ang (1-7) on AngII-induced NLRP3 Inflammasome Activation by Targeting Spry1 in lung fibroblasts.
Topics: Angiotensin I; Angiotensin II; Animals; Apoptosis; Bleomycin; Cells, Cultured; Collagen Type I; Fibroblasts; Inflammasomes; Lung; Male; MAP Kinase Signaling System; MicroRNAs; Nerve Tissue Proteins; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Peptide Fragments; Peptide Hormones; Pulmonary Fibrosis; Rats; Rats, Wistar; Signal Transduction | 2017 |
Paracrine and Intracrine Angiotensin 1-7/Mas Receptor Axis in the Substantia Nigra of Rodents, Monkeys, and Humans.
Topics: Aging; Angiotensin I; Angiotensin II; Animals; Astrocytes; Case-Control Studies; Cell Nucleus; Cells, Cultured; Dopaminergic Neurons; Gene Deletion; Haplorhini; Male; Mesencephalon; Microglia; Mitochondria; Models, Biological; Neuroprotection; Oxidative Stress; Paracrine Communication; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Reactive Nitrogen Species; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Rodentia; Signal Transduction; Substantia Nigra | 2018 |
Obligatory Metabolism of Angiotensin II to Angiotensin III for Zona Glomerulosa Cell-Mediated Relaxations of Bovine Adrenal Cortical Arteries.
Topics: Abattoirs; Adrenal Cortex; Aldosterone; Aminopeptidases; Angiotensin I; Angiotensin II; Angiotensin III; Animals; Arterioles; Cattle; Cells, Cultured; Endothelium, Vascular; Gene Expression Regulation, Enzymologic; In Vitro Techniques; Muscle, Smooth, Vascular; Peptide Fragments; Protease Inhibitors; Vasodilation; Zona Glomerulosa | 2018 |
Angiotensin 1-7 modulates electrophysiological characteristics and calcium homoeostasis in pulmonary veins cardiomyocytes via MAS/PI3K/eNOS signalling pathway.
Topics: Angiotensin I; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium; Homeostasis; Male; Membrane Potentials; Myocytes, Cardiac; Nitric Oxide Synthase Type III; Patch-Clamp Techniques; Peptide Fragments; Phosphatidylinositol 3-Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pulmonary Veins; Rabbits; Receptors, G-Protein-Coupled; Sarcoplasmic Reticulum; Signal Transduction | 2018 |
Angiotensin-converting enzyme 2-angiotensin (1-7)-Mas axis prevents pancreatic acinar cell inflammatory response via inhibition of the p38 mitogen-activated protein kinase/nuclear factor-κB pathway.
Topics: Acinar Cells; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Humans; Imidazoles; Inflammation; Mice; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Pancreas; Peptide Fragments; Peptides; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyridines; Receptors, G-Protein-Coupled; Signal Transduction | 2018 |
Beneficial Effects of Angiotensin-(1-7) on CD34+ Cells From Patients With Heart Failure.
Topics: Angiotensin I; Antigens, CD34; Case-Control Studies; Cell Movement; Cells, Cultured; Female; Heart Failure; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Nitric Oxide; Peptide Fragments; Phenotype; Reactive Oxygen Species; Renin-Angiotensin System | 2018 |
Angiotensin 1-7, but not the thrombin-cleaved osteopontin C-terminal fragment, attenuates osteopontin-mediated macrophage-induced endothelial-cell inflammation.
Topics: Angiotensin I; Cells, Cultured; Endothelial Cells; Humans; I-kappa B Proteins; Inflammation; Intercellular Adhesion Molecule-1; Macrophages; NF-kappa B; Osteopontin; Peptide Fragments; U937 Cells; Vascular Cell Adhesion Molecule-1 | 2018 |
DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
Topics: ADAM17 Protein; Adaptor Proteins, Signal Transducing; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Animals, Newborn; Apoptosis; beta Catenin; Cardiomegaly; Cell Proliferation; Disease Models, Animal; Fibroblasts; Fibrosis; Glycogen Synthase Kinase 3 beta; Inflammation; Intercellular Signaling Peptides and Proteins; Matrix Metalloproteinases; Mice, Inbred C57BL; Peptide Fragments; Peptidyl-Dipeptidase A; Perfusion; Phosphorylation; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1 | 2018 |
Angiotensin-(1-7) and Vascular Function: The Clinical Context.
Topics: Angiotensin I; Angiotensin II; Humans; Muscle, Smooth, Vascular; Peptide Fragments | 2018 |
Nrf2 Deficiency Upregulates Intrarenal Angiotensin-Converting Enzyme-2 and Angiotensin 1-7 Receptor Expression and Attenuates Hypertension and Nephropathy in Diabetic Mice.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation, Enzymologic; Hypertension; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; NF-E2-Related Factor 2; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Up-Regulation | 2018 |
Activation of ACE2/angiotensin (1-7) attenuates pancreatic β cell dedifferentiation in a high-fat-diet mouse model.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cell Dedifferentiation; Cell Lineage; Diet, High-Fat; Glucose Intolerance; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Peptidyl-Dipeptidase A; Weight Gain | 2018 |
Protective effect of angiotensin-(1-7) against hyperglycaemia-induced injury in H9c2 cardiomyoblast cells via the PI3K̸Akt signaling pathway.
Topics: Angiotensin I; Animals; Apoptosis; Cardiotonic Agents; Caspases; Cell Line; Cell Survival; Cytoprotection; Glucose; Hyperglycemia; Inflammation; Membrane Potential, Mitochondrial; Myocytes, Cardiac; Peptide Fragments; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Reactive Oxygen Species; Signal Transduction | 2018 |
Angiotensin 1-7 ameliorates caerulein-induced inflammation in pancreatic acinar cells by downregulating Toll-like receptor 4/nuclear factor-κB expression.
Topics: Acinar Cells; Angiotensin I; Angiotensin II; Animals; Cell Line; Ceruletide; Down-Regulation; Inflammation; Interleukin-10; Interleukin-6; Microscopy, Fluorescence; NF-kappa B; Peptide Fragments; Rats; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2018 |
The role of ACE2, angiotensin-(1-7) and Mas1 receptor axis in glucocorticoid-induced intrauterine growth restriction.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Dexamethasone; Female; Fetal Growth Retardation; Glucocorticoids; Peptide Fragments; Peptidyl-Dipeptidase A; Placenta; Pregnancy; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Signal Transduction | 2017 |
Modulating Role of Ang1-7 in Control of Blood Pressure and Renal Function in AngII-infused Hypertensive Rats.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Hypertension; Male; Natriuresis; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Signal Transduction; Urodynamics | 2018 |
Angiotensin-(1-7)-induced Mas receptor activation attenuates atherosclerosis through a nitric oxide-dependent mechanism in apolipoproteinE-KO mice.
Topics: Angiotensin I; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Blood Pressure; Cyclic GMP; Male; Mice; Mice, Inbred C57BL; Mice, Knockout, ApoE; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Vasodilation | 2018 |
Angiotensin‑(1‑7) prevents lipopolysaccharide‑induced hepatocellular inflammatory response by inhibiting the p38MAPK/AP‑1 signaling pathway.
Topics: Angiotensin I; Animals; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Gene Expression Regulation; Hepatocytes; Lipopolysaccharides; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Protective Agents; Rats; Signal Transduction; Transcription Factor AP-1 | 2018 |
Angiotensin 1-7 ameliorates 6-hydroxydopamine lesions in hemiparkinsonian rats through activation of MAS receptor/PI3K/Akt/BDNF pathway and inhibition of angiotensin II type-1 receptor/NF-κB axis.
Topics: Angiotensin I; Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Corpus Striatum; Male; NF-kappa B; Oxidopamine; Parkinsonian Disorders; Peptide Fragments; Phosphatidylinositol 3-Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Signal Transduction | 2018 |
Angiotensin-(1-7) Promotes Resolution of Eosinophilic Inflammation in an Experimental Model of Asthma.
Topics: Angiotensin I; Animals; Apoptosis; Asthma; Biomarkers; Bronchoalveolar Lavage Fluid; Caspase 3; Cell Survival; Disease Models, Animal; Eosinophils; Fluorescent Antibody Technique; GATA3 Transcription Factor; Leukocyte Count; Male; Mice; NF-kappa B; NF-KappaB Inhibitor alpha; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2018 |
Angiotensin 1-7 Overexpression Mediated by a Capsid-optimized AAV8 Vector Leads to Significant Growth Inhibition of Hepatocellular Carcinoma
Topics: Angiotensin I; Animals; Capsid; Cell Line, Tumor; Humans; Immunohistochemistry; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mutation; Peptide Fragments; Phosphorylation; Placenta Growth Factor; Receptor Protein-Tyrosine Kinases; Receptor, EphA3; Receptors, Vascular Endothelial Growth Factor; Ubiquitination; Vascular Endothelial Growth Factor A | 2018 |
Ang-(1-7) protects HUVECs from high glucose-induced injury and inflammation via inhibition of the JAK2/STAT3 pathway.
Topics: Angiotensin I; Cell Survival; Cytoprotection; Endothelial Cells; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Janus Kinase 2; Oxidative Stress; Peptide Fragments; Protective Agents; Signal Transduction; STAT3 Transcription Factor | 2018 |
Stimulation of ACE2/ANG(1-7)/Mas Axis by Diminazene Ameliorates Alzheimer's Disease in the D-Galactose-Ovariectomized Rat Model: Role of PI3K/Akt Pathway.
Topics: Alzheimer Disease; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Cell Survival; Cognition; Diminazene; Female; Galactose; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Inflammation; Maze Learning; Nerve Growth Factors; Neuronal Plasticity; Organelle Biogenesis; Ovariectomy; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Glutamate; Receptors, Nicotinic; Signal Transduction; tau Proteins | 2018 |
Altered global microRNA expression in hepatic stellate cells LX-2 by angiotensin-(1-7) and miRNA-1914-5p identification as regulator of pro-fibrogenic elements and lipid metabolism.
Topics: Angiotensin I; Cell Transdifferentiation; Cells, Cultured; Fibrosis; Gene Expression Regulation; Hepatic Stellate Cells; Humans; Lipid Metabolism; MicroRNAs; Peptide Fragments; Signal Transduction; Vasodilator Agents | 2018 |
Neuroprotection by post-stroke administration of an oral formulation of angiotensin-(1-7) in ischaemic stroke.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Angiotensin I; Animals; Blood Pressure; Cerebrovascular Circulation; Endothelin-1; Infarction, Middle Cerebral Artery; Male; Neuroprotection; Neuroprotective Agents; Peptide Fragments; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Stroke | 2018 |
Neuroprotective effect of angiotensin-(1-7) against rotenone-induced oxidative damage in CATH.a neurons.
Topics: Angiotensin I; Animals; Cell Line; Cell Survival; Glutathione; Mice; NADPH Oxidases; Neurons; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Rotenone; Superoxide Dismutase | 2018 |
AVE0991, a nonpeptide analogue of Ang-(1-7), attenuates aging-related neuroinflammation.
Topics: Aging; Angiotensin I; Animals; Brain; Imidazoles; Inflammation; Mice; Microglia; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2018 |
Acetylation and Amination Protect Angiotensin 1-7 from Physiological Hydrolyzation and Therefore Increases Its Antitumor Effects on Lung Cancer.
Topics: A549 Cells; Acetylation; Amination; Angiotensin I; Animals; Antineoplastic Agents; Chemistry, Pharmaceutical; Drug Synergism; Half-Life; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Paclitaxel; Peptide Fragments; Rats; Rats, Sprague-Dawley; Treatment Outcome; Xenograft Model Antitumor Assays | 2018 |
Angiotensin-(1-7) reduces cardiac effects of thyroid hormone by GSK3Β/NFATc3 signaling pathway.
Topics: Angiotensin I; Animals; Cardiomegaly; Cells, Cultured; Echocardiography; Glycogen Synthase Kinase 3 beta; Hyperthyroidism; Male; Myocytes, Cardiac; NFATC Transcription Factors; Peptide Fragments; Rats, Sprague-Dawley; Rats, Transgenic; Rats, Wistar; Renin-Angiotensin System; Signal Transduction; Triiodothyronine | 2018 |
[ACE2 agonist DIZE alleviates lung injury induced by limb ischemia-reperfusion in mice].
Topics: Acute Lung Injury; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diminazene; Hindlimb; Male; Mice; Mice, Inbred ICR; Mice, Transgenic; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Reperfusion Injury | 2018 |
FGF21 Prevents Angiotensin II-Induced Hypertension and Vascular Dysfunction by Activation of ACE2/Angiotensin-(1-7) Axis in Mice.
Topics: Adipose Tissue; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Cardiovascular System; Fibroblast Growth Factors; Hypertension; Kidney; Loss of Function Mutation; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Peptidyl-Dipeptidase A | 2018 |
Link between FGF21 and blood pressure.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Fibroblast Growth Factors; Humans; Hypertension; Mice; Peptide Fragments; Peptidyl-Dipeptidase A | 2018 |
FGF21 ACEs hypertension.
Topics: Angiotensin I; Angiotensin II; Animals; Fibroblast Growth Factors; Hypertension; Mice; Peptide Fragments; Peptidyl-Dipeptidase A | 2018 |
Influence and mechanism of Angiotensin 1-7 on biological properties of normal prostate epithelial cells.
Topics: Angiotensin I; Cell Adhesion; Cell Cycle; Cell Line; Cell Proliferation; Epithelial Cells; Epithelial-Mesenchymal Transition; Humans; Male; Peptide Fragments; Phosphatidylinositol 3-Kinases; Prostate | 2018 |
Lower circulating levels of angiotensin-converting enzyme (ACE) in patients with schizophrenia.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Female; Humans; Male; Middle Aged; Peptide Fragments; Peptidyl-Dipeptidase A; Schizophrenia | 2018 |
[Role of mesenteric lymph drainage in the balance of ACE/ACE2 in murine myocardium following hemorrhagic shock].
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Drainage; Fluid Therapy; Lymph; Lymph Nodes; Male; Mesentery; Mice; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Resuscitation; Shock, Hemorrhagic | 2017 |
Angiotensin (1-7) does not interact directly with MAS1, but can potently antagonize signaling from the AT1 receptor.
Topics: Angiotensin I; Angiotensin II; Animals; Arrestins; beta-Arrestins; Cell Line; CHO Cells; Cricetulus; Endothelial Cells; GTP-Binding Proteins; HEK293 Cells; Humans; Mitogen-Activated Protein Kinases; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Signal Transduction | 2018 |
Lipoxin A
Topics: Acute Lung Injury; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cell Line, Tumor; Disease Models, Animal; Humans; Imidazoles; Leucine; Lipopolysaccharides; Lipoxins; Male; Mice; NF-kappa B; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Signal Transduction | 2018 |
Development of angiotensin II (1-7) analog as an oral therapeutic for the treatment of chemotherapy-induced myelosuppression.
Topics: Administration, Oral; Angiotensin I; Animals; Deoxycytidine; Gemcitabine; Humans; Immunosuppressive Agents; Mice; Myelopoiesis; Peptide Fragments | 2018 |
Sini decoction alleviates E. coli induced acute lung injury in mice via equilibrating ACE-AngII-AT1R and ACE2-Ang-(1-7)-Mas axis.
Topics: Acute Lung Injury; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Drugs, Chinese Herbal; Escherichia coli; Escherichia coli Infections; Gene Expression Regulation; Male; Mice; Mice, Inbred ICR; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2018 |
ACE2 activator diminazene aceturate reduces adiposity but preserves lean mass in young and old rats.
Topics: Adiposity; Age Factors; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Diminazene; Disease Models, Animal; Gene Expression; Male; Obesity; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred F344; Renin-Angiotensin System | 2018 |
Tanshinone IIA attenuates paraquat‑induced acute lung injury by modulating angiotensin‑converting enzyme 2/angiotensin‑(1‑7) in rats.
Topics: Abietanes; Acute Lung Injury; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Biopsy; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Gene Expression; Immunohistochemistry; L-Lactate Dehydrogenase; Male; Neutrophil Infiltration; Paraquat; Peptide Fragments; Peptidyl-Dipeptidase A; Rats | 2018 |
Perindopril ameliorates lipopolysaccharide-induced brain injury through modulation of angiotensin-II/angiotensin-1-7 and related signaling pathways.
Topics: Angiotensin I; Angiotensin II; Animals; Biomarkers; Brain; Brain Injuries; Glutathione; Lipopolysaccharides; Male; Malondialdehyde; Peptide Fragments; Perindopril; Rats; Rats, Wistar; Signal Transduction; Transcription Factor RelA | 2018 |
Genetic deletion of the Angiotensin-(1-7) receptor Mas leads to a reduced ovulatory rate.
Topics: Angiotensin I; Animals; Female; Gene Deletion; Gene Expression Regulation; Insulin-Like Growth Factor I; Mice; Mice, Knockout; Ovarian Follicle; Ovulation; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2018 |
Dynamics of Renin, Angiotensin II, and Angiotensin (1-7) during Pregnancy and Predisposition to Hypertension-Associated Complications.
Topics: Adult; Angiotensin I; Angiotensin II; Blood Pressure; Female; Humans; Hypertension; Middle Aged; Peptide Fragments; Pregnancy; Renin; Vasoconstrictor Agents | 2018 |
[Role of ACE2-Ang (1-7)-Mas receptor axis in heart failure with preserved ejection fraction with hypertension].
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Atrial Remodeling; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Heart Failure; Humans; Hypertension; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Stroke Volume; Ventricular Function, Left; Ventricular Remodeling | 2018 |
Angiotensin 1-7 suppresses angiotensin II mediated aldosterone production via JAK/STAT signaling inhibition.
Topics: Adrenocortical Carcinoma; Aldosterone; Angiotensin I; Angiotensin II; Cardiovascular Diseases; Cell Line, Tumor; Culture Media, Conditioned; Cytochrome P-450 CYP11B2; Humans; Janus Kinases; Peptide Fragments; Phosphorylation; Signal Transduction; STAT Transcription Factors | 2019 |
Effects of angiotensin-(1-7) and angiotensin II on vascular tone in human cirrhotic splanchnic vessels.
Topics: Angiotensin I; Angiotensin II; Female; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Omentum; Peptide Fragments; Renin-Angiotensin System; Vasodilation | 2018 |
Angiotensin-converting enzyme 2 deficiency accelerates and angiotensin 1-7 restores age-related muscle weakness in mice.
Topics: Age Factors; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Biomarkers; Disease Models, Animal; Gene Expression Profiling; Glucose Tolerance Test; Mice; Mice, Knockout; Muscle Weakness; Muscle, Skeletal; Oxygen Consumption; Peptide Fragments; Peptidyl-Dipeptidase A; Physical Conditioning, Animal; Transcriptome | 2018 |
Involvement of angiotensin-(1-7) in the neuroprotection of captopril against focal cerebral ischemia.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Brain; Brain Ischemia; Captopril; Male; Neuroprotection; Peptide Fragments; Proto-Oncogene Mas; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 2018 |
Suppression of Angiotensin-(1-7) on the Disruption of Blood-Brain Barrier in Rat of Brain Glioma.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Blood-Brain Barrier; Brain Edema; Brain Neoplasms; Cell Membrane Permeability; Glioma; Humans; Male; MAP Kinase Signaling System; Peptide Fragments; Rats; Rats, Sprague-Dawley; Tight Junctions; Tumor Cells, Cultured | 2019 |
Increased expression of miR-33a in monocytes from Mexican hypertensive patients in elevated carotid intima-media thickness.
Topics: Aged; Angiotensin I; Angiotensin II; Carotid Intima-Media Thickness; Case-Control Studies; Female; Humans; Hypertension; Male; MicroRNAs; Middle Aged; Monocytes; Peptide Fragments; Sterol Regulatory Element Binding Proteins | 2018 |
Angiotensin (1-7) inhibits arecoline-induced migration and collagen synthesis in human oral myofibroblasts via inhibiting NLRP3 inflammasome activation.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Anti-Inflammatory Agents; Antioxidants; Arecoline; Cell Movement; Cells, Cultured; Collagen; Disease Models, Animal; Humans; Male; Myofibroblasts; NADPH Oxidase 4; NLR Family, Pyrin Domain-Containing 3 Protein; Oral Submucous Fibrosis; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyroptosis; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Signal Transduction | 2019 |
Circulating miR-421 Targeting Leucocytic Angiotensin Converting Enzyme 2 Is Elevated in Patients with Chronic Kidney Disease.
Topics: 3' Untranslated Regions; Aged; Aged, 80 and over; Angiotensin I; Angiotensin-Converting Enzyme 2; Cell Line; Female; Humans; Leukocytes; Male; MicroRNAs; Middle Aged; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Renal Dialysis; Renal Insufficiency, Chronic; Uremia | 2019 |
Blockade of Endogenous Angiotensin-(1-7) in Hypothalamic Paraventricular Nucleus Attenuates High Salt-Induced Sympathoexcitation and Hypertension.
Topics: Angiotensin I; Animals; Antioxidants; Blood Pressure; Hypertension; Male; Oxidative Stress; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Rats, Sprague-Dawley; Reactive Oxygen Species; Sodium Chloride, Dietary | 2019 |
ACE-2/ANG1-7 ameliorates ER stress-induced apoptosis in seawater aspiration-induced acute lung injury.
Topics: Acute Lung Injury; Alveolar Epithelial Cells; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Cells, Cultured; Endoplasmic Reticulum Stress; Endothelial Cells; Lung; Male; Membrane Proteins; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Seawater; X-Box Binding Protein 1 | 2018 |
Angiotensin 1-7 modulates molecular and cellular processes central to the pathogenesis of prostate cancer.
Topics: Angiotensin I; Cell Adhesion; Cell Count; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Extracellular Matrix Proteins; Gene Expression Regulation, Neoplastic; Humans; Male; Neoplasm Invasiveness; Peptide Fragments; Prostatic Neoplasms; RNA, Messenger; Signal Transduction | 2018 |
Angiotensin-(1-7) attenuates organ injury and mortality in rats with polymicrobial sepsis.
Topics: Angiotensin I; Animals; Apoptosis; Biomarkers; Coinfection; Disease Models, Animal; Interleukin-6; Organ Dysfunction Scores; Oxidative Stress; Peptide Fragments; Rats; Rats, Wistar; Sepsis; Statistics, Nonparametric; Superoxides; Tissue Survival | 2018 |
Blood Pressure-Independent Effect of Olmesartan on Albuminuria in Mice Overexpressing Renin.
Topics: Albuminuria; Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Biomarkers; Blood Pressure; Blotting, Western; Imidazoles; Male; Mice; NADPH Oxidases; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin; Renin-Angiotensin System; Tetrazoles | 2018 |
Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts.
Topics: Angiotensin I; Animals; Autophagy; Cell Line, Tumor; Down-Regulation; Humans; Male; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Peptide Fragments; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2018 |
Obesity is Associated with Higher Blood Pressure and Higher Levels of Angiotensin II but Lower Angiotensin-(1-7) in Adolescents Born Preterm.
Topics: Adolescent; Angiotensin I; Angiotensin II; Body Mass Index; Cross-Sectional Studies; Female; Humans; Hypertension; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Male; Pediatric Obesity; Peptide Fragments; Pregnancy; Premature Birth; Prospective Studies | 2019 |
BML-111, a lipoxin receptor agonist, protects against acute injury via regulating the renin angiotensin-aldosterone system.
Topics: Angiotensin I; Angiotensin II; Animals; Cytoprotection; Down-Regulation; Heptanoic Acids; Liver; Lung Injury; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Lipoxin; Renin-Angiotensin System; Up-Regulation | 2019 |
Anti-hypersensitive effect of angiotensin (1-7) on streptozotocin-induced diabetic neuropathic pain in mice.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Hyperesthesia; Male; Mice; Neuralgia; p38 Mitogen-Activated Protein Kinases; Pain Perception; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Spinal Cord; Vasodilator Agents | 2019 |
Effects of Resveratrol on the Renin-Angiotensin System in the Aging Kidney.
Topics: Albuminuria; Angiotensin I; Angiotensin II; Animals; Anti-Inflammatory Agents; Antioxidants; Collagen Type IV; Fibronectins; Fibrosis; Kidney; Male; Mice, Inbred C57BL; NADPH Oxidases; Nitric Oxide Synthase Type III; Oxidative Stress; Peptide Fragments; Plant Extracts; Proto-Oncogene Proteins; Receptors, Angiotensin; Receptors, G-Protein-Coupled; Renal Insufficiency, Chronic; Renin-Angiotensin System; Resveratrol; Superoxide Dismutase | 2018 |
Long-Term Administration of Angiotensin (1-7) to
Topics: Angiotensin I; Animals; Diabetes Mellitus, Experimental; Gene Expression Regulation, Enzymologic; Kidney; Kidney Glomerulus; Male; Mice, Inbred C57BL; NADPH Oxidases; Nitric Oxide Synthase Type III; Oxidative Stress; Peptide Fragments; Phosphorylation; Shear Strength; Tyrosine | 2018 |
Anti-inflammatory effects of Ang-(1-7) via TLR4-mediated inhibition of the JNK/FoxO1 pathway in lipopolysaccharide-stimulated RAW264.7 cells.
Topics: Angiotensin I; Angiotensin II; Animals; Anti-Inflammatory Agents; Forkhead Box Protein O1; Interleukin-6; Lipopolysaccharides; Macrophages; MAP Kinase Kinase 4; Mice; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; RAW 264.7 Cells; Receptors, G-Protein-Coupled; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2019 |
Efficacy of lanthionine-stabilized angiotensin-(1-7) in type I and type II diabetes mouse models.
Topics: Alanine; Angiotensin I; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Insulin; Mice; Mice, Inbred C57BL; Peptide Fragments; Streptozocin; Sulfides; Treatment Outcome | 2019 |
Comparison of Candesartan and Angiotensin-(1-7) Combination to Mito-TEMPO Treatment for Normalizing Blood Pressure and Sympathovagal Balance in (mREN2)27 Rats.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Arterial Pressure; Baroreflex; Benzimidazoles; Biphenyl Compounds; Brain; Disease Models, Animal; Drug Combinations; Free Radical Scavengers; Heart; Heart Rate; Hypertension; Male; Mitochondria; Organophosphorus Compounds; Peptide Fragments; Piperidines; Rats, Transgenic; Reactive Oxygen Species; Renin; Sympathetic Nervous System; Tetrazoles; Vagus Nerve | 2019 |
[Aliskiren inhibits angiotensin II/angiotensin 1-7(Ang II/Ang1-7) signal pathway in rats with diabetic nephropathy].
Topics: Amides; Angiotensin I; Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fumarates; Male; Peptide Fragments; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction | 2018 |
Decreased Ang-(1-7) and Downregulated Intrarenal RAS May Contribute to the Direct Podocyte Injury With Proteinuria in Preeclampsia.
Topics: Actins; Adult; Angiotensin I; Animals; Blood Pressure; Cell Line; Down-Regulation; Female; Humans; Hypertension, Pregnancy-Induced; Membrane Proteins; Mice; Peptide Fragments; Podocytes; Pre-Eclampsia; Pregnancy; Proteinuria; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Zonula Occludens-1 Protein | 2019 |
Acute intrarenal angiotensin (1-7) infusion decreases diabetes-induced glomerular hyperfiltration but increases kidney oxygen consumption in the rat.
Topics: Angiotensin I; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; Male; Oxygen Consumption; Peptide Fragments; Rats; Rats, Sprague-Dawley | 2019 |
A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation-Related Memory Dysfunction.
Topics: Angiotensin I; Animals; Behavior, Animal; Biomarkers; Brain; Cognitive Dysfunction; Dementia, Vascular; Electrocardiography; Glycosylation; Half-Life; Heart Failure; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Male; Maze Learning; Memory; Mice; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, G-Protein-Coupled; Spatial Memory; Ventricular Remodeling | 2019 |
Molecular and Cellular Effect of Angiotensin 1-7 on Hypertensive Kidney Disease.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Blood Pressure; Blotting, Western; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Hypertension, Renal; Kidney; Lymphokines; Male; Nephritis; Oxidative Stress; Peptide Fragments; Platelet-Derived Growth Factor; Rats; Rats, Sprague-Dawley; RNA; Tissue Inhibitor of Metalloproteinases; Vascular Endothelial Growth Factor D | 2019 |
The angiotensin-(1-7)/Mas receptor axis protects from endothelial cell senescence via klotho and Nrf2 activation.
Topics: Angiotensin I; Cells, Cultured; Cellular Senescence; Glucuronidase; Human Umbilical Vein Endothelial Cells; Humans; Klotho Proteins; NF-E2-Related Factor 2; Peptide Fragments; Receptors, G-Protein-Coupled | 2019 |
Assessing the effects of Ang-(1-7) therapy following transient middle cerebral artery occlusion.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blood-Brain Barrier; Contrast Media; Disease Models, Animal; Gene Expression Regulation; Humans; Infarction, Middle Cerebral Artery; Inflammation; Magnetic Resonance Imaging; Microglia; Middle Cerebral Artery; NADPH Oxidase 1; Neuroprotective Agents; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Rats; Renin-Angiotensin System; Reperfusion; RNA, Messenger; Stroke | 2019 |
Reduced disease severity following therapeutic treatment with angiotensin 1-7 in a mouse model of multiple sclerosis.
Topics: Angiotensin I; Animals; Cell Proliferation; Disease Progression; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Male; Mice; Neuroprotection; Neuroprotective Agents; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Severity of Illness Index; Treatment Outcome | 2019 |
Angiotensin-(1-7) inhibits sodium transport via Mas receptor by increasing nitric oxide production in thick ascending limb.
Topics: Angiotensin I; Animals; Loop of Henle; Male; Natriuresis; Natriuretic Agents; Nitric Oxide; Oxygen Consumption; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Sodium; Up-Regulation | 2019 |
Unique mechanistic insights into the beneficial effects of angiotensin-(1-7) on the prevention of cardiac fibrosis: A metabolomic analysis of primary cardiac fibroblasts.
Topics: Angiotensin I; Angiotensin II; Animals; Arachidonic Acid; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Differentiation; Cell Proliferation; Cells, Cultured; Fibroblasts; Fibrosis; Gas Chromatography-Mass Spectrometry; Glutathione; Heart Diseases; Male; Metabolome; Oxidative Stress; Peptide Fragments; Rats, Sprague-Dawley; Reactive Oxygen Species | 2019 |
Angiotensin-(1-7) induced vascular relaxation in spontaneously hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Animals; Arterial Pressure; Coronary Vessels; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Male; Mesenteric Arteries; Nitric Oxide; Peptide Fragments; Pulmonary Artery; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, G-Protein-Coupled; Signal Transduction; Vasodilation | 2019 |
Egg White-Derived Antihypertensive Peptide IRW (Ile-Arg-Trp) Reduces Blood Pressure in Spontaneously Hypertensive Rats via the ACE2/Ang (1-7)/Mas Receptor Axis.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Egg Proteins; Endothelium, Vascular; Male; Matrix Metalloproteinase 9; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Inbred SHR; Receptors, G-Protein-Coupled; Vasodilation | 2019 |
Beneficial Effects of the Angiotensin-Converting Enzyme 2 Activator Dize in Renovascular Hypertension.
Topics: Acetylglucosaminidase; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cytokines; Diminazene; Enzyme Activators; Hypertension, Renovascular; Inflammation; Kidney; Male; Nitric Oxide; Peptide Fragments; Peptidyl-Dipeptidase A; Peroxidase; Rats, Wistar; Renin-Angiotensin System | 2019 |
Central ANG-(1-7) infusion improves blood pressure regulation in antenatal betamethasone-exposed sheep and reveals sex-dependent effects on oxidative stress.
Topics: Age Factors; Angiotensin I; Animals; Baroreflex; Betamethasone; Blood Pressure; Enzyme Activation; Female; Gestational Age; Glucocorticoids; Heart Rate; Homeostasis; Infusions, Intraventricular; Male; Medulla Oblongata; Mitogen-Activated Protein Kinases; Oxidative Stress; Peptide Fragments; Pregnancy; Prenatal Exposure Delayed Effects; Sex Factors; Sheep, Domestic | 2019 |
Chronic Angiotensin 1-7 Infusion Prevents Angiotensin-II-Induced Cognitive Dysfunction and Skeletal Muscle Injury in a Mouse Model of Alzheimer's Disease.
Topics: Alzheimer Disease; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Body Weight; Cerebrovascular Circulation; Cognitive Dysfunction; Disease Models, Animal; Hippocampus; Maze Learning; Mice; Muscle, Skeletal; Peptide Fragments; Rotarod Performance Test | 2019 |
Cardioprotection Conferred by Sitagliptin Is Associated with Reduced Cardiac Angiotensin II/Angiotensin-(1-7) Balance in Experimental Chronic Kidney Disease.
Topics: Angiotensin I; Angiotensin II; Animals; Anti-Inflammatory Agents; Antioxidants; Blood Pressure; Body Weight; Cardiotonic Agents; Diastole; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Kidney; Kidney Function Tests; Male; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Rats, Wistar; Renal Insufficiency, Chronic; Renin-Angiotensin System; Sitagliptin Phosphate; Up-Regulation; Ventricular Remodeling | 2019 |
Aerobic exercise training prevents obesity and insulin resistance independent of the renin angiotensin system modulation in the subcutaneous white adipose tissue.
Topics: Adipose Tissue, White; Adiposity; Angiotensin I; Angiotensin II; Animals; Biomarkers; Body Weight; Feeding Behavior; Glucose; Insulin Resistance; Male; Mice, Inbred C57BL; Obesity; Peptide Fragments; Peptides; Physical Conditioning, Animal; Renin-Angiotensin System; RNA, Messenger; Subcutaneous Fat; Thermogenesis; Uncoupling Protein 1 | 2019 |
Subcutaneous Administration of Angiotensin-(1-7) Improves Recovery after Traumatic Brain Injury in Mice.
Topics: Angiotensin I; Animals; Brain; Brain Injuries, Traumatic; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Peptide Fragments; Recovery of Function | 2019 |
Cardiac hypertrophy in mice submitted to a swimming protocol: influence of training volume and intensity on myocardial renin-angiotensin system.
Topics: Angiotensin I; Angiotensin II; Animals; Cardiomegaly; Hypertrophy, Left Ventricular; Male; Mice, Inbred BALB C; Myocardium; Peptide Fragments; Physical Conditioning, Animal; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Swimming; Ventricular Remodeling | 2019 |
Sini decoction ameliorates sepsis-induced acute lung injury via regulating ACE2-Ang (1-7)-Mas axis and inhibiting the MAPK signaling pathway.
Topics: Acute Lung Injury; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Drugs, Chinese Herbal; Human Umbilical Vein Endothelial Cells; Humans; Lung; Male; MAP Kinase Signaling System; Mice, Inbred ICR; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Sepsis | 2019 |
Modulation of renin angiotensin system components by high glucose levels in the culture of collecting duct cells.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cell Line; Glucose; Kidney Tubules, Collecting; Mice; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2019 |
Both aldosterone and spironolactone can modulate the intracellular ACE/ANG II/AT1 and ACE2/ANG (1-7)/MAS receptor axes in human mesangial cells.
Topics: Aldosterone; Angiotensin I; Angiotensin-Converting Enzyme 2; Cells, Cultured; Glycosylation; Humans; Mesangial Cells; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Spironolactone; Vesicular Transport Proteins | 2019 |
Targeting the RAS axis alleviates silicotic fibrosis and Ang II-induced myofibroblast differentiation via inhibition of the hedgehog signaling pathway.
Topics: Adult; Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anthracosis; Captopril; Cell Differentiation; Cell Line; Collagen; Disease Models, Animal; Female; Hedgehog Proteins; Humans; Lung; Male; Middle Aged; Myofibroblasts; Oligopeptides; Peptide Fragments; Pulmonary Fibrosis; Rats, Wistar; Renin-Angiotensin System; Signal Transduction; Silicosis | 2019 |
Superoxide anions mediate the effects of angiotensin (1-7) analog, alamandine, on blood pressure and sympathetic activity in the paraventricular nucleus.
Topics: Angiotensin I; Animals; Autonomic Pathways; Blood Pressure; Male; NADPH Oxidases; Oligopeptides; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Rats; Rats, Inbred SHR; Reactive Oxygen Species; Superoxides; Sympathetic Nervous System | 2019 |
The clinical impact of angiotensin-(1-7)/mitochondrial assembly receptor axis in esophageal squamous cell carcinoma patients receiving curative esophagectomy.
Topics: Adult; Aged; Angiotensin I; Biomarkers, Tumor; Cell Line, Tumor; Disease-Free Survival; Dose-Response Relationship, Drug; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Male; Middle Aged; Peptide Fragments; Prognosis; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Retrospective Studies; Risk Factors; Treatment Outcome | 2020 |
Effect of preventive or therapeutic treatment with angiotensin 1-7 in a model of bleomycin-induced lung fibrosis in mice.
Topics: Angiotensin I; Animals; Bleomycin; Disease Models, Animal; Leukocytes, Mononuclear; Lung; Male; Mice, Inbred C57BL; Peptide Fragments; Pulmonary Fibrosis; Survival Analysis | 2019 |
Protective Effect of Angiotensin (1-7) on Silicotic Fibrosis in Rats.
Topics: Actins; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Animals, Newborn; Cell Differentiation; Cells, Cultured; Collagen Type I; Disease Models, Animal; Lung; Myofibroblasts; Peptide Fragments; Peptidyl-Dipeptidase A; Rats, Wistar; Silicosis | 2019 |
Prehypertension exercise training attenuates hypertension and cardiac hypertrophy accompanied by temporal changes in the levels of angiotensin II and angiotensin (1-7).
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Cardiomegaly; Diastole; Male; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Physical Conditioning, Animal; Prehypertension; Rats, Inbred SHR; Rats, Inbred WKY; Ventricular Remodeling | 2019 |
Intrarenal Renin-Angiotensin-System Dysregulation after Kidney Transplantation.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Enzyme Activation; Female; Gene Expression Regulation, Enzymologic; Humans; Kidney; Kidney Transplantation; Male; Middle Aged; Models, Biological; Peptide Fragments; Postoperative Complications; Renin; Renin-Angiotensin System | 2019 |
Ang-(1-7) treatment attenuates lipopolysaccharide-induced early pulmonary fibrosis.
Topics: Angiotensin I; Angiotensin II; Animals; Bronchoalveolar Lavage Fluid; Cadherins; Drug Evaluation, Preclinical; Imidazoles; Lipopolysaccharides; Lung; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pulmonary Fibrosis; Random Allocation; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Transforming Growth Factor beta; Vasodilator Agents; Vimentin | 2019 |
Interaction of N-acetyl-seryl-aspartyl-lysyl-proline with the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis attenuates pulmonary fibrosis in silicotic rats.
Topics: Actins; Angiotensin I; Angiotensin II; Animals; Cell Differentiation; Cells, Cultured; Collagen; Collagen Type I; Fibroblasts; Humans; Male; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pulmonary Fibrosis; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Silicosis | 2019 |
The ameliorative effect of angiotensin 1-7 on experimentally induced-preeclampsia in rats: Targeting the role of peroxisome proliferator-activated receptors gamma expression & asymmetric dimethylarginine.
Topics: Angiotensin I; Animals; Arginine; Blood Pressure; Female; Oxidative Stress; Peptide Fragments; Placenta; PPAR gamma; Pre-Eclampsia; Pregnancy; Proteinuria; Rats, Wistar; Sodium | 2019 |
Addition of cyclic angiotensin-(1-7) to angiotensin-converting enzyme inhibitor therapy has a positive add-on effect in experimental diabetic nephropathy.
Topics: Alanine; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Drug Therapy, Combination; Half-Life; Humans; Kidney Glomerulus; Lisinopril; Male; Mice; Mice, Transgenic; Microscopy, Electron, Transmission; Peptide Fragments; Peptides, Cyclic; Proteinuria; Sulfides | 2019 |
Angiotensin 1-7 and the Sympathetic Nervous System in Hypertensive Kidney Disease.
Topics: Angiotensin I; Humans; Hypertension, Renal; Peptide Fragments; Sympathetic Nervous System | 2019 |
Sex differences in metabolic effects of angiotensin-(1-7) treatment in obese mice.
Topics: Angiotensin I; Animals; Diet, High-Fat; Energy Metabolism; Female; Glucose Intolerance; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Obesity; Peptide Fragments; Sex Characteristics | 2019 |
Sex-related differences in the intratubular renin-angiotensin system in two-kidney, one-clip hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Constriction; Disease Models, Animal; Estrogens; Female; Hypertension; Hypertrophy, Left Ventricular; Kidney Tubules; Macrophages; Male; Ovariectomy; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renal Artery; Renin-Angiotensin System; Sex Factors; Signal Transduction | 2019 |
Relationship between circulating levels of angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS axis and coronary heart disease.
Topics: Aged; Angiotensin I; Angiotensin-Converting Enzyme 2; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Risk Factors; Sex Factors | 2020 |
Exogenous angiotensin (1-7) directly inhibits epithelial-mesenchymal transformation induced by transforming growth factor-β1 in alveolar epithelial cells.
Topics: A549 Cells; Alveolar Epithelial Cells; Angiotensin I; Animals; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Humans; Lung; Mice; Mice, Inbred C57BL; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Signal Transduction; Transforming Growth Factor beta1 | 2019 |
Angiotensin-converting enzyme 2 attenuates inflammatory response and oxidative stress in hyperoxic lung injury by regulating NF-κB and Nrf2 pathways.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Bronchoalveolar Lavage Fluid; Diminazene; Hyperoxia; Imidazoles; Leucine; Lung Injury; Male; Mice; Mice, Inbred BALB C; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A | 2019 |
Angiotensin-(1-7) oral treatment after experimental myocardial infarction leads to downregulation of CXCR4.
Topics: Administration, Oral; Angiotensin I; Animals; Down-Regulation; Male; Mitochondria, Heart; Myocardial Infarction; Myocardium; Peptide Fragments; Proteome; Proteomics; Rats; Rats, Wistar; Receptors, CXCR4 | 2019 |
The angiotensin converting enzyme 2/angiotensin-(1-7)/Mas Receptor axis as a key player in alveolar bone remodeling.
Topics: Alkaline Phosphatase; Alveolar Process; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Animals, Newborn; Blotting, Western; Bone Remodeling; Cell Survival; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Humans; Immunohistochemistry; In Vitro Techniques; Male; Osteoblasts; Osteoclasts; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2019 |
Adipocyte deficiency of ACE2 increases systolic blood pressures of obese female C57BL/6 mice.
Topics: Adipocytes; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Diet, High-Fat; Female; Gene Expression Regulation; Male; Mice; Obesity; Peptide Fragments; Peptidyl-Dipeptidase A; Sex Characteristics | 2019 |
Underlying mechanisms behind the protective effect of angiotensin (1-7) in experimental rat model of ovarian ischemia reperfusion injury.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Antioxidants; Female; Gene Expression; Malondialdehyde; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Ovary; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Receptors, G-Protein-Coupled; Reperfusion Injury; Serum; Tumor Necrosis Factor-alpha | 2019 |
Stimulation of the ACE2/Ang-(1-7)/Mas axis in hypertensive pregnant rats attenuates cardiovascular dysfunction in adult male offspring.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Cardiovascular Diseases; Diminazene; Enzyme Activators; Female; Heart; Hypertension, Pregnancy-Induced; Kidney; Male; Myocardial Contraction; Peptide Fragments; Peptidyl-Dipeptidase A; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Ventricular Function, Left | 2019 |
Angiotensin 1-7 alleviates aging-associated muscle weakness and bone loss, but is not associated with accelerated aging in ACE2-knockout mice.
Topics: Adipose Tissue; Aging; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Body Weight; Bone Resorption; Cyclin-Dependent Kinase Inhibitor p16; Forelimb; Gene Deletion; Hand Strength; Male; Mice, Inbred C57BL; Mice, Knockout; Muscle Weakness; Muscles; Organ Size; PAX3 Transcription Factor; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Time Factors | 2019 |
AVE 0991 Attenuates Pyroptosis and Liver Damage after Heatstroke by Inhibiting the ROS-NLRP3 Inflammatory Signalling Pathway.
Topics: Angiotensin I; Angiotensin II; Animals; Biomarkers; Heat Stroke; Hepatocytes; Humans; Imidazoles; Inflammasomes; Inflammation; Interleukin-1beta; Liver; Liver Cirrhosis; Male; NLR Family, Pyrin Domain-Containing 3 Protein; Peptide Fragments; Prospective Studies; Pyroptosis; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction | 2019 |
Angiotensin-(1-7) for diabetic kidney disease: better than an angiotensin-converting enzyme inhibitor alone?
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus; Diabetic Nephropathies; Kidney; Lisinopril; Mice; Peptide Fragments | 2019 |
Therapeutic Delivery of Ang(1-7) via Genetically Modified Probiotic: A Dosing Study.
Topics: Aging; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Drug Administration Schedule; Lacticaseibacillus paracasei; Male; Models, Animal; Peptide Fragments; Pharmaceutical Vehicles; Probiotics; Proof of Concept Study; Rats; Rats, Inbred BN; Rats, Inbred F344; Recombinant Proteins | 2020 |
Angiotensin 1-7 formation in breast tissue is attenuated in breast cancer - a study on the metabolism of angiotensinogen in breast cancer cell lines.
Topics: Angiotensin I; Angiotensinogen; Breast; Breast Neoplasms; Cell Line; Female; Humans; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2019 |
Angiotensin-(1-7) mitigated angiotensin II-induced abdominal aortic aneurysms in apolipoprotein E-knockout mice.
Topics: Angiotensin I; Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Disease Models, Animal; Mice; Mice, Inbred C57BL; Mice, Knockout, ApoE; Peptide Fragments | 2020 |
Correlation between angiotensin 1-7-mediated Mas receptor expression with motor improvement, activated STAT3/SOCS3 cascade, and suppressed HMGB-1/RAGE/NF-κB signaling in 6-hydroxydopamine hemiparkinsonian rats.
Topics: Angiotensin I; Animals; Corpus Striatum; Dopaminergic Neurons; Gene Expression; HMGB1 Protein; Male; Motor Activity; NF-kappa B; Oxidopamine; Parkinsonian Disorders; Peptide Fragments; Proteins; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Wistar; Receptor for Advanced Glycation End Products; Receptors, G-Protein-Coupled; Signal Transduction; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Vasodilator Agents | 2020 |
Ang-(1-7)/ MAS1 receptor axis inhibits allergic airway inflammation via blockade of Src-mediated EGFR transactivation in a murine model of asthma.
Topics: Angiotensin I; Animals; Asthma; Blotting, Western; Bronchoalveolar Lavage Fluid; Chemotaxis, Leukocyte; Disease Models, Animal; ErbB Receptors; Fluorescent Antibody Technique; Lung; Male; Mice; Mice, Inbred BALB C; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Respiratory Hypersensitivity; Signal Transduction; src-Family Kinases | 2019 |
Cyclic angiotensin-(1-7) contributes to rehabilitation of animal performance in a rat model of cerebral stroke.
Topics: Angiotensin I; Animals; Disease Models, Animal; Male; Peptide Fragments; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Recovery of Function; Stroke; Stroke Rehabilitation | 2020 |
Assessment of Pregabalin-Induced Cardiotoxicity in Rats: Mechanistic Role of Angiotensin 1-7.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Biomarkers; Cardiotoxicity; Cyclic AMP-Dependent Protein Kinases; Heart Diseases; Male; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphatidylinositol 3-Kinase; Pregabalin; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction; Stroke Volume; Ventricular Function, Left | 2020 |
Significance of the angiotensin I/angiotensin II/angiotensin-(1-7) axis in the pathogenesis of systemic sclerosis.
Topics: Adult; Aged; Angiotensin I; Angiotensin II; Female; Humans; Male; Middle Aged; Peptide Fragments; Scleroderma, Systemic; Young Adult | 2020 |
Mas receptor is translocated to the nucleus upon agonist stimulation in brainstem neurons from spontaneously hypertensive rats but not normotensive rats.
Topics: Active Transport, Cell Nucleus; Angiotensin I; Animals; Animals, Newborn; Arachidonic Acid; Brain Stem; Cells, Cultured; Disease Models, Animal; Endocytosis; Extracellular Signal-Regulated MAP Kinases; Hypertension; Ligands; Neurons; Nitric Oxide; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, G-Protein-Coupled | 2020 |
Effects of Angiotensin-(1-7) and Angiotensin II on Acetylcholine-Induced Vascular Relaxation in Spontaneously Hypertensive Rats.
Topics: Acetylcholine; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Hypertension; Male; Nitric Oxide; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasodilation | 2019 |
Oral formulation angiotensin-(1-7) therapy attenuates pulmonary and systemic damage in mice with emphysema induced by elastase.
Topics: Administration, Oral; Angiotensin I; Animals; Disease Models, Animal; Homeostasis; Interleukin-1beta; Locomotion; Lung; Male; Mice; Mice, Inbred C57BL; Pancreatic Elastase; Peptide Fragments; Pulmonary Alveoli; Pulmonary Emphysema; Swine | 2020 |
Angiotensin-(1-7) induces beige fat thermogenesis through the Mas receptor.
Topics: Adipose Tissue, Beige; Adipose Tissue, White; Adult; Angiotensin I; Animals; Cell Respiration; Cells, Cultured; Energy Metabolism; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Obesity; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Transgenic; Receptors, G-Protein-Coupled; Thermogenesis; Young Adult | 2020 |
ACE2/Angiotensin 1-7 protective anti-inflammatory and antioxidant role in hyperoxic lung injury: support from studies in Bartter's and Gitelman's syndromes.
Topics: Angiotensin I; Anti-Inflammatory Agents; Antioxidants; Bartter Syndrome; Gitelman Syndrome; Humans; Lung Injury; Peptide Fragments | 2020 |
Tsantan Sumtang attenuated chronic hypoxia-induced right ventricular structure remodeling and fibrosis by equilibrating local ACE-AngII-AT1R/ACE2-Ang1-7-Mas axis in rat.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Hypertrophy, Right Ventricular; Hypoxia; Male; Medicine, Tibetan Traditional; Peptide Fragments; Peptidyl-Dipeptidase A; Plant Preparations; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Ventricular Remodeling | 2020 |
Role of Angiotensin-(1-7) via MAS receptor in human sperm motility and acrosome reaction.
Topics: Acrosome Reaction; Adult; Angiotensin I; Angiotensin II; Asthenozoospermia; Humans; Male; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Sperm Motility; Spermatozoa | 2020 |
[Regulation of angiotensin-converting enzyme 2-angiotensin (1-7)-Mas axis provides a new target for the treatment of cardiac remodeling and heart failure].
Topics: Angiotensin I; Heart Failure; Humans; Peptide Fragments; Ventricular Remodeling | 2019 |
Severe food restriction activates the central renin angiotensin system.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Arterial Pressure; Autoradiography; Caloric Restriction; Female; Heart Rate; Hypothalamus; Injections, Intraventricular; Losartan; Organum Vasculosum; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Peptidyl-Dipeptidase A; Preoptic Area; Rats; Rats, Inbred F344; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Starvation; Subfornical Organ | 2020 |
Effect of spinal angiotensin-converting enzyme 2 activation on the formalin-induced nociceptive response in mice.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diminazene; Disease Models, Animal; Formaldehyde; Humans; Injections, Spinal; Male; Mice; Microglia; Neurons; Nociception; p38 Mitogen-Activated Protein Kinases; Pain; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Spinal Cord | 2020 |
Downregulation of spinal angiotensin converting enzyme 2 is involved in neuropathic pain associated with type 2 diabetes mellitus in mice.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Down-Regulation; Male; Mice; Mice, Knockout; Mice, Obese; Mice, Transgenic; Neuralgia; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Peptidyl-Dipeptidase A; Spinal Cord | 2020 |
High hydrostatic pressure induces atrial electrical remodeling through angiotensin upregulation mediating FAK/Src pathway activation.
Topics: Angiotensin I; Angiotensin II; Animals; Anti-Arrhythmia Agents; Atrial Appendage; Atrial Fibrillation; Atrial Remodeling; Cell Line, Tumor; Focal Adhesion Kinase 1; Humans; Hydrostatic Pressure; Mice; Myocytes, Cardiac; Peptide Fragments; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; src-Family Kinases; Up-Regulation; Valsartan | 2020 |
Angiotensin (1-7) Decreases Myostatin-Induced NF-κB Signaling and Skeletal Muscle Atrophy.
Topics: Angiotensin I; Animals; Cell Line; Mice; Muscle Fibers, Skeletal; Muscle Proteins; Myostatin; NF-kappa B; Peptide Fragments; Reactive Oxygen Species; Signal Transduction; SKP Cullin F-Box Protein Ligases; Tripartite Motif Proteins; Tumor Necrosis Factor-alpha; Ubiquitin-Protein Ligases | 2020 |
AVE0991, a nonpeptide angiotensin-(1-7) mimic, inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E knockout mice.
Topics: Angiotensin I; Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Blood Pressure; Disease Models, Animal; Humans; Imidazoles; Immunohistochemistry; Lipids; Male; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Knockout; Molecular Mimicry; Myocytes, Smooth Muscle; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Peptide Fragments | 2020 |
Angiotensin-(1-7) Attenuates Protein O-GlcNAcylation in the Retina by EPAC/Rap1-Dependent Inhibition of O-GlcNAc Transferase.
Topics: Angiotensin I; Animals; Captopril; Cyclic AMP-Dependent Protein Kinases; Diabetic Retinopathy; Mice; N-Acetylglucosaminyltransferases; Peptide Fragments; Renin-Angiotensin System; Retina; Signal Transduction | 2020 |
Angiotensin-(1-7) reduces doxorubicin-induced cardiac dysfunction in male and female Sprague-Dawley rats through antioxidant mechanisms.
Topics: Angiotensin I; Animals; Antineoplastic Agents; Antioxidants; Cardiotoxicity; Catalase; Doxorubicin; Female; Heart Diseases; Heart Rate; Male; Malondialdehyde; Mitral Valve; Myocardium; NADPH Oxidases; Peptide Fragments; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxide Dismutase | 2020 |
AVE0991, a Nonpeptide Angiotensin 1-7 Receptor Agonist, Improves Glucose Metabolism in the Skeletal Muscle of Obese Zucker Rats: Possible Involvement of Prooxidant/Antioxidant Mechanisms.
Topics: Angiotensin I; Animals; Antioxidants; Glucose; Imidazoles; Male; Peptide Fragments; Rats; Rats, Zucker | 2020 |
Potential role of angiotensin-(1-7) in the improvement of vascular insulin sensitivity after a bout of exercise.
Topics: Angiotensin I; Animals; Insulin; Insulin Resistance; Male; Peptide Fragments; Rats; Rats, Wistar; Renin-Angiotensin System; Vasodilation | 2020 |
Electroacupuncture Improved Chronic Cerebral Hypoperfusion-Induced Anxiety-Like Behavior and Memory Impairments in Spontaneously Hypertensive Rats by Downregulating the ACE/Ang II/AT1R Axis and Upregulating the ACE2/Ang-(1-7)/MasR Axis.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Anxiety; Cerebrovascular Disorders; Down-Regulation; Electroacupuncture; Hippocampus; Male; Memory Disorders; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction; Up-Regulation | 2020 |
OIP5-AS1 Attenuates Microangiopathy in Diabetic Mouse by Regulating miR-200b/ACE2.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Caspase 3; Cognition; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Gene Knockdown Techniques; Hippocampus; Maze Learning; Mice; Mice, Knockout; MicroRNAs; Peptide Fragments; Peptidyl-Dipeptidase A; Platelet Endothelial Cell Adhesion Molecule-1; RNA, Long Noncoding | 2020 |
Angiotensin (1-7) and Apelin co-therapy: New strategy for heart failure treatment of rats.
Topics: Adrenergic beta-Agonists; Angiotensin I; Animals; Apelin; Cardiomegaly; Heart Failure; Hemodynamics; Isoproterenol; L-Lactate Dehydrogenase; Male; Malondialdehyde; Myocardium; Peptide Fragments; Random Allocation; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 2020 |
Angiotensin converting enzyme 2 and angiotensin (1-7) axis in pulmonary arterial hypertension.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Pulmonary Arterial Hypertension | 2020 |
Substituting Angiotensin-(1-7) to Prevent Lung Damage in SARS-CoV-2 Infection?
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Lung; Lung Injury; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Local ocular renin-angiotensin-aldosterone system: any connection with intraocular pressure? A comprehensive review.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Glaucoma; Humans; Intraocular Pressure; Peptide Fragments; Proto-Oncogene Mas; Renin-Angiotensin System; Vasodilator Agents | 2020 |
Interaction between Mas1 and AT1RA contributes to enhancement of skeletal muscle angiogenesis by angiotensin-(1-7) in Dahl salt-sensitive rats.
Topics: Angiotensin I; Animals; Electric Stimulation; Male; Mass Spectrometry; Models, Animal; Muscle, Skeletal; Mutation; Neovascularization, Physiologic; Peptide Fragments; Proteomics; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Signal Transduction | 2020 |
Central angiotensin-(1-7) attenuates systemic inflammation via activation of sympathetic signaling in endotoxemic rats.
Topics: Angiotensin I; Animals; Endotoxemia; Male; Peptide Fragments; Rats; Rats, Wistar | 2020 |
Association of circulating uric acid and angiotensin-(1-7) in relation to higher blood pressure in adolescents and the influence of preterm birth.
Topics: Adolescent; Angiotensin I; Angiotensin II; Blood Pressure; Cross-Sectional Studies; Female; Humans; Hypertension; Infant, Newborn; Peptide Fragments; Pregnancy; Premature Birth; Renin; Renin-Angiotensin System; Uric Acid | 2020 |
Diminazene aceturate extenuate the renal deleterious consequences of angiotensin-II induced by γ-irradiation through boosting ACE2 signaling cascade.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diminazene; Gamma Rays; Glutathione; Male; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Superoxide Dismutase | 2020 |
Critical Role of Neprilysin in Kidney Angiotensin Metabolism.
Topics: Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Case-Control Studies; Chymases; Enzyme Inhibitors; Female; Humans; Kidney; Male; Mice, Inbred C57BL; Middle Aged; Neprilysin; Peptide Fragments; Renal Insufficiency, Chronic; Renin-Angiotensin System | 2020 |
Exercise as medicine for COVID-19: An ACE in the hole?
Topics: Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Susceptibility; Exercise; Host Microbial Interactions; Humans; Models, Biological; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Receptors, Virus; SARS-CoV-2 | 2020 |
Angiotensin-(1-7) receptor Mas antagonist (A779) influenced gliosis and reduced synaptic density in the spinal cord after peripheral axotomy.
Topics: Angiotensin I; Angiotensin II; Animals; Astrocytes; Axotomy; Fluorescent Antibody Technique; Gliosis; Male; Mice, Inbred C57BL; Microglia; Peptide Fragments; Receptors, G-Protein-Coupled; Spinal Cord; Synapses | 2020 |
Angiotensin (1-7) through modulation of the NMDAR-nNOS-NO pathway and serotonergic metabolism exerts an anxiolytic-like effect in rats.
Topics: Angiotensin I; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Disease Models, Animal; Hippocampus; Male; Monoamine Oxidase; Nitric Oxide; Nitric Oxide Synthase Type I; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Serotonin; Signal Transduction | 2020 |
Expression of Concern to: The role of ACE2, angiotensin-(1-7) and Mas1 receptor axis in glucocorticoid-induced intrauterine growth restriction.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Fetal Growth Retardation; Glucocorticoids; Humans; Peptide Fragments; Proto-Oncogene Mas; Receptors, G-Protein-Coupled | 2020 |
Angiotensin (1-7) delivered orally via probiotic, but not subcutaneously, benefits the gut-brain axis in older rats.
Topics: Angiotensin I; Animals; Brain; Male; Peptide Fragments; Probiotics; Rats | 2020 |
The serum angiotensin-converting enzyme 2 and angiotensin-(1-7) concentrations after optimal therapy for acute decompensated heart failure with reduced ejection fraction.
Topics: Aged; Angiotensin I; Angiotensin-Converting Enzyme 2; Biomarkers; Case-Control Studies; Female; Heart Failure; Humans; Male; Middle Aged; Peptide Fragments; Recovery of Function; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left | 2020 |
Physiological cyclic stretch up-regulates angiotensin-converting enzyme 2 expression to reduce proliferation and migration of vascular smooth muscle cells.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Cell Movement; Cell Proliferation; Cells, Cultured; Enzyme Induction; Humans; JNK Mitogen-Activated Protein Kinases; Mechanotransduction, Cellular; Muscle Spindles; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; Peptide Fragments; Protein Kinase C beta; Transcription Factor AP-1 | 2020 |
Lower urinary α-Klotho is associated with lower angiotensin-(1-7) and higher blood pressure in young adults born preterm with very low birthweight.
Topics: Angiotensin I; Blood Pressure; Cesarean Section; Cross-Sectional Studies; Female; Glucuronidase; Humans; Hypertension; Infant, Newborn; Infant, Very Low Birth Weight; Klotho Proteins; Peptide Fragments; Pregnancy; Premature Birth; Prospective Studies; Young Adult | 2020 |
Protective Effect of Angiotensin 1-7 on Sarcopenia Induced by Chronic Liver Disease in Mice.
Topics: Angiotensin I; Animals; Autophagy; Biomarkers; Chronic Disease; Fibrosis; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Muscle Fibers, Skeletal; Muscle Proteins; Muscle Strength; Muscle, Skeletal; Muscular Atrophy; Peptide Fragments; Proteasome Endopeptidase Complex; Sarcopenia; SKP Cullin F-Box Protein Ligases; Tripartite Motif Proteins; Ubiquitin; Ubiquitin-Protein Ligases | 2020 |
Treatment with inhaled formulation of angiotensin-(1-7) reverses inflammation and pulmonary remodeling in a model of chronic asthma.
Topics: Administration, Inhalation; Airway Remodeling; Angiotensin I; Animals; Asthma; Biomarkers; Cytokines; Disease Models, Animal; Immunoglobulin E; Lung; Matrix Metalloproteinases; Mice; Ovalbumin; Peptide Fragments; Vasodilator Agents | 2020 |
Effect of angiotensin II and angiotensin-(1-7) on proliferation of stem cells from human dental apical papilla.
Topics: Adolescent; Angiotensin I; Angiotensin II; Cell Proliferation; Cells, Cultured; Dental Papilla; Female; Humans; Imidazoles; Male; MAP Kinase Signaling System; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphorylation; Pyridines; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Stem Cells | 2021 |
The renin-angiotensin system: An integrated view of lung disease and coagulopathy in COVID-19 and therapeutic implications.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blood Coagulation Disorders; Coronavirus Infections; COVID-19; Cytokines; Humans; Hypertension; Lung; Lung Diseases; Obesity; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptor, Angiotensin, Type 1; Severity of Illness Index | 2020 |
Apelin-potential therapy for COVID-19?
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Apelin; Apelin Receptors; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; Mice; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; SARS-CoV-2 | 2020 |
SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis.
Topics: Alveolar Epithelial Cells; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Betacoronavirus; Coronavirus Infections; COVID-19; Host Microbial Interactions; Humans; Lung; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Pulmonary Fibrosis; Receptors, Coronavirus; Receptors, Virus; Renin-Angiotensin System; SARS-CoV-2; Transforming Growth Factor beta | 2020 |
Angiotensin-Ⅱ and angiotensin-(1-7) imbalance affects comorbidity of depression and coronary heart disease.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Case-Control Studies; China; Comorbidity; Coronary Disease; Depression; Female; Gene Expression Regulation; Genotype; Humans; Linear Models; Male; Middle Aged; Peptide Fragments; Polymorphism, Single Nucleotide; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; ROC Curve; Signal Transduction; Surveys and Questionnaires | 2020 |
Angiotensin-(1-7) and Obesity: Role in Cardiorespiratory Fitness and COVID-19 Implications.
Topics: Angiotensin I; Betacoronavirus; Cardiorespiratory Fitness; Coronavirus Infections; COVID-19; Humans; Infections; Obesity; Pandemics; Peptide Fragments; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Impact of diminazene aceturate on renin-angiotensin system, infectious myocarditis and skeletal myositis in mice: An in vitro and in vivo study.
Topics: Angiotensin I; Animals; Cell Line; Chagas Cardiomyopathy; Chagas Disease; Diminazene; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred BALB C; Myocarditis; Myocytes, Cardiac; Myositis; Peptide Fragments; Rats; Renin-Angiotensin System; Trypanocidal Agents | 2020 |
Angiotensin-(1-7) Treatment Restores Pancreatic Microcirculation Profiles: A New Story in Acute Pancreatitis.
Topics: Angiotensin I; Animals; Ceruletide; Endothelium, Vascular; Lipopolysaccharides; Male; Mice, Inbred C57BL; Microcirculation; Microscopy, Electron, Transmission; Pancreas; Pancreatitis; Peptide Fragments | 2020 |
Angiotensin-(1-7) Improves Islet Function in a Rat Model of Streptozotocin- Induced Diabetes Mellitus by Up-Regulating the Expression of Pdx1/Glut2.
Topics: Angiotensin I; Animals; Diabetes Mellitus, Experimental; Glucose Transporter Type 2; Homeodomain Proteins; Insulin-Secreting Cells; Islets of Langerhans; Male; Peptide Fragments; Rats; Rats, Wistar; Streptozocin; Trans-Activators; Up-Regulation | 2021 |
ACE2 modulates glucose homeostasis through GABA signaling during metabolic stress.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cell Line; gamma-Aminobutyric Acid; Glucose; Glutamate Decarboxylase; Homeodomain Proteins; Homeostasis; Insulin-Secreting Cells; Mice; Mice, Knockout; Peptide Fragments; Signal Transduction; Trans-Activators | 2020 |
Angiotensin-(1-7) Improves Integrated Cardiometabolic Function in Aged Mice.
Topics: Aging; Angiotensin I; Animals; Antihypertensive Agents; Blood Pressure; Glucose; Hypertension; Insulin; Insulin Resistance; Male; Mice, Inbred C57BL; Peptide Fragments; Renin-Angiotensin System | 2020 |
ACE2 activator diminazene aceturate ameliorates Alzheimer's disease-like neuropathology and rescues cognitive impairment in SAMP8 mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Brain Chemistry; Cognitive Dysfunction; Cytokines; Diminazene; Infusions, Parenteral; Male; Maze Learning; Mice; Mice, Neurologic Mutants; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; tau Proteins | 2020 |
COVID-19: Critical Role of Angiotensin 1-7 in ACE2 Modulation.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Cardioprotection Generated by Aerobic Exercise Training is Not Related to the Proliferation of Cardiomyocytes and Angiotensin-(1-7) Levels in the Hearts of Rats with Supravalvar Aortic Stenosis.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Aortic Stenosis, Supravalvular; Aurora Kinase B; Cell Cycle; Cell Proliferation; Chromatography, High Pressure Liquid; Cyclin D2; Echocardiography; Exercise Test; Male; Myeloid Ecotropic Viral Integration Site 1 Protein; Myocardium; Myocytes, Cardiac; Peptide Fragments; Physical Conditioning, Animal; Rats; Rats, Wistar; Renin-Angiotensin System | 2020 |
Alteration and association between serum ACE2/ angiotensin(1-7)/Mas axis and oxidative stress in chronic kidney disease: A pilot study.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Angiotensin I; Angiotensin II; Case-Control Studies; Female; Humans; Male; Middle Aged; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Pilot Projects; Renal Insufficiency, Chronic; Renin-Angiotensin System | 2020 |
COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Anticoagulants; Cardiovascular Diseases; COVID-19; Humans; Hypertension; Models, Theoretical; Peptide Fragments; Renin-Angiotensin System; Respiration; Risk Factors; Venous Thromboembolism; Virus Internalization | 2020 |
Lung ACE2 and ADAM17 in pulmonary arterial hypertension: Implications for COVID-19?
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Pulmonary Arterial Hypertension; SARS-CoV-2 | 2020 |
COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella.
Topics: Adipokines; Angiotensin I; Angiotensin-Converting Enzyme 2; Betacoronavirus; Coronavirus Infections; COVID-19; Diabetes Mellitus, Type 2; Humans; Metabolic Syndrome; Obesity; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; SARS-CoV-2; Severe Acute Respiratory Syndrome | 2020 |
Angiotensin-converting enzyme 2 activator, DIZE in the basolateral amygdala attenuates the tachycardic response to acute stress by modulating glutamatergic tone.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Basolateral Nuclear Complex; Diminazene; Glutamic Acid; Heart Rate; Neurons; Peptide Fragments; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Tachycardia | 2020 |
Antiepileptic effects of long-term intracerebroventricular infusion of angiotensin-(1-7) in an animal model of temporal lobe epilepsy.
Topics: Angiotensin I; Animals; Anticonvulsants; Anxiety; Disease Models, Animal; Elevated Plus Maze Test; Epilepsy, Temporal Lobe; Hippocampus; Infusions, Intraventricular; Male; Motor Activity; Peptide Fragments; Photoperiod; Rats, Wistar; Weight Gain | 2020 |
Angiotensin-(1-7), Angiotensin-Converting Enzyme 2 and Mas Receptor in Rat Polycystic Ovaries.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Female; Peptide Fragments; Polycystic Ovary Syndrome; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction | 2021 |
The angiotensin-converting enzyme 2/angiotensin (1-7)/mas axis protects against pyroptosis in LPS-induced lung injury by inhibiting NLRP3 activation.
Topics: Acute Lung Injury; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; NLR Family, Pyrin Domain-Containing 3 Protein; Peptide Fragments; Pyroptosis | 2020 |
Localization of angiotensin-(1-7) and Mas receptor in the rat ovary throughout the estrous cycle.
Topics: Angiotensin I; Angiotensin II; Animals; Biomarkers; Enzyme Activation; Estrous Cycle; Female; Granulosa Cells; Immunohistochemistry; Ovarian Follicle; Ovary; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptors, G-Protein-Coupled; RNA, Messenger | 2020 |
Altered Serum Levels of Renin-Angiotensin System Markers in Migraine.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Biomarkers; Cross-Sectional Studies; Female; Humans; Male; Migraine Disorders; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Severity of Illness Index; Young Adult | 2020 |
Coronavirus disease 2019 is associated with low circulating plasma levels of angiotensin 1 and angiotensin 1,7.
Topics: Angiotensin I; COVID-19; Female; Humans; Male; Peptide Fragments | 2021 |
Ambient fine particulate matter induced the elevation of blood pressure through ACE2/Ang(1-7) pathway: The evidence from urine metabolites.
Topics: Acetylglucosaminidase; Air Pollutants; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; beta-Galactosidase; Biomarkers; Blood Pressure; Hypertension; Lipid Metabolism; Male; Metabolome; Metabolomics; Mice; Mice, Inbred C57BL; Particulate Matter; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2020 |
Different reactive species modulate the hypotensive effect triggered by angiotensins at CVLM of 2K1C hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Disease Models, Animal; Heart Rate; Hypertension, Renovascular; Male; Medulla Oblongata; Peptide Fragments; Rats; Reactive Oxygen Species; Renin-Angiotensin System; Vasoconstrictor Agents | 2020 |
Angiotensin-(1-7) prevents T3-induced cardiomyocyte hypertrophy by upregulating FOXO3/SOD1/catalase and downregulating NF-ĸB.
Topics: Angiotensin I; Animals; Antioxidants; Catalase; Down-Regulation; Forkhead Box Protein O3; Hypertrophy; Male; Models, Biological; Myocytes, Cardiac; NF-kappa B; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Rats, Transgenic; Rats, Wistar; Reactive Oxygen Species; Receptors, G-Protein-Coupled; Superoxide Dismutase-1; Triiodothyronine; Up-Regulation | 2021 |
Ameliorative effect of AT2R and ACE2 activation on ischemic renal injury associated cardiac and hepatic dysfunction.
Topics: Acute Kidney Injury; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Diminazene; Imidazoles; Ischemia; Kidney; Liver; Male; Myocardium; Oxidative Stress; Peptide Fragments; Peroxidase; Rats, Wistar; Receptor, Angiotensin, Type 2; Sulfonamides; Thiophenes | 2020 |
Upregulation of the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas receptor axis by a combination of Yinyanghuo (Herba Epimedii Brevicornus) and Cheqianzi (Semen Plantaginis) improves erectile function in spontaneously hypertensive rats.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Drug Therapy, Combination; Drugs, Chinese Herbal; Erectile Dysfunction; Humans; Male; Nitric Oxide Synthase Type I; Penile Erection; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Up-Regulation | 2020 |
N-Acetyl-Seryl-Asparyl-Lysyl-Proline regulates lung renin angiotensin system to inhibit epithelial-mesenchymal transition in silicotic mice.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cell Line; Epithelial-Mesenchymal Transition; Fibrosis; Losartan; Lung; Male; Mice, Inbred C57BL; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Silicosis | 2020 |
Angiotensinergic receptors in the medial amygdaloid nucleus differently modulate behavioral responses in the elevated plus-maze and forced swimming test in rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Behavior, Animal; Corticomedial Nuclear Complex; Imidazoles; Losartan; Male; Maze Learning; Peptide Fragments; Pyridines; Rats; Rats, Wistar; Swimming | 2021 |
Activation of angiotensin II type-2 receptor protects against cigarette smoke-induced COPD.
Topics: Airway Remodeling; Angiotensin I; Angiotensin II; Animals; Anti-Inflammatory Agents; Antioxidants; Cytokines; Disease Models, Animal; Female; Imidazoles; Inflammation Mediators; Lung; Macrophages, Alveolar; Mice, Inbred BALB C; Neutrophils; Oxidative Stress; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction; Smoke; Sulfonamides; Thiophenes; Tobacco Products | 2020 |
The beneficial effects of angiotensin-converting enzyme II (ACE2) activator in pulmonary hypertension secondary to left ventricular dysfunction.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diminazene; Disease Models, Animal; Drug Evaluation, Preclinical; Enzyme Activators; Humans; Hypertension, Pulmonary; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Ventricular Dysfunction, Left | 2020 |
Angiotensin (1-7)-attenuated vasoconstriction is associated with the Interleukin-10 signaling pathway.
Topics: Angiotensin I; Animals; Interleukin-10; Janus Kinase 1; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Phenylephrine; STAT3 Transcription Factor; Time Factors; Vasoconstriction | 2020 |
Angiotensin-(1-7), the product of ACE2 ameliorates NAFLD by acting through its receptor Mas to regulate hepatic mitochondrial function and glycolipid metabolism.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cell Line, Tumor; Down-Regulation; Glycolipids; Hep G2 Cells; Humans; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Mitochondria; Non-alcoholic Fatty Liver Disease; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Signal Transduction | 2020 |
Mica Can Alleviate TNBS-Induced Colitis in Mice by Reducing Angiotensin II and IL-17A and Increasing Angiotensin-Converting Enzyme 2, Angiotensin 1-7, and IL-10.
Topics: Aluminum Silicates; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Colitis; Eating; Enzyme-Linked Immunosorbent Assay; Interleukin-10; Interleukin-17; Male; Mice; Peptide Fragments; Trinitrobenzenesulfonic Acid | 2020 |
Differential responses of bone to angiotensin II and angiotensin(1-7): beneficial effects of ANG(1-7) on bone with exposure to high glucose.
Topics: 3T3 Cells; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Development; Glucose; Male; Mice; Osteoblasts; Osteoclasts; Osteoporosis; Peptide Fragments; Phosphorylation; Rats; Rats, Inbred SHR; RAW 264.7 Cells | 2021 |
Synthesis and Biological Evaluation of
Topics: Angiotensin I; Chemistry Techniques, Synthetic; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Humans; Imidazolines; Peptide Fragments; Peptidomimetics; Peptidyl-Dipeptidase A | 2020 |
Alamandine through MrgD receptor induces antidepressant-like effect in transgenic rats with low brain angiotensinogen.
Topics: Angiotensin I; Angiotensinogen; Animals; Antidepressive Agents; Brain; Injections, Intraventricular; Male; Nerve Tissue Proteins; Oligopeptides; Peptide Fragments; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Receptors, G-Protein-Coupled | 2021 |
Relevance of angiotensin-(1-7) and its receptor Mas in pneumonia caused by influenza virus and post-influenza pneumococcal infection.
Topics: A549 Cells; Angiotensin I; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Cytokines; Dogs; Humans; Influenza A virus; Lung; Madin Darby Canine Kidney Cells; Male; Mice, Inbred C57BL; Mice, Knockout; Neutrophils; Peptide Fragments; Peroxidase; Phagocytosis; Pneumococcal Infections; Pneumonia, Viral; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Streptococcus pneumoniae | 2021 |
LP2, the first lanthipeptide GPCR agonist in a human pharmacokinetics and safety study.
Topics: Alanine; Angiotensin I; Animals; Arthropod Proteins; Dogs; Dose-Response Relationship, Drug; Healthy Volunteers; Humans; Oligopeptides; Peptide Fragments; Peptides; Proteolysis; Rats; Receptors, G-Protein-Coupled; Sulfides | 2021 |
Uremic Apelin and Leucocytic Angiotensin-Converting Enzyme 2 in CKD Patients.
Topics: Aged; Aged, 80 and over; Angiotensin I; Angiotensin-Converting Enzyme 2; Apelin; Apelin Receptors; Cell Line; Cells, Cultured; Female; Humans; Interleukin-6; Male; MicroRNAs; Middle Aged; Monocytes; Peptide Fragments; Receptors, Angiotensin; Renal Insufficiency, Chronic; Signal Transduction; THP-1 Cells; Tumor Necrosis Factor-alpha; Uremia | 2020 |
Modeling the Molecular Impact of SARS-CoV-2 Infection on the Renin-Angiotensin System.
Topics: Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Computer Simulation; COVID-19; COVID-19 Drug Treatment; Humans; Models, Theoretical; Peptide Fragments; Renin; Renin-Angiotensin System; SARS-CoV-2; Viral Load | 2020 |
Angiotensin-(1-7) Prevents Lipopolysaccharide-Induced Autophagy via the Mas Receptor in Skeletal Muscle.
Topics: Angiotensin I; Animals; Autophagy; Cathepsin L; Cell Line; Lipopolysaccharides; Male; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Muscle, Skeletal; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, G-Protein-Coupled | 2020 |
Angiotensin-(1-7) Expressed From Lactobacillus Bacteria Protect Diabetic Retina in Mice.
Topics: Angiotensin I; Animals; Diabetes Mellitus; Lactobacillus; Mice; Peptide Fragments; Retina | 2020 |
Angiotensin-(1-7) attenuates collagen-induced arthritis via inhibiting oxidative stress in rats.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Arthritis; Cattle; Collagen; Cytokines; Male; Oxidative Stress; Peptide Fragments; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2021 |
Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1-7) and Angiotensin II in Human Plasma.
Topics: Angiotensin I; Angiotensin II; Chromatography, Agarose; COVID-19; Enzyme-Linked Immunosorbent Assay; Humans; Peptide Fragments; Radioimmunoassay; Reference Standards; Renin-Angiotensin System; SARS-CoV-2; Sensitivity and Specificity; Specimen Handling | 2021 |
Metabolism of angiotensin peptides by angiotensin converting enzyme 2 (ACE2) and analysis of the effect of excess zinc on ACE2 enzymatic activity.
Topics: Aminopeptidases; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Humans; Peptide Fragments; Peptides; Peptidyl-Dipeptidase A; Recombinant Proteins; Renin-Angiotensin System; Zinc | 2021 |
Central Administration of Angiotensin-(1-7) Improves Vasopressin Impairment and Hypotensive Response in Experimental Endotoxemia.
Topics: Angiotensin I; Animals; Endotoxemia; Gene Expression Regulation; Hypotension; Inflammation; Lactic Acid; Lipopolysaccharides; Male; Osmolar Concentration; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Wistar; Receptors, G-Protein-Coupled; Sodium; Vasopressins | 2021 |
Angiotensin-(1-7) treatment blocks lipopolysaccharide-induced organ damage, platelet dysfunction, and IL-6 and nitric oxide production in rats.
Topics: Angiotensin I; Animals; Blood Platelets; Endotoxemia; Hypotension; Interleukin-6; Lipopolysaccharides; Male; Multiple Organ Failure; Peptide Fragments; Rats; Rats, Wistar; Sepsis; Vasodilator Agents | 2021 |
ACE2 abrogates tumor resistance to VEGFR inhibitors suggesting angiotensin-(1-7) as a therapy for clear cell renal cell carcinoma.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Peptide Fragments; Peptidyl-Dipeptidase A; Protein Kinase Inhibitors; Vascular Endothelial Growth Factor A | 2021 |
Ang (1-7)/Mas receptor-axis activation promotes amyloid beta-induced altered mitochondrial bioenergetics in discrete brain regions of Alzheimer's disease-like rats.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin I; Animals; Apoptosis; Brain Chemistry; Energy Metabolism; Heme Oxygenase-1; Male; Memory; Mitochondria; Parasympathetic Nervous System; Peptide Fragments; Psychomotor Performance; Rats; Rats, Wistar | 2021 |
Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Case-Control Studies; COVID-19; Female; Humans; Male; Middle Aged; Peptide Fragments; Peptidyl-Dipeptidase A; Prospective Studies; Renin; Renin-Angiotensin System; SARS-CoV-2 | 2021 |
Mas receptor activation attenuates allergic airway inflammation via inhibiting JNK/CCL2-induced macrophage recruitment.
Topics: Acute Disease; Angiotensin I; Animals; Asthma; Chemokine CCL2; Cytokines; Imidazoles; Inflammation; Macrophage Activation; Macrophages; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Ovalbumin; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Respiratory System | 2021 |
Aldosterone and cortisol synthesis regulation by angiotensin-(1-7) and angiotensin-converting enzyme 2 in the human adrenal cortex.
Topics: Adrenal Cortex; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Cytochrome P-450 CYP11B2; Humans; Hydrocortisone; Peptide Fragments; Proto-Oncogene Mas | 2021 |
Angiotensin 1-7 protects against ventilator-induced diaphragm dysfunction.
Topics: Angiotensin I; Animals; Diaphragm; Disease Models, Animal; Female; Humans; Infusions, Intravenous; Muscle Contraction; Muscle Weakness; Muscular Disorders, Atrophic; Oxidative Stress; Peptide Fragments; Rats; Respiration, Artificial | 2021 |
Xanthenone, ACE2 activator, counteracted gentamicin-induced nephrotoxicity in rats: Impact on oxidative stress and ACE2/Ang-(1-7) signaling.
Topics: Acute Kidney Injury; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blotting, Western; Gentamicins; Interleukins; Male; Oxidative Stress; Peptide Fragments; Rats; Rats, Wistar; Signal Transduction; Xanthones | 2021 |
Longdan Xiegan Tang attenuates liver injury and hepatic insulin resistance by regulating the angiotensin-converting enzyme 2/Ang (1-7)/Mas axis-mediated anti-inflammatory pathway in rats.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Cytokines; Drugs, Chinese Herbal; Fasting; I-kappa B Kinase; Insulin Resistance; Liver; Male; NF-kappa B; Olanzapine; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled | 2021 |
Improved pharmacokinetics and bone tissue accumulation of Angiotensin-(1-7) peptide through bisphosphonate conjugation.
Topics: Angiotensin I; Animals; Biological Availability; Bone and Bones; Diphosphonates; Drug Delivery Systems; Drug Stability; Male; Peptide Fragments; Rats; Rats, Wistar; Solid-Phase Synthesis Techniques; Tissue Distribution | 2021 |
Strengthening CoViD-19 therapy via combinations of RAS modulators.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; COVID-19 Drug Treatment; Humans; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2021 |
Myocardial Angiotensin Metabolism in End-Stage Heart Failure.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Disease Progression; Female; Heart Failure; Heart Transplantation; Humans; Male; Mass Spectrometry; Middle Aged; Myocardium; Peptide Fragments; Renin-Angiotensin System; Stroke Volume | 2021 |
Chronic administration of pharmacological doses of angiotensin 1-7 and iodoangiotensin 1-7 has minimal effects on blood pressure, heart rate, and cognitive function of spontaneously hypertensive rats.
Topics: Angiotensin I; Animals; Blood Pressure; Cognition; Heart Rate; Hypertension; Iodine Radioisotopes; Male; Peptide Fragments; Protein Binding; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1 | 2021 |
Amplifying effect of chronic lisinopril therapy on diastolic function and the angiotensin-(1-7) Axis by the G1 agonist in ovariectomized spontaneously hypertensive rats.
Topics: Angiotensin I; Animals; Cyclopentanes; Diastole; Female; Lisinopril; Ovariectomy; Peptide Fragments; Quinolines; Rats; Rats, Inbred SHR; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2021 |
A Low-Sodium Diet Boosts Ang (1-7) Production and NO-cGMP Bioavailability to Reduce Edema and Enhance Survival in Experimental Heart Failure.
Topics: Angiotensin I; Animals; Biological Availability; Biomarkers; Blood Pressure; Cardiomyopathy, Dilated; Cyclic GMP; Diet, Sodium-Restricted; Edema; Heart Failure; Kidney; Male; Mice, Inbred C57BL; Natriuretic Peptide, Brain; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Phosphoric Diester Hydrolases; Pleural Effusion; Renin-Angiotensin System; Survival Analysis; Systole | 2021 |
Angiotensin (1-7) Alleviates Postresuscitation Myocardial Dysfunction by Suppressing Oxidative Stress Through the Phosphoinositide 3-Kinase, Protein Kinase B, and Endothelial Nitric Oxide Synthase Signaling Pathway.
Topics: Angiotensin I; Animals; Apoptosis; Cardiopulmonary Resuscitation; Cells, Cultured; Disease Models, Animal; Heart Arrest; Heart Diseases; Male; Myocytes, Cardiac; Nitric Oxide Synthase Type III; Oxidative Stress; Peptide Fragments; Phosphatidylinositol 3-Kinase; Proto-Oncogene Mas; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Return of Spontaneous Circulation; Signal Transduction; Ventricular Function, Left; Ventricular Pressure | 2021 |
Angiotensin (1-7) Attenuates the Nociceptive Behavior Induced by Substance P and NMDA via Spinal MAS1.
Topics: Angiotensin I; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Injections, Spinal; Male; Mice; N-Methylaspartate; Nociception; Nociceptive Pain; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Receptors, N-Methyl-D-Aspartate; Receptors, Neurokinin-1; Spinal Cord; Substance P | 2021 |
Oral administration of angiotensin-(1-7) decreases muscle damage and prevents the fibrosis in rats after eccentric exercise.
Topics: Administration, Oral; Angiotensin I; Animals; Fibrosis; Male; Muscle, Skeletal; Peptide Fragments; Physical Conditioning, Animal; Rats; Rats, Wistar | 2021 |
The role of angiotensin-(1-7) on acquired platinum resistance-induced angiogenesis in non-small cell lung cancer in vitro and in vivo.
Topics: Angiotensin I; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Peptide Fragments; Phosphatidylinositol 3-Kinases; Platinum; Vascular Endothelial Growth Factor A | 2021 |
The usefulness of angiotensin-(1-7) and des-Arg
Topics: Angiotensin I; Biomarkers; Bradykinin; Humans; Metabolic Syndrome; Peptide Fragments | 2021 |
Diminazene Aceturate Stabilizes Atherosclerotic Plaque and Attenuates Hepatic Steatosis in apoE-Knockout Mice by Influencing Macrophages Polarization and Taurine Biosynthesis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Apolipoproteins E; Atherosclerosis; Diet, High-Fat; Diminazene; Disease Models, Animal; Fatty Liver; Female; Gene Expression Regulation; Humans; Liver; Macrophage Activation; Macrophages; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Knockout, ApoE; Peptide Fragments; Plaque, Atherosclerotic; Taurine; THP-1 Cells | 2021 |
Ang(1-7) exerts Nrf2-mediated neuroprotection against amyloid beta-induced cognitive deficits in rodents.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin I; Animals; Behavior, Animal; Cognitive Dysfunction; Disease Models, Animal; Heme Oxygenase (Decyclizing); Hippocampus; Infusions, Intraventricular; Male; Maze Learning; Mitochondria; Neuroprotective Agents; NF-E2-Related Factor 2; Peptide Fragments; Rats; Rats, Wistar; Signal Transduction; Treatment Outcome | 2021 |
Angiotensin-(1-7) as a biomarker of childhood obesity: Is there a causal relationship?
Topics: Angiotensin I; Biomarkers; Child; Humans; Pediatric Obesity; Peptide Fragments | 2021 |
Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; COVID-19; Female; Gene Expression Profiling; HLA-DR Antigens; Humans; Lipopolysaccharide Receptors; Male; Middle Aged; Monocytes; Peptide Fragments; Pilot Projects; Prospective Studies; RNA, Messenger; Virus Shedding | 2021 |
Angiotensin-(1-7)/Mas receptor modulates anti-inflammatory effects of exercise training in a model of chronic allergic lung inflammation.
Topics: Angiotensin I; Animals; Asthma; Disease Models, Animal; Exercise Therapy; Male; Mice, Inbred BALB C; Peptide Fragments; Pneumonia | 2021 |
Resveratrol Confers Protection Against Ischemia/Reperfusion Injury by Increase of Angiotensin (1-7) Expression in a Rat Model of Myocardial Hypertrophy.
Topics: Angiotensin I; Animals; Disease Models, Animal; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Peptide Fragments; Proto-Oncogene Mas; Rats, Wistar; Resveratrol; Tachycardia, Ventricular; Ventricular Fibrillation | 2021 |
Angiotensin-(1-7) protects against sepsis-associated left ventricular dysfunction induced by lipopolysaccharide.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Cardiotonic Agents; Cells, Cultured; Inflammation; Lipopolysaccharides; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Nerve Tissue Proteins; Peptide Fragments; Proto-Oncogene Mas; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Sepsis; Ventricular Dysfunction, Left | 2021 |
The renal excretory responses to acute renal interstitial angiotensin (1-7) infusion in anaesthetised spontaneously hypertensive rats.
Topics: Angiotensin I; Peptide Fragments | 2021 |
Oral Angiotensin-(1-7) Peptide Modulates Intestinal Microbiota Improving Metabolic Profile in Obese Mice.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blood Glucose; Cholesterol; Computational Biology; Diet, High-Fat; Gastrointestinal Microbiome; Humans; Intestines; Lipoproteins, LDL; Male; Metabolome; Mice; Mice, Obese; Obesity; Peptide Fragments; Toll-Like Receptor 4; Triglycerides | 2021 |
Alamandine, a derivative of angiotensin-(1-7), alleviates sepsis-associated renal inflammation and apoptosis by inhibiting the PI3K/Ak and MAPK pathways.
Topics: Angiotensin I; Animals; Apoptosis; Cell Line; Dose-Response Relationship, Drug; Humans; Inflammation; Kidney; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Oligopeptides; Peptide Fragments; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Sepsis; Signal Transduction | 2021 |
Hemodynamic phenotyping of transgenic rats with ubiquitous expression of an angiotensin-(1-7)-producing fusion protein.
Topics: Angiotensin I; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Flow Velocity; Blood Pressure; Cardiovascular System; Disease Models, Animal; Genotype; Glial Fibrillary Acidic Protein; Hemodynamics; Hypertension; Male; Peptide Fragments; Phenotype; Rats, Sprague-Dawley; Rats, Transgenic; Recombinant Fusion Proteins; Regional Blood Flow; Sympathetic Nervous System; Time Factors; Vascular Resistance | 2021 |
Activation of angiotensin-converting enzyme 2/angiotensin (1-7)/mas receptor axis triggers autophagy and suppresses microglia proinflammatory polarization via forkhead box class O1 signaling.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Autophagy; Humans; Mice; Microglia; Neuroinflammatory Diseases; Peptide Fragments; Signal Transduction; Transfection | 2021 |
Ang-(1-7) protects skeletal muscle function in aged mice.
Topics: Angiotensin I; Animals; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Skeletal; Peptide Fragments | 2021 |
Scorpion bradykinin potentiating factor mitigates lung damage induced by γ-irradiation in rats: Insights on AngII/ACE/Ang(1-7) axis.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Gamma Rays; Lung; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Scorpions | 2021 |
Participation of angiotensin-(1-7) in exercise-induced analgesia in rats with neuropathic pain.
Topics: Analgesia; Angiotensin I; Animals; Hyperalgesia; Male; Neuralgia; Peptide Fragments; Physical Conditioning, Animal; Rats; Rats, Wistar | 2021 |
Neurofilament light: a possible prognostic biomarker for treatment of vascular contributions to cognitive impairment and dementia.
Topics: Angiotensin I; Animals; Biomarkers; Cognitive Dysfunction; Cytokines; Dementia, Vascular; Male; Mice; Mice, Inbred C57BL; Neurofilament Proteins; Peptide Fragments; Prognosis; Stroke Volume | 2021 |
Resistance exercise shifts the balance of renin-angiotensin system toward ACE2/Ang 1-7 axis and reduces inflammation in the kidney of diabetic rats.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Kidney; Male; Nephritis; Peptide Fragments; Rats; Rats, Wistar; Renin-Angiotensin System; Resistance Training | 2021 |
Angiotensin 1-7 prevents the excessive force loss resulting from 14- and 28-day denervation in mouse EDL and soleus muscle.
Topics: Angiotensin I; Animals; Denervation; Mice; Muscle Contraction; Muscle, Skeletal; Peptide Fragments | 2021 |
Sex differences in the lung ACE/ACE2 balance in hypertensive rats.
Topics: ADAM17 Protein; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Down-Regulation; Female; Lung; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Wistar; RNA, Messenger; Sex Characteristics | 2021 |
Oral Treatment with Angiotensin-(1-7) Attenuates the Kidney Injury Induced by Gentamicin in Wistar Rats.
Topics: Acute Kidney Injury; Administration, Oral; Angiotensin I; Animals; Drug Evaluation; Gentamicins; Male; Peptide Fragments; Rats; Rats, Wistar | 2021 |
Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries.
Topics: ADAM17 Protein; Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; COVID-19; Enzyme Activation; Female; Follow-Up Studies; Humans; Male; Middle Aged; Peptide Fragments; Prognosis; Prospective Studies; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Renin-Angiotensin System; Respiration, Artificial; Risk; SARS-CoV-2; Treatment Outcome | 2022 |
Role of Ang1-7 in renal haemodynamics and excretion in streptozotocin diabetic rats.
Topics: Acetylcholine; Angiotensin I; Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diuresis; Drinking; Kidney; Nitric Oxide; Norepinephrine; Peptide Fragments; Random Allocation; Rats; Rats, Sprague-Dawley; Sympathomimetics; Vasodilator Agents | 2022 |
Angiotensin (ang) 1-7 inhibits ang II-induced atrial fibrosis through regulating the interaction of proto-oncogene tyrosine-protein kinase Src (c-Src) and Src homology region 2 domain-containing phosphatase-1 (SHP-1)).
Topics: Angiotensin I; Angiotensin II; Animals; Fibrosis; Matrix Metalloproteinase 2; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-fyn; Rats; Rats, Sprague-Dawley; Signal Transduction; src Homology Domains; Transforming Growth Factor beta | 2021 |
Angiotensin-(1-7)/MasR axis promotes migration of monocytes/macrophages with a regulatory phenotype to perform phagocytosis and efferocytosis.
Topics: Angiotensin I; Animals; Cells, Cultured; Disease Models, Animal; Humans; Inflammation; Macrophages; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Monocytes; Peptide Fragments; Peritonitis; Phagocytosis; Phenotype; Proto-Oncogene Mas; Receptors, CCR2 | 2022 |
Combined Administration of Andrographolide and Angiotensin- (1-7) Synergically Increases the Muscle Function and Strength in Aged Mice.
Topics: Angiotensin I; Animals; Diterpenes; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Muscular Diseases; Peptide Fragments; Sarcopenia | 2022 |
Probiotic Releasing Angiotensin (1-7) in a Drosophila Model of Alzheimer's Disease Produces Sex-Specific Effects on Cognitive Function.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Angiotensin I; Animals; Brain; Cognition; Drosophila; Female; Gastrointestinal Microbiome; Humans; Male; Memory Disorders; Peptide Fragments; Probiotics; Sex Factors | 2022 |
The Effects of Angiotensin II or Angiotensin 1-7 on Rat Pial Microcirculation during Hypoperfusion and Reperfusion Injury: Role of Redox Stress.
Topics: Angiotensin I; Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Female; Male; Microcirculation; Microscopy, Fluorescence; Peptide Fragments; Pia Mater; Proto-Oncogene Mas; Rats; Reactive Oxygen Species; Reperfusion Injury; Tetrazoles | 2021 |
Angiotensin Type 2 and Mas Receptor Activation Prevents Myocardial Fibrosis and Hypertrophy through the Reduction of Inflammatory Cell Infiltration and Local Sympathetic Activity in Angiotensin II-Dependent Hypertension.
Topics: Angiotensin I; Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Fibrosis; Hypertension; Imidazoles; Injections, Intraperitoneal; Losartan; Male; Peptide Fragments; Proto-Oncogene Mas; Rats; Rats, Sprague-Dawley; Sulfonamides; Thiophenes; Tyrosine 3-Monooxygenase | 2021 |
Renin-angiotensin system blockade on angiotensin-converting enzyme 2 and TMPRSS2 in human type II pneumocytes.
Topics: Adult; Age Factors; Aged; Alveolar Epithelial Cells; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Female; Humans; Lung; Male; Middle Aged; Peptide Fragments; Renin-Angiotensin System; Retrospective Studies; Serine Endopeptidases; Smoking | 2022 |
Angiotensin-(1-7) ameliorates high glucose-induced vascular endothelial injury through suppressing chloride channel 3.
Topics: Angiotensin I; Animals; Chloride Channels; Diabetes Mellitus; Endothelium, Vascular; Glucose; Mice; Peptide Fragments | 2022 |
Angiotensin-(1-7) improves diabetes mellitus-induced erectile dysfunction in rats by regulating nitric oxide synthase levels.
Topics: Angiotensin I; Animals; Calcium; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Erectile Dysfunction; Humans; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Peptide Fragments; Proto-Oncogene Proteins c-akt; Rats | 2022 |
Angiotensin-(1-7), a protective peptide against vascular aging.
Topics: Aged; Aging; Angiotensin I; Angiotensin II; Frailty; Humans; Peptide Fragments; Renin-Angiotensin System | 2022 |
Angiotensin (1-7) peptide replacement therapy with plasma transfusion in COVID-19.
Topics: Adult; Aged, 80 and over; Angiotensin I; Blood Component Transfusion; COVID-19; Critical Illness; Female; Humans; Male; Oxygen; Peptide Fragments; Plasma; SARS-CoV-2; Treatment Outcome | 2022 |
Exercise training improves cardiovascular control in sinoaortic denervated SHR by reducing the elevated angiotensin II and augmenting angiotensin-(1-7) availability within autonomic and neuroendocrine PVN nuclei.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Hypertension; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Rats; Rats, Inbred SHR | 2022 |
Treatment with Angiotensin-(1-7) Prevents Development of Oral Papilloma Induced in K-ras Transgenic Mice.
Topics: Angiotensin I; Animals; Carcinoma, Squamous Cell; Mice; Mice, Transgenic; Mouth Neoplasms; Papilloma; Papillomavirus Infections; Peptide Fragments; Phosphatidylinositol 3-Kinases; Tamoxifen | 2022 |
Angiotensin(1-7) Improves Islet Function in Diabetes Through Reducing JNK/Caspase-3 Signaling.
Topics: Angiotensin I; Animals; Apoptosis; Blood Glucose; Caspase 3; Diabetes Mellitus, Experimental; Insulin; Male; Peptide Fragments; Rats; Rats, Wistar | 2022 |
Angiotensin-(1-7) promotes mitochondrial translocation of human telomerase reverse transcriptase in HUVECs through the TOM20 complex.
Topics: Angiotensin I; Angiotensin II; Human Umbilical Vein Endothelial Cells; Humans; Lipopolysaccharides; Mitochondrial Precursor Protein Import Complex Proteins; Mitochondrial Proteins; Peptide Fragments; Telomerase | 2022 |
An advanced endothelial murine HFpEF model: eNOS is critical for angiotensin 1-7 rescue of the diabetic phenotype.
Topics: Angiotensin I; Animals; Diabetes Mellitus; Endothelium, Vascular; Heart Failure; Mice; Nitric Oxide Synthase Type III; Peptide Fragments; Phenotype; Stroke Volume | 2022 |
Angiotensin (1-7) protects against renal ischemia-reperfusion injury via regulating expression of NRF2 and microRNAs in Fisher 344 rats.
Topics: Acute Kidney Injury; Angiotensin I; Animals; Antioxidants; Ischemia; Kidney; Male; MicroRNAs; NF-E2-Related Factor 2; Peptide Fragments; Rats; Reperfusion Injury | 2022 |
Angiotensin-Converting Enzyme 2 Activation Mitigates Behavioral Deficits and Neuroinflammatory Burden in 6-OHDA Induced Experimental Models of Parkinson's Disease.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Diminazene; Mice; Models, Theoretical; Oxidopamine; Parkinson Disease; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Rats; Receptors, G-Protein-Coupled; Signal Transduction | 2022 |
Angiotensin 1-7 mitigates rhabdomyolysis induced renal injury in rats via modulation of TLR-4/NF-kB/iNOS and Nrf-2/heme‑oxygenase-1 signaling pathways.
Topics: Angiotensin I; Angiotensin II; Animals; Heme; Kidney; Male; NF-kappa B; Nitric Oxide Synthase Type II; Peptide Fragments; Rats; Receptors, G-Protein-Coupled; Rhabdomyolysis; Signal Transduction; Toll-Like Receptor 4 | 2022 |
Angiotensin 1-7 Stimulates Proliferation of Lung Bronchoalveolar Progenitors-Implications for SARS-CoV-2 Infection.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cell Proliferation; COVID-19; Inflammasomes; Lung; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Respiratory Distress Syndrome; SARS-CoV-2 | 2022 |
Renin-Angiotensin System in Huntington's Disease: Evidence from Animal Models and Human Patients.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Disease Models, Animal; Humans; Huntington Disease; Mice; Peptide Fragments; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2022 |
Improved lipogenesis gene expression in liver is associated with elevated plasma angiotensin 1-7 after AT1 receptor blockade in insulin-resistant OLETF rats.
Topics: Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Type 2; Fatty Liver; Gene Expression; Glucose; Insulin; Lipogenesis; Liver; Metabolic Syndrome; Obesity; Peptide Fragments; Rats; Rats, Inbred OLETF; Receptor, Angiotensin, Type 1 | 2022 |
Unveiling the G4-PAMAM capacity to bind and protect Ang-(1-7) bioactive peptide by molecular dynamics simulations.
Topics: Amino Acids; Angiotensin I; COVID-19; Dendrimers; Humans; Molecular Dynamics Simulation; Peptide Fragments; Peptides | 2022 |
Angiotensin 1-7 and its analogue decrease blood pressure but aggravate renal damage in preeclamptic mice.
Topics: Angiotensin I; Animals; Blood Pressure; Female; Guinea Pigs; Humans; Mice; Pre-Eclampsia; Pregnancy; Receptor, Angiotensin, Type 1 | 2022 |
Add-On Cyclic Angiotensin-(1-7) with Cyclophosphamide Arrests Progressive Kidney Disease in Rats with ANCA Associated Glomerulonephritis.
Topics: Angiotensin I; Animals; Antibodies, Antineutrophil Cytoplasmic; Cyclophosphamide; Glomerulonephritis; Peptide Fragments; Proteinuria; Rats; Rats, Inbred WKY | 2022 |
Angiotensin (1-7) Delivered Orally via Probiotic in Combination With Exercise: Sex-Dependent Influence on Health Span.
Topics: Angiotensin I; Angiotensin II; Animals; Female; Peptide Fragments; Quality of Life; Rats; Renin-Angiotensin System | 2023 |
Activation of Angiotensin-converting Enzyme 2 Protects Against Lipopolysaccharide-induced Glial Activation by Modulating Angiotensin-converting Enzyme 2/Angiotensin (1-7)/Mas Receptor Axis.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Anti-Inflammatory Agents; Lipopolysaccharides; Male; Neuroglia; Neuroinflammatory Diseases; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled | 2023 |
Peptide inhibitors of angiotensin-I converting enzyme based on angiotensin (1-7) with selectivity for the C-terminal domain.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Humans; Peptides; Peptidyl-Dipeptidase A | 2022 |
Attenuation of Smooth Muscle Cell Phenotypic Switching by Angiotensin 1-7 Protects against Thoracic Aortic Aneurysm.
Topics: Angiotensin I; Angiotensin II; Animals; Aortic Aneurysm, Thoracic; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Myocytes, Smooth Muscle; Phenotype | 2022 |
Angiotensin-(1-7) can promote cell migration and tumor growth of clear cell renal cell carcinoma.
Topics: Angiotensin I; Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Humans; Kidney Neoplasms; Mice; Mice, Nude; Peptide Fragments; Proto-Oncogene Mas | 2022 |
Restoration of the gut barrier integrity and restructuring of the gut microbiome in aging by angiotensin-(1-7).
Topics: Aging; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Claudin-1; Dysbiosis; Gastrointestinal Microbiome; Male; Mice; Occludin; Peptide Fragments; Peptidyl-Dipeptidase A | 2023 |
Effects of Angiotensin 1-7 and Mas Receptor Agonist on Renal System in a Rat Model of Heart Failure.
Topics: Angiotensin I; Angiotensin II; Animals; Cardiomegaly; Heart Failure; Kidney; Peptide Fragments; Rats; Renin-Angiotensin System | 2023 |
Atomistic Molecular Insights into Angiotensin-(1-7) Interpeptide Interactions.
Topics: Amino Acids; Angiotensin I; Cluster Analysis; Peptide Fragments; Sodium Chloride | 2023 |